PREDICATE,SUBJECT_NAME,OBJECT_NAME,cause_category,factuality_score,Factuality_Score
AFFECTS,Estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
PREDISPOSES,FGFR2 gene|FGFR2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,BRCA1 gene|BRCA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,NDUFB3|TNFAIP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RAD51,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Topotecan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ACSL4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MicroRNAs,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Body mass index,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Metabolites,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,anthracene,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"oxoguanine glycosylase 1, human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Malignant Neoplasms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Topoisomerase,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Methylcholanthrene,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Cadmium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,C-reactive protein level,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cell Proliferation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carcinoma of the Large Intestine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Phytoestrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AUGMENTS,Estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
PREDISPOSES,Single Nucleotide Polymorphism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CD44 gene|CD44,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cell Cycle Progression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Vitamin D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptor Status,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MTRR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MTA2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Growth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pregnancy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,DYRK2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Velcade,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carcinogens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hormone replacement therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Insulin-Like-Growth Factor I Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,lycopene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SMURF1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Metabolic Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"DNA, Mitochondrial",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,polyphenols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Obesity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Etodolac,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MST1R gene|MST1R,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Lactation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Interleukin-6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Well in self,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Human Papillomavirus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,1-Phosphatidylinositol 3-Kinase,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AFFECTS,Androgens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TARBP2,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Tobacco smoke,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Annexin A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RAD51,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,BCL9 gene|BCL9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,GATA3,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,CHEK2 gene|CHEK2,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,beta-cryptoxanthin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,response,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Physical activity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Signal Pathways,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TARBP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SELENOP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,polyphenols,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Weight Gain,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,pleiotropism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Enhancer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AFFECTS,GATA3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prognostic Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Monocyte Chemoattractant Protein-1|CCL2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Complication,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,kahweol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,INPP5J,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,heparanase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fitness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Progestins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PTGS2 gene|PTGS2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Nitrogen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GLTSCR2 gene|NOP53,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Polymorphism, Genetic",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Malignant Neoplasms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
PREDISPOSES,Ethanol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ERBB2 gene|ERBB2,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
CAUSES,TP53 gene|TP53,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Endocrine therapy,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,BRCA2 gene|BRCA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Base Excision Repair,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Tumor Suppressor Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Angiogenesis Inhibitors,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Adiponectin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CENPN,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Reproductive History,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Menopausal Status,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,KISS1R,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ABCB1 gene|ABCB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Regular exercise,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Antisense RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Progesterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ZNF410,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Diabetes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Total cholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nuts,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Therapeutic procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CHEK2 gene|CHEK2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Estrogen Receptor alpha,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Psychosocial problem,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Red meat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lesion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Single Nucleotide Polymorphism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Hypothalamic inhibiting factor,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,DNM1 gene|DNM1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,Heterocyclic Amines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cyclin E,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Primigravida,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BRCA1 gene|BRCA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Phosphotransferases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Stromal Cell-Derived Factor 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pharmacotherapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Enzymes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitamin D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
DISRUPTS,Isoflavones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Taxotere,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ERBB2 gene|ERBB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,S100A7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Calcium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,BRCA2 gene|BRCA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Antioxidants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,educational intervention,Malignant neoplasm of breast,Educational Factors,0.0,0.3386613386613387
CAUSES,anthracene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Receptors, Opioid, delta",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Amino Acyl-tRNA Synthetases|TRNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Antibodies,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,AKR1C3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PGR gene|PGR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Radial scar,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,methyl 4-azidophenylacetimidate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Methionine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Catechol O-Methyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TLR3 gene|TLR3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Vascular Endothelial Growth Factor Receptor-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,dihydroxyacetone sulfate,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Estradiol,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Tamoxifen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Apoptosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Taxanes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,fulvestrant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,BSG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Thromboembolic event,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CXCR4 gene|CXCR4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,"Alpha-MMC protein, Momordica charantia",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Ovarian Serous Adenocarcinoma,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,EGFR gene|EGFR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Neoplasm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Aryl Hydrocarbon Receptor|AHR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,HRH4 gene|HRH4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,6-sulfatoxymelatonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Methylnitrosourea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carrier of disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Fatty Acids, Omega-6",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Not significant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Citrate,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,RASAL2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Genistein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Estrogens, Synthetic",Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
CAUSES,"9,10-Dimethyl-1,2-benzanthracene",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDKN1A gene|CDKN1A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Bilateral salpingectomy with oophorectomy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Arginine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Drug resistance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Wine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Menopause,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alcohol consumption,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Endocrine therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Meat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Smoking,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,sulfuretin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Proto-Oncogenes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gene Expression,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,FGF10 gene|FGF10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Methyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,HSF1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Iodine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Genes,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Protein Expression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Polyunsaturated Fatty Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Clusterin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cytokine Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PRKACA gene|PRKACA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Dietary Fats,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Eosinophilia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin Resistance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Proto-Oncogenes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,MAD2L2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Drugs, Investigational",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Urokinase,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Neoplasm Metastasis,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,gamma-tocotrienol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TERT gene|TERT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,EGFR gene|EGFR,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Oxidative Stress,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Solvents,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,palm oil,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CHEK2 gene|CHEK2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Tongue feature,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Blueberries,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,ITK gene|ITK,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,inhibitors,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Insulin-Like Growth Factor I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,protein tyrosine phosphatase 1B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Triclosan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Threonine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptor alpha,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Medical History,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Progestins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CLOCK gene|CLOCK,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Insulin-Like Growth Factor Binding Protein 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CA-15-3 Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MicroRNAs,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Genomic Stability,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Methylation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MicroRNAs,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ERBB2 gene|ERBB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Doxorubicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,bevacizumab,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prior Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Medical Imaging,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ATM Gene Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,inner centromere protein|INCENP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIRN132 gene|MIR132,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,Tumorigenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Xenograft procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ginkgo biloba extract,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCNB1 gene|CCNB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,chemokine receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Therapeutic procedure,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Germ-Line Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Vimentin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MTR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Carotenoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Adverse reactions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Oxidoreductase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Baclofen,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Diphosphonates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Folate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ORALIT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sex Hormone-Binding Globulin,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Testosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,c-myc Genes|MYC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Carotenoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,alpha-carotene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"9,10-Dimethyl-1,2-benzanthracene",Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Treatment Protocols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,DHX9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cigarette Smoking,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,stromelysin 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Worried,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BARD1 gene|BARD1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Raloxifene Hydrochloride,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,ERBB3 gene|ERBB3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Somatic mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,ANO1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diet,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Operative Surgical Procedures,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Pharmaceutical Preparations,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Klinefelter's Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Translation, Genetic",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,alpha Tocopherol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Estrogens,Breast Carcinoma,Hormonal Factors,0.0,0.027972027972027972
PREDISPOSES,Carrier status,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Doxorubicin,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 3,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,distilled alcoholic beverage,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Flap Endonuclease-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Contraceptives, Oral",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Whole milk,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PARITY,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lymph Node Involvement,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Body Weight Changes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,osteopontin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Progestins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Interleukin-4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cessation of life,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"Ether, Ethyl",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,humoral defense mechanism (sensu Vertebrata),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TP53 gene|TP53,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,gonadotropin inhibitor,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Adverse effects,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Androgens,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,BRCA2 gene|BRCA2,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,High fat diet NOS,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Polychlorinated Biphenyls,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,protein kinase C eta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Steroid hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Conflict (Psychology),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYR61,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,anastrozole,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Dietary Modification,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Childbirth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prostate-Specific Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Previous pregnancies 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Infertility,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Proanthocyanidins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Chemotherapy-Oncologic Procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Systemic Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Folate,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Atypical lobular hyperplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BCHE|SNORA73A|ENOPH1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Tumor Angiogenesis,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Malignant Neoplasms,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,Cyclooxygenase 2 Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Melatonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Progesterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Diet,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Tumor Markers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,inhibitors,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Estrogen Antagonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Norplant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Chemicals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cholecalciferol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Menopausal symptom,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Matrix Metalloproteinases,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,E-Cadherin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,"Herpesvirus 4, Human",Malignant neoplasm of breast,Herpetic Genetic Factors,0.0,0.3386613386613387
AFFECTS,Gene-Environment Interaction,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Galectin 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Vitamin D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aromatase Inhibitors,Malignant neoplasm of breast,Treatments,0.0,0.3386613386613387
PREDISPOSES,Hyperinsulinism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estradiol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,DNA Adducts,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Ethylnitrosourea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Beverages,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,BRCA1 gene|BRCA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Axillary Lymph Node Dissection,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BRCA1 Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Meat intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Free estradiol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Operative Surgical Procedures,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Mammary Tumor Virus, Mouse",Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,BRCA1 gene|BRCA1,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
CAUSES,Cytomegalovirus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Linoleic Acid,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,DNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,KAT6A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Vegetables,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fibroblast Growth Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breast Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitamin A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Carcinogens, Environmental",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Genistein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Methylnitrosourea,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Tamoxifen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Smoker,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Deficiency of testosterone biosynthesis,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
CAUSES,SV40 T Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Hydroxyestrones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Food,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Dietary Fiber,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
CAUSES,Diet,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
CAUSES,Carcinogens,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Androgens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Pesticides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mastectomy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,dehydroepiandrosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Paclitaxel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Oils,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen excess,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,"9,10-Dimethyl-1,2-benzanthracene",Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Dactinomycin,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Aromatase Inhibitors,Breast cancer metastatic,Treatments,0.0,0.027972027972027972
AFFECTS,Early Diagnosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Polycyclic Hydrocarbons, Aromatic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitamin C intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Combined Oral Contraceptives,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Proto-Oncogenes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TFF1 gene|TFF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Radiation therapy,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Breast cancer recurrent,Malignant neoplasm of breast,Other,0.0174,0.3386613386613387
CAUSES,Serum,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,v-Ha-ras Oncogenes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Dietary Fats,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
CAUSES,"Genes, Dominant",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Dysplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Growth Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dehydroepiandrosterone Sulfate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tetradecanoylphorbol Acetate,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Nuclear Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PREDICTED,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,methylurea,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Birth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breast Fibrocystic Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ras Oncogene,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,Estrogen Antagonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Fibronectins,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Egg Food Product,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Melatonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Tenascin,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Cholestyramine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Agent,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
DISRUPTS,Progestins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Ovulatory,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,4'-deoxydoxorubicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Imidazole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,paracrine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Fats, Unsaturated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Somatomedins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Early menarche,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Triceps skin fold thickness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplasm,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Genes,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
CAUSES,c-myc Genes|MYC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cancer-Predisposing Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Pregnancy,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Thyroid Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CATHEPSIN D|CTSD,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fusion procedure,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,"Contraceptives, Oral",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,PNMA3,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Hormone replacement therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,body mass,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cytotoxic Chemotherapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gene Amplification,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Radiation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Histopathology,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fluoroscopy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breast Diseases,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Cystic Fibrosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Gonadotropin-Releasing Hormone Analog,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,"Genes, Suppressor",Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Therapeutic procedure,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Fatty Acids,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Alkaline Phosphatase,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Cholera Toxin,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Propionate,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Contraceptive Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,alpha-latrotoxin receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Acute leukemia,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Methoxamine,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
CAUSES,diphenyl,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,leukemia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Relaxin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,DNA,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Transforming Growth Factor beta,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Fucose,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"Receptors, Progesterone",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Glycol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,soy protein isolate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Peptide Nucleic Acids,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"Chemotherapy, Adjuvant","Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,adjuvant therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,estrophilin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,BRCA1 gene|BRCA1,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
AFFECTS,Combination Chemotherapy,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"Breast Fibrocystic Change, Proliferative Type",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,G-Actin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Theophylline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Androgens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cisplatin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Digitoxin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Cyclin D1|LMOD1|BBS9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Tamoxifen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aggressive behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Infection,Malignant neoplasm of breast,Herpetic Genetic Factors,0.0,0.3386613386613387
AFFECTS,"TGFB1 protein, human|TGFB1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cancer-Predisposing Gene,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
AFFECTS,Screening mammography,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Schistosomiasis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Gonadorelin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Chemotherapy, Adjuvant",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cell Communication,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prolactin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Familial cancer of breast,Sporadic Breast Carcinoma,Other,0.0185,0.0
AUGMENTS,Ethanol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estradiol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,C-Peptide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Polychlorinated Biphenyls,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,Dietary fat intake,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Breast Carcinoma,Malignant neoplasm of breast,Other,0.0166,0.3386613386613387
PREDISPOSES,Tamoxifen,Contralateral breast cancer,Other,0.0,0.001998001998001998
AFFECTS,Retinoblastoma Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Brain hemorrhage,"Carcinoma, Ductal, Breast",Demographic Factors,0.0,0.002997002997002997
AFFECTS,Ethanol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alleles,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Mammography,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"(meso-1,2-bis-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum(II)",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Lymphocyte Specific Protein Tyrosine Kinase p56(lck)|LCK,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CYP17A1 gene|CYP17A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Long menstrual cycle,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Viral Oncogene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Lymphocyte Specific Protein Tyrosine Kinase p56(lck)|LCK,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Hereditary Malignant Neoplasm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Testosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tobacco,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Receptors, Nuclear",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,beta catenin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,Carcinogens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,vitamin analog,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Tumor Suppressor Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,celecoxib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,COMT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Retinoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Beer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hereditary Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Prostaglandins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,stearic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,steroid hormone receptor,Sporadic Breast Carcinoma,Other,0.0,0.0
AUGMENTS,CUL4A gene|CUL4A,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
CAUSES,Antioxidants,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,CAMP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mutation,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
CAUSES,Dietary Fats,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Polyamines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estrogen Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Silicones,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Glycosylated hemoglobin A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Agent,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,NCOA3 gene|NCOA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,MYC gene|MYC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Ovarian Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ATM gene|ATM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Ethylene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Antigens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"TACSTD1 protein, human|EPCAM",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Hydrocarbons, Chlorinated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Mammary Tumor Virus, Mouse",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Signal Transduction Pathways,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,maspin|SERPINB5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AFP gene|AFP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Growth Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Psychological adjustment,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,diagnostic procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FHIT gene|FHIT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Merozoite Surface Protein 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,APC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Micronutrients,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hexachlorobenzene,Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,Growth Factor,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,High weight,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,17-Ketosteroids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"PTPN6 protein, human|PTPN6",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Epidermal Growth Factor|EGF,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Contraceptives, Oral",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Microsatellite Instability,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GSTT1 gene|GSTT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Raloxifene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,impression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mismatch Repair,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Urokinase Plasminogen Activator Receptor|PLAU|PRAP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Transforming Growth Factor beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,hydroxytamoxifen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogens,Carcinoma of Male Breast,Hormonal Factors,0.0,0.004995004995004995
DISRUPTS,Venoms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pre-Eclampsia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Fatty Acids, Essential",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Progestins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Prolactin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Somatotropin-Releasing Hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Oncogenes,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Curative Surgery,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,methylurea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Dietary intake,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Oestrogen deficiency,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Thromboembolism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Genistein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,beta catenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dieldrin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,leukemia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Butyric Acid,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,fascin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Retinoblastoma Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Polychlorinated Biphenyls,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,Sausage,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,cofactor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Apoptosis Inhibiting Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Li-Fraumeni Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dichlorodiphenyl Dichloroethylene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Phytic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Intrinsic factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aryl Hydrocarbon Receptor|AHR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GGCT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,anastrozole,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,DNA Sequence,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Conjugated Equine Estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AUGMENTS,Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,EGFR gene|EGFR,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
CAUSES,Amines,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,"Etiology, operative procedure, as cause of",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,estrone sulfatase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Beer intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,trilostane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Protein Kinase C,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nutrients,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Tamoxifen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Glucose,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Vitamins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Epithelial Cell Proliferation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Development of the breasts,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Transgenes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Breast Feeding,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,B-pyridine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mastodynia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PGR gene|PGR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,GSTM1 gene|GSTM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,NFKB1,Sporadic Breast Carcinoma,Other,0.0,0.0
DISRUPTS,Vitamin A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,AROMATICS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin-Like Growth Factor I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Symptoms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KLK14,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tocopherols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TP53 gene|TP53,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Permeability,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Phytoestrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AUGMENTS,ATP7B,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Tamoxifen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,GGCT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TSG101 gene|TSG101,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
CAUSES,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Aromatase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tryptophan|TYRP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Mastitis, associated with childbirth",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,trastuzumab,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SLC19A3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Nutrients,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Primary carcinoma of the liver cells,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Bone Density,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Cellular Retinol Binding Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Down-Regulation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CYR61,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Raloxifene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LMO4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Oncogenes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Peptidyl-Dipeptidase A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Immunologic Adjuvants,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
PREDISPOSES,Body Fat Distribution,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SNAI3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diphosphonates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CYP19A1 gene|CYP19A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Thyroid Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Mammary Neoplasms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Spontaneous abortion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Mutation, Missense",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Soybean Oil,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Abortion, Induced",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Epidermal Growth Factor|EGF,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Oestrogen increased,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cyclooxygenase 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NCOA3 gene|NCOA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PPIG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Contraceptives, Oral",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Polychlorinated Biphenyls,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"Fatty Acids, Omega-3",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Somatomedins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Adhesions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,11q13,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Unspecified Abortion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DNA Damage,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
DISRUPTS,Raloxifene,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Tumor Promoters,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Somatomedins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Noninfiltrating Intraductal Carcinoma,Malignant neoplasm of breast,Other,0.0692,0.3386613386613387
PREDISPOSES,Vegetables,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Chronic Stress,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PIN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Docosahexaenoic Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Enzymes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,maspin|SERPINB5,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,cyclooxygenase 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,protein kinase inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Nuclear Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Leptin|LEP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aneuploidy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breast Microcalcification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Progestogen hormone therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ERBB2|NEU1|NEURL1,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Epidermal growth factor receptor inhibitor,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Kininogenase|KLK4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Oligonucleotides, Antisense",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Infiltrating duct carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BONE MASS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BIRTHPLACE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Skin problem,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mammographic breast density,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Mutation, Nonsense",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Metals, Heavy",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Single Nucleotide Polymorphism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Dietary Fats,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,mammary gland development,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,19p13.3,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Leucine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Magnetic Resonance Imaging,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,EMSY,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Insulin-Like Growth Factor II,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Folate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Diethylstilbestrol,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AUGMENTS,MCM2 gene|MCM2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ESTROGEN USE,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Normal growth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitamin D3 Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Environmental Pollutants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,genotoxicity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,stressor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,connexin 26,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DDT (Insecticide),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Stromal Cell-Derived Factor 1|CXCL12,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,STK6 gene|AURKA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Vitamin E,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Soy Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Somatomedins,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Urokinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pollutant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Transcriptional Activation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gelatinase B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Thromboembolic event,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Testosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Encounter due to Screening for malignant neoplasm of breast,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SPRY2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LAG3 gene|LAG3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Estrogenic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,protective factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Signal Transduction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Estrogen Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Raloxifene,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,cyclooxygenase 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Oxidative Stress,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AUGMENTS,Pharmaceutical Preparations,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lipoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Transforming Growth Factor beta|TGFB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prenatal Exposure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Polycyclic Hydrocarbons, Aromatic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Diastolic blood pressure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Neoplasm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Short menstrual cycle,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CA9 gene|CA9,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
DISRUPTS,Estrogen Receptor alpha,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cytotoxin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Osteoporosis,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Dietary Carbohydrates,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AUGMENTS,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen Receptor alpha|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CXCR4 gene|CXCR4,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Cruciferous Vegetable,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Coffee,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Encounter due to genetic counseling,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Estrogens,Breast Carcinoma,Hormonal Factors,0.0,0.027972027972027972
PREDISPOSES,Calcium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PGR gene|PGR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Fruit,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Progestational Hormones, Synthetic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,isoflavonoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SLC25A18,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Juice,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Focal Adhesion Protein-Tyrosine Kinases,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,"Hemoglobin, Glycosylated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Granulocyte Colony-Stimulating Factor,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Estrogenic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Phytoestrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AFFECTS,Meat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Isoleucine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Metabolic Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Carotenoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fat tissue increased,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Contraceptive Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,indole-3-carbinol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Isoflavones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cyclin D1|LMOD1|BBS9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Abruptio Placentae,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Hydrocarbons, Chlorinated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SULT gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Fruit,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vegetable intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ERBB2 gene|ERBB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,PTGS2 gene|PTGS2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Human papillomavirus 16,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,MET gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cholesterol levels raised,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Postmenopause,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,caveolin 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CHEK2 gene|CHEK2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Androgen Receptor|AR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Melatonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Female Breast Carcinoma,Carcinoma of Male Breast,Other,0.0174,0.004995004995004995
PREDISPOSES,Lobular hyperplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Prolactin|PRL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Dietary restriction NOS,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
CAUSES,Polycyclic Hydrocarbons,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Li-Fraumeni Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen receptor positive tumor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Iron intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Hyperparathyroidism, Primary",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,migration stimulating factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Magnetic field,Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,Chemicals,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Obesity,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
CAUSES,sulforafan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ERCC2 gene|ERCC2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Monoclonal Antibody Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Arachidonic Acid,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Hyposensitivity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Polycyclic Hydrocarbons, Aromatic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,decaffeinated coffee,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,mammaglobin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,ADAM12,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Integrin beta3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,apolipoprotein D|APOD,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Motility,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,CDV3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"progesterone, micronized",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SR-2508,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Quercetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PBRM1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CISH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,rho GTP-Binding Proteins,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,NCOA3 gene|NCOA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Adiponectin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RETN gene|RETN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
COMPLICATES,Adverse effects,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,caspase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Soy Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cancer Promoting Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,HIC1 gene|HIC1,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
CAUSES,hemagglutinin I,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,cytokine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Menopause, Premature",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Oestrogen therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Receptor Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Fusion Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Molecular Fingerprint of Tumor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Impaired cognition,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,APOA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Prolactin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Disease,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Combined Modality Therapy,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,ATM gene|ATM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Transcription Repressor/Corepressor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,beta-adrenergic receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nicotinamide adenine dinucleotide (NAD),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SLC45A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ERBB2|NEU1|NEURL1,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,ETS1 gene|ETS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Exercise,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,S-Phase Fraction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,HSF1 gene|HSF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Biguanides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KLLN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MLLT11,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Drink,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,DNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Indigotindisulfonate Sodium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Catechin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Garlic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"TNF protein, human|TNF",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Acids,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,WISP3 gene|WISP3,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AUGMENTS,Estrogen Receptor alpha,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen Receptor alpha,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Neoplasm Metastasis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Xeroderma pigmentosum, group C",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Steroids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LAMR1 gene|RPSA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,osteosarcoma,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,TWIST1 gene|TWIST1,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
AFFECTS,Ultrasonography,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Androgen therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,erlotinib,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Sentinel Lymph Node Mapping,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RAD50,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sedentary,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BLCAP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CpG Islands,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,14q31,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"RNA, Untranslated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"RBL2 protein, human|RBL2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Oncogene ErbB2|ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,"2,5-dichloro-4-bromophenol",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SHFM1 gene|SEM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,DUSP4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,participation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DNA Repair Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Processed meat intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Receptors, Progesterone",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Interleukin-6,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Breast tenderness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MicroRNAs,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,stress-activated protein kinase 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MTHFR gene|MTHFR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Pharmaceutical Preparations,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cardiovascular Diseases,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,gemcitabine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Screening mammography,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Isoflavones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pumpkin seeds,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Phytochemical,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,trastuzumab,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fruit intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Aromatase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Angiogenesis Inhibitors,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Decreased translucency,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,atorvastatin,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Phosphoglycerate dehydrogenase|PHGDH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor Suppressor Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Collagen,Breast Carcinoma,Demographic Factors,0.0,0.027972027972027972
AFFECTS,1-Phosphatidylinositol 3-Kinase,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
PREDISPOSES,Topoisomerase Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nitrate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Angiopoietin-2|ANG,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Neoplasm progression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,receptor,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Mucins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Folate intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Phosphotransferases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Contraceptive Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,Flavonoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Animal Feed,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BRD7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Body mass index,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Atypical hyperplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Quercetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Virus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Obesity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BRIP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Epidermal Growth Factor|EGF,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Point Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Lesion,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Hypoxia,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,ERBB2|NEU1|NEURL1,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,MicroRNAs,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,Vitamins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carcinogenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,FOXP3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Serine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,lycopene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pathogenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SRSF1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Nuclear Receptor Subfamily 4, Group A, Member 1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Leptin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Angiogenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Antibodies, Anti-Idiotypic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,paclitaxel liposome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitamin D intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alleles,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,AXL gene|AXL,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,JTB gene|JTB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Interferon Alpha, Human|IFNA1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitamin intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,toxicant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Insulin, Long-Acting",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Prolactin|PRL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Radiotherapy, Adjuvant",Contralateral breast cancer,Other,0.0,0.001998001998001998
DISRUPTS,Taxol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,SPDEF,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,S100A4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,equol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,VEGFA,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,BRIP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Soy Foods,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BEX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,HIF1A gene|HIF1A,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,Metabolic syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BRCA2 gene|BRCA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Transcription, Genetic",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Atypical antipsychotic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Visual Accommodation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cancer prevention,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hormone Receptor,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,CISH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Placental Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,METHYLATE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,GPER1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ERBB2 gene|ERBB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,congener,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Xanthine Dehydrogenase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,progesterone analog,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Single Nucleotide Polymorphism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Epidermal Growth Factor Receptor|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CASP8 gene|CASP8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,NCOA3|ANIB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Xenograft Model,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Progestins,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Estrogen Receptor beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Glutathione S-Transferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BHMT gene|BHMT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CXCL12 gene|CXCL12,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Therapeutic procedure,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,response,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Phytochemical,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DNA Adducts,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RASSF1A,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,Thyrotropin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PTEN gene|PTEN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Candidate Disease Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,HDAC9,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,ESTROGEN USE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mutation,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
AFFECTS,Gelatinase A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cyclooxygenase 2 Inhibitors,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Tumorigenicity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ITGA11,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Small Nucleolar RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TOX3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Physically active,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Niacinamide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Protein p53|TP53,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DNA Repair Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,epigallocatechin gallate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Paravertebral anesthesia,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Matrix Metalloproteinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,gene polymorphism,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Psychotherapy, Multiple",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MicroRNAs,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,TP53 gene|TP53,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,Body Weight decreased,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hypertensive disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Collagen,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Malignant Bone Neoplasm,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Endocrine Disruptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cardiovascular Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIRN34A gene|MIR34A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,fisetin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,systemic administration,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GM2A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,progesterone receptor positive,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIR655,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alcohol consumption,Contralateral breast cancer,Other,0.0,0.001998001998001998
AFFECTS,peoniflorin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Phosphatidylethanolamine N-Methyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Cholesterol,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,SPRY1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Epidermal growth factor receptor inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Choline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Depressed mood,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Vitamin D3 Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Receptor Activation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Epidermal growth factor receptor inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Fibronectins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Lipopolysaccharides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Secondary malignant neoplasm of lymph node,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,F3 gene|F3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,RSU1 gene|RSU1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,3' Untranslated Regions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Induction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Paget's Disease,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,curdione,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pharmacotherapy,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,14q24.1,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,GATA3 gene|GATA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cyclophosphamide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,SOAT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Response Elements,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,HIF1A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,LOH11CR2A gene|VWA5A,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Tumor Suppressor Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Dietary fiber intake,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,PALB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Prevention,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PTPN12 gene|PTPN12,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Extracellular Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Atypical hyperplasia,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Functional RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen Receptor beta|ESR2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FOXC1 gene|FOXC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ARNTL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Infiltration,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Therapeutic agent (substance),Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,DNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Neoplasm Metastasis,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,PORPHOBILINOGEN SYNTHASE|ALAD,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hyperandrogenemia,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Histone Deacetylase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,RAB8A gene|RAB8A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Physical activity,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Tubulin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,ZYX gene|ZYX,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MBTPS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NCOR2 gene|NCOR2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Ethacrynic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ZNF423,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,6q25.1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Exertion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Transcript,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TRIM25,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,MIR520C,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Tetradecanoylphorbol Acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,C6orf106,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"MAPK14 protein, human|MAPK14",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Functional RNA,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Disease,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Fibroblast Growth Factor Receptors,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,UBE3A,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Dehydration,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Steroids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Progesterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tumor Cell Invasion,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Pesticides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Transforming Growth Factor beta Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Estradiol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"Receptors, Interleukin-1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Forkhead Transcription Factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,G0S2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Phosphoric Monoester Hydrolases,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Death (finding),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,zoledronic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,F Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Diabetes Mellitus, Non-Insulin-Dependent",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TFF3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Advance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Ribosomal Protein S6 Kinases, 70-kDa|RPS6KB1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Metalloproteases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Receptors, Progesterone|PGR",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,vasodilator-stimulated phosphoprotein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Curcumin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Neoadjuvant Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,anastrozole,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,PLAC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,docetaxel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Transforming Growth Factor beta|TGFB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Overweight,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Neoantigen,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,TNFRSF6B gene|TNFRSF6B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,XRCC3 gene|XRCC3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,NF-kappa B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,prevention through information dissemination,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Zinc,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Metaplastic Breast Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Lymph,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SETD7,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,PIP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cytotoxic Chemotherapy,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,"Fatty Acids, Omega-3",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CYP27A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CA-15-3 Antigen,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,tumor growth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,P2RY6,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,MAGI3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,diallyl disulfide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Performance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Dietary Component,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Transcript,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Metabolites,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,stanniocalcin 2,Breast cancer recurrent,Other,0.0,0.004995004995004995
DISRUPTS,Paclitaxel,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Genes,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,Aromatase Inhibitors,Malignant neoplasm of breast,Treatments,0.0,0.3386613386613387
AUGMENTS,synaptotagmin I|RELA|SYT1|GORASP1|WNK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,EPHB2|MAPK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Soluble ErbB-1|EGFR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Transforming Growth Factor beta,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,CYR61,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Primary Neoplasm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Signal Transduction Pathways,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,CAMK2B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,HOXD10,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Honey,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Polymerase|ERVK-9|ERVK-19|ERVK-11,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Synaptophysin|SYP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ADIPOR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ISL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Interleukin-2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RUNX1 gene|RUNX1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Estradiol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,hepatocellular carcinoma protein 1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,"RNA, Messenger",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Regulatory Element,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Granulocyte-Macrophage Colony-Stimulating Factor|CSF2|LAMC2,Breast cancer metastatic,Demographic Factors,0.0,0.027972027972027972
AFFECTS,Gelatinase B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MIR gene|MLXIP|MYLIP|MARCH8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cytotoxic T-Lymphocyte-Associated Protein 4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,Noninfiltrating Intraductal Carcinoma,Other,0.3988,0.01098901098901099
AFFECTS,Tocopherols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Anthocyanins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DMXL2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Curcumin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,POU5F1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Stromal Cell-Derived Factor 1,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,OBSCN gene|OBSCN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,STAT5A gene|STAT5A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,WBP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,myricetin,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Ethanol,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Ultrasonography,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PITX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SUMO1P3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Autophagy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Secondary malignant neoplasm of bone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SOHLH2,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Clomiphene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AKT2 gene|AKT2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,GPR1 gene|GPR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,DNAJB4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,discoidin domain receptor 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PLAUR gene|PLAUR,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,SHH gene|SHH,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,trastuzumab,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NEK6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,O-GlcNAc transferase,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Tea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Phosphoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ACKR3,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,MicroRNAs,"cellular diagnosis, breast cancer",Other,0.0,0.0
AFFECTS,Cisplatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,"Lung Diseases, Interstitial",Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Cisplatin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Dinoprostone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Transcriptase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immunity,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
CAUSES,BRCA2 gene|BRCA2,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,Reading,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,depolarization,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,HRG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,GATA3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MERTK gene|MERTK,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Vitamin B 12,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Peptides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Cyclic AMP-Responsive DNA-Binding Protein,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Thrombosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Variation (Genetics),Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Genes, X-Linked",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,FOXA1,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,GAS5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GGN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,SLC4A7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"PDGFA protein, human|PDGFA",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Crisis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Calcitriol,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,RICTOR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GACAT3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,preference,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,"Biological function, NOS",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Twin birth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP3A4 gene|CYP3A4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,CXCL13 gene|CXCL13,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PSMB4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Carcinoma, Non-Small-Cell Lung",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PRMT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Small cell carcinoma of lung,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,gefitinib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RAD51,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cruciferous Vegetable,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PTHLH gene|PTHLH,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,FBXL14,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BRCA1 gene|BRCA1,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
AFFECTS,Topoisomerase Inhibitors,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,ERBB2 gene|ERBB2,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,BDE-99,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Radionuclide Imaging,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Risedronate,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,"Antibodies, Anti-Idiotypic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,recessive allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cyclooxygenase 2,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,DNAJC2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,HORMAD1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Habits,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,EREG|ESR1,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,N-Cadherins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,16q12.1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Interleukin-6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,C3|ERVK-2,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Hypothyroidism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CDKN1A gene|CDKN1A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,S100A4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prognosis bad,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cell Cycle,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,resveratrol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ADAM17,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,sunflower seed oil,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sun Exposure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Raloxifene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Oils,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TYMS gene|TYMS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cytokeratin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,KDM1A,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Transcript,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
DISRUPTS,"sal protein, Drosophila",Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,Coffee,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,RAP1A|RABGEF1|TERF2IP,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Mutate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gonadal Steroid Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,piperine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SPC24,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Endocrine substance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,EGFL6 gene|EGFL6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Tubulin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Focal Adhesion Protein-Tyrosine Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MULTISECTION:FINDING:POINT IN TIME:BREAST:NARRATIVE:MRI,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NOTCH1 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LSINCT5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,decaffeinated coffee,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,high-dose chemotherapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fibrosis,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,Steryl-sulfatase|STS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Oils,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,blood lipid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Phosphotransferases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LINC00310,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Black tea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Premarin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ESR2 gene|ESR2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,EPHB4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,EIF4G1,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Inflammation Mediators,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,baicalein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,erbB-2 Receptor|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,racial differences,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Histologic type,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Raloxifene,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"UBD protein, human|UBD",Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,CDC16,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mammary Tumorigenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,DNA Modification Methylases|DNMT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"FRAP1 protein, human|MTOR",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ARHGAP9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogenic effect,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Metformin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Membrane Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cell invasion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,lysophosphatidic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MMP9 gene|MMP9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Postmenopausal syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hyperthyroidism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Compete,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,Head circumference,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Succinate Dehydrogenase|SARDH|SDHB|SDS,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,cell motility,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen hormone therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Pleural Effusion, Malignant",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immunologic Adjuvants,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
AUGMENTS,SULF2 gene|SULF2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ARF6,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Alcoholic Beverages,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,Progestins,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BAX gene|BAX,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hormone replacement therapy,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Uterine Cancer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,health-related beliefs,Malignant neoplasm of breast,Ethical and Cultural Factors,0.0,0.3386613386613387
PREDISPOSES,Hypoxia,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,ZD 6126,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"VEGF protein, human|VEGFA",Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Mucins,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,Tyrphostins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Lactation,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Organochlorine pesticide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lean body mass,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Somatomedins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,genetic aspects,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Beta Carotene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Osteoporosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Daily drinker,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Thinness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pain relief,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,alpha-carotene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Amitriptyline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Polyamines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Sulfuric Acid Esters,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDKN2A gene|CDKN2A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Somatomedins,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,BNIP3,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
CAUSES,Steroid hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Reexcision,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,"Endometriosis, site unspecified",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GSTT1 gene|GSTT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Anti-Inflammatory Agents, Non-Steroidal",Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,GSTP1 gene|GSTP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Insulin Resistance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,BP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,celecoxib,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,PRSS3P2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"TACSTD2 protein, human|TACSTD2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,VEGF gene|VEGFA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Physical activity,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,leptin receptor|LEPR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Dichlorodiphenyl Dichloroethylene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,sulfotransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Progesterone Receptor Status,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Ibandronate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RGS17,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Behavior showing increased motor activity,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Progesterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fever,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Anthracyclines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Almond Nut,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,Breast cancer invasive NOS,Other,0.3988,0.00999000999000999
AFFECTS,Up-Regulation (Physiology),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ERCC5 gene|ERCC5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Secondary malignant neoplasm of liver,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FOXL2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RHOA gene|RHOA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LGMN gene|LGMN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Enkephalins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Antihypertensive Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Gonadal Steroid Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PRKD1,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Atypia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CD55|TCN2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Waist circumference,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Antigens, CD5",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,tibolone,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Diagnostic Neoplasm Staging,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pancreatectomy,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,MicroRNAs,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AUGMENTS,MicroRNAs,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,personal experience,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Choline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,syndecan 2,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Selenium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Tumor Antigens,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Recreation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor Angiogenesis,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,Minipill,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Angiotensin-Converting Enzyme Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ablation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Detection,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Energy Metabolism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Aromatase Inhibitors,Malignant neoplasm of breast,Treatments,0.0,0.3386613386613387
AUGMENTS,BRCA2 gene|BRCA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Breast Diseases,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Sentinel Lymph Node Biopsy,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,8q24,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Angiotensin-Converting Enzyme Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hydroxyestrones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Iron,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estrogen Antagonists,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,IGFBP3 gene|IGFBP3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,RHOC gene|RHOC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Promoter Regions (Genetics),Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,DDT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Berries,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Disease,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Peptidyl-Dipeptidase A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Malignant Neoplasms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,binge drinking,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cyclooxygenase 2 Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,17q12,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Antidepressive Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Fiber,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,mammary tumor virus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"KLK15 protein, human|KLK15",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,response,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,IL6 gene|IL6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Positron-Emission Tomography,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Insulin-Like Growth Factor I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PRLR gene|PRLR|PTP4A3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LOC118430 gene,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,FCER1A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Endometrial Carcinoma,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Exploration procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SHC1 gene|SHC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Free Radicals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hormone Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ELF3 gene|ELF3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Fatty Acids, Saturated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pesticides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Stearoyl-CoA Desaturase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Antidepressive Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Doxorubicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Recombinant Erythropoietin,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Prolactin Receptor|PRLR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,capecitabine,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Tocotrienols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BMP7 gene|BMP7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Complication,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Low Dose Radiation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,hemiplegia; ascending,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HPR gene|HPR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MUTYH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,soy protein isolate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Endocrine Disruptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Beta-carotene intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pulse vegetables,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,claudin 6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,soy protein isolate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tretinoin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Epirubicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,UQCRFS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,pterostilbene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Folic Acid Deficiency,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Duffy blood group phenotype,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Asthma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"NUP214 protein, human|NUP214",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCNE1 gene|CCNE1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Sleep disturbances,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,argatroban,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Genes,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,taxane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,retinoic acid receptor beta 2,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Osteoporosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CLOCK gene|CLOCK,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Proto-Oncogene Proteins c-akt|AKT1,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,HERC4,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,responsibility,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,pulmonary complications,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,[X]Unspecified osteoporosis with pathological fracture,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,mRNA Expression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Gonadal Steroid Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RHOA gene|RHOA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Lectin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,OSU 03012,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fine needle aspiration biopsy,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Methylenetetrahydrofolate reductase (NADPH)|MTHFR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Oncogene ErbB2|ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Low glycemic index food,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Encounter due to In vitro fertilization,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ovarian cancer prevention,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Abdominal obesity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Collagen,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Endocrine therapy,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Transforming Growth Factor beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Insulin-Like Growth Factor I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Dimethyl Sulfoxide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,HGS gene|HGS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,research outcome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,hypercholesterolemia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tomatoes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gross' disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mucin 1 protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Metastatic malignant neoplasm to brain,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ductal Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,abnormal glucose tolerance test,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Functional RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ID1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Interstitial Collagenase|MMP1,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,Cadmium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Paclitaxel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,APOBEC3A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PPARG gene|PPARG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LOX gene|LOX,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Human papilloma virus infection,Malignant neoplasm of breast,Herpetic Genetic Factors,0.0,0.3386613386613387
AFFECTS,3' Untranslated Regions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SULT1A1|SULT1A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breast size,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FTO,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Cyclooxygenase Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Antigens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,C-reactive protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TNF gene|TNF,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Carcinoembryonic Antigen|CEACAM5|CEACAM3|PSG2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breast size,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Underweight,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BRCA2 Mutation,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
AUGMENTS,Adiponectin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RNF8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,STN gene|EEF1A2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Depressive disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Ascorbic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Botanicals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SOX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KLF4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Weight fluctuates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carboplatin,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Equine laminitis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptors,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Thyroid dysfunction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,NMU gene|NMU,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,GAL3ST1|SLC35A1|CASZ1|CST12P,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Diethylhexyl Phthalate,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Hypoxia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lymphedema,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Motion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PTGS2 gene|PTGS2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,breast cancer diagnosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,tibolone,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Pharmacotherapy,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,"RNA, circular",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Seizures,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Bendroflumethiazide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FLII,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,aurora kinase,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Insulin|INS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KIF4A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ultrasonography,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,ELK3 gene|ELK3|KCNH8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Peanut butter,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Strenuous Exercise,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Diffuse Scleroderma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Symptoms,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Diet,Breast cancer recurrent,Behavioral Factors,0.0,0.004995004995004995
DISRUPTS,Metastasis Suppressor Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Gastrin|GAST,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TLR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Estrogen Receptor alpha|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Oral contraception,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hypersensitivity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Organochlorine pesticide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Reduction mammaplasty,Contralateral breast cancer,Other,0.0,0.001998001998001998
AFFECTS,Nephroblastoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Excision,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,ELK3 gene|ELK3|KCNH8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Pork,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Transforming Growth Factor beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dietary Fiber,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,CCND1 gene|CCND1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Zn-alpha-2-glycoprotein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Epithelial hyperplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Nuclear Hormone Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,resistin|RETN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Curcumin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vegetables,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Reflexology,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Inflammation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,vinorelbine,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Willing,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,S100A4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KISS1 gene|KISS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Stress,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Protein Subunits,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,BRCA1 gene|BRCA1,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,MAP Kinase Kinase Kinase 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CHD5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,zoledronic acid,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Aspirin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Caffeine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptor 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Tomography, Emission-Computed",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TWIST2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cyclophosphamide/fluorouracil/methotrexate protocol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Metals, Heavy",Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,XRCC6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mammography,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Migraine Disorders,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Metformin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Histopathology,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PRLR gene|PRLR|PTP4A3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Androgen Receptor|AR,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,"Diet, Mediterranean",Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,HIF1A gene|HIF1A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Fish intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,feral,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,5-Alpha reductase inhibitor,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Follistatin,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Inflammatory Response,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TGFB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Engine Exhaust,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dioxygenases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Receptor, Angiotensin, Type 1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cyclooxygenase 2,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,Mass Screening,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Cyclooxygenase 2 Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Microsatellite Repeats,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,Sentinel Lymph Node Biopsy,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,"Antidepressive Agents, Tricyclic",Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Chinese cabbage,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Oncogene Proteins,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,anastrozole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Screening mammography,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Vitamins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Environmental Tobacco Smoke,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,mullerian-inhibiting hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,XRCC1 gene|XRCC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Defense Mechanisms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Expressed Sequence Tags,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Dissection,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Red meat intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Skin necrosis,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,SOX10,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,XRCC2 gene|XRCC2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Autoantibodies,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Dinoprostone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogens,Noninfiltrating Intraductal Carcinoma,Hormonal Factors,0.0,0.01098901098901099
DISRUPTS,DNA Repair Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Non-Invasive Lesion,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,PREDICTED,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,trastuzumab,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitality,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hormone Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KMT5A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Blood hormone levels,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,bicalutamide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,oleuropein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ALKBH3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Metformin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Chemopreventive Agent,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
CAUSES,Malignant Neoplasms,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Cytochrome P-450 CYP1A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Progesterone,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Lesion,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"Polymorphism, Genetic",Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,GH1 gene|GH1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
CAUSES,Glucose,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Untranslated Regions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Virus Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Epidermal Growth Factor Receptor|EGFR,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Angiogenesis Factor,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Genes,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,SLC45A2,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,25-hydroxyvitamin D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,sulfotransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,DNA topoisomerase II alpha|TOP2A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RHBDD1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Gelatinase B|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIRN150 gene|MIR150,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,tibolone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Adenosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Discrepancy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Needle biopsy procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cyclin-Dependent Kinase 10,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Secondary malignant neoplasm of lung,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Medroxyprogesterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,exemestane,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Invasive Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hot flushes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP2D6 gene|CYP2D6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,GGT1|GGTLC5P|GGTLC3|GGT2|GGTLC4P,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Polychlorinated Biphenyls,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,cyclin D3|CCND3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Hormone Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lipids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Serotonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SMAD3 gene|SMAD3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,USP11,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Ethanol,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Aspirin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IRF4 gene|IRF4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Radiation therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Composition,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Magnetic Resonance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MAP2K3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP2D6 gene|CYP2D6,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,CXCR4 gene|CXCR4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,DNA Repair,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,P-Cadherin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Doxorubicin Hydrochloride,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,QUINTILE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mass of body structure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diagnostic radiologic examination,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,Calcium Channel Blockers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Strenuous Exercise,Breast cancer invasive NOS,Behavioral Factors,0.0,0.00999000999000999
AUGMENTS,Environmental Estrogen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,receptor activator of NF-kappaB,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Exposure to,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,collapsin response mediator protein-2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitamin D Deficiency,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,equol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"2,3-bis(3'-hydroxybenzyl)butyrolactone",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GSTT1 gene|GSTT1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Cyclophosphamide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitamin A intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hydroxymethylglutaryl-CoA Reductase Inhibitors,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,Sentinel Lymph Node Biopsy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Genome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Red breast,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
CAUSES,endogenous steroids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Iron, Dietary",Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
DISRUPTS,Hetastarch,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Polyunsaturated Fatty Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,White bread,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Endometrial Hyperplasia,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,"1,4-dioxin",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Lasofoxifene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carcinogens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"1,4-dioxin",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DNA,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Noninfiltrating Intraductal Carcinoma,"Carcinoma, Ductal, Breast",Other,0.0692,0.002997002997002997
PREDISPOSES,XRCC3 gene|XRCC3,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,MTA2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Human Development,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,G-T mismatch-binding protein|MSH6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CCL1 gene|CCL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,STAT3 gene|STAT3,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,retinoic acid receptor beta 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ID2 gene|ID2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cullin 1|CUL1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,erbB-2 Receptor|ERBB2,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,IARS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Proteasome inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Functional RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Genetic Markers,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Chronic inflammatory disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Interleukins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,DSCAM-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ORALIT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,S100A7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PIK3CA gene|PIK3CA,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Trans Fatty Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Protein phosphatase,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Trans Fats,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Corticosterone,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Tryptophan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,K-ras Oncogene|KRAS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Alanine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Interleukin-8,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,DNA Sequence,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GTP-Binding Protein alpha Subunits,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TBX3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,HOXC6 gene|HOXC6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Body mass index procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Peptide Nucleic Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Disease,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,anastrozole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DANCR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Growth Hormone Receptor|GHR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Urokinase|PLAU|PRAP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Proto-Oncogene Proteins c-myc|MYC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,CYP1B1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,survivin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Primary idiopathic dilated cardiomyopathy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Polysaccharides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SNORA7B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,NanoGel,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Positive Lymph Node,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Small Inducible Cytokine A18|CCL18,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,BRCA2 Mutation,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Serum Proteins,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,Physiological stress,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Anisotropy,Breast cancer recurrent,Other,0.0,0.004995004995004995
CAUSES,STAR gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Exons,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Genes, ras",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,RPE65|UVRAG|TP63|CKAP4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MAFG gene|MAFG,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,TWIST1 gene|TWIST1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Self-Examination,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PARVA gene|PARVA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CBFB gene|CBFB|NFYA|NFYB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CYP1B1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Arachidonic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Plant Preparations,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Parabens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LINC00968,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,leukemia,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Gastric Inhibitory Polypeptide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SNHG7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tic disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Biopsy,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,"RNA, Untranslated",Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,CYP1B1,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AUGMENTS,PLK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GALNT16,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Disease susceptibility,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"CHEK2 protein, human|CHEK2",Familial cancer of breast,Other,0.0,0.003996003996003996
AFFECTS,taxane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Red meat,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Digital mammography,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,LINC00460,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CUL4B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,honokiol,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,DNA Repair,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Epstein-Barr Virus Infections,Breast Carcinoma,Herpetic Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,TUFT1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Insulin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Glucocorticoid Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tumor Cell Invasion,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Malignant neoplasm of lung,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCAT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SCUBE2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Anthracycline Antibiotics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,trastuzumab,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"N',N''-diacetylspermine",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Aromatase|CYP19A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Receptors, Steroid",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin-Like Growth Factor II,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Leptin|LEP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gelatinase A,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Medication use,Carcinoma in situ of breast,Pharmacological Factors,0.0,0.001998001998001998
AFFECTS,Vascular Endothelial Growth Factor Receptor-2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Electromagnetic Energy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Coffee,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NCAPD2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Radiotherapy, Adjuvant",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ginsenoside M1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Metformin hydrochloride,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Spermine Synthase|SMS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Gonadal Steroid Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hip circumference,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PCB 180,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIRN34A gene|MIR34A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,silybin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KDM5B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Ascorbic Acid,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Flavonoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,activated RNA polymerase II transcription cofactor 4|IFRD1|KRT6B|SUB1|PCSK4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Methyl-CpG-Binding Protein 2|MECP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Androgen Receptor|AR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prognosis good,contralateral breast cancer,Other,0.0,0.002997002997002997
AFFECTS,Combined Modality Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,sulforafan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Secondary Neoplasm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PRNCR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RHOA gene|RHOA,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,everolimus,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Functional assessment,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIR99A gene|MIR99A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Stable weight,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,27-hydroxycholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ATP8A2,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,YAP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CELF6 gene|CELF6,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Menstruation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Mitogen-Activated Protein Kinase 3|MAPK3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CGRRF1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ZMYND10,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,DNMT3B gene|DNMT3B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MicroRNAs,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,RNA metabolic process,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Chemotherapy Regimen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dense breasts NOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vascular Endothelial Growth Factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Low absolute lymphocyte count,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Bilateral Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Paralogous Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PAK6 gene|PAK6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,LINC00173 gene|LINC00173,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Angiogenic Process,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Positron Emission Tomography and Magnetic Resonance Imaging,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,clinical aspects,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,claudin 4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breast Density,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hypertriglyceridemic Waist,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PDZRN4 gene|PDZRN4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,MK 2206,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
CAUSES,BRD7 gene|BRD7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,KDM1A gene|KDM1A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MIR451A gene|MIR451A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Genes,Hereditary Breast and Ovarian Cancer Syndrome,Genetic Factors,0.0,0.0
DISRUPTS,LINC00993 gene|LINC00993,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,JAG1 gene|JAG1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,"Leukemia Virus, Bovine",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,tamoxifen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TP53 gene|TP53,contralateral breast cancer,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Breast-Conserving Surgery,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Secondary Neoplasm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Menopause Status,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SFRP2 gene|SFRP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,tamoxifen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Exogenous Factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplasms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Reproductive History,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Histamine H1 Antagonists,contralateral breast cancer,Other,0.0,0.002997002997002997
AFFECTS,FNDC5 gene|FNDC5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Family history,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CNN1 gene|CNN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,beta catenin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,citronellol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,osteopontin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FOXK1 gene|FOXK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Variation (Genetics),Invasive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,RNA Sequence,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"ITK protein, human|ITK",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"ATP Binding Cassette Transporter, Sub-Family G, Member 2|ABCG2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Proteins,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,GSTM1 gene|GSTM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Tumor size,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,sulforafan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DNA Motifs,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CHEK2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Mirn124a microRNA, human",Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,SDHC gene|SDHC,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
CAUSES,Vaccines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hypersensitivity,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,Gene Mutant,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,TFCP2 gene|TFCP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Diagnosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,RWDD4 gene|RWDD4,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,Discordance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Calcium-Sensing Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hormone Receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,tissue-factor-pathway inhibitor 2|TFPI2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,neoplasm-associated factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tumor Escape,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,High Level,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Signs and Symptoms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Subjective:Finding:Point in time:^Patient:Narrative,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SOX10 gene|SOX10,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Aggressive behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Muscle Strength,Malignant neoplasm of female breast,Other,0.0,0.0
AUGMENTS,"MET protein, human",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,Long Intergenic Non-Protein Coding RNA,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,CDYL2 gene|CDYL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Quintile,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FGFR3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carotenoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Matrix Metalloproteinase 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Stiffness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CBLB gene|CBLB|MMAB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Mammographic Breast Density,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,NES gene|NES,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ribonucleotide reductase M2|RRM2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TRDMT1 gene|TRDMT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,tamoxifen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Physical Inactivity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,brown adipose tissue uncoupling protein,Basal-Like Breast Carcinoma,Other,0.0,0.003996003996003996
DISRUPTS,daunorubicin liposomal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tumor Suppressor Genes,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,"TGFB1 protein, human|TGFB1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,bisphenol A,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,Pharmacotherapy,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,Aromatase Inhibitors,Malignant neoplasm of breast,Treatments,0.0,0.3386613386613387
AFFECTS,TMPO-AS1 gene|TMPO-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Epidermal Growth Factor Receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,huaier,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Flavonoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prune Belly Syndrome,contralateral breast cancer,Other,0.0,0.002997002997002997
PREDISPOSES,Human Class I Antigens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Increased risk,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NUDT21 gene|NUDT21,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,concise,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,NEK10 gene|NEK10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,GPER1 gene|GPER1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,letrozole,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,YES1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,CCL8 gene|CCL8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,polygene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,RUNX1,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Carbohydrate intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplastic Cell Transformation,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,MCM3AP-AS1 gene|MCM3AP-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,interleukin-10,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pathologic Response,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,antiporter,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,ELAVL2 gene|ELAVL2,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
PREDISPOSES,Genes,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Neuropilin-1|NRP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Finding of body mass index,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fumigant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cyclin B1|CCNB1,Luminal B Breast Carcinoma,Other,0.0,0.0
AUGMENTS,RNA Sequence,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,calycopterin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,arctigenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fibrin fragment D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,pristimerin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"CD69 protein, human|CD69",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sedentary lifestyle,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,kusunokinin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DAPK1 gene|DAPK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Late Relapse,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,risk factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FGFBP1 gene|FGFBP1,estrogen receptor-negative breast cancer,Genetic Factors,0.0,0.0
AFFECTS,ZEB1 gene|ZEB1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TNF wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Puberty,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RIOK1 gene|RIOK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,magnesium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplasms,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,IMPACT gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Disease,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,ergocalciferol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Biological Markers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"CD69 protein, human|CD69",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,naringenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Flavanones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Metastatic malignant neoplasm to brain,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,"RNA, Messenger",Recurrent Breast Carcinoma,Other,0.0,0.000999000999000999
CAUSES,wogonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BCL11A gene|BCL11A,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AFFECTS,Transcript,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,podofilox,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ERR1 protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LIMK2 gene|LIMK2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Antimalarials,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MLF2 gene|MLF2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,MALAT1 gene|MALAT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Tumor size,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,sunitinib,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,Hyperthyroidism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AMH gene|AMH,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ACVR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Androgen Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ELAVL2 gene|ELAVL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CKLF gene|CKLF,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Screening procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PRKN gene|PRKN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,baicalin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Epidermal Growth Factor Receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,simvastatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Anti-Mullerian Hormone Receptor Type II, Human|AMHR2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Excessive dietary caloric intake,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Genetic Polymorphism,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SNAI1 gene|SNAI1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ADIPOR1 gene|ADIPOR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Fibroblast Growth Factor Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,APOBEC3B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Protein, Organized by Structure",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Angiogenic Process,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,tamoxifen,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Organophosphate pesticides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HER-2 protein|ERBB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hormone Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,water,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Biological Response Modifiers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,dna genetics,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"DNM1L protein, human|DNM1L",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,GSTP1P1 gene|GSTP1P1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FANCM gene|FANCM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,SNAI2 gene|SNAI2,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,Trichorhinophalangeal dysplasia type I,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Sodium-Glucose Transporter 2 Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ZFPM2-AS1 gene|ZFPM2-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,BBOX1 gene|BBOX1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Uptake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Early-Stage Breast Carcinoma,Other,0.0,0.0
AFFECTS,Conventional Treatment,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,"Chemotherapy, Adjuvant",Carcinoma breast stage I,Other,0.0,0.0
CAUSES,Injection,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Oils,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,TP53 gene|TP53,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,SERPINE1 gene|SERPINE1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,RASAL2 gene|RASAL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,LINC00922 gene|LINC00922,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,c-Mer Tyrosine Kinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Moderate risk,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Processed meat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,estrogens,Triple Negative Breast Neoplasms,Hormonal Factors,0.0,0.01898101898101898
PREDISPOSES,HMGB1 gene|HMGB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"PDIA3 protein, human|PDIA3",Invasive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,MIR30E gene|MIR30E,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,HOTAIR gene|HOTAIR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Estrogen Receptor beta,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,MTOR gene|MTOR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AUGMENTS,RSPO3 Gene|RSPO3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Present,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP1A1 gene|CYP1A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,A2M-AS1 gene|A2M-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Progranulins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Thymidylate Synthase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SALL4 gene|SALL4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Anthracyclines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KCNQ1OT1 gene|KCNQ1OT1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,METTL14 gene|METTL14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Hypoxia-Inducible Factor 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,cryptotanshinone,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,Malignant neoplasm of breast,estrogen receptor-positive breast cancer,Other,0.3988,0.008991008991008992
AFFECTS,TUG1 gene|TUG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Biological Neural Networks,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,mortalin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Zearalenone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Alternative Splicing,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,resistin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,bisphenol A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PCAT7 gene|PCAT7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,lamin B2,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,High Level,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LINC01271 gene|LINC01271,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Elasticity Imaging Techniques,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Epidermal Growth Factor Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"RNA, Untranslated",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Magnetic Resonance Imaging,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,hereditary factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PTEN gene|PTEN,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,UBE3C gene|UBE3C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"IL2RB protein, human|IL2RB",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ZNF670-ZNF695 gene|ZNF670-ZNF695,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,ATM gene|ATM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Risk Scores,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AUGMENTS,OXER1 gene|OXER1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FBXO22 gene|FBXO22,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,selenium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Uncertainty,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,aspirin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,mullerian-inhibiting hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TINCR gene|TINCR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LINC00665 gene|LINC00665,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Bilateral mastectomy,contralateral breast cancer,Other,0.0,0.002997002997002997
AFFECTS,Pharmacotherapy,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,iron,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Tumor Promotion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,UCHL1 gene|UCHL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Lactates,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,CHEK2 gene|CHEK2,Hereditary Breast and Ovarian Cancer Syndrome,Genetic Factors,0.0,0.0
PREDISPOSES,AGAP2-AS1 gene|AGAP2-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Psychosocial Intervention,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoadjuvant Chemotherapy,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Immune Checkpoint Blockade,Triple Negative Breast Neoplasms,Immunological Factors,0.0,0.01898101898101898
PREDISPOSES,SDHC gene|SDHC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MBD2 gene|MBD2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Adiponectin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Obesity, Abdominal",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Leisure physical activity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LINC01271 gene|LINC01271,malignant neoplasm of breast staging,Genetic Factors,0.0,0.0
PREDISPOSES,calcium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,leptin receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,tamoxifen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Nutrients,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Calcium intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hypoxia,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,TP53 gene|TP53,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"RNA, Circular",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Metric (substance),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FZD2 gene|FZD2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,gambogic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,"Breast Cancer, Familial",Other,0.3988,0.0
AFFECTS,hydroxyl group,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Secondary Neoplasm,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,CPT1A gene|CPT1A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,calmodulin-dependent protein kinase III,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SENP3 gene|SENP3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,elaidic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"CD69 protein, human|CD69",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"CDKN1A protein, human|CDKN1A",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ATM gene|ATM,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Heterogeneous-Nuclear Ribonucleoprotein K,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,O(6)-Methylguanine-DNA Methyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Ovarian failure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYTOR gene|CYTOR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Immunologic Surveillance,estrogen receptor-positive breast cancer,Immunological Factors,0.0,0.008991008991008992
AFFECTS,COVID-19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Inhibitor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Tumor Microenvironment,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LRRC3B gene|LRRC3B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Fatty Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,recreational activity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Hypoxia-Inducible Factor 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Zinostatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Systemic Inflammatory Response Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ropivacaine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NF-kappa B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Body mass index procedure,malignant neoplasm of breast staging,Other,0.0,0.0
AFFECTS,"PLK1 protein, human|PLK1",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Prognostic Factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FBXO32 gene|FBXO32,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,ELF5 gene|ELF5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ENTPD1 wt Allele|ENTPD1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDK15 gene|CDK15,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Transcription Coactivator,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Neoantigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Adrenergic beta-Antagonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ropivacaine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FADS1 gene|FADS1,Recurrent Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
DISRUPTS,hyaluronic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fetal valproate syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DPP6 gene|DPP6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TWIST1 gene|TWIST1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Intronic Mutation,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
PREDISPOSES,PADI1 gene|PADI1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MIR599 gene|MIR599,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Dynamic Contrast-Enhanced Magnetic Resonance Imaging,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FANCA gene|FANCA,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
DISRUPTS,LOC100505851,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIR638 gene|MIR638,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LOC105371267,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carcinoembryonic Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,receptor operated channel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Graphene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hydroxymethylglutaryl-CoA reductase,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Thrombophilia,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,vitamin A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ARHGAP1 gene|ARHGAP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,WNT9B gene|WNT9B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,VGLL1 gene|VGLL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Collagen Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MIR21 gene|MIR21,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,HAGLR gene|HAGLR,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,cytotoxicity,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,KIF23 gene|KIF23,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Consideration,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"herstatin protein, human",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Xenograft procedure,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,CDKN2B-AS1 gene|CDKN2B-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,medication risk,Malignant neoplasm of breast,Pharmacological Factors,0.0,0.3386613386613387
PREDISPOSES,Full Term Birth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,VCAN-AS1 gene|VCAN-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"EZH2 protein, human|EZH2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LINC01094 gene|LINC01094,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cerebrovascular accident,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,epithelial to mesenchymal transition,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IL27 gene|MYDGF|IL27,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,"Metals, Heavy",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hepatocyte Nuclear Factor 3-alpha|FOXA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,GLUT-1 protein,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,LINC01315 gene|LINC01315,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Adhesions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Coronary Arteriosclerosis,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,"Drug Resistance, Neoplasm",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,NEIL2 gene|NEIL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,ursolic acid,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,bone morphogenetic protein 4|BMP4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ZBTB7A|AKIRIN2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diagnosis,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,fluorouracil,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,LINC00922 gene|LINC00922,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Inflammation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,cytokine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,baicalin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carbohydrates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Stress,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
DISRUPTS,Vascular Endothelial Growth Factor A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,HOXC10 gene|HOXC10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,New medications,Malignant neoplasm of breast,Pharmacological Factors,0.0,0.3386613386613387
AFFECTS,Tumor Progression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Transcript,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"EIF4EL3 protein, human|EIF4E2",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,"herstatin protein, human",HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,"RNA, Small Interfering",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,Mucin-1 Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Problem,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MICAL2 gene|MICAL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,TLR1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Endoplasmic Reticulum Stress,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,COVID-19,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,EHD1 wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"CD69 protein, human|CD69",malignant neoplasm of breast staging,Other,0.0,0.0
PREDISPOSES,Fiber intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,HSPA9 gene|HSPA9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,New Diagnosis Procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ergocalciferol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,high weight,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,2-(4-morpholinoanilino)-6-cyclohexylaminopurine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,High residue diet,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AUGMENTS,RBM38 gene|RBM38,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"herstatin protein, human",HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Lactation established in non-human animal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDC20 gene|CDC20,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,granzyme B,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Prieto X-linked mental retardation syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NFIL3 gene|NFIL3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,KRT19P3 gene|KRT19P3,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,PTEN gene|PTEN,Ductal Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
PREDISPOSES,Pathologic Complete Response,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,"LATS1 protein, human|LATS1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CARD.RISK,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,"Genes, cdc",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,omega-3 fatty acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,liquiritigenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Autophagy,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Vital activity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,oxaliplatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ADRB2 gene|ADRB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,doxorubicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"EZH2 protein, human|EZH2",Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,Antibody Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Agonist,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,hydrogen peroxide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Obesity, Visceral",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Chemicals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Ultrasound scan finding,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SRP9 gene|SRP9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,tramadol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,HTR1A gene|HTR1A,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,LINC00466 gene|LINC00466,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,OPRM1 gene|OPRM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,KLK3 gene|KLK3,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
AUGMENTS,DDT (Insecticide),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Life Expectancy Less than Five Years,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ARHGAP17 gene|ARHGAP17,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Duration,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,tegaserod maleate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,NEAT1 gene|NEAT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Nutrients,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Sports,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hypoxia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Screening mammography,Early-Stage Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Migraine Disorders,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,physiological aspects,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NEDD4L gene|NEDD4L,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Neoadjuvant Chemotherapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIR210HG gene|MIR210HG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CD31 Antigens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,mRNA Expression,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,G-Protein-Coupled Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TRIP13 gene|TRIP13,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Keratin-19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cisplatin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,RAB8A gene|RAB8A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PSAT1 gene|PSAT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CCR2 gene|CCR2,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,RAB8A gene|RAB8A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Epithelial ovarian cancer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SREBF1 gene|SREBF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Score,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Metabolism,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Has difficulty doing (qualifier value),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,interleukin-6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"tropomyosin-related kinase-B, human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,iron,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pediatric Obesity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NCAPD2 gene|NCAPD2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hyperactive behavior,Secondary malignant neoplasm of breast,Behavioral Factors,0.0,0.002997002997002997
CAUSES,Players,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,Endoplasmic Reticulum Stress,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,purinoceptor P2X4|P2RX4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Manipulation procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"CD274 protein, human|CD274",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GTSE1 gene|GTSE1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Magnetic Field Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hypersensitivity,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,Biological Response Modifiers,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,"Human B-Lymphocyte Antigen CD20, human|MS4A1|KRT20",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,anhydroicaritin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Growth Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Physical function,Locally advanced breast cancer,Other,0.0,0.0
AFFECTS,Breast Self-Examination,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LINC01287 gene|LINC01287,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Adipokines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Frailty,Locally advanced breast cancer,Other,0.0,0.0
PREDISPOSES,Dietary Habits,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,"Receptor, PAR-1",Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,dietary fiber intake,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Diabetes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ATAD2B gene|ATAD2B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Neoadjuvant Chemotherapy,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,FOXD3-AS1 gene|FOXD3-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Triglycerides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Post-mastectomy radiotherapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DDX21 gene|DDX21,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Nicotinamide Phosphoribosyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"protein TDP-43, human",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,si-wu-tang,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Comorbidity,Female Breast Carcinoma,Other,0.0,0.004995004995004995
DISRUPTS,folic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,benzene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hydrogen Sulfide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Vascular Endothelial Growth Factor A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,2-mercaptoethanesulfonic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,gamma-Secretase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PSME2 gene|PSME2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ergocalciferol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Helicobacter pylori,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,SCG2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Carcinogens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ZNHIT1 gene|ZNHIT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Biological Markers,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,GUSBP11 gene|GUSBP11,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,CUEDC2 gene|CUEDC2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,RNA Recognition Motif,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TP53,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Florid red complexion (finding),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Orthologous Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,GTF2H1 gene|GTF2H1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,CD47,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,Aurora Kinase A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,intrinsic factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Claudins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PON1 gene|PON1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Eosinum, eosin, Homeopathic preparation",malignant neoplasm of breast staging,Other,0.0,0.0
PREDISPOSES,Androgen Binding Protein|SHBG|CCHCR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"CD274 protein, human|CD274",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Sleep,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,catalpol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mammographic Breast Density,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
CAUSES,Peptides,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Lymphatic Metastasis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Saturated fat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LINC00520 gene|LINC00520,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,"RNA, Untranslated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,High grade serous carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PIK3CA Gene Mutation,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,TRANSCRIPTION FACTOR,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,Rich food,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"RNA, Long Untranslated",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,Colorectal Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Antibody-Drug Conjugates,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carcinogens,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,BVES gene|BVES,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Diet, Paleolithic",Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,DNMT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cardiac event,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Inhibitor,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,SLC1A5 gene|SLC1A5,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Parabens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,adenosine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Pharmaceutical Preparations,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,BRCA2 gene|BRCA2,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,SPATA25 gene|SPATA25,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Metric (substance),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,pigment epithelium-derived factor,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,Intercellular adhesion molecule 1|ICAM1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,IGHG1 gene|IGHG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,agonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Screening procedure,Early-Stage Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,GAS5 gene|GAS5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,DDX11-AS1 gene|DDX11-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Cerulenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Life Expectancy Less than Five Years,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,FTO gene|FTO,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,High Density Lipoprotein Cholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Receptors, Progesterone",Advanced breast cancer diagnosis,Other,0.0,0.0
AFFECTS,Poly(ADP-ribose) Polymerase Inhibitors,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AUGMENTS,arsenic trioxide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Liposomes,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,Diagnosis,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,"RAF Proto-Oncogene Serine/Threonine-Protein Kinase, human|RAF1",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Provisional,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,metformin,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,tiliroside,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,"CD69 protein, human|CD69",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Polyunsaturated Fatty Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Programmed cell death ligand 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Transection (procedure),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Drugs, Non-Prescription",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Hypoxia Inducible Factor Family,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SMURF1 gene|SMURF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,genistein,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,insulin-like growth factor 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,choline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Catechols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Microcalcification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,methionine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,GNAO1 gene|GNAO1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,CCND1 gene|CCND1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,AXL,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,FOXO1 gene|FOXO1,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
AFFECTS,CCN1 gene|CCNA2|CYR61|PPP3CA,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Metabolic marker,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Transcription Factor AP-2 Beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SIRT1 gene|SIRT1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
CAUSES,DANCR gene|DANCR,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,Tumor Suppressor Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,malignant disease,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
CAUSES,IGF2BP1 gene|IGF2BP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Pharmaceutical Preparations,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"High Mobility Group Protein HMG-I, Human|HMGA1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,beta-arrestin 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,AKTIP gene|AKTIP,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
AFFECTS,Prolactin Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,green tea extract,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Drug resistance,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,eriocalyxin B,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,HULC gene|HULC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Fatty Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,USP13 gene|USP13,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
DISRUPTS,NLRP3 gene|NLRP3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Biological Factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PHB2 gene|PHB2,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,dietary fat intake,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Senility,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,toosendanin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,VDR gene|VDR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Amino Sugars,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Meal (occasion for eating),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Lactates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,clinical aspects,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,eltrombopag,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,TTC17 gene|TTC17,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
CAUSES,BRCA2 gene|BRCA2,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
PREDISPOSES,Atrial Fibrillation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Exogenous hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Amino Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,factor VII,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PKMYT1 gene|PKMYT1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Specific antibody,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"DICER1 protein, human|DICER1",Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,NUMB gene|NUMB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,collagen,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Obesity,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,COG2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ultrasonography,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Salpingo-oophorectomy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor Microenvironment,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Sleep duration:Time:Pt:^Patient:Qn,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ursolic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hydroxy Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"SDHD protein, human|SDHD",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immune checkpoint inhibitor therapy,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
AFFECTS,Lactates,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,"CTSH protein, human|CTSH",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Nicotinamide Phosphoribosyltransferase,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,Immune Checkpoint Proteins,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
AFFECTS,TYMS|PYCARD,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,CDK1 gene|CDK1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,SNRPC gene|SNRPC,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Epithelial proliferation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fibronectins,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,COPS6 gene|COPS6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Life Expectancy Less than Ten Years,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,KIF2C gene|KIF2C,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Severe (severity modifier),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Neoplasms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MIR326 gene|MIR326,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"HMGA2 protein, human|HMGA2",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,RNA-Binding Protein Musashi Homolog 1,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Non-Small Cell Lung Carcinoma,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
CAUSES,arsenic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IPO7 gene|IPO7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ROR2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Peripheral Nerve Sheath Neoplasm,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,"TNF protein, human|TNF",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,"2,3-bis(3'-hydroxybenzyl)butyrolactone",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RNA-Binding Protein Musashi Homolog 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Peptides,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Biological Markers,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,PPP1R14B-AS1 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,doxorubicin,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,RNA-Binding Protein Musashi Homolog 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FOXP3 gene|FOXP3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,GATA3 gene|GATA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,palbociclib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BRCA2 Gene Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Inflammasomes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant Neoplasms,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,leptin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,zinc,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HIPK3 gene|HIPK3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,pre-miRNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Metabolite,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,alpha Catenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,YOD1 gene|YOD1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Obesity,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,SMYD2 gene|SMYD2,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Cell Growth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,TUSC2 gene|TUSC2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,GPX4 gene|GPX4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Circulating Tumor DNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,interleukin-6,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,AURKA gene|AURKA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"CREB1 protein, human|CREB1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cervical Cancer Screening,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Protons,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ascorbic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Performance,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,zoledronate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Caspase-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,astragaloside IV,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,mammaglobin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,TMED2 gene|TMED2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Secondary Neoplasm,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,HASPIN gene|HASPIN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Ferritin Light Chain,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SNHG14 gene|SNHG14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Lymphatic Invasion,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Allele-Specific Oligonucleotide,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,beta catenin,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,NR1D1 gene|NR1D1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Mitosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,risk factors,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,metformin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,estrogens,estrogen receptor-positive breast cancer,Hormonal Factors,0.0,0.008991008991008992
AFFECTS,euphorbia factor L1,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,ketamine,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Oncogenes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FOXO3 gene|FOXO3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,1-Phosphatidylinositol 3-Kinase,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
DISRUPTS,andrographolide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NEK2 gene|NEK2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Flavonoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pharmacologic Substance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,signaling cascade,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Phosphates,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,PAXX gene|PAXX,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Obesity,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,Sesquiterpenes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TP53,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Colorectal Carcinoma,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,PIN1 gene|PIN1,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
CAUSES,Trace Elements,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,FMO4 gene|FMO4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Fibroblast Growth Factor Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Vacuum assisted biopsy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIR223 wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,taxane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Inhibitor,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
DISRUPTS,hydroxypropylbetadex (0.58-0.68 MS),Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,"POSTN protein, human|POSTN",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,TWIST1 gene|TWIST1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
CAUSES,chelidonine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Homologous Recombination Repair Gene,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
DISRUPTS,YBX1 gene|YBX1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Plasma Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,raloxifene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FBXO3 gene|FBXO3,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Precision Medicine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Chlordan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Shift worker,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Stress, Psychological",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MTDH gene|MTDH,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,calcifediol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Low Level,Female Breast Carcinoma,Other,0.0,0.004995004995004995
DISRUPTS,c-src Genes|SRC,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,HSP90 Inhibitor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Psychotic Disorders,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,Ubiquitin-Conjugating Enzymes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Equilibrium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TIPARP gene|TIPARP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Proliferative vitreoretinopathy,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Complementary therapies,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RAD51 gene|RAD51,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Duration,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,GALNT7 gene|GALNT7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Nicotinamide Phosphoribosyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MELK gene|MELK,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Leukotriene B4 Receptors,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,GRB2 gene|GRB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,LIAS gene|LIAS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,HER2/Neu Positive,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,SNORD16 gene|SNORD16,Early-Stage Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,clinical aspects,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,FBXO8 gene|FBXO8,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,Fertility Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,icariin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Receptor Protein-Tyrosine Kinases,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,cadmium chloride,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Oxidoreductase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ECM1 gene|ECM1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,SNHG1 gene|SNHG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Personal status - Adopted,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"ORF74 protein, Human herpesvirus 8",Triple Negative Breast Neoplasms,Herpetic Genetic Factors,0.0,0.01898101898101898
DISRUPTS,Tea Extract,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,DNA Modification Methylases|DNMT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Ubiquitin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SNORD49B gene|SNORD49B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Healthy Lifestyle,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,YAP1 gene|YAP1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,"herstatin protein, human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Clinical Significance,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,HOTAIR gene|HOTAIR,malignant neoplasm of breast staging,Genetic Factors,0.0,0.0
AFFECTS,Secondary Neoplasm,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,Reactive Oxygen Species,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"ATP8A2 protein, human|ATP8A2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Menarche,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ABCB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Alzheimer's Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pathogenic Variant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alzheimer's Disease,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Performance,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Obesity,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,UGT2B7 gene|UGT2B7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,HIF1A gene|HIF1A,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,O(6)-Methylguanine-DNA Methyltransferase|MGMT,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,baicalein,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Biological Processes,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,GCKR gene|GCKR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PDP1 gene|PDP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Gene Family,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,FSCN1 gene|FSCN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,thiostrepton,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Malignant Neoplasms,Hereditary Breast and Ovarian Cancer Syndrome,Other,0.0,0.0
AFFECTS,"Diabetes Mellitus, Non-Insulin-Dependent",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"CDK7 protein, human|CDK7",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NODAL gene,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AUGMENTS,"Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6, human|CEACAM6",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Progranulins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Uridine Diphosphate Glucose Dehydrogenase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Personal Behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
DISRUPTS,Oligoribonucleotides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nitric Oxide Synthase Type II,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,FAS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TCF7L2 gene|TCF7L2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,NCOA1 gene|NCOA1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,CYP19A1 gene|CYP19A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MLH1 gene|MLH1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Motility,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"GMNN protein, human|GMNN",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PAK1|PKN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Fatty Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Methotrexate,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Adenosine A1 Receptor|ADORA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aromatase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mammary Neoplasms,Carcinoma in situ of breast,Other,0.0,0.001998001998001998
PREDISPOSES,DNMT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carcinogens,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,LSP1 gene|LSP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,indole-3-carbinol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TNFSF6 gene|FASLG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Prevention,Familial cancer of breast,Other,0.0,0.003996003996003996
DISRUPTS,bortezomib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Methionine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,NME1 gene|NME1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AUGMENTS,Amyloid beta-Protein Precursor,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,survivin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Connexins,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Compound V,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pharmaceutical Preparations,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Bacterial Endocarditis,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,activating transcription factor 3|ATF3,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Immune Cell Activation,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
PREDISPOSES,CD47 gene|CD47,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Estrogen Receptors,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Interleukin-17,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MMP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,bone morphogenetic protein 6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,AR gene|AR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,NTRK2 gene|NTRK2,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
AUGMENTS,PITPNM1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,IGKC gene|IGKC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CIP2A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,mammaglobin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cadmium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,BST2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitamin B6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptor beta|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Encounter due to genetic counseling,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,ethnic differences,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,BMP2 gene|BMP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Free Radicals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"TNF protein, human|TNF",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen receptor positive,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,High Density Lipoprotein Cholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,mullerian-inhibiting hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Antineoplastic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
CAUSES,Catenins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MYC gene|MYC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Genes, cdc",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,nitidine chloride,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"DNA, Mitochondrial",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BIRC4 gene|XIAP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Contraceptive Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,MC4R gene|MC4R,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,KIFC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Syndrome,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,PSMB6|YY1|DLL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,RNA-Binding Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,cilostazol,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,FOXM1 gene|FOXM1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,PAWR gene|PAWR,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
AFFECTS,UBE2N,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,STMN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IQGAP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,profilin 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KISS1R,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Neuromedin U|NMU,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pain,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mullerian-inhibiting substance receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptor alpha|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIR98,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CENPA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,isoliquiritigenin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Hormone Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Centchroman,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,MIRN21 gene|MIR21,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,RASAL2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Estradiol,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,ERBB2IP gene|ERBIN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,RARRES3 gene|RARRES3,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Adenocarcinoma of large intestine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,dihydroxyacetone sulfate,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,PALB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"RNA, Messenger",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Leisure Time,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,EPSTI1 gene|EPSTI1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,Prodrugs,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NRIP1 gene|NRIP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,platelet-derived growth factor C,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"TIMP1 protein, human|TIMP1",Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Estriol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cyclophosphamide,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Diethylstilbestrol,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Encounter due to genetic counseling,Contralateral breast cancer,Genetic Factors,0.0,0.001998001998001998
PREDISPOSES,Thymidylate Synthase,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,APC gene|APC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cyclin D1|CCND1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Urokinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Genes,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
DISRUPTS,cyclooxygenase 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Breast cancer invasive NOS,Malignant neoplasm of breast,Other,0.0587,0.3386613386613387
DISRUPTS,Orosomucoid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CTCF,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TLR4 gene|TLR4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Sialoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Trace Elements,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CHEK1 gene|CHEK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Organic Chemicals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Leptin|LEP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,XRCC4 gene|XRCC4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Phosphotransferases,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,estrone sulfate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Glutamate Carboxypeptidase II,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CDH1 gene|CDH1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,KISS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"HGF protein, human|HGF",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,STAT5B gene|STAT5B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,transcription cofactor activity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KLF5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Supraventricular arrhythmia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Wiskott-Aldrich Syndrome Protein,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Proto-Oncogene Proteins c-sis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CA-125 Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PFN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Sodium Selenite,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GRHL3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Epigenetic Process,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Glutamic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,1-Phosphatidylinositol 4-Kinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Receptors, Tumor Necrosis Factor, Type II",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PELP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SOX11,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,Interleukin 4 Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CMA1|SLC16A1|MCAT|MCTS1,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Isoflavones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Polysaccharides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,gamma-secretase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carboxypeptidase U,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Atrial Fibrillation,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Cancer of Rectum,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,TNFSF10 gene|TNFSF10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Epstein-Barr virus antibody,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TSG101 gene|TSG101,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,Neoplasm,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,Epinephrine,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Reserpine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Castration,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIRN17 gene|MIR17,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"SHC1 protein, human|SHC1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,In complete remission,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aspartic Endopeptidases,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Reproduction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Up-Regulation (Physiology),Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,chromosome 17q,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Milk intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Chronic inflammation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fibrosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Caseins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Menstrual cycle,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Androgens,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Reserpine,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,SRC gene|SRC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,OLFM4 gene|OLFM4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Circadian Rhythms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Virus,Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,retinol acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Selenium intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Vinyl Chloride,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,N-acetyltransferase 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,retinyl methyl ether,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BRCA2 gene|BRCA2,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,Interleukin-13,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,inhibitors,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Exogenous hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,calcification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GPER1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"RARB protein, human|RARB",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LEPR gene|LEPR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Xeroradiography,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AFFECTS,Bread,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,leptin receptor|LEP,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,Exogenous hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Cyclin E,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogens,Breast cancer metastatic,Hormonal Factors,0.0,0.027972027972027972
DISRUPTS,"CST6 protein, human|CST6",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Metabolites,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Fatty Acids, Essential",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Puberty, Female",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Vitamin D3 Receptor|VDR,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,pyrrolidino-4-iodotamoxifen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Transcriptional Activation,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,valyl-valyl-valine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Infusion procedures,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,20q13.2,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Proto-Oncogene Proteins c-akt|AKT1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,LOX,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Somatotropin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Progesterone,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Fibroblast Growth Factor 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BONE MASS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Urokinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,No past history,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Candidate Disease Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Molecular Abnormality,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Indoles,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estradiol,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Immunotherapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Involution,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Cadherins,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Biopsy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Melatonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Retroviridae,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Enzymes,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,EYA2,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Pill,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,neu Differentiation Factor,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Reproductive History,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,parathyroid hormone-related protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hyaluronan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aromatic Amines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Dietary Fats,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Neoplasm,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,CA1|S100A10,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Binding Sites,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Proto-Oncogenes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Urea,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Melatonin,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Fenretinide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Oncogene, HST|FGF4|HSF1",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Estrogen Replacement Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Arginine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sterility,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Benzanthracenes,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Absolute Alcohol,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AFFECTS,Cytotoxic agent,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Polyunsaturated fat intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Polyamines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,3-hydroxytamoxifen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PHENYL,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Termination of pregnancy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,adjuvant therapy,Breast cancer recurrent,Other,0.0,0.004995004995004995
CAUSES,Secondary malignant neoplasm of bone,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Growth Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estrone,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,hormonal changes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fluorouracil,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TAG 12,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Term pregnancy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alkaline Phosphatase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Breast Carcinoma,Malignant neoplasm of breast,Other,0.0166,0.3386613386613387
PREDISPOSES,Alkaline Phosphatase,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Advance,Breast cancer stage II,Other,0.0,0.0
PREDISPOSES,Athletics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,EGF gene|EGF,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Height / growth measure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ARGINASE,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Breast Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Seizures,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Induction,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Malignant transformation,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Thyroid Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tissue Polypeptide Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Glycoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pharmacotherapy,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Malignant neoplasm of stomach,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Testicular Neoplasms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mammography,Breast Mucinous Carcinoma,Other,0.0,0.0
AFFECTS,Haloperidol,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Hysterectomy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Medroxyprogesterone 17-Acetate,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Ovariectomy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,v-H-ras Oncogenes,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,Prolactin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Hair Dyes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Neuromedin U|NMU,Breast Carcinoma,Other,0.0,0.027972027972027972
COMPLICATES,"Liver Failure, Acute",Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Ovariectomy,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Monoterpenes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Hydrocortisone,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,melanoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen Antagonists,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Neurotropism,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Cystic Lesion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Contraction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Prostaglandins,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,2-hydroxyestrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Hamartoma Syndrome, Multiple",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aminoglutethimide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Antipyrine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Levamisole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,transglutaminase 1,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Hydrocortisone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PGR gene|PGR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Goserelin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Visual impairment,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor Antigens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Scanning,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogenic,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Introns,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Flutamide,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,CATHEPSIN D|CTSD,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,TP53 gene|TP53,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Dichlorodiphenyl Dichloroethylene,Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,Acetyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carrier of disorder,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,"(meso-1,2-bis-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum(II)",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Mixture,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,E2F1 gene|E2F1|UBE2L3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Human Chorionic Gonadotropin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Date of birth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Short stature,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cyclin D1|CCND1,Sporadic Breast Carcinoma,Other,0.0,0.0
DISRUPTS,Complex carbohydrate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SERPINB2 gene|SERPINB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Magnetic Resonance Spectroscopy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PTK2B gene|PTK2B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Phenothiazines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Focal Adhesion Protein-Tyrosine Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,retinoic acid receptor alpha,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Cyclic AMP Receptor Protein,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Maternal history,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Vegetable Oils,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,6-pyruvoyltetrahydropterin synthase|SLC25A3|REG1A|PTPRU,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Beans,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Insulin-Like Growth-Factor-Binding Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Integrins,Breast Carcinoma,Other,0.0,0.027972027972027972
COMPLICATES,Pathological fracture,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Enzymes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nulliparous,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mean blood pressure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,glypican 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Herpesvirus 4, Human",Breast Carcinoma,Herpetic Genetic Factors,0.0,0.027972027972027972
AUGMENTS,DNA,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,"Smoking, Passive",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lhermitte-Duclos disease,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,BRCA2 gene|BRCA2,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
AFFECTS,"Hydrocarbons, Chlorinated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CDKN2A gene|CDKN2A,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,NAT2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Overnutrition,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Transcription Factor AP-2 Alpha|FABP4|GTF3A|TFAP2A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SPO11 gene|SPO11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ultraviolet Rays,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GRB7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Premature Birth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gene Expression,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,Mitogens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gene Amplification,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
CAUSES,ras Oncogene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Invasive Carcinoma,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Fibroadenoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Receptors, Nuclear",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cytochrome P450 3A4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,estriol 3-sulfate,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,CHGA gene|CHGA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,MDM2 gene|MDM2,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,Vascular Endothelial Growth Factor Receptor-1|VEGFA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Disintegrins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,NMU gene|NMU,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Pre-Eclampsia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ovarian function,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogens,Breast Carcinoma,Hormonal Factors,0.0,0.027972027972027972
CAUSES,Gross' disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Polycyclic Hydrocarbons, Aromatic",Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Vitamin E,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Dichlorodiphenyl Dichloroethylene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Endostatins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,glutathione S-transferase M1|CHRM1|MRLN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Radiation therapy,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,bone sialoprotein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"TRIM25 protein, human|TRIM25",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Adrenal carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Encounter due to prophylactic surgery, unspecified",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Scanning,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,psychological stressor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Opioid Peptide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BRCA1 Protein|BRCA1,Sporadic Breast Carcinoma,Other,0.0,0.0
AUGMENTS,Depo-Provera,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Stress, acute",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,3MC,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Malignant neoplasm of breast,Breast cancer metastatic,Other,0.3988,0.027972027972027972
CAUSES,Chemopreventive Agent,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Epoxy Compounds,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Methylcholanthrene,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Ibuprofen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Beta Carotene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ESRRA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ERBB2 gene|ERBB2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,specific immunity,Breast Carcinoma,Immunological Factors,0.0,0.027972027972027972
PREDISPOSES,Repressor Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Radioimmunotherapy,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,TIE gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Thyroid Hormone Receptor Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,HDAC1 gene|HDAC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Androgen Receptor|AR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ATM gene|ATM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Gelatinase A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,XRCC2 gene|XRCC2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Therapeutic procedure,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Kininogenase|KLK4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,EGFR gene|EGFR,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
CAUSES,Substance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ZHX2,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Sporadic Breast Carcinoma,Malignant neoplasm of breast,Other,0.0365,0.3386613386613387
PREDISPOSES,Oleic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GTPase-Activating Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CHEK2 gene|CHEK2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Telomerase,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,COMT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin-Like Growth-Factor-Binding Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cysteine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Estrogens, Synthetic",Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
CAUSES,Guanosine Triphosphate Phosphohydrolases,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,TP53 gene|TP53,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,Apple,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Hydrocarbons, Chlorinated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,parathyroid hormone-related protein,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Female genital tract problem,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fatty food,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Embolism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CHEK2 gene|CHEK2,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
CAUSES,Carcinoma of Male Breast,Malignant neoplasm of breast,Other,0.0253,0.3386613386613387
DISRUPTS,"SKIL protein, human|SKIL",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ADAM23,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"retinoic acid binding protein II, cellular",Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,CANADIAN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mass in breast,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Carcinoma, Lobular","Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
CAUSES,Medroxyprogesterone 17-Acetate,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Lignans,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BRCA1 Mutation,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
DISRUPTS,Prolactin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Mammary Neoplasms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BIRC5 gene|BIRC5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Creatinine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Mammary Tumorigenesis,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
AFFECTS,Hepatocyte Growth Factor|HGF,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"JARID1B protein, human|KDM5B",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Receptiveness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,pregnancy hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Recreation,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,peptide I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IGKV2D-40,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carbohydrates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of prostate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Hexachlorobenzene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HFE gene|HFE,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
CAUSES,Methylcholanthrene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Single-Stranded Conformational Polymorphism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Emotional support,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,WNT7B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Therapeutic procedure,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,Synucleins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Conjugated Equine Estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
DISRUPTS,beta-ionone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Androgen therapy,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,death receptor-4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Iodides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Tumor Protein p53 Binding Protein 2,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,Oncogenes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Paroxysmal atrial tachycardia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Endocrine Disruptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Estrogenic,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,Hyperglycemia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Carcinogens, Environmental",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Thrombospondin 1|THBS1|CRISP2|PRSS55,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Increase in blood pressure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Convenience food,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,AKR1C1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptor beta|ESR2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,EVL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogens,Breast cancer invasive NOS,Hormonal Factors,0.0,0.00999000999000999
PREDISPOSES,"Contraceptives, Oral",Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Fibrin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CHEST PATHOLOGY,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,CYP1A2 gene|CYP1A2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Transcription Initiation Site,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aggressive cancer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,connective tissue growth factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Dopamine Antagonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,WNT7B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Cyclic Peptides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Spray,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,N-Cadherins,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Antibiotics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,EGFR gene|EGFR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,HSP90 Heat-Shock Proteins|HSP90AA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Dairy Products,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SLC25A18,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Transcript,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,Female Breast Carcinoma,Other,0.3988,0.004995004995004995
PREDISPOSES,Climacteric discomfort,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Valine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Microdochectomy,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Molecular Chaperones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Trans Fatty Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Integrins,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,"Diabetes, Gestational",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,intestinal bacteria,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Prolactin level,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplasm Metastasis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor Suppressor Genes,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
DISRUPTS,ADRA1D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,IRS1 gene|IRS1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Pregnanes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Valine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carbon,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PRL increased,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Molecular Target,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PTH gene|PTH,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Tocotrienols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Biopsy,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,IGF1 gene|IGF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,E-Cadherin,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,allyl sulfide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP1B1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Antibiotics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Tetanus Vaccine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Biological Models,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mouse Pancreatic Intraepithelial Neoplasia-1B,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,"Estrogens, Catechol",Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
PREDISPOSES,Lymph Node Involvement,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Anti-Inflammatory Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Betaine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Platelet-Derived Growth Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,gamma-Glutamyl Hydrolase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Integrins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Endocrine Disruptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CD44 gene|CD44,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Matrix Metalloproteinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitamin B Complex,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mutation,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
DISRUPTS,BRMS1 gene|BRMS1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Disclosure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,phospholipid-hydroperoxide glutathione peroxidase,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
DISRUPTS,alpha-Fetoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SIRT7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tea intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TP53 gene|TP53,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,CATHEPSIN D|CTSD,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TP53 gene|TP53,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
AUGMENTS,Metalloproteases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Diethylstilbestrol,Breast Carcinoma,Behavioral Factors,0.0,0.027972027972027972
PREDISPOSES,Coronary heart disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Serotonin Uptake Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Pesticides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Detectors,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,XRCC1 gene|XRCC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Serine Protease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,prolylarginine|ABL2|RERE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CHEK2 gene|CHEK2,Contralateral breast cancer,Genetic Factors,0.0,0.001998001998001998
AFFECTS,Insulin|INS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PARP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cortisol level,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BRCA1 Protein|BRCA1,Familial cancer of breast,Other,0.0,0.003996003996003996
AFFECTS,NEK3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,EGFR gene|EGFR,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Thrombospondin 1,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Aldosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Anthracycline Antibiotics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CCNA2 gene|CCNA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Anti-Inflammatory Agents, Non-Steroidal",Breast cancer invasive NOS,Demographic Factors,0.0,0.00999000999000999
AFFECTS,Estrogen Receptor beta|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tumor Cell Invasion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,saturated fat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NES gene|NES,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,TRANSCRIPTION FACTOR,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,NPY1R gene|NPY1R,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,High Density Lipoprotein Cholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HGS gene|HGS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Ascorbic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FANCA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Actin bundling protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hypermethylation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Oligonucleotides,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Metabolic syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PGR gene|PGR,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
CAUSES,Cyproterone Acetate,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Malignant Neoplasms,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,"EPIDERMAL GROWTH FACTOR, HUMAN",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Development of the breasts,Breast cancer recurrent,Other,0.0,0.004995004995004995
CAUSES,PIN1,Sporadic Breast Carcinoma,Other,0.0,0.0
DISRUPTS,Alpha tocopheryl succinate,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Obesity,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,steroid hormone receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Guanosine Triphosphate Phosphohydrolases,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Alar,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ANXA1 gene|ANXA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,estradiol-17 beta-glucuronide,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,NF1 gene|NF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Receptors, Notch",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ERBB2 gene|ERBB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Organic Anion Transport Polypeptides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Nucleotides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Polyomavirus Middle T Antigens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Thymidine Phosphorylase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Study models,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hyperthyroidism,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,SLC25A4|CD5|IL1RL1|TRAPPC9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CENPH gene|CENPH,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,erlotinib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aging,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,lapatinib,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,Androgens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Carcinogens, Environmental",Sporadic Breast Carcinoma,Other,0.0,0.0
AUGMENTS,Mitogen-Activated Protein Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Telomerase,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,JAG2,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,PARP1|COL11A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CD27,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,"Estrogens, Catechol",Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
PREDISPOSES,Vanadium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cancer Treatment,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SPN|DEAF1|PPP1R9B,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,CLDN2 gene|CLDN2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Sex Behavior,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Estrogen Antagonists,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,BRCA1 gene|BRCA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,TWSG1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Enzyme variant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Development of the breasts,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,PIK3R1,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,CD24,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,dehydroepiandrosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Levonorgestrel,Breast cancer recurrent,Other,0.0,0.004995004995004995
DISRUPTS,Epicatechin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Vascular Endothelial Growth Factor C|VEGFA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SH3KBP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Double Strand Break Repair,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"TGFB1 protein, human|TGFB1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SLC9A3R1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MicroRNAs,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,LEPR gene|LEPR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Mutagens,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Homeostasis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ESR1 gene|ESR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Migraine Disorders,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mastication,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,2q35,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cell physiology,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Carcinogenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Sphingosine-1-Phosphate Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Nicotinic Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Angiogenesis,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,Insulin|INS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,8q24,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,src-Family Kinases|SRC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Microsatellite Repeats,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Increased estrogen level,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Oxidation-Reduction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MicroRNAs,Breast cancer recurrent,Other,0.0,0.004995004995004995
CAUSES,B3GNT2|B3GNTL1,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,FRAGMENTS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CD44 gene|CD44,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,FOXA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Elevated insulin-like growth factor I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,WWP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Calcium, Dietary",Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,High Mobility Group Proteins,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Calgranulin B|S100A9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BRAZILIAN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hydroxide Ion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Angiotensin-Converting Enzyme Inhibitors,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Adenosine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RAD51C gene|RAD51C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,6q22.33,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NF-kappa B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,brightness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,SPN|DEAF1|PPP1R9B,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,FHL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Leptin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Sodium Valproate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TOPBP1 Gene|TOPBP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Proteins,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,RPE65|UVRAG|TP63|CKAP4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Somatomedins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,epithelial to mesenchymal transition,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Enhancer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Phosphatidylethanolamine Binding Protein,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,PTPN11 gene|PTPN11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,cadherin 5,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,METHYLATE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,1-Phosphatidylinositol 3-Kinase,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AFFECTS,Disease,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,soy protein isolate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,SNAI2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen Receptor beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,patient family history,Familial cancer of breast,Other,0.0,0.003996003996003996
PREDISPOSES,Tamoxifen,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Sirolimus (substance),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MicroRNAs,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
CAUSES,Malignant neoplasm of cervix uteri,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"TNF protein, human|TNF",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Receptors, Cytoplasmic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mutation,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,MS4A1|BBS9|IGKV7-3|SPANXB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Very high,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Paraffin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RAB1B,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,PYRUVATE CARBOXYLASE|PC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Annexin A1|ANXA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,IL18,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Integral Membrane Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Arthralgia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PIAS1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Chemotaxis,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Lead compound,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,treatment method,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,betaine-homocysteine methyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CYP4Z1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,STAT3 gene|STAT3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PRICKLE1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Transfer RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PROTEIN KINASE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Choline dehydrogenase|CHDH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,N-ras Genes|NRAS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,saturated fat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Extravasation,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,IGF2BP2|IMMP2L|SPPL3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ABCG2 gene|ABCG2,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,furanodiene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Androgen Receptor|AR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PTEN gene|PTEN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,2q33,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Tumor Necrosis Factor Receptor Superfamily, Member 10B",Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Noninfiltrating Intraductal Carcinoma,Malignant neoplasm of breast,Other,0.0692,0.3386613386613387
AUGMENTS,IL33,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vascular Cell Adhesion Molecule-1,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,OTUD1,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Neurofibromin 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,BRCA1 gene|BRCA1,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,Annexin A3|ANXA3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,galangin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Environmental Estrogen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Processed meat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PALB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,tubeimoside I,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Sulindac,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PAQR3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,G-Protein-Coupled Receptors,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,RECQL gene|RECQL,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Trans-Activation (Genetics),Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Biological Response Modifiers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pyrimidine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SOX17,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Disease,Carcinoma in situ of breast,Other,0.0,0.001998001998001998
DISRUPTS,"DICER1 protein, human|DICER1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,myristoylated alanine-rich C kinase substrate,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Ovarian ablation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,IKBKB,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Secondary malignant neoplasm of lymph node,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Osteopenia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Extracellular Matrix Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RHOBTB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SYF2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Enhancer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CTSO,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dietary cholesterol intake,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,PK 11195,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TAF7L gene|TAF7L,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,IL8RB gene|CXCR2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,NEUROD1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Maternal history,Contralateral breast cancer,Other,0.0,0.001998001998001998
DISRUPTS,Diphosphonates,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Solid tumor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,KDM6A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Matrix Metalloproteinase Inhibitor,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,butylbenzyl phthalate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Prolactin,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Recombinant Interferon-gamma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BRD7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Myosin Light Chain Kinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pain relief,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Magnetic field,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Curcumin,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,STXBP4 gene|STXBP4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Treatment Protocols,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Extracellular Matrix Proteins,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,EGF gene|EGF,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,cyclopamine,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,GABPA|NFE2L2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,GTF2H1|SQSTM1|KHDRBS1|NUP62|DCTN4,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,sphingosine 1-phosphate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PRDM1 gene|PRDM1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,Iodine-131,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,XRCC1 gene|XRCC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Epigenetic Process,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Morphine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Triazoles,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MicroRNAs,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,recombinational repair,Sporadic Breast Carcinoma,Other,0.0,0.0
CAUSES,BMP4 gene|BMP4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,ADAMTS18,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,MAS1 gene|MAS1,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,Housekeeping Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,"Genes, Developmental",Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Birth length,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,beta catenin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Genes,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,WNT10B gene|WNT10B,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
CAUSES,Helminths,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIRN200A gene|MIR200A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PVT1 gene|PVT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,BRF1 gene|ZFP36L1|BRF1|MST1L,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,RECQL4 gene|RECQL4,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
CAUSES,RAB11FIP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,molecular chaperone GRP78,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of stomach,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Sirolimus (substance),Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,TCP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fibroblast Growth Factor Receptor 2|FGFR2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Vascular Endothelial Growth Factor C,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,EHMT2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MST1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ZEB2,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,FGFR1 gene|FGFR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,NF-kappa B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,pertuzumab,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Nelfinavir,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CDK6-associated protein p18,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Metastasis Suppressor Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,cucurbitacin B,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,imbalance,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Hypogonadism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,WBP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Atenolol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mammographic breast density,Breast cancer recurrent,Other,0.0,0.004995004995004995
AUGMENTS,STX3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Methylene blue,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,EIF4G2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,epigallocatechin gallate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mammary Neoplasms,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,SKP2 gene|SKP2,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
CAUSES,Reactive Oxygen Species,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,HIF1A,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,exemestane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,BCYRN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,chrysophanic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SRPK1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,capecitabine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Body Weight decreased,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,SRD5A2 gene|SRD5A2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Calcitriol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,proto-oncogene protein Spi-1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Biological Factors,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Neprilysin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,EIF4G1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cardiovascular event,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,resistin|RETN,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Monoclonal Antibodies,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,EZH2 gene|EZH2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cereals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NF-kappa B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor Suppressor Genes,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AUGMENTS,Estradiol,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,TCF4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,UGT2B4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,LATS1 gene|LATS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"RNA, Small Interfering",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,IQUB,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SYVN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Sponges, Gauze",Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,KLF5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,LIMK2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Luciferases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PCDH17,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CD8B1 gene|CD8B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,endogenous steroids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,POMC gene|POMC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,DLG5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Quercetin,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,CDK14,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Does stand,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Therapeutic agent (substance),Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,genetic locus,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,PMS2 gene|PMS2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TSLP gene|TSLP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TP53BP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ITGB2 gene|ITGB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,BIBR 1532,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Tumorigenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,extracellular signal-regulated kinase 3|MAPK6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Extracellular Matrix Proteins,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,MFN2 gene|MFN2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Insulin-Like Growth Factor I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,brca gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,REST gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,PKM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin-Like Growth-Factor Binding Protein 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,E2F1 gene|E2F1|UBE2L3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP17A1 gene|CYP17A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,RNF5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Membrane Transport Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SPRY4-IT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"PER2 protein, mammalian",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,cytokine,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Alkaloids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Eicosanoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Vision,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ADAM12,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,LINC01116,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TP53 gene|TP53,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,OIP5-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,polyphenols,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Blue light,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MIR195,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,phenyl ether,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Heparitin Sulfate,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
CAUSES,Study models,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Insulin-Like Growth Factor II|CD74|GCNT2|TCN2|VIPR1|TAF8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FAS gene|FAS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hesperidin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mutagens,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
DISRUPTS,PDK4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Garlic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Multiple Myeloma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Anesthesia procedures,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Soybeans,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cyclical mastalgia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NAT2 gene|NAT2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Yogurt,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,UGT8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nuclear Factor 45 Protein|ILF2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"DNA, Mitochondrial",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PSMD2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,antibody conjugate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GSTM2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sterol Regulatory Element Binding Protein 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,chemokine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,src-Family Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MYC gene|MYC,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,Chicken Meat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,S100A7,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,CD24,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYTH3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Interleukin-2,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,UGT1A1 gene|UGT1A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,2-chloroethyl ethyl sulfide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ERBB2 gene|ERBB2,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,Signal Transduction,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Flavonols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Alcoholic Beverages,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,Epidermal Growth Factor|EGF,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estrogenic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Depressed mood,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ZFHX3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Functional disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Intellectual functioning disability,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CD247,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Epidermal Growth Factor Receptor|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Transfer RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,gene therapy,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,lysophosphatidic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Measles-Mumps-Rubella Vaccine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,agonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,THBS1 gene|THBS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PIP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Loss of Heterozygosity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Smoke,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,WWOX,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,Deoxycholic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,polymorphic microsatellite markers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Epidermal Growth Factor Receptor|EGFR,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
CAUSES,cytokine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of endometrium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Menstrual cycle,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,dietary intervention,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Reliance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PSYCHIATRIC HISTORY,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,Neoplastic Processes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fibroblast Growth Factor Receptor 2|FGF7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"RNA, Messenger",Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,"DNA, Complementary",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Histamine H2 Antagonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Antipsychotic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
CAUSES,Hormones,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,ESR1 gene|ESR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,interleukin-23,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CXCL1 gene|CXCL1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Acetaminophen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diphosphonates,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Malignant neoplasm of breast,Female Breast Carcinoma,Other,0.3988,0.004995004995004995
CAUSES,benzanthracene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GSTM1 gene|GSTM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,BP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,adjuvant therapy,Contralateral breast cancer,Other,0.0,0.001998001998001998
AFFECTS,Disease Progression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Radiation therapy,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,Strenuous Exercise,Carcinoma in situ of breast,Behavioral Factors,0.0,0.001998001998001998
PREDISPOSES,EGR1 gene|EGR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Gel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptors,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Malignant Neoplasms,Familial cancer of breast,Other,0.0,0.003996003996003996
PREDISPOSES,"Insulin, Glargine, Human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Zinc,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,IL13Ralpha2,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Ataxia Telangiectasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Analgesics,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Insulin Receptor|INSR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immune response,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
AFFECTS,Calcium Channel Blockers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,alcohol effect,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BRCA1 gene|BRCA1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
CAUSES,Ovarian Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Female Homosexuality,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Proto-Oncogene Protein pp60 (c-src)|SRC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,delta-hexachlorocyclohexane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Manganese Superoxide Dismutase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Receptor Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,DPF3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cytochrome P-450 CYP1A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Personality Traits,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Paraoxonase 1|PON1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hydroxyestrones,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,checkpoint kinase 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,HMGB1 gene|HMGB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,HSD11B1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Growth Factor,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,DNA Methylation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ZNF217 gene|ZNF217,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Tenascin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IRS1 gene|IRS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CXC Chemokines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Organic solvent product,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,Simvastatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,bevacizumab,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Ethanol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Inflammation Process,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Moderate Exercise,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Uniparental Disomy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Rubidium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,19p13.1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Injection procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Plasminogen Activator Inhibitor 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sitting height,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,JNK Mitogen-Activated Protein Kinases|JUN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,E2F3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,polyphenols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BRCA1 gene|BRCA1,Contralateral breast cancer,Genetic Factors,0.0,0.001998001998001998
PREDISPOSES,6/4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,capecitabine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Heme Oxygenase-1,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Pregnancy,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Metric,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Insulin|INS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CpG Islands,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RABGEF1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,participation,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,FLOT2 gene|FLOT2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Behavior,Familial cancer of breast,Behavioral Factors,0.0,0.003996003996003996
AFFECTS,Thromboembolism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,response,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,NBN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Chronic lymphocytic inflammation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Organic Food,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HFE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"APEX1 protein, human|APEX1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RRM2 gene|RRM2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Chemotherapy-Oncologic Procedure,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Enrich,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ERBB2 gene|ERBB2,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,Nipple discharge NOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Symptoms,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,Hair Dyes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Histopathology,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Renin-angiotensin system inhibition,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,MAP Kinase Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Autoantibody NOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neutropenia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Decalcification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Asthenia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Nicotine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sulfonylurea Compounds,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Protein-Serine-Threonine Kinases,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
CAUSES,Cyclin D1|CCND1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pharmacotherapy,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Vitamin D-Binding Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ursolic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Physical activity,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,NANOG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breastfeeding performance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CHEK2 gene|CHEK2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,TRAN gene|TRA-TGC7-1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Overweight,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Estrogens,Breast cancer metastatic,Hormonal Factors,0.0,0.027972027972027972
PREDISPOSES,Depressive Symptoms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,receptor for advanced glycation endproducts,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Anorexia Nervosa,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,crocetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,AKT1 gene|AKT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,delphinidin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Common wart,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,apolipoprotein D|APOD,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Inflammation,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,LAPTM4B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,COPS5,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"Breast Feeding, Exclusive",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,everolimus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Xenograft Model,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Radiation-Induced Change,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Stress,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Self-Examination,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Breast neoplasm screening,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BRCA1 gene|BRCA1,Female Breast Carcinoma,Genetic Factors,0.0,0.004995004995004995
AFFECTS,Multiple alleles,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Deficient knowledge,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CLCN3 gene|CLCN3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ethylmalonic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,HTATIP gene|KAT5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Taurine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Genes,Female Breast Carcinoma,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,Menopausal Status,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Angiotensin-Converting Enzyme Inhibitors,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Benzodiazepines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Untranslated Regions,Breast cancer recurrent,Other,0.0,0.004995004995004995
DISRUPTS,LINC01585,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MGMT gene|MGMT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Natural Products,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Physical activity,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Ibuprofen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Serine Protease,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Emergency contraception,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Carbon ion,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Prognostic Factor,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Chemical Exposure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,vitamin supplement,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,coenzyme Q10,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MicroRNAs,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Verbal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Genes,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,PGR gene|PGR,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,CCDC6 gene|CCDC6,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
CAUSES,BRCA2 gene|BRCA2,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,Personal Satisfaction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Oligonucleotide Arrays,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hot water,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Methotrexate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Consanguinity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Verbal,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Ions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BLM gene|BLM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Tamoxifen,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,DMBT1 gene|DMBT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,TBX3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Multiple Sclerosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Positron-Emission Tomography,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Noninfiltrating Intraductal Carcinoma,Breast cancer invasive NOS,Other,0.0692,0.00999000999000999
PREDISPOSES,Human Chorionic Gonadotropin|CGA|HTC2|CGB5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Steroidal Aromatase Inhibitor,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,"Obesity, Morbid",Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,perfluorooctanoic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,F2RL1|NR1I2|SLC52A1,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
CAUSES,Arginine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Rheumatoid Arthritis,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,NFKB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,letrozole,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,GHRL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MATP gene|SLC45A2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,BRCA1 gene|BRCA1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Animal fat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP19A1 gene|CYP19A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Dietary Carbohydrates,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,peroxiredoxin I|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GHSR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,NBS1 gene|NBN|NLRP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Estrone sulfotransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Recombinant Interferon-gamma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,[V]Follow-up examination,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Diphosphonates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breasts asymmetrical,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Long chain fatty acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Interleukin-2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,HSD17B6,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Positive Lymph Node,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,XRCC5 gene|XRCC5,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
DISRUPTS,Epidermal Growth Factor Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Steryl-sulfatase|STS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Triglycerides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Membrane Glycoproteins,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Systemic Scleroderma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breast composition,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LHX1 gene|LHX1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,density,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Infection,Malignant neoplasm of breast,Herpetic Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Life Style,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PGRMC1 gene|PGRMC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PIWIL2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ANLN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ethnic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gynecomastia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NAT2 gene|NAT2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,WWC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Adverse effects,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,pertuzumab,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Behcet Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carrier of disorder,Contralateral breast cancer,Other,0.0,0.001998001998001998
AUGMENTS,"Polycyclic Hydrocarbons, Aromatic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Egg Food Product,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Whole-Brain Radiotherapy,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Perceived comfort level,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Glutamate Dehydrogenase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Anovulation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,phenylpyruvate tautomerase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Ovarian Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FANCM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Invasive Malignant Neoplasm,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,tibolone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,chemokine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Obesity,Breast cancer recurrent,Other,0.0,0.004995004995004995
AUGMENTS,CCAT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Levonorgestrel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Free testosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mimicry,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Operative Surgical Procedures,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
DISRUPTS,1-Phosphatidylinositol 3-Kinase|PI3,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
DISRUPTS,Vaccines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Sclerosis,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,flavan-3-ol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Breast cancer invasive NOS,Noninfiltrating Intraductal Carcinoma,Other,0.0587,0.01098901098901099
CAUSES,MME gene|MME,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MicroRNAs,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Lignans,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Galectin 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gene Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PARK7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,alpha Tocopherol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Excision,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Endocrine therapy,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Protein Overexpression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen receptor negative,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,BRCA2 Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Gall Bladder Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,STAT5A gene|STAT5A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PTEN gene|PTEN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Calcium Channel Blockers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ionizing radiation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin-Like Growth Factor I|INS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Polyunsaturated Fatty Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Carcinoma,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Lignans,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Bleomycin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Testosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MSH6 gene|MSH6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Suspensions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Coronary Arteriosclerosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alcoholic Beverages,Breast cancer recurrent,Demographic Factors,0.0,0.004995004995004995
PREDISPOSES,Maternal Mortality,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Reaction emotional,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sulfonylurea Compounds,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Neoplasm,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,KDM4A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"7,3'-dihydroxy-4'-methoxyisoflavone",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cerebrovascular accident,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Undifferentiated carcinoma of ovary,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,glutathione S-transferase M1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,brca gene,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,MDM4,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,FOXM1 gene|FOXM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,KPNA2,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,cytotoxicity,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Positive Finding,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MFG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Diethylstilbestrol,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,desires,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Prolactin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,bufadienolide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tamoxifen,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,PGK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carcinoembryonic Antigen|CEACAM5,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,ZNHIT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SEMA3C,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,beta catenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Amino Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Little's Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ginsenoside Rk1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Physiological Processes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Pimozide,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,ZNF423,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,RNA Sequence,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Antidiabetics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,HIF1alpha protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Adriamycin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Glucose,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,caveolin 1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,ZNHIT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SNHG7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MALAT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SOX8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MIRN106A gene|MIR106A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,CXCR4 gene|CXCR4,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,Epidermal Growth Factor Receptor|EGFR,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Myocardial Ischemia,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,phthalates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Leucine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CDC2 gene|CDK1|POLD1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Cancer-Predisposing Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ERBB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,shikonin,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,NFE2L3,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,lysyllysine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,G3BP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CBX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Interleukin-4,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,Monomeric GTP-Binding Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PPM1D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Mitomycin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Luteolin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Endocrine System Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cell motility,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,ataxia telangiectasia mutated protein|ATM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,glutathione S-transferase M1|GSTM1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Xenobiotics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,9-deoxy-delta-9-prostaglandin D2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Liposomes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,activated RNA polymerase II transcription cofactor 4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HGS gene|HGS,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
CAUSES,Cadmium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Formaldehyde,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Natural Products,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Phenols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,preference,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PIK3R1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LINC00339,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,VIRMA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,VIRMA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Compete,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Platelet-Derived Growth Factor beta Receptor|PDGFRB,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"3,4-Methylenedioxyamphetamine",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Single Nucleotide Polymorphism,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,Bariatric Surgery,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Integrin alphaVbeta3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,IDO1,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,kaempferol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Nephroblastoma,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Diphenylamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Homologous Gene,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,SERPINI2 gene|SERPINI2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,centromere protein F,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Aging-Related Process,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,anillin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"PTTG1 protein, human|PTTG1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Poly(ADP-ribose) Polymerases|WDTC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FBXL19-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Treatment Protocols,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Polychlorinated Biphenyls,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TAGLN2 gene|TAGLN2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,gadoterate meglumine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PCB 138,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Antipsychotic Agents,Carcinoma in situ of breast,Demographic Factors,0.0,0.001998001998001998
PREDISPOSES,SLC4A11,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Antioestrogen therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,UDP-Glucuronosyltransferase 1A1|SLC45A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pigment,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mitochondrial Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Formance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CHD4 gene|CHD4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,gambogic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,RPS27 gene|RPS27,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FAS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,hippo signaling,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,BARD1 gene|BARD1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,cholecalciferol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,food product,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Functional RNA,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Albendazole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Activator,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Interleukin-17,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hydrogel,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Glioblastoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Untranslated Regions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LINC-ROR gene|LINC-ROR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TTN-AS1 gene|TTN-AS1,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
PREDISPOSES,"MMP14 protein, human|MMP14",Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,RASAL2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,small molecule,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Profilins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,HAND2-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Lipid Peroxides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pre-op diagnosis,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,HSPA5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SOX2 Transcription Factor|SOX2,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Letter:Finding:Point in time:{Setting}:Document:{Provider},Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP27A1 gene|CYP27A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ENO1 gene|ENO1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,BRCA2 Gene Mutation,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
AFFECTS,rosemary extract,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Fatty Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hormone use,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RESF1 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Integrin alpha3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PPEF1 gene|PPEF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,HDAC5 gene|HDAC5,Malignant neoplasm of female breast,Genetic Factors,0.0,0.0
AFFECTS,Colorectal Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP7B1 gene|CYP7B1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PAK2 gene|PAK2|PKN2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,socioeconomic differences,Malignant neoplasm of breast,Socio-economic Factors,0.0,0.3386613386613387
AFFECTS,epigallocatechin gallate,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,FTSJ3 gene|FTSJ3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"SFRP1 protein, human|SFRP1",Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Alternative Splicing,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"CD69 protein, human|CD69",HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,GACAT3 gene|GACAT3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Adriamycin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,SPRY4-IT1 gene|SPRY4-IT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,KLK12 gene|KLK12,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,"GOLPH3 protein, human|GOLPH3",Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Underlying,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Microsatellite Instability,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,prolactin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,USP43 gene|USP43,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,"CEACAM5 protein, human|CEACAM5",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TRIP6 gene|TRIP6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,mica,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Detection,Early-Stage Breast Carcinoma,Other,0.0,0.0
AFFECTS,paclitaxel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ERR1 protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immune response,HER2-positive carcinoma of breast,Immunological Factors,0.0,0.008991008991008992
DISRUPTS,FOXN4 gene|FOXN4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Soluble fiber (substance),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,High expression,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,leptin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"CD69 protein, human|CD69",Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,MYCN gene|MYCN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Transforming Growth Factor alpha,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Chemotherapy, Adjuvant",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,inhibitors,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Genome,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,ATM,contralateral breast cancer,Other,0.0,0.002997002997002997
AUGMENTS,glypican 4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PTTG1 gene|PTTG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Adipokines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lectin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CTCb regimen,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,lumican,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,doxorubicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SOAT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tissue-factor-pathway inhibitor 2|TFPI2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NEAT1 gene|NEAT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FOXM1 gene|FOXM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Marital Status,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AUGMENTS,MYC,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,SLCO6A1|GSTK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gestational Diabetes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CERNA2 gene|CERNA2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,"TP53BP1 protein, human|TP53BP1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,interleukin-4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CBR3-AS1 gene|CBR3-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ALKBH5 gene|ALKBH5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,BET Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen Receptor alpha,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Diagnostic Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Integrin alpha5,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,IMPACT gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ECE1 gene|ECE1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,lovastatin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Invasive Carcinoma,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,XRCC3 gene|XRCC3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Angiogenic Process,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,GKLF protein,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,PRR14 gene|PRR14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,GKLF protein,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Equol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,hexane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,RNA-Binding Protein Musashi Homolog 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Account number:Identifier:Point in time:^Patient:Nominal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,KIF15 gene|KIF15,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,bisphenol A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,D Vitamin,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,FZR1 wt Allele|CDH1,"Breast Cancer, Familial",Other,0.0,0.0
PREDISPOSES,LINC00707 gene|LINC00707,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,FGFR1 wt Allele|FGFR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Abnormal metabolism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,aquaporin 7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,COTL1 gene|COTL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,GPX3 gene|GPX3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Herbicides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,caspase-3|CASP3,Luminal B Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,"SLC16A3 protein, human|SLC16A3",Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Pivot,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,NME1 gene|NME1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,erastin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Metastatic malignant neoplasm to brain,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Anti-Inflammatory Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
CAUSES,Tumor Progression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TNIP2 gene|TNIP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,acetylglucosamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Alternative Splicing,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,purpurin 18,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,hesperetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Geldanamycin Analogue,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,XIST gene|XIST,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Flavonols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ado-trastuzumab emtansine|DMPK|IGHD1-7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Dysbiosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Therapeutic Effect,malignant neoplasm of breast staging,Other,0.0,0.0
PREDISPOSES,Matrix Metalloproteinase 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fatty-acid synthase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mucin-1 Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,aspirin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,OIP5-AS1 gene|OIP5-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hyperlipidemia,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,Sexual function,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Diagnostic radiologic examination,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CERNA2 gene|CERNA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Diphosphonates,Early-Stage Breast Carcinoma,Other,0.0,0.0
CAUSES,Viral Tumor Antigens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"RNA, Circular",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Disease Progression,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,CMTM5 gene|CMTM5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ethanol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIR22 wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Serum Proteins,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,arbutin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Diet high in saturated fats,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,MSH2 gene|MSH2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PCNAP1 gene|PCNAP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,aspirin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FOSL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LINC00346 gene|LINC00346,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Signaling Protein,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
CAUSES,YTHDF1 gene|YTHDF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ANGPTL4 gene|ANGPTL4,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Negative Regulation of Apoptosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CD8A wt Allele|CD8A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,sunitinib,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,brazilin,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,cyclooxygenase 2|PTGS2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RAD21 gene|RAD21,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,DYRK2 gene|DYRK2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Interpretation:Impression/interpretation of study:Point in time:^Patient:Nominal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,prolactin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,leptin,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,TT genotype,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Water consumption,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AUGMENTS,Vitronectin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Product containing glucagon-like peptide 1 receptor agonist (product),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CYP27B1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIR100HG gene|MIR100HG,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,diethylstilbestrol,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
DISRUPTS,Biological Response Modifiers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Sphingomyelins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Infiltration,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,Thyroid Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,melatonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Acetylserotonin N-Methyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Sleeve,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MicroRNAs,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Rheumatoid Arthritis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MicroRNA 205-5p,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Cyclin-Dependent Kinase Inhibitor p16|CDKN2A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,periodate-oxidized adenosine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Nicotinamide Phosphoribosyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Acidosis,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Intercellular adhesion molecule 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,KIF15 gene|KIF15,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,Erythropoietin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,K-ras Oncogene|KRAS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Breast Imaging Reporting and Data System,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,DNMT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diagnosis,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AFFECTS,Circulating Tumor DNA,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,ciclesonide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,cisplatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,paclitaxel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,NRG1 gene|NRG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Ryanodine Receptor 3|RYR3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PPP2R2B gene|PPP2R2B,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,FN1 gene|FN1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,patient characteristics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Weight decreased,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,amygdalin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GPM6B gene|GPM6B,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,HHEX gene|HHEX,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Copy Number Polymorphism,"Breast Cancer, Familial",Other,0.0,0.0
DISRUPTS,SOY ISOFLAVONES,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,verteporfin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,High expression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Apoptosis Inducing Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BTF3 gene|BTF3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Metastatic malignant neoplasm to brain,Carcinoma breast stage IV,Other,0.0,0.0
CAUSES,butein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ST8SIA6-AS1 gene|ST8SIA6-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,si-wu-tang,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,"ITK protein, human|ITK",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,A2M-AS1 gene|A2M-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Matrix Metalloproteinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant Neoplasms,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,MIR22HG gene|MIR22HG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Bilateral mastectomy,Unilateral Breast Carcinoma,Other,0.0,0.0
AFFECTS,CBR3-AS1 gene|CBR3-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,27-hydroxycholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,paclitaxel,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Detection,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,DSCAM-AS1 gene|DSCAM-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PGK1 gene|PGK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Neuropeptides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tumor size,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,EZH2 gene|EZH2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Diphosphonates,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
CAUSES,interleukin-10,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,"WFDC2 protein, human|WFDC2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Proliferation (morphologic abnormality),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,testosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SMAD2 gene|SMAD2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,IL6ST gene|IL6ST,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,COVID-19,Early-Stage Breast Carcinoma,Other,0.0,0.0
DISRUPTS,TRIM6 gene|TRIM6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"UBASH3A protein, human|UBASH3A",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PALB2 gene|PALB2,Hereditary Breast and Ovarian Cancer Syndrome,Genetic Factors,0.0,0.0
PREDISPOSES,"CD69 protein, human|CD69",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,YY1 gene|YY1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LAGE3 gene|LAGE3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,LINC00885 gene|LINC00885,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,CCL5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mutation,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
PREDISPOSES,ZNF385B gene|ZNF385B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Pain relief,Early-Stage Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Connexin 43|GJA1,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,CHFR gene|CHFR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,pristane,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,ruthenium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,tripterine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Secondary malignant neoplasm of bone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Trans Fatty Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IL20RA gene|IL20RA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Health behavior,"Breast Cancer, Familial",Behavioral Factors,0.0,0.0
PREDISPOSES,paclitaxel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Functional Status,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Phosphatidylinositide 3-Kinase Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,AQP5 gene|AQP5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,LINC00511 gene|LINC00511,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,MDM2 gene|MDM2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,Transforming Growth Factor beta,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,"FRAP1 protein, human|MTOR",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,OLFML2A gene|OLFML2A,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Basis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gene Mutant,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,High Level,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,Volatile Organic Compounds,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,USP6NL gene|USP6NL,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,"Transcription, Genetic",HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
AFFECTS,Tumor Microenvironment,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,HOXB5 gene|HOXB5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Gamma-glutamyl transferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hormone Therapy,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,MTUS1 gene|MTUS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,SF3B3 gene|SF3B3,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,cytokine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,IMPACT gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,"LCN2 protein, human|LCN2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ATP5F1B gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Breast Cancer Prognostic Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Discoidin Domain Receptor 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,polyphenols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Photochemotherapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen Receptor 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoantigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Diuretics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Long Intergenic Non-Protein Coding RNA,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,Transcript,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,arsenic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Matrix Metalloproteinases,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Pills,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Autoimmune Diseases,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
AFFECTS,antagonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,paracrine,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Radiation,Early-Stage Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,GA-Binding Protein Transcription Factor|GABPA|NFE2L2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ferroptosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Candidate Disease Gene,Recurrent Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,Central Serous Chorioretinopathy,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,triclosan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cyclin E,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RAD51 gene|RAD51,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"HIF1A protein, human|HIF1A",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,high density lipoprotein binding protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,HOXB7 gene|HOXB7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Pathologic Complete Response,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,paclitaxel,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Tobacco smoking behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Infiltration,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PIR gene|PIR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CDC25C gene|CDC25C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,progesterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CLEC2D gene|CLEC2D,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,sirolimus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"MEN1 protein, human|MEN1",estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Brominated Diphenyl Ethers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ACSL4 gene|ACSL4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Flap Endonuclease-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,IDO1 gene|IDO1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Immune response,Triple Negative Breast Neoplasms,Immunological Factors,0.0,0.01898101898101898
PREDISPOSES,>40 years,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cyclin-Dependent Kinases,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,DPP3 gene|DPP3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,niclosamide,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
CAUSES,PQBP1 gene|PQBP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Antihypertensive Agents,HER2-positive carcinoma of breast,Demographic Factors,0.0,0.008991008991008992
PREDISPOSES,Responsive Disease,Locally advanced breast cancer,Other,0.0,0.0
PREDISPOSES,CEP295 gene|CEP295,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,tissue polypeptide specific antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,beta catenin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,PBXIP1 gene|PBXIP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Pyroptosis,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Duration,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Axillary node METASTASIS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIR655 gene|MIR655,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,LOC105371267,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ITGA2B wt Allele|ITGA2B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Pathogenic Variant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"E2F1 protein, human|E2F1|UBE2L3",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,phthalates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplasm,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,CATHEPSIN D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Possible,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,IL27 gene|MYDGF|IL27,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,AZD4547,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Gene Mutant,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,GANT 61,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MARCHF5 gene,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,GLI1 gene|GLI1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LGALS8-AS1 gene|LGALS8-AS1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Body mass index procedure,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,Liposomes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Drug resistance,Carcinoma breast stage IV,Other,0.0,0.0
CAUSES,HOXD9 gene|HOXD9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Immunologic Adjuvants,Noninfiltrating Intraductal Carcinoma,Immunological Factors,0.0,0.01098901098901099
AFFECTS,Genome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,POTEH-AS1 gene|POTEH-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,STAT3 gene|STAT3,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AUGMENTS,FAM111B gene|FAM111B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Growth Differentiation Factor 15|PAEP,Early-Stage Breast Carcinoma,Other,0.0,0.0
DISRUPTS,AR gene|AR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Decreased translucency,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Performance,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,TSPAN1 gene|TSPAN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,astaxanthin,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,Hypoxia-Inducible Factor 1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Elevated Expression,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,KLF5 gene|KLF5,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
AFFECTS,SETDB1 gene|SETDB1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,"RNA, Circular",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,"TNFSF10 protein, human|TNFSF10",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"WNK1 protein, human|WNK1",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,ENPP1 gene|ENPP1,Recurrent Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,METTL14 gene|METTL14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,NDUFV1 gene|NDUFV1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Hydrogel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NOLC1 gene|NOLC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Resistance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AMACR wt Allele,Female Breast Carcinoma,Other,0.0,0.004995004995004995
DISRUPTS,ADRB2 gene|ADRB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"SEP15 protein, human|SELENOF",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HOXC-AS3 gene|HOXC-AS3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Mutant Proteins,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,AA genotype,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Architectural Distortion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,EPB41L4A-AS1 gene|EPB41L4A-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Genomic Instability,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Consideration,"Breast Cancer, Familial",Other,0.0,0.0
PREDISPOSES,Circulating Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Elevated Expression,Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,KCNQ1OT1 gene|KCNQ1OT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,GA-Binding Protein Transcription Factor|GABPA|NFE2L2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,endosulfine,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Hormone Receptor,Recurrent Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,fusion transcript,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,YTHDF1 gene|YTHDF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Protein Subunits,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,COVID-19,malignant neoplasm of breast staging,Other,0.0,0.0
PREDISPOSES,PPP1R14C gene|PPP1R14C,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Ovarian hyperstimulation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,brazilian,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Breast Cancer Therapeutic Procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Healthy Lifestyle,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,choline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NFIB gene|NFIB,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Pathogenic Variant,"Breast Cancer, Familial",Other,0.0,0.0
AUGMENTS,fluvastatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RAC2 gene|RAC2,estrogen receptor-negative breast cancer,Genetic Factors,0.0,0.0
PREDISPOSES,interleukin-6,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,GSDMB gene|GSDMB,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,Immune,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
PREDISPOSES,Hypercholesterolemia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,LINC00092 gene|LINC00092,Invasive Ductal Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,"Sleep Apnea, Obstructive",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HMMR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AFFECTS,Agent,Triple Negative Breast Neoplasms,Demographic Factors,0.0,0.01898101898101898
PREDISPOSES,Organic solvent product,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AFFECTS,DDX5 gene|DDX5,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,Pharmacologic Substance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,1 time,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,secretory protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MDM2 gene|MDM2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Alcohol consumption,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,"IL17A protein, human|IL17A",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LINC00472 gene|LINC00472,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Diffusion Kurtosis Imaging,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,CCNB2 gene|CCNB2,Stage 0 Breast Cancer AJCC v6 and v7,Genetic Factors,0.0,0.0
CAUSES,Adenocarcinoma in Situ,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Carcinoma, Lobular","Breast Cancer, Familial",Other,0.0,0.0
AFFECTS,anastrozole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"CD69 protein, human|CD69","Breast Cancer, Familial",Other,0.0,0.0
AUGMENTS,RBMS1 gene|RBMS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Tea without milk,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,genetic risk factors,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Infantile Neuroaxonal Dystrophy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,doxorubicin liposome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,sigma-2 receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SNHG3 gene|SNHG3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,HMGB1 gene|HMGB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Biological Processes,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,Gene Silencing,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,False Positive,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Multifactorial,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MEDAG gene|MEDAG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,GTF2H1 gene|GTF2H1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Post-mastectomy radiotherapy,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,PIK3CA gene|PIK3CA,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,"Antibodies, Bispecific",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,FBXW7 gene|FBXW7,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AUGMENTS,CCL3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mitochondrial mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Basis,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,MIR191 wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GLI4 gene|GLI4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Convenience food intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cancer Therapeutic Procedure,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,PEDS1 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Monoclonal Antibodies,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,fluoxetine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,canagliflozin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,PAFAH1B1 gene|PAFAH1B1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Proto-Oncogene Protein c-kit,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,CCDC102B gene|CCDC102B,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,RACK1 gene|RACK1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Imbrication (procedure),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,catalpol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"RNA, Untranslated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Score,Early-Stage Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Transsexual (finding),Secondary malignant neoplasm of breast,Demographic Factors,0.0,0.002997002997002997
PREDISPOSES,Responsive Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"IL17A protein, human|IL17A",Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,ZNF276 gene|ZNF276,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Antioxidants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Anabolism,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,TIMM8A gene|TIMM8A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Estrus,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,METTL3 gene|METTL3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,FER1L4 gene|FER1L4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Vitamin D Deficiency,Malignant neoplasm of female breast,Other,0.0,0.0
AUGMENTS,UBE2C gene|UBE2C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,diltiazem,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
DISRUPTS,resveratrol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FRG1 gene|FRG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,NF2 gene|NF2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Observation parameter,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Emodin,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,Clinical Significance,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,"PIK3CB protein, human|PIK3CB",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,METTL14 gene|METTL14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,N-acetyltransferase 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,progesterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Selective Estrogen Receptor Down Regulator,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,water channel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diffusion weighted imaging,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,ARL11 gene|ARL11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
COMPLICATES,MIR217 gene|MIR217,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ERBB2 Overexpression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FOXN3 gene|FOXN3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,ellagic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Retinol-Binding Proteins, Cellular",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cancer-Related Death,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,Cell-Free DNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Duration,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,Risk Scores,contralateral breast cancer,Other,0.0,0.002997002997002997
PREDISPOSES,Present,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,1-Phosphatidylinositol 3-Kinase,HER2-positive carcinoma of breast,Hormonal Factors,0.0,0.008991008991008992
AFFECTS,"neoisoliquiritin, (E)-isomer",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Phosphotransferases,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Matrix Metalloproteinase 9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,HDAC7 gene|HDAC7,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,IGF2BP2 gene|IGF2BP2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,BCL2A1 gene|BCL2A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cell Cycle Arrest,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,GNAS gene|GNAS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,arginylproline|ABL2|RERE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,hexanoic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Antipsychotic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Tripe,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RMI2 gene|RMI2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Candidiasis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SCAMP3 gene|SCAMP3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SPC25 gene|SPC25,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,"RNA, Circular",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,KDM4A gene|KDM4A,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
AFFECTS,Treatment Protocols,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Neuregulin 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pharmaceutical Preparations,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,LBH589,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CBX7 gene|CBX7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PRAF2 gene|PRAF2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Histone H3 Lysine 27,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Low Level,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,paclitaxel,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,"WWTR1 protein, human|WWTR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Malignant neoplasm of breast,Secondary malignant neoplasm of breast,Other,0.3988,0.002997002997002997
PREDISPOSES,Genetic Loci,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ANTXR1 wt Allele|ATR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Genes,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
AFFECTS,FKBP12-rapamycin associated protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ROS1 wt Allele|ROS1,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,Mitophagy,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,"FABP1 protein, human|FABP1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,gamma-aminobutyric acid,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
CAUSES,Mouse mammary tumor virus infection,Malignant neoplasm of breast,Herpetic Genetic Factors,0.0,0.3386613386613387
AFFECTS,chaperone-mediated autophagy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dairy Products,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen receptor positive,estrogen receptor-negative breast cancer,Other,0.0,0.0
AFFECTS,Neoadjuvant Therapy,Early-Stage Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,KAT7 gene|KAT7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Anxiety,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,stanniocalcin 2|STC2,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,RNF43 gene|RNF43,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,Secondary Neoplasm,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,SLC2A1 gene|SLC2A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,F-Actin,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,CPVL gene|CPVL,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Vegetarian diet,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
CAUSES,TMEM105 gene|TMEM105,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,SIRT7 gene|SIRT7,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
DISRUPTS,SNRPC gene|SNRPC,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,Biological Response Modifiers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,estradiol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RHD gene|RHD,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MYC,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,STAT1 gene|STAT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Axillary node METASTASIS,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,SNRPC gene|SNRPC,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,HHEX gene|HHEX,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,polyphenols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Kanglaite Injection,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,SIRT7 gene|SIRT7,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
PREDISPOSES,SDC1 gene|SDC1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,"RNA, Long Untranslated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Marital Status,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,CARD.RISK,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Agent,Carcinoma breast stage IV,Demographic Factors,0.0,0.0
CAUSES,human papillomavirus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,kaempferol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,dydrogesterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Ribonucleoprotein, U1 Small Nuclear",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,USP29 gene|USP29,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,"Galanin peptides, human (123 aa, ~13 kDa)",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NDC80 gene|NDC80,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Inflammatory Response,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KLF2 gene|KLF2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Luteolin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,"PDCD1 protein, human|PDCD1",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Magnetic Resonance Imaging,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,copper,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,VEGFA gene|VEGFA,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Negative Surgical Margin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Agonist,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GAS5 gene|GAS5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,NUCB2 gene|NUCB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Mouse mammary tumor virus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ZEB1 gene|ZEB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Oligonucleotides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Betaretrovirus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,stanniocalcin 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Methylnitrosourea,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,epithelial to mesenchymal transition,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,CDH12 gene|CDH12,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Pharmacotherapy,HER2-negative breast cancer,Other,0.0,0.0
CAUSES,Invasive Ductal Breast Carcinoma,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,RNA-Binding Protein Musashi Homolog 2,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,16 alpha-hydroxyestrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,hydrocortisone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ectonucleotide pyrophosphatase phosphodiesterase 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,oxybenzone,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Menstrual period late,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pediatric Obesity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,lysine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NR2F1-AS1 gene|NR2F1-AS1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,MCM6 gene|MCM6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Psoriasis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MAP7D3 gene|MAP7D3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,DEGS1 wt Allele|DEGS1,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Pharmacotherapy,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AFFECTS,polyphyllin D,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,tocopherol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SPDEF gene|SPDEF,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,FAM171A1 gene|FAM171A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,olive oil,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Poly(ADP-ribose) Polymerase Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HNRNPA2B1 gene|HNRNPA2B1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,EYA4 gene|EYA4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Parafibromin|CDC73,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RHOV gene|RHOV,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,LINC01140 gene|LINC01140,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Tumor Progression,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,"TNFSF10 protein, human|TNFSF10",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoadjuvant Therapy,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,TYMSOS gene|TYMSOS,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Mutation,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
DISRUPTS,Glycoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ligands,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,CD69,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Life Expectancy Less than Five Years,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Decreased Expression,Early-Stage Breast Carcinoma,Other,0.0,0.0
DISRUPTS,Phenols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,medroxyprogesterone acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SEMA3B-AS1 gene|SEMA3B-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Anti-HER2 Monoclonal Antibody|ERBB2,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,C-reactive protein,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,MIR122 gene|MIR122,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MAF1 gene|MAF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Toll-Like Receptor 1, human|TLR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,perfluorooctanoic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Oncogenes,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
AUGMENTS,CD82 gene|CD82,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Biological Markers,Stage 0 Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Matrix Metalloproteinases,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,Carbohydrates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ketogenic Diet,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,MicroRNA Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PSMD14 gene|PSMD14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LINC00702 gene|LINC00702,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Phytochemicals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DNPH1 gene|DNPH1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,IMPA2 gene|IMPA2,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
DISRUPTS,FBXO3 gene|FBXO3,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Cell Survival,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,OLT1177,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Neuroleptic Malignant Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,beta catenin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Crohn Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HMGB3 gene|HMGB3,Invasive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
AFFECTS,Tumor Markers,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,"COPEB protein, human|KLF6",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,quercetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Secondary Neoplasm,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Cardiorespiratory Fitness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"PIK3CB protein, human|PIK3CB",Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,Radiation-Sensitizing Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,STMN1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Waist Circumference,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,olaparib,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,Mammographic Breast Density,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,PALMD gene|PALMD,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,1+,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,NOTCH3 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Ferroptosis,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,CELSR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,WASF3 gene|WASF3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Rhythm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Thrombospondin 1,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Dormancy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIR203A gene|MIR203A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,lutein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Secondary malignant neoplasm of liver,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Macrophage Activation Syndrome,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Diagnosis,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Mouse Model,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,post surgery radiation therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Pathogenic Variant,Hereditary Breast and Ovarian Cancer Syndrome,Other,0.0,0.0
AFFECTS,Cell Death,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Plasma Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ARHGAP6 gene|ARHGAP6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ELAVL1 gene|ELAVL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FRY gene|FRY,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,IDO1 gene|IDO1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"CLEC11A protein, human|CLEC11A",Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
DISRUPTS,Polynucleotide Adenylyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,idebenone,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,"Tenascin, human|TNC|TNNC1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breast Fibrocystic Disease,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,OGG1 gene|OGG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,PDZK1 gene|PDZK1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Poly(ADP-ribose) Polymerase Inhibitors,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,MTCH2 gene|MTCH2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Infiltration,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,KLRK1 gene|KLRK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LINC01572 gene|LINC01572,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,Dickkopf-Related Protein 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,RAMP2-AS1 gene|RAMP2-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TLR2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,HOTAIR gene|HOTAIR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,BRCA1 gene|BRCA1,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
PREDISPOSES,SLCO1B1 gene|SLCO1B1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ezetimibe,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,NR2F2 gene|NR2F2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Nanotubes, Carbon",Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,Follistatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,AGRN gene|AGRN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,NKAIN1 gene|NKAIN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,mitochondrial calcium uniporter,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ononin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,tanshinone II A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,S14 gene|PSMD8|RPS14|THRSP|LOC107228383,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,TCF7L2 gene|TCF7L2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,oncostatin M receptor|OSMR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Anthocyanins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Prostaglandins,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin used,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TAL1 gene|TAL1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,Tumor Markers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DNMT3B gene|DNMT3B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,resveratrol,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,RHOC gene|RHOC,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
PREDISPOSES,Human plasma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,glycosylation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen Antagonists,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,CA2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Steroid 17-alpha-monooxygenase|CYP17A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Adenosine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,EZH2 gene|EZH2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cardiovascular morbidity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IKZF2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Interleukin-24,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tumor Necrosis Factor Ligand Superfamily Member 6|FASLG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TAZ gene|TAZ,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Protein-tyrosine kinase inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Benzoic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"Anti-Inflammatory Agents, Non-Steroidal",Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
DISRUPTS,Estrogen Receptor alpha,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,SMARCA4 gene|SMARCA4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Radioisotope scan of lymphatic system,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplasm,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,RHOA gene|RHOA,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Folic acid supplementation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Acrylamide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ESTROGEN USE,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,recombinational repair,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,KDM5B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Menopause, Premature",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,APC2 gene|APC2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CETN1,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Aging,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Metaplastic carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Suicide Gene Therapy,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Combined Modality Therapy,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,GATA3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDX2 gene|CDX2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,DUSP4 gene|DUSP4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Selenium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FLT1 gene|FLT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Menstrual migraine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Malignant transformation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Eclampsia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nucleic Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,APOBEC3B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Immunologic Adjuvants,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
CAUSES,Whole Cell Vaccine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,XBP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cancer Model,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Calcium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cytochrome P-450 CYP1A1|CYP2B6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,High fiber food,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,Breast Carcinoma,Other,0.3988,0.027972027972027972
AUGMENTS,MAP3K3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,UDP-Glucuronosyltransferase 1A1|SLC45A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NANOG,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,CADMIUM EXPOSURE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,TISSUE TRANSGLUTAMINASE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Glycoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TLR3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Quinones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Progestins,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Therapeutic agent (substance),Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,VEGF gene|VEGFA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,[D]Nausea and vomiting NOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,JAG1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"Fatty Acids, Saturated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,8q22,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,transcription factor PEA3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TLR4 gene|TLR4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"Genes, Homeobox",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Deferoxamine,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Estrogens,Carcinoma of Male Breast,Hormonal Factors,0.0,0.004995004995004995
PREDISPOSES,PCAF gene|KAT2B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Specimen from breast,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIR27B,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,"9,10-Dimethyl-1,2-benzanthracene",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,BIRC5 gene|BIRC5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,RUNX1|MECOM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ANKRD12|ANKRD11,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Interleukin-8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RNASE3L gene|DROSHA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,RHOBTB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Paclitaxel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TP53 gene|TP53,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Estrogen excess,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
DISRUPTS,ID1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,cyclooxygenase 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Leptin|LEP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MULTISECTION:FINDING:POINT IN TIME:BREAST:NARRATIVE:MRI,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Transferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Quantitative Trait Loci,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MRPS30,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Genes, Homeobox",Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,BIRC7 gene|BIRC7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Annexin A2|ANXA2,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,ATR gene|ATR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Fatty-acid synthase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TSLP gene|TSLP,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
CAUSES,Endostatins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SH3KBP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,S100A9 gene|S100A9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Nitrite,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Breast Cancer Treatment,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Protein-tyrosine kinase inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ARF6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Extracellular Signal Regulated Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immunoglobulin G,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Gonadal Steroid Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDKN1B gene|CDKN1B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CTNNB1 gene|CTNNB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Antiperspirants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,EGFR gene|EGFR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Leptin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Signaling Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,asparaginylendopeptidase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Soy Foods,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,20q,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,STAT3 gene|STAT3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,CXCR3 gene|CXCR3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,PTPN11 gene|PTPN11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Malignant neoplasm of endometrium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Interleukin 7 Receptor|IL7R,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Livebirth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Disease Outcome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BMPR1B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sulfuric Acid Esters,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BMPR2 gene|BMPR2,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
DISRUPTS,Antineoplastic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Laminin Receptor,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Protein-Serine-Threonine Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Magnetic Resonance Imaging,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Environmental Effects,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ACR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Metabolic Rates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CATHEPSIN D|CTSD,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,"Antibodies, Anti-Idiotypic",Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Carotenoids,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Growth Factor Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Fibroadenoma,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Insulin-Like Growth Factor Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,cDNA Library,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrous Cycle,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Toxic effect,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Irregular menstrual cycle NOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Pregnancy, Multiple",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TACSTD2 gene|TACSTD2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cystic Breast Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BRCA1 gene|BRCA1,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
AFFECTS,LAMR1 gene|RPSA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,fulvestrant,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,BCAS1 gene|BCAS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,HSD17B4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nifedipine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mechanics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MDM2 gene|MDM2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Body mass index,Carcinoma in situ of breast,Other,0.0,0.001998001998001998
AUGMENTS,LRRC32,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Cysteine Proteinase Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Signal Pathways,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,salinomycin,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,mutant gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Reconstructive Surgical Procedures,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Prostaglandin-Endoperoxide Synthase,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,GALNT14,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,mammary tumor virus,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Cadherins,Sporadic Breast Carcinoma,Other,0.0,0.0
CAUSES,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Manganese Superoxide Dismutase,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Genes,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
DISRUPTS,Tretinoin,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Medroxyprogesterone,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Para 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Dessert,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Trihalomethanes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ZNF121,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Paraffin,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Antigens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Retroviridae,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Cytologic finding,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GATA3,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,hybrid gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,CCND1 gene|CCND1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Etoposide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Collagen,Ductal Breast Carcinoma,Demographic Factors,0.0,0.000999000999000999
PREDISPOSES,activity level,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Biological Factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Trans-Activators,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SHBG gene|SHBG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Athletic Training,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Aromatic Amines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Androgens,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Anovulation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,alpha-Lactalbumin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,FGF3 gene|FGF3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Prolactin Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Operative Surgical Procedures,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Serum Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Photosensitivity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Tamoxifen,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Female Breast Carcinoma,Malignant neoplasm of breast,Other,0.0174,0.3386613386613387
AFFECTS,Electromagnetic Fields,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Phosphotransferases,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,DNA biosynthesis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"TFF1 protein, human|TFF1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Hypercalcemia,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"serine repeat antigen, Plasmodium",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Estrogenic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pharmaceutical Preparations,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Animal protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Proto-Oncogene Proteins p21(ras)|HRAS,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,Estrogen Antagonists,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,FGF3 gene|FGF3,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,international differences,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Genes, Suppressor",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,"Hydrocarbons, Aromatic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,onapristone,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Paraffin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Monoclonal Antibodies,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Debrisoquin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gonadorelin|GNRH1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Urea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor Burden,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,"9,10-Dimethyl-1,2-benzanthracene",Breast cancer recurrent,Other,0.0,0.004995004995004995
CAUSES,Dimethyl Sulfoxide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BCL-2 Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,beta-hexachlorocyclohexane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gamma-glutamyl transferase,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Interferons,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Bromocriptine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,IGF2 gene|IGF2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,methylurea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Secondary malignant neoplasm of bone,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Pathogenesis,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Prognostic Factor,Breast cancer recurrent,Other,0.0,0.004995004995004995
CAUSES,Advanced cancer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ascorbic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Antigens, Viral",Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Steroids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,AFP gene|AFP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"9,10-Dimethyl-1,2-benzanthracene",Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Antipsychotic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,HRAS gene|HRAS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Antineoplastic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
CAUSES,Breast cancer invasive NOS,Noninfiltrating Intraductal Carcinoma,Other,0.0587,0.01098901098901099
PREDISPOSES,PIP,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Wound Healing,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CDKN2A gene|CDKN2A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Proteins,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Lymph node excision,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Genes, Regulator",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,High income,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lutein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Radionuclide Imaging,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,X-Pro dipeptidase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,New finding,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Antibiotics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Obesity,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,CATHEPSIN D|CTSD,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,tissue-factor-pathway inhibitor 2|PPP5C|TFPI2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fever,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,alpha-Linolenic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MLH1 gene|MLH1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,regular physical activity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ELK3 gene|ELK3|KCNH8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Transfection,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NBEAL2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Linoleic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carcinoma in Situ,Lobular carcinoma in situ of breast,Other,0.0,0.0
PREDISPOSES,C2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,BUB1B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Glucagon|GCG,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"Fatty Acids, Unsaturated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MFT 279,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estradiol,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,GATA5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ETS Variant Gene 6 Protein|ETV6,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,folligen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Cyclin D1|CCND1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Genes, Regulator",Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,sodium-iodide symporter,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prolactin|PRL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Indomethacin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Increased body mass index,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Integrins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Insulin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Decapeptyl,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Radium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Interstitial Collagenase,Breast cancer invasive NOS,Demographic Factors,0.0,0.00999000999000999
CAUSES,MYC gene|MYC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,HIV Infections,Malignant neoplasm of breast,Herpetic Genetic Factors,0.0,0.3386613386613387
AFFECTS,Allelic Imbalance,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,response to hormone stimulus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,glycosylation,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Polyamines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cell Communication,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Genistein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Electromagnetic Energy,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Chronic Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Protein Overexpression,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,CDC25A gene|CDC25A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,checkpoint kinase 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Passive smoker,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hypokinesia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Isotopes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Sterol Regulatory Element Binding Protein 1c,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aspirin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Psychometrics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,I Kappa B-Alpha,Sporadic Breast Carcinoma,Other,0.0,0.0
DISRUPTS,Antioxidants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Triethylenemelamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,fluorodeoxyglucose positron emission tomography,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Lymphoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NFKBIA gene|NFKBIA,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,Fibroblast Growth Factor 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Chromosome abnormality,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Kininogenase|KLK4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CLARITY,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ral Guanine Nucleotide Exchange Factor|RALGDS,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,letrozole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Transcription Coactivator,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Retroviral Vector,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Serine Protease,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Saturated fat intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"N,N-dimethyl-4-anisidine",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BRCA1 gene|BRCA1,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,skills,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,EMSY,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Family history of breast cancer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Amino Acid Substitution,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Reproductive Behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,ERCC4 gene|ERCC4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Steroids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Genes,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
PREDISPOSES,Venous Thrombosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,VEGF gene|VEGFA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Quantitative Trait Loci,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Prempro,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PGR gene|PGR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,maspin|SERPINB5,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Dehydroepiandrosterone Sulfate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Phosphotransferases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Micronutrients,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Retinoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ID-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Polypeptides,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,MPO,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Soy bean product,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Cancer-Predisposing Gene,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
CAUSES,Angiogenic Switch,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,ID1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Cryptococcus,Cancer en cuirasse,Other,0.0,0.0
AFFECTS,Infertility,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,EEF1B2P2|BHLHE22,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Decreased density,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CD82 gene|CD82,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Protein Kinase C Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NQO1 gene|NQO1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,apomucin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,NELFB,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Neoplasm Metastasis,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
CAUSES,repair enzyme,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,Orthologous Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Estrogen Antagonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CASP1 gene|CASP1,Lobular carcinoma in situ of breast,Genetic Factors,0.0,0.0
PREDISPOSES,TNFRSF1B gene|TNFRSF1B,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,Granulocyte Colony-Stimulating Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tamoxifen,Carcinoma in situ of breast,Other,0.0,0.001998001998001998
AFFECTS,cyclooxygenase 2,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,IL8 gene|CXCL8,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Steroidal Estrogen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Fibroblast Growth Factor 7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MFG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Catechol O-Methyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hyperprolactinemia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aromatase Inhibitors,Noninfiltrating Intraductal Carcinoma,Treatments,0.0,0.01098901098901099
CAUSES,CAV1 gene|CAV1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Tamoxifen,Contralateral breast cancer,Other,0.0,0.001998001998001998
AFFECTS,Estradiol,Sporadic Breast Carcinoma,Other,0.0,0.0
CAUSES,Lignans,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,lariciresinol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Single Nucleotide Polymorphism,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Raloxifene,Carcinoma in situ of breast,Other,0.0,0.001998001998001998
PREDISPOSES,Anovulatory,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sore to touch,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gegenhalten,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CLCA2 gene|CLCA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Xanthine Dehydrogenase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,pleiotrophin|PTN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,epigallocatechin gallate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,beta catenin,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,WISP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Glutathione S-Transferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Endopeptidases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,anti-apoptosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Environmental stimuli,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Asparagine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,HPSE gene|HPSE,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Steryl-sulfatase|STS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Cytochrome P450 3A4|CYP3A4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Signaling Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,polyphenols,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Estrogen Receptors,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Breast Cyst,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Retinoblastoma Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mannose Binding Lectin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Stanolone,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
CAUSES,YBX1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ghrelin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Ovarian Cysts,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Adaptor Signaling Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptor alpha|EREG|ESR1,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Fertility Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
DISRUPTS,Thrombospondins,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Catecholamines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Oxytocinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Apolipoprotein E|APOE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Isoflavones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Encounter due to puberty,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CXCL12 gene|CXCL12,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,PLAT gene|PLAT,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TSPYL5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SIPA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PPAR gamma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Operative Surgical Procedures,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,CXCR4 gene|CXCR4,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Vitamin E,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Walking,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ABCC11,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CXCL12 gene|CXCL12,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Primary Prevention,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"Antibodies, Anti-Idiotypic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SHFM1 gene|SEM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Thrombolytic Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,14q24.1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,NRP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MTNR1A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"PSMD10 protein, human|PSMD10",Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,MTNR1B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Receptors, Progesterone|PGR",Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Titanium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gastric Adenocarcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,mTOR Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Clonal Expansion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Acetyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Metformin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ADH1B gene|ADH1B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SULT1A1|SULT1A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Potato,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breast tenderness,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,TNFSF11 gene|TNFSF11,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
CAUSES,Phytoestrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AFFECTS,Transfection,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Autoimmune thyroiditis,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
AUGMENTS,OPN1LW|CRCP|RAB11FIP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,K-ras Oncogene|KRAS,Ductal Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
CAUSES,Carcinogenesis,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Transforming Growth Factor beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,gene polymorphism,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,PREDICTED,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Interleukin-15,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NEK8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Cigarette smoke,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Sulfatases|ARSH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,estrogen receptor gamma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PALB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Single Nucleotide Polymorphism,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,TRANCE protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KL gene|KL,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CCDC88A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Retinoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estrogen Receptors|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Agent,Breast cancer metastatic,Demographic Factors,0.0,0.027972027972027972
DISRUPTS,"Fatty Acids, Omega-6",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SP1 gene|SP1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,G-Protein-Coupled Receptors,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Diabetes Mellitus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Carbon,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CYP1A1 gene|CYP1A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Somatomedins,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Hypermethylation,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,Phototherapy,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Granulocyte Colony-Stimulating Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"TGFB1 protein, human|TGFB1",Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,IL8 gene|CXCL8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,UTS2R|SLC14A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ANP32B gene|ANP32B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Compete,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Magnesium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Calgranulin A|S100A8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cytochrome P450,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ERR1 protein|ESRRA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ETV4,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Bone Morphogenetic Proteins,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"PTH protein, human|PTH",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Minisatellite Repeats,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Anabolic steroids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PPAR gamma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,NOTCH4 gene,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,S100A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Growth retardation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CYP1A1 gene|CYP1A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Niacin intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SIX1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,EGFR gene|EGFR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Arrestins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BACH1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,chromosome decondensation factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PHB2|SIL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Advance,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,VEGFA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MAPK14 gene|MAPK14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Protein Isoforms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,DNA Adducts,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SLX4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Tetradecanoylphorbol Acetate,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,amsonic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alcoholic Liver Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,AKT1 gene|AKT1,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,Catechol O-Methyltransferase|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Sex Hormone-Binding Globulin,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,MRE11,Breast cancer recurrent,Other,0.0,0.004995004995004995
AUGMENTS,protein-tyrosine kinase c-src|SRC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,vasodilator-stimulated phosphoprotein,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Methyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,hesperetin,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,BRIP1,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AUGMENTS,ING5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Angioendotheliomatosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Phosphatidylethanolamine Binding Protein,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Aromatase Inhibitors,Breast cancer recurrent,Treatments,0.0,0.004995004995004995
PREDISPOSES,Pharmaceutical Preparations,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,"2,3-bis(3'-hydroxybenzyl)butyrolactone",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,BRCA1 gene|BRCA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,BCL6 gene|BCL6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Paclitaxel,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,RPRD1B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,XPO5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"TNF protein, human|TNF",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Therapeutic procedure,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Natural menopause,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MYC gene|MYC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,sphingosine kinase-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,KLF9 gene|KLF9,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,NKD1,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,Hyperbaric Oxygenation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,USP21 gene|USP21,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hexachlorobenzene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CRHBP gene|CRHBP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,"Myeloid Leukemia, Chronic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ERBB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,benzyl isothiocyanate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Genes,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Oxides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ABCB10,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SMAD3 gene|SMAD3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"TACSTD2 protein, human|TACSTD2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"20-hydroxy-5,8,11,14-eicosatetraenoic acid",Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,shikonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KLF4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,fucoidan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PROTEIN KINASE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,letrozole,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Cyclin E,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,"Lupus Erythematosus, Systemic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Steroids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BRCA1 gene|BRCA1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Lipogenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Malignant meningitis,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Folic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NBAT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Promoter Regions (Genetics),Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SULF2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,arctigenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,xanthohumol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Interstitial Collagenase,Breast cancer metastatic,Demographic Factors,0.0,0.027972027972027972
DISRUPTS,BVES,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,POU5F1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MSI2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ANXA3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,curcumol,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,iron ion homeostasis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Oxygen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Transferrin,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Phosphotransferases,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,pomegranate juice,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,LRRC3B gene|LRRC3B,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
AFFECTS,MET gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,YAP1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,ITGB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,discoidin domain receptor 2,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,protein tyrosine phosphatase 1B,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Heat Shock Protein 27,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Complement 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HVCN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IGKV6D-21,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fertility,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cell invasion,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Tenascin|TNC,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Heightened perception,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,C1GALT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Bone remodeling,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,caveolin 1|CA5A|CAV2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Functional RNA,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Malignant neoplasm of breast,Sporadic Breast Carcinoma,Other,0.3988,0.0
AFFECTS,Malignant tumor of colon,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PGR gene|PGR,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Serotonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ANG gene|ANG,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,CALCA gene|CALCA,Ductal Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
PREDISPOSES,Lactate,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Agent,Breast Carcinoma,Demographic Factors,0.0,0.027972027972027972
PREDISPOSES,Diabetes,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,bakuchiol,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Dyslipidemias,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TFF3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,pregnane X receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplasm Metastasis,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,OGG1 gene|OGG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,MT2A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Endocrine therapy,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,isoalantolactone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LEF1,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Raloxifene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,HIST2H2AC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Epithelial antibody,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"BCAR1 protein, human|BCAR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fluoxetine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,sinomenine hydrochloride,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Interleukin-17,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,TARDBP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitamin B6 intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Fibroblast Growth Factor Receptors,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Estrogen Receptor beta|ESR2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,exemestane,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Adenocarcinoma of esophagus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ADAM33,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pharmacotherapy,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,Homologous Recombination,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,RNA,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,TP53 gene|TP53,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,hepatocellular carcinoma protein 1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,HOTAIR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,VTCN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RELN gene|RELN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Urine protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FCRL3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DNA,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,PARP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Interleukin-1 beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"Antibodies, Anti-Idiotypic",Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Enzymes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,intervention program,Familial cancer of breast,Other,0.0,0.003996003996003996
DISRUPTS,PTEN gene|PTEN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,SHARPIN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,methyl 4-azidophenylacetimidate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Total estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
CAUSES,PGR gene|PGR,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
AFFECTS,Polycomb,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,S1PR2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SP7,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,CD44,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCL20 gene|CCL20,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,ITK gene|ITK,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,RNU4-2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,meleagrin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Brown rice,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,AR gene|AR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CD29 Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Forkhead Transcription Factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Transcriptase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen Receptors,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,salinomycin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ANKLE1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,skills,Familial cancer of breast,Other,0.0,0.003996003996003996
AUGMENTS,sigma-1 receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MAPT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Orthologous Gene,Female Breast Carcinoma,Genetic Factors,0.0,0.004995004995004995
CAUSES,Polysaccharides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,TGFBR1,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,NBS1 gene|NBN|NLRP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Apoptosis Inhibiting Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,sphingosine kinase-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ischemia,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Food,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,S100A4,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Cervix carcinoma,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Stem cell transplant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,progesterone receptor negative,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Soybean preparation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BRD7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Therapeutic procedure,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
DISRUPTS,CDC42 gene|CDC42,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Multiple malignancy,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,SENP2 gene|SENP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,SUCLA2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Neoplasm,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,CDCA7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,diallyl disulfide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Relaxin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GEN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,4-chlorophenyl methyl sulfide,Contralateral breast cancer,Other,0.0,0.001998001998001998
CAUSES,H2AFX gene|H2AFX,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
CAUSES,CDH1 gene|CDH1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Difficulty sleeping,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PRI-2191,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Collagen,Breast Carcinoma,Demographic Factors,0.0,0.027972027972027972
AUGMENTS,CXCR4 gene|CXCR4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Toremifene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MSH6 gene|MSH6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CCND2 gene|CCND2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,GLS gene|GLS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Dietary Component,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Interleukin-1 beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Isoprostanes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TXNIP gene|TXNIP,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
DISRUPTS,WWC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,phenidone,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,MALAT1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,fibulin-3,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Chitosan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MAPK8 gene|MAPK8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,ZEB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"PER2 protein, mammalian",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"9,10-Dimethyl-1,2-benzanthracene",Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,"RNA, Satellite",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LGALSL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,aloperine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CD80 gene|CD80,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Protein Precursors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hydrogels,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ERBB2 gene|ERBB2,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Adverse effects,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,Estradiol,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Test Result,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TAZ gene|TAZ,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cancer cachexia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fibrosis,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Membrane receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Glycine Hydroxymethyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,beta catenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Luteolin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,TLN2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,erbB-2 Receptor|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Gelatinase B,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,disease stage,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,midkine|MDK,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,pregnane X receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cigarette Smoking,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,BITTER MELON,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BCAR3 gene|BCAR3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,crystalloid,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,genetic locus,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,CDKN2A gene|CDKN2A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,BP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CHI3L2,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,3MC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,AR gene|AR,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,FGFR2 gene|FGFR2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TMEM25,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KLK10 gene|KLK10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CD247,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,YAP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Oncogene Proteins,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MLL gene|KMT2A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CDH1 gene|CDH1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Antineoplastic Agents,Breast Carcinoma,Demographic Factors,0.0,0.027972027972027972
AFFECTS,TP53 gene|TP53,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Cyclin D1|CCND1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Axillary Lymph Node Involvement,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,"TNF protein, human|TNF",Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Mutation,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,CATHEPSIN D|CTSD,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Skim milk,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Lipids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Epidermal Growth Factor Receptor|EGFR,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Dissection,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Symptoms,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Atypical lobular hyperplasia,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Hexachlorobenzene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,personal responsibility,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,beta-hexachlorocyclohexane,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Growth,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,receptor expression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Generalized obesity,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,RHCE|FIP1L1,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Ischemic stroke,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Malignant disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Aromatase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Tamoxifen,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,CD27,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SALL2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,cathepsin K|CTSK,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mitogen-Activated Protein Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,paxillin|PXN,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Metformin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,CTHRC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CTHRC1,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Hydroxyl Radical,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,DDT (Insecticide),Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,Medication use,Malignant neoplasm of breast,Pharmacological Factors,0.0,0.3386613386613387
PREDISPOSES,Depo-Provera,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Composition,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Ductal Breast Hyperplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,prednisolone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,5-hydroxymethyl-2'-deoxyuridine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diabetic Retinopathy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,APC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Depressive disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SYK gene|SYK,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DHFR gene|DHFR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ERBB2|NEU1|NEURL1,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,Genes,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
DISRUPTS,IGF1 gene|IGF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Aspirin,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"TRIM25 protein, human|TRIM25",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Dairy Products,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Maternal status,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PAX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vascular Endothelial Growth Factor Receptor-1|FLT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Paclitaxel,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,OR10J3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IRS2 gene|IRS2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Fine needle aspiration biopsy,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,ERBB2 gene|ERBB2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Therapeutic regimen,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,CYP1B1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Allelic Imbalance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Soy Foods,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,2-hydroxyestrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MTHFR gene|MTHFR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Early Diagnosis,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Lobular Neoplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ultrasonography,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,small molecule,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Noscapine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,S100A6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,VEGFA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,response,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,SLCO1B1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CD40 gene|CD40,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,Acquired Immunodeficiency Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Systemic Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KISS1 gene|KISS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,osteopontin,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Zeranol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ZNF365,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Leg length,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Worried,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Calgranulin B|S100A9,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,CCNE1 gene|CCNE1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Tumor Suppressor Genes,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
CAUSES,Progesterone,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,MIRN27A gene|MIR27A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,B3GNT2|B3GNTL1,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,coping resources,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,DDX5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aberrant DNA Methylation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,aldehyde dehydrogenases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"ribosomal protein S6 kinase, 70kD, polypeptide 2|RPS6KB2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,S100A9 gene|S100A9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ORAI1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,XRCC3 gene|XRCC3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Creatinine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Speech reception threshold,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Interleukin-17,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,osteopontin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Therapeutic procedure,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,SOD2 gene|SOD2,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
AFFECTS,Metaplastic Breast Carcinoma,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Testosterone,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,Free Radicals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Berberine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Squamous cell carcinoma,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,AG 14361,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Functional disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Amenorrhea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Biological function, NOS",Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,"Receptors, Progesterone|PGR",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fluoxetine,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,SMARCE1 gene|SMARCE1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,PTEN gene|PTEN,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,GSTT1 protein|SLC25A4|CD5|IL1RL1|TRAPPC9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GSTT1 protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Oral form estradiol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Microinvasive carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Diabetes Mellitus, Non-Insulin-Dependent",Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,beta Sitosterol,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Pharmaceutical Preparations,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Estradiol acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cell fusion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KDM3A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,May-Hegglin anomaly,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Invasive Malignant Neoplasm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MMP9 gene|MMP9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,trastuzumab,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
CAUSES,crocin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PGR gene|PGR,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Rare Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PGRMC1 gene|PGRMC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,meningioma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Deferoxamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Bread,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Rifabutin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Supplementation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Diabetes Mellitus, Insulin-Dependent",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alcohol consumption,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,XIST,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Glucocorticoids,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,RNASEL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Arsenic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,oncostatin M|OSM,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Not significant,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,"Metals, Heavy",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Carcinogens,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,MIRN223 gene|MIR223,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ERBB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TERT gene|TERT,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Prophylactic immunotherapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TP53 gene|TP53,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
CAUSES,RNA I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fertility problem,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,HTATIP2 gene|HTATIP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,IL10 gene|IL10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,cyclooxygenase 2|XK,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,S-Adenosylmethionine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hyperparathyroidism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,household cleaner,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Behavior,Breast cancer recurrent,Behavioral Factors,0.0,0.004995004995004995
PREDISPOSES,LUM gene|LUM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
COMPLICATES,Extravasation of lymph,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CAV1 gene|CAV1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Breast surgery,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PRKDC gene|PRKDC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Ethanol Metabolism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ABCB1 gene|ABCB1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,BAX gene|BAX,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,acadesine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIRN21 gene|MIR21,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cyclooxygenase Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,NR4A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alcohol interaction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Insulin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Angiography, Digital Subtraction",Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Malaise,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CDK2AP1 gene|CDK2AP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CD28 gene|CD28,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,Disease Outcome,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Primary tumor size,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Genes,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
AFFECTS,S100A9 gene|S100A9,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,breast cancer prevention,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SPSB1,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,TNFRSF1B gene|TNFRSF1B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Inflammatory Breast Carcinoma,Malignant neoplasm of breast,Other,0.0177,0.3386613386613387
DISRUPTS,Aromatase Inhibitors,Malignant neoplasm of breast,Treatments,0.0,0.3386613386613387
AUGMENTS,SLC2A1 gene|SLC2A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Cytochrome P450,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fertilization in Vitro,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ligands,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cookie and/or cracker,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Heregulin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Kininogenase|KLK4,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"TERT protein, human|TERT",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Conjugated Equine Estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
PREDISPOSES,Uterine hemorrhage,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,steroid sulfate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Clinical Protocols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Beef,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RNA Interference,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Saponins,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,glutathione S-transferase M1|CHRM1|MRLN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Plasminogen Activator Inhibitor 1|SERPINE1|SERPINB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Saponins,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Maximum,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,versican|VCAN,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Regional Disease,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Glucocorticoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Unreported,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Total cholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Chlorogenic Acid,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,SGCB|APOBEC3B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AANAT gene|AANAT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,4-hydroxy-2-nonenal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"Contraceptives, Oral",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CD2 gene|CD2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PROCR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SELPLG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mammographic breast density,Contralateral breast cancer,Other,0.0,0.001998001998001998
AUGMENTS,TIAM1 gene|TIAM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Examination of breast,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Detection,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,CDKN1C gene|CDKN1C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,8-oxo-7-hydrodeoxyguanosine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carboplatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Chemoprevention,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DAND5,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Cosmic Radiation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,loss; bone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,lobaplatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Peptide Hydrolases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,zoledronic acid,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,DMBT1 gene|DMBT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,arginylarginine|ABL2|RERE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Female Breast Carcinoma,Malignant neoplasm of breast,Other,0.0174,0.3386613386613387
AUGMENTS,ABCG2 gene|ABCG2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Adaptation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Toll-like receptor 9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,IGF1R gene|IGF1R,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Adenocarcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplasm,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Atypical lobular hyperplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,kinase inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,AR gene|AR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Not significant,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,Hemoglobin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Propranolol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cosmetic surgery,Familial cancer of breast,Other,0.0,0.003996003996003996
AFFECTS,Paget's Disease,"Carcinoma, Ductal, Breast",Demographic Factors,0.0,0.002997002997002997
CAUSES,NF-kappa B,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,MIRN107 gene|MIR107,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,Breast cancer recurrent,Other,0.3988,0.004995004995004995
AFFECTS,Thioctic Acid,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Mammaplasty,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fat graft,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Regulatory Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"ESR1 protein, human|ESR1",Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,"FRAP1 protein, human|MTOR",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Initiative - finding,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,tumor growth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Iron,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Calcium Channel Blockers,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Adverse effects,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,autoimmune thyroid disease,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
AFFECTS,Injectables,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Proto-Oncogenes|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
CAUSES,Tumor necrosis factor receptor 11b,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Local Anesthetics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Thymine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Puberty,Familial cancer of breast,Other,0.0,0.003996003996003996
PREDISPOSES,Tumor Markers,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,"Absorptiometry, Photon",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Osteocalcin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Alendronate,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,KDM4A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,phthalate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TINCR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KRT19 gene|KRT19,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,DDT EXPOSURE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Radiation therapy,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,"Receptors, Progesterone|EREG|ESR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Benzanthracenes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Vimentin|VIM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Latent Virus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Malignant neoplasm of breast,Breast Carcinoma,Other,0.3988,0.027972027972027972
AUGMENTS,phospholipase C beta2|NEUROD1|TUBB4B,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Folic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Steroid hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,EVI1 gene|RUNX1|MECOM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ATG9A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MUTYH,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Periodontal Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Receptors, Progesterone|EREG|ESR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,K-ras Oncogene|KRAS,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,Morphine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LINC00339,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MKNK1,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,nicotinamide phosphoribosyltransferase|NAMPT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Induction,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,VEGFA,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Little's Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,HOXA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fluphenazine Hydrochloride,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen receptor negative,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Naloxone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Glucosides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FOXP4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Antibodies,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FOXP4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SNORA7B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Magnesium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CASC9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fatty acid glycerol esters,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Infiltration,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Small Inducible Cytokine A18|CCL18,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,beta catenin,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,LINC01857,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tissue Model,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Schizophrenia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Antisense RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CASC9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,glycogen synthase kinase 3 beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NR0B1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,schisandrin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Antigens, Fos-Related|FOS",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Treatment Protocols,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,RFP2 gene|TRIM13,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Green Fluorescent Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FSIP1 gene|FSIP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,SIRT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,racial differences,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,COPB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Binding Sites,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,tropomyosin-4|TPM4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KDM1A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Steroid 17-alpha-monooxygenase|CYP17A1,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Estrogen receptor positive,Breast cancer recurrent,Other,0.0,0.004995004995004995
DISRUPTS,saikosaponin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of lung,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RHPN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Chronic inflammation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LINC00460,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,UBE2D2 gene|UBE2D2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,RASSF1A|RASSF1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,TGFB1 gene|TGFB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CYP24A1 gene|CYP24A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,SATB1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,ENOLASE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ACSF3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Red Meat Consumption,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,E2F1 gene|E2F1|UBE2L3,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,"Estrogens, Conjugated (USP)",Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
PREDISPOSES,NCK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Matrix Metalloproteinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ENO1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CUL5 gene|CUL5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,BODY HEIGHT:LENGTH:POINT IN TIME:^PATIENT:QUANTITATIVE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Apocrine adenocarcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FOSL1 gene|FOSL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,mastitis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Ribosomal RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PCB 153,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,STIM2,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,NBEAL1,Familial cancer of breast,Other,0.0,0.003996003996003996
AUGMENTS,PCB 153,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,acetylacetone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,betulinic acid,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,CYP24A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ADCY4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AZIN2|GADL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PCB 118,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,11-beta-Hydroxysteroid Dehydrogenase Type 2|HSD11B2|RNU1-4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Implantation procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,caspase-8|CASP8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Electromagnetic Energy,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,PALB2,Familial cancer of breast,Other,0.0,0.003996003996003996
PREDISPOSES,Polycystic Ovary Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neuropathy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,GTPase-Activating Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,C11orf74|C17orf49,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Biological Markers,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,ATP8A2 gene|ATP8A2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
CAUSES,Aromatase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,regulatory loop,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Enrich (product),Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,CGRRF1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,estrogens,estrogen receptor-positive breast cancer,Hormonal Factors,0.0,0.008991008991008992
AFFECTS,GTPase-Activating Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor-Associated Process,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PPAR gamma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,NAMPT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PRDM2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"CD69 protein, human|CD69",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,Thrombospondin 1,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,MIR223 wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Hepatolenticular Degeneration,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Nuclear Receptor Coactivator 3|NCOA3|ANIB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MAP2K4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LHX1 gene|LHX1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,blood test result,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MIR195 gene|MIR195,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,quinoline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Deoxyuridine,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,High Confidence,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,UGT2B7 gene|UGT2B7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Biological Markers,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,LINC02657 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,ZEB1-AS1 gene|ZEB1-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,thrombin,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,prasterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Substance with phenol structure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,thymoquinone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Cyclin D1,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,"TFF1 protein, human|TFF1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SETD3 gene|SETD3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Biological Markers,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,melatonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diagnostic Imaging,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,GADD45A gene|GADD45A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,LSR gene|LSR,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,27-hydroxycholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,H19 gene|H19|HILS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Accumulation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Radiopharmaceuticals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prognosis bad,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,DNA Minor Groove Binding Agent,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
CAUSES,Sex Hormone-Binding Globulin,Invasive carcinoma of breast,Demographic Factors,0.0,0.008991008991008992
AFFECTS,GSTT1 gene|GSTT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,mullerian-inhibiting hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NOP2 gene|NOP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,E2F3 gene|E2F3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,gamma-linolenic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Adriamycin,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,PLSCR1 gene|PLSCR1,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
AFFECTS,glutathione S-transferase pi|GSTP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Primigravida,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,MIR454 gene|MIR454,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Binge Drinking,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Basaloid squamous cell carcinoma,Basal-Like Breast Carcinoma,Other,0.0,0.003996003996003996
PREDISPOSES,apolipoprotein D|APOD,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,IGFBP7|SFPQ,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,Small Molecule,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TXNIP gene|TXNIP,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,platinum,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,"EIF2C2 protein, human|AGO2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,pioglitazone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,gonadorelin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,S100A14 gene|S100A14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,LINC00261 gene|LINC00261,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Methyl-CpG-Binding Protein 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CTHRC1 gene|CTHRC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,rhein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"POU5F1 protein, human|POU5F1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIR622 gene|MIR622,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,TFEB gene|TFEB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Profilin 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Aromatase,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,Hypersensitivity,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,RB1CC1 gene|RB1CC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Mitotic Activity,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,LMNB1,Luminal B Breast Carcinoma,Other,0.0,0.0
CAUSES,ESM1 wt Allele,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Cereal intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,aggressive cancer,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,LOXL4 gene|LOXL4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Extensive Necrosis,Basal-Like Breast Carcinoma,Other,0.0,0.003996003996003996
PREDISPOSES,quercetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TMPO wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"RNA, Messenger",Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,MIR145 gene|MIR145,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,HOPX gene|HOPX,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,risk factors,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,CD163,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neurosurgical Procedures,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,LMNB1,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,3-methylquercetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TMED3 gene|TMED3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,GPC1 gene|GPC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Transcript,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Industrial fungicide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Biological Factors,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Negative,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Malignant neoplasm of breast,malignant neoplasm of breast staging,Other,0.3988,0.0
AFFECTS,NEAT1 gene|NEAT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TAC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alleles,"Breast Cancer, Familial",Other,0.0,0.0
AFFECTS,Negative Regulation of S Phase,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,SALL4 gene|SALL4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Immunoregulation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,IL31 gene|IL31,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,fos-related antigen 1|FOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cyclophosphamide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SAMD4A gene|SAMD4A,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,LINC-ROR gene|LINC-ROR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,WWOX wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Treatment modification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SMAD7 gene|SMAD7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Residual Tumor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Androgen Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Low Density Lipoprotein Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Illness (finding),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,UGT1A1 gene|UGT1A1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,SKA3 gene|SKA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Glucocorticoid Receptor,Basal-Like Breast Carcinoma,Other,0.0,0.003996003996003996
AFFECTS,Nucleotides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HOMER1 gene|HOMER1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Blood Proteins,malignant neoplasm of breast staging,Other,0.0,0.0
PREDISPOSES,Hyperphagia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hypomethylation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cytokine,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Synthetic glucocorticoid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HOTAIR gene|HOTAIR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,fructose,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,CYFIP1 gene|CYFIP1,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
AFFECTS,HER2-negative breast cancer,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,"GPER protein, human|GPER1",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Family history,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Deubiquitinating Enzymes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,doxorubicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Family history,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,"CRYAB protein, human|CRYAB",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"YAP1 protein, human|YAP1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,DSCC1 gene|DSCC1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,ZEB1 gene|ZEB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Benzo(a)pyrene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cyclin-Dependent Kinase Inhibitor Proteins,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,ATXN8OS gene|ATXN8OS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Diabetes Mellitus, Non-Insulin-Dependent",estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,CHPF gene|CHPF,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,palbociclib,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,epithelial to mesenchymal transition,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Aurora Kinase A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SLC12A8 gene|SLC12A8,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Transferrin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Deodorants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,beta catenin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,Alleles,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,thioguanine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Copy Number Polymorphism,"Breast Cancer, Familial",Other,0.0,0.0
PREDISPOSES,"Receptor, Transforming Growth Factor-beta Type I|TGFBR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,cadmium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Binding Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GOLPH3L gene|GOLPH3L,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Cystathionine beta-Synthase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Color doppler ultrasound,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Genes,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
PREDISPOSES,KIF15 gene|KIF15,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,osthol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,KIF3B gene|KIF3B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,DNA Methyltransferase Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,letrozole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Agent,Carcinoma breast stage IV,Demographic Factors,0.0,0.0
AFFECTS,mitogen-activated protein kinase kinase kinase 11,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,KIF3B gene|KIF3B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Cathepsin L,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,Squalene monooxygenase,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,osthol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Transforming Growth Factor beta,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Hormone Receptor Positive Breast Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"ABCG2 protein, human|ABCG2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Genes,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
AFFECTS,PARP inhibitor therapy,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ITM2A gene|ITM2A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,thymoquinone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,TOX3 gene|TOX3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MIR22 gene|MIR22,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,LINC-ROR gene|LINC-ROR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Insulin Receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,estradiol,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
CAUSES,saffron extract,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alcohol consumption,Recurrent Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,beta-2 Microglobulin,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,small size,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SHISA3 gene|SHISA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,GSEC gene|GSEC,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Smoking,contralateral breast cancer,Other,0.0,0.002997002997002997
DISRUPTS,ST7-AS1 gene|ST7-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Alleles,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,KIAA1109 gene|KIAA1109,Female Breast Carcinoma,Genetic Factors,0.0,0.004995004995004995
AFFECTS,Aquaporin 1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,ACTL8 gene|ACTL8,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Stimulation procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Epidermal Growth Factor Receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,2 times,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,interleukin-10,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Botanical,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"RNA, Small Untranslated",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,LGMN gene|LGMN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,research results,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SLAMF7 gene|SLAMF7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Childbirth,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,calcium ion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,bisphenol A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fatty-acid synthase,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,UGT1A7 wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Modest-Temperature Hyperthermia,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,SRSF1 gene|SRSF1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,PVR gene|PVR,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,"CD274 protein, human|CD274",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,E-Box Elements,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Long Intergenic Non-Protein Coding RNA,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,FBXO5 gene|FBXO5,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,SRSF1 gene|SRSF1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,CEP55 gene|CEP55,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Artificially Sweetened Beverages,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Mood:-:Point in time:^Patient:-,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Crotoxin,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,jolkinolide B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Antigen Processing,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DPP4 gene|DPP4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Dietary Intake,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
COMPLICATES,Portal Hypertension,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIR526B gene|MIR526B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Biological Processes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Heparin Binding Growth Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,EN1 gene|EN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Smoke Exposure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Microcalcification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IFI30 gene|IFI30,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,EGR1 gene|EGR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,DPP10 gene|DPP10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Glycosphingolipids,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,pyridine,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,cyclin B2,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Xenograft procedure,Luminal B Breast Carcinoma,Other,0.0,0.0
AUGMENTS,ANLN gene|ANLN,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,LINC01089 gene|LINC01089,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Copy Number Polymorphism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SMUG1 gene|SMUG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,RNA modification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ataxia telangiectasia mutated protein|ATM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Stilbenes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Biological Markers,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,NOL10 gene|NOL10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,TMEM238L gene|TMEM238L,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Drug Combinations,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,IMPACT gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MIR155 gene|MIR155,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Monocyte Chemoattractant Protein-1,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,Intravenous therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TCOF1 gene|TCOF1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,TBX15 gene|TBX15,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,MicroRNAs,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,disorder control (procedure),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,H1-5 gene|HIST1H1B,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
AFFECTS,caveolin 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Oils,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Breast Density,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Coronary Arteriosclerosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tRNA modification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BRCA1 Mutation,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Normal weight,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIR4521 gene|MIR4521,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Periodontitis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,lead,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Polyunsaturated fatty acid intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Response to treatment,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Parity,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,hyaluronic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LIG1 gene|LIG1|LRIG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ARHGAP9 gene|ARHGAP9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,mortalin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RPS6KA3 gene|RPS6KA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Matrix Metalloproteinase 11,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Hypersensitivity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tanshinol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,glucose,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RTL8C gene|RTL8C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Genes,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
DISRUPTS,JAM2 gene|JAM2|JAM3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,progesterone,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,SYVN1 gene|SYVN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Constitutive skin pigmentation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Genetic Profile,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Vitamin D3 Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MALAT1 gene|MALAT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,FAM189A2 gene|FAM189A2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,sinomenine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Lipoxygenase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,VIRMA gene|VIRMA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TSHZ1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MRPS30-DT gene|MRPS30-DT,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,SOX2 Transcription Factor|SOX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Taxol,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,HOXC-AS3 gene|HOXC-AS3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,LPAR6 gene|LPAR6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,estradiol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Very Important,Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,Anti-Bacterial Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,"Injections, Intraperitoneal",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Receptors, KIR2DL4",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,EIF6 gene|EIF6,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Rhythm,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,ANKDD1A gene|ANKDD1A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MEOX2 gene|MEOX2,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,MIR660 gene|MIR660,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Malignant Neoplasms,Luminal B Breast Carcinoma,Other,0.0,0.0
AUGMENTS,UHRF1 gene|UHRF1,Invasive Ductal Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,mRNA Precursor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDC42,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,PDE5A wt Allele|PDE5A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pregnancy,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,"IL22 protein, human|IL22",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Homologous Recombination Deficiency,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,inermin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,STAMBPL1 gene|STAMBPL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,LINC00472 gene|LINC00472,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Therapeutic procedure,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,GZMK gene|GZMK,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
AFFECTS,CDK16 gene|CDK16,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,Sulfatases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"RNA, Untranslated",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,Indicators,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Protein p53|TP53,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Genes,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
CAUSES,diallyl trisulfide,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Malignant Neoplasms,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,ATP6AP2 gene|ATP6AP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,LMNB1 gene|LMNB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Alleles,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Secondary malignant neoplasm of bone,Recurrent Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,MARK2 gene|MARK2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,GATA3 gene|GATA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,RBIS gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,corynoline,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Ovarian Stimulation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,urokinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Mouse mammary tumor virus,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,History of previous events,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Micelles,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
DISRUPTS,cytochrome b561,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,File Being Validated,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,C17orf49 gene|C17orf49,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,docetaxel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,eribulin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,MYC gene|MYC,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,RUNX2 gene|RUNX2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SNHG14 gene|SNHG14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,intracellular protein transport,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,WNT2 gene|WNT2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,fulvestrant,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,"Food, Preserved",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant Neoplasms,"Breast Cancer, Familial",Other,0.0,0.0
PREDISPOSES,Elevated Expression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KIF11 gene|KIF11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Lactic acid dehydrogenase isoenzyme 5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ANLN gene|ANLN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,COL11A1 gene|COL11A1,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,Melanocyte stimulating hormone,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,ACTA2-AS1 gene|ACTA2-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,"IRS1 protein, human|IRS1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,progesterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor Necrosis Factor Signaling Process,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IMPA1 gene|IMPA1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,Long Intergenic Non-Protein Coding RNA,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,LINC01194 gene|LINC01194,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,4 times,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,perfluorooctane sulfonic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sulfonic Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Disease,Refractory Breast Carcinoma,Other,0.0,0.0
AFFECTS,EGF,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,New medications,Malignant neoplasm of breast,Pharmacological Factors,0.0,0.3386613386613387
AUGMENTS,MRPS7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ascorbic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,sirolimus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Matrix Metalloproteinase 9|MMP9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Generalized obesity,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,IMPA1 gene|IMPA1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider},Triple Negative Breast Neoplasms,Demographic Factors,0.0,0.01898101898101898
PREDISPOSES,Membrane Transport Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,E2F6 gene|E2F6,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,Androgen Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,homocysteine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,TP53 gene|TP53,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,ACBD3 gene|ACBD3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,GAS6-AS1 gene|GAS6-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SERPINA12 gene|SERPINA12,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,SEMA3B-AS1 gene|SEMA3B-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Calcinosis universalis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SLC3A2 gene|SLC3A2,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,GLI1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,carbidopa,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,RYK gene|RYK,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,heparanase,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Matrix Metalloproteinase 2|MMP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,FRY gene|FRY,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"ITK protein, human|ITK",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MUC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"ERCC5 protein, human|ERCC5",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MYCL gene|MYCL,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,CXCL14 gene|CXCL14,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,AURKB gene|AURKB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Lipopolysaccharides,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AUGMENTS,lidocaine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HSPB2 gene|HSPB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Early Diagnosis,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,RECQL4 gene|RECQL4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,EXO1 gene|EXO1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ZNF217,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Ligands,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Mevalonate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immunogenic Cell Death,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Pathogenic Variant,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Metabolite,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,glutathione S-transferase pi|GSTP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LINC00473 gene|LINC00473,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Inhibitor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,FOXA1 gene|FOXA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,glutathione,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ELAVL2 gene|ELAVL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,BARRIER,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Antiplatelet Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
CAUSES,Basis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,USP37 gene|USP37,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
DISRUPTS,PPARA gene|PPARA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Vitamin D3 Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,boswellic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Biological Markers,Early-Stage Breast Carcinoma,Other,0.0,0.0
AFFECTS,dihydrotanshinone I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,aspirin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SOX8 gene|SOX8,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,Low-Dose Aspirin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,health knowledge,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LINC00536 gene|LINC00536,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,panobinostat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CBX3 gene|CBX3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,arsenic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Anti-Inflammatory Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Interventional procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SOAT2 gene|SOAT2,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
AFFECTS,FRMD3 gene|FRMD3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ENOLASE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Biological Markers,HER2-negative breast cancer,Other,0.0,0.0
PREDISPOSES,perfluorooctanoate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,thiamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IMPACT gene,contralateral breast cancer,Genetic Factors,0.0,0.002997002997002997
CAUSES,SDC1 gene|SDC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Circulating MicroRNA,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,TINCR gene|TINCR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,birth control pill use,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MIR497HG gene|MIR497HG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Differential Diagnosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Responsive Disease,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,LAPTM5 gene|LAPTM5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,CLDN6 gene|CLDN6,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,TAF15 gene|TAF15,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,RHOV gene|RHOV,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,Transforming Growth Factor beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,sauchinone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Targeted Therapy,Malignant neoplasm of breast,Treatments,0.0,0.3386613386613387
DISRUPTS,GABRD gene|GABRD,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MVP wt Allele|RPSA|LRP1|PTPRA|MVP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CBFB|NFYA|NFYB,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SIRT7 gene|SIRT7,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
PREDISPOSES,MicroRNAs,Early-Stage Breast Carcinoma,Other,0.0,0.0
AUGMENTS,caspase-3,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Disease/diagnosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Energy Balance,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,MYBL2 gene|MYBL2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Improved,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NOTCH1 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,COMMD3 gene|COMMD3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Leisure behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
DISRUPTS,NPY1R gene|NPY1R,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,cyclic guanosine monophosphate-adenosine monophosphate,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,Biological Markers,estrogen receptor-negative breast cancer,Other,0.0,0.0
PREDISPOSES,Sugar-Sweetened Beverages,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
CAUSES,Cobalt dichloride,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,Hexokinase 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"herstatin protein, human",Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,"Adaptor Proteins, Signal Transducing",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PLPP4 gene|PLPP4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,TIPARP gene|TIPARP,Invasive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
AFFECTS,Metabolic Profile,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Hexokinase 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estrogen Antagonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GJA1 gene|GJA1,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,Pathogenic Variant,contralateral breast cancer,Other,0.0,0.002997002997002997
CAUSES,Phytochemicals,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,Pyrenes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,C1QL4 gene|C1QL4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Food Habits,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Noninfiltrating Intraductal Carcinoma,Triple Negative Breast Neoplasms,Other,0.0692,0.01898101898101898
AFFECTS,fruit extracts,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,progesterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Heat Shock Protein 27,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Sulfhydryl Compounds,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,IDO2 gene|IDO2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Players,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,NDC80 gene|NDC80,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,reproductive hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ADAR gene|ADAR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Liposomes,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,GPT2 gene,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,Long Interspersed Nucleotide Element-1,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,PTCSC3 gene|PTCSC3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,histone deacetylase 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SCRIB gene|SCRIB,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
DISRUPTS,"CD274 protein, human|CD274",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,FOXM1 gene|FOXM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Infiltration,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,cholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor Microenvironment of Metastasis Density,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Immune,HER2-negative breast cancer,Immunological Factors,0.0,0.0
PREDISPOSES,IRF7 gene|IRF7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,HDAC1 gene|HDAC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Ferritin Light Chain,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hypothalamic inhibiting factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,MED1 gene|MED1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Triple Negative Breast Neoplasms,Malignant neoplasm of breast,Other,0.0298,0.3386613386613387
AFFECTS,MAPK1 gene|MAPK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Carcinogenesis,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
AFFECTS,xiaoyaosan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gravidity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cytochrome b561,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Obesity,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,Suppressor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Multiple tumors,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
CAUSES,agonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Thrombotic Microangiopathies,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Dynamic Contrast-Enhanced Magnetic Resonance Imaging,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Alkaloids,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,ZNF831 gene|ZNF831,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,MC1R gene|MC1R,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,estrogens,estrogen receptor-positive breast cancer,Hormonal Factors,0.0,0.008991008991008992
DISRUPTS,pristane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Non-alcoholic Fatty Liver Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ginsenosides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ethanol,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,40-49,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,interleukin-6|IL6,Invasive Ductal Breast Carcinoma,Other,0.0,0.0
AUGMENTS,"estrogens, conjugated (USP)",Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
PREDISPOSES,MIR429 gene|MIR429,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,"Interleukin-16, human",HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,polyphyllin II,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"ATF2 protein, human|ATF2",estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AUGMENTS,FTO gene|FTO,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,mahanine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,trastuzumab deruxtecan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,VIRMA gene|VIRMA,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,doxorubicin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,KLF5 gene|KLF5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Perimenopause,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,FZR1 wt Allele|CDH1,"Breast Cancer, Familial",Other,0.0,0.0
AFFECTS,Screening for malignant neoplasm of breast,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FAM83D gene|FAM83D,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,RACK1 gene|RACK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,interleukin-6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CXCL8,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,A1BG-AS1 gene|A1BG-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ANO6 gene|ANO6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,DNAJB4 gene|DNAJB4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,AFF4 gene|AFF4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,PROS1 gene|PROS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,testosterone,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Hemoglobin,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,chemokine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,butylbenzyl phthalate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lesch-Nyhan Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CAVIN1 gene|CAVIN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,"Receptors, Opioid, kappa",estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,AMACR wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TDRKH-AS1 gene|TDRKH-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"IMP3 protein, human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"MFGE8 protein, human|MFGE8",Invasive Ductal Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Organic solvent product,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Endometriosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TTPAL gene|TTPAL,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,FOXK1 gene|FOXK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MIR205 gene|MIR205,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Non-alcoholic Fatty Liver Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Implants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ESR1,malignant neoplasm of breast staging,Other,0.0,0.0
AFFECTS,FTO gene|FTO,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,GNAO1 gene|GNAO1,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
CAUSES,Tobacco,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FOXQ1 gene|FOXQ1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Tea,Breast cancer stage II,Other,0.0,0.0
AUGMENTS,PARK7 gene|PARK7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,PPARGC1B gene|PPARGC1B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TPM2 gene|TPM2,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Pivot,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
DISRUPTS,RSRC2 gene|RSRC2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,erbB-2 Receptor|ERBB2,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
COMPLICATES,Sarcoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"CD69 protein, human|CD69",Female Breast Carcinoma,Other,0.0,0.004995004995004995
AUGMENTS,Estrogen Receptor alpha,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Score,Recurrent Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,SIK2 gene|SIK2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Carney Complex,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"interleukin-1, beta",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,magnesium cation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplastic Cell Transformation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,pimozide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Movement,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIR205 gene|MIR205,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Androgen Receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,SLC7A11 gene|SLC7A11,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Gene Expression,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
AFFECTS,MT-RNR1 gene|RNR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,RAB5A gene|RAB5A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CAT gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Patient Derived Xenograft,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CCDC150 gene|CCDC150,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Male-to-female transsexual (finding),Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Autoantibodies,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MXRA5 gene|MXRA5,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,claudin 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,doxorubicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NF2 gene|NF2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,humanin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,translation factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,WWOX gene|WWOX,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,metformin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,EP300 gene|EP300,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Leucine-Rich Repeat Proteins,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,scopolamine,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
COMPLICATES,EYA2 gene|EYA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PKMYT1 gene|PKMYT1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,ME1 gene|ME1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CACNG4 gene|CACNG4,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Upstaging,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,obeticholic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoadjuvant Therapy,bilateral breast cancer,Other,0.0,0.0
AUGMENTS,CCL20 gene|CCL20,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MBD2 gene|MBD2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"IL1A protein, human|IL1A",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,IL22 gene|IL22,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Neoadjuvant Therapy,Luminal B Breast Carcinoma,Other,0.0,0.0
DISRUPTS,taurine,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,Multiple Sclerosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Targeted Therapy,HER2-positive carcinoma of breast,Treatments,0.0,0.008991008991008992
PREDISPOSES,Trichorhinophalangeal dysplasia type I,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Bee Venoms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Human Class I Antigens,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,DNA Replication,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,CCNB1 gene|CCNB1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,Urolithin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Protective Factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,pyruvate dehydrogenase kinase 4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tissue texture abnormality,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Basal Diet,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AUGMENTS,SLC38A5 gene|SLC38A5,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,FGF11 gene|FGF11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,phosphatidylinositols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,4-aminohippuric acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ZBTB10 gene|ZBTB10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Combination Chemotherapy,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Folliculin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nitric Oxide Synthase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,20q13,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GRB7 gene|GRB7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,CCL18 gene|CCL18,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,TBX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FAS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TIMM50,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Stromelysin 1|MMP3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,EPHA10 gene|EPHA10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cancer-Predisposing Gene,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,MAP3K1 gene|MAP3K1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Estrogens,Breast cancer metastatic,Hormonal Factors,0.0,0.027972027972027972
AFFECTS,Integrin alpha4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,intraoperative radiotherapy,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Menopause,Female Breast Carcinoma,Other,0.0,0.004995004995004995
DISRUPTS,BRMS1L,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,CYP1A1 gene|CYP1A1,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
AUGMENTS,"WBSCR22 protein, human|BUD23",Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,11q13,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Environmental Estrogen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Cyclin D1|LMOD1|BBS9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Renal Cell Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,cyclin A1|CCNA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Oxygen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Pollutant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tangeretin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Enhancer Elements (Genetics),Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Glutamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Heregulin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIRN143 gene|MIR143,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,RAD51C gene|RAD51C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,AATF gene|AATF,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,beta catenin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,STF,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Selective serotonin re-uptake inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SLC39A6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PTGS2 gene|PTGS2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,8-Oxoguanine DNA Glycosylase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Annexin A1|ANXA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Organized pneumonia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Methotrexate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,IFNB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor Suppressor Genes,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,VEGFA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Interleukin-18,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Receptors, Opioid, delta",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,IL18 gene|IL18,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Androgen Receptor|AR,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Pads,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Hypoxia,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Autophagy,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Genuineness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,BAG3,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"Carcinoma, Ductal, Breast",Malignant neoplasm of breast,Other,0.0396,0.3386613386613387
AUGMENTS,SNAI1,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cytotoxicity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,NOP14,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Rectal hemorrhage,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,NRIP1 gene|NRIP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Activins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Microtubule-Associated Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Phosphoglycerate dehydrogenase|PHGDH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,WRAP53,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Epidermal Growth Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,STC1 gene|STC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Environmental Pollutants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SNAI1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,TRIM62,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Wound Healing,Sporadic Breast Carcinoma,Other,0.0,0.0
DISRUPTS,ERBB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,osteoblast cadherin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Congestive heart failure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,octylphenol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ir Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ADGRF5,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Salts,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,FH: Father NOS,Familial cancer of breast,Other,0.0,0.003996003996003996
AFFECTS,carnosol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Insulin-Like Growth Factor Receptor,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,ADRA2A gene|ADRA2A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,"1,4-dioxin",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,icariin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gene Expression Regulation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MIR200A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"ST13 protein, human|ST13",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PIK3R1|PIK3R2|ARHGEF7|CBFA2T2|PPP1R13B|PPP1R12C,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Physical activity decreased,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,anthracene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FABP5 gene|FABP5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Follicle Stimulating Hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PRLR gene|PRLR|PTP4A3,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,GSTA1 gene|GSTA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,retinyl methyl ether,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PIK3CA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cytokine,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,High Vegetable Diet,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Levodopa,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,receptor,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Gin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Oncogenes,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Insulin-Like Growth Factor I,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Clomiphene,bilateral breast cancer,Other,0.0,0.0
CAUSES,Viral Tumor Antigens,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,mammaglobin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Diphosphonates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,glycosyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Brachytherapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Proliferating Cell Nuclear Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Nifedipine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cytokine,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Central Nervous System Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
DISRUPTS,Estrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AFFECTS,Dichlorodiphenyl Dichloroethylene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ukrain,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cyclin D1|LMOD1|BBS9,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Human papillomavirus 16,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Malignant mixed salivary gland tumor,Cancer en cuirasse,Other,0.0,0.0
DISRUPTS,"Receptors, Progesterone",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Human Platelet Antigens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,reproductive hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TARBP2,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Alcohol consumption,bilateral breast cancer,Other,0.0,0.0
CAUSES,Agent,Breast Carcinoma,Demographic Factors,0.0,0.027972027972027972
AFFECTS,MAPKAP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CTTN gene|CTTN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Atypical proliferation,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Tumor Antigens,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Edema,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Voluntary,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Sulfones,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Polyunsaturated Fatty Acids,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,CD44 gene|CD44,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
CAUSES,Herpesviridae,Malignant neoplasm of breast,Herpetic Genetic Factors,0.0,0.3386613386613387
CAUSES,Microsatellite Repeats,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Fatty Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Z-alpha-chlorochalcone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PRLR gene|PRLR|PTP4A3,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,LALBA gene|LALBA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,R-38486,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Malignant neoplasm of breast,Breast cancer invasive NOS,Other,0.3988,0.00999000999000999
AFFECTS,Cyclophosphamide,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,"TFF1 protein, human|TFF1",Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Carotenoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MENSTRUAL STATUS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Common Neoplasm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Menopausal Status,Contralateral breast cancer,Other,0.0,0.001998001998001998
AUGMENTS,Mechlorethamine,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Goiter,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Epidermal Growth Factor Receptor|EGF,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,OK-432,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tall stature,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,dehydroepiandrosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Caloric Restriction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Esters,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Hodgkin Disease,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,"Carcinogens, Environmental",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Atrophic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Excessive self-esteem,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Confident,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Dinoprost,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,cDNA Library,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,FGF4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fibrosing adenosis,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,Epoprostenol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RBBP1L1 Protein|ARID4B,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,FGF4 gene|FGF4,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Pregnancy review,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Zuclomiphene,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,EMD 16795,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Silicones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Malignant Carcinoid Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ergocornine,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Cisplatin,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,2-Acetylaminofluorene,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Hypolipidemia,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Retinoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Tamoxifen,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Hormone manipulation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Transgenes,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Microsatellite Repeats,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Adipositas,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Drink,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen Replacements,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Neoplasm,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,ATM gene|ATM,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,Noninfiltrating Intraductal Carcinoma,Breast cancer invasive NOS,Other,0.0692,0.00999000999000999
AFFECTS,TP73|ARHGAP24,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,thermography,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Calcium Glucarate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Psychological Impact,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,p65|RELA|SYT1|GORASP1|WNK1,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Dietary Fats,Breast Carcinoma,Behavioral Factors,0.0,0.027972027972027972
AFFECTS,PPARBP gene|MED1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Insulin-Like Growth Factor I,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,whey protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TP53 gene|TP53,bilateral breast cancer,Genetic Factors,0.0,0.0
AFFECTS,Osteoclastic resorption,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,SYK gene|SYK,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Microsatellite Instability,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,2-chloroethyl ethyl sulfide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Jogging,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TFF1 gene|TFF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Postmenopausal Hormone Replacement Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pregnenes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,casein kinase II,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Overweight,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Tumor Angiogenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,matrix metalloproteinase 26,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,8-hydroxy-2'-deoxyguanosine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,glutathione S-transferase pi|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Germ-Line Mutation,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
AFFECTS,Integrin alphaV,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,alpha-Fetoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BIN1 gene|BIN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,BIRC5 gene|BIRC5,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
CAUSES,Meat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Encounter due to Unspecified general medical examination,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Neoplasm,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,ERBB2|NEU1|NEURL1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,SLC39A6,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Diet,Breast Carcinoma,Behavioral Factors,0.0,0.027972027972027972
CAUSES,Pollutant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Parkinson Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Menopausal hot flushes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CD82 gene|CD82,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,Tumor Suppressor Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Amphiregulin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TNFSF10 gene|TNFSF10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Transforming Growth Factor alpha|TGFA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Tumor Suppressor Genes,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
AFFECTS,"Diagnosis, Computer-Assisted",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,estrone sulfatase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ABL2|RERE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Bone Resorption,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Phytoestrogens,Breast cancer recurrent,Hormonal Factors,0.0,0.004995004995004995
AUGMENTS,SNCG gene|SNCG,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,"Fatty Acids, Monounsaturated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,H-ras Genes,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
CAUSES,Carcinoembryonic Antigen,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,REL gene|REL,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Selenium,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Ethylnitrosourea,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,"N,N-dimethyl-4-anisidine",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tamoxifen,Contralateral breast cancer,Other,0.0,0.001998001998001998
CAUSES,"BCAR1 protein, human|BCAR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,AKT3 gene|AKT3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Surgical biopsy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Technetium Tc 99m Sestamibi,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,Hexestrol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Opioid Peptide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,stanniocalcin 2|STC2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Early menarche,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AUGMENTS,8-hydroxyguanine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Fatty Acids, Omega-6",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Anti-Inflammatory Agents, Non-Steroidal",Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,"Receptor, Melatonin, MT1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Antidepressive Agents, Tricyclic",Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,LIG4 gene|LIG4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Antineoplastic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,SNCG gene|SNCG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Mitotic Activity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tamoxifen,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Alpha heavy chain,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"1,2-dibromo-3-chloropropane",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BRCA2 gene|BRCA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Tumor Suppressor Genes,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,BRCA1 Protein|BRCA1,Sporadic Breast Carcinoma,Other,0.0,0.0
DISRUPTS,Soy Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Slow acetylator status,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ibandronate,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,"NOS2A protein, human|NOS2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,3' Untranslated Regions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carcinoma in Situ,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PTEN gene|PTEN,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
AFFECTS,Glutathione S-Transferase|SLCO6A1|GSTK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Embolism, Tumor",Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Therapeutic regimen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Myocardial Infarction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pharmaceutical Preparations,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,ATP12A|HK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogenic effect,Breast cancer recurrent,Other,0.0,0.004995004995004995
AUGMENTS,FGF3 gene|FGF3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,P-Cadherin,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Prenatal Exposure,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,BAG1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Eicosapentaenoic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cytokinesis of the fertilized ovum,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,adjuvant therapy,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Phosphorylcholine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fatty-acid synthase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dydrogesterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Calgranulin B,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,SPOCK2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RUNX3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Obstruction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,8q24,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Genes,Female Breast Carcinoma,Genetic Factors,0.0,0.004995004995004995
DISRUPTS,Folate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cold temperature,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,helicase|HFM1,Familial cancer of breast,Other,0.0,0.003996003996003996
AFFECTS,Epithelial Cell Proliferation,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Radiation,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Fanconi's Anemia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Atypia,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Monocyte Chemoattractant Protein-1|CCL2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,TNF,Familial cancer of breast,Other,0.0,0.003996003996003996
PREDISPOSES,RANTES|CCL5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Recombinant Interleukin-8|CXCL8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Angiotensin Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,E-Cadherin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Apigenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Palmitic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"STK6 protein, human|AURKA",Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,AROMATICS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,N-6 fatty acid intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tanshinone II A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Malignant neoplasm of prostate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Puberty, Precocious",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Chronic Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Estrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Oxidoreductase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Elements,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TNFSF6 gene|FASLG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Delayed menopause,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,protein tyrosine phosphatase 1B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ERBB3 gene|ERBB3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Testosterone,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,PPAR gamma|PPARG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Estrogen Receptor Modulators,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MERTK gene|MERTK,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ASAP1|MYCBPAP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Glycol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PARP1,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Oncogenes,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
DISRUPTS,polyphenon E,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Chemopreventive Agent,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Insulin-Like Growth Factor Binding Protein 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Activins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"RNA, Small Interfering",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Plants, Edible",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Analgesics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Disintegrins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Carbon,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,prohibitin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Phosphatidylinositols,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Paclitaxel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Conjugated Equine Estrogens,Breast cancer invasive NOS,Hormonal Factors,0.0,0.00999000999000999
PREDISPOSES,leucylproline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Carbon,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Antihormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Connexins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,podocalyxin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,HIVEP2 gene|HIVEP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Platelet-Derived Growth Factor Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Non-esterified cholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ERbetacx,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Insulin-Like Growth Factor Binding Protein 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Receptors, Cell Surface",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GSDME,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Norgestrel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,reproductive hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IFNG gene|IFNG,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
AFFECTS,Amphiregulin|AREG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,bone morphogenetic protein 2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Proto-Oncogene Protein pp60 (c-src)|SRC,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Epidermal Growth Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Body mass index,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Specific antibody,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CHEK2 gene|CHEK2,Female Breast Carcinoma,Genetic Factors,0.0,0.004995004995004995
CAUSES,RAD50,Familial cancer of breast,Other,0.0,0.003996003996003996
PREDISPOSES,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Alleles,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CA-125 Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gene Expression,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,EGLN2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MTHFR gene|MTHFR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Glutathione S-Transferase|SLCO6A1|GSTK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CD24,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,STK11 gene|STK11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,anti-apoptosis,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Estrogen Receptors,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Cell Communication,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,ERBB2 gene|ERBB2,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
AFFECTS,CTCFL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LIN28A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Compound Q,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Simvastatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Human Chorionic Gonadotropin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,protein tyrosine phosphatase 1B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HMMR gene|HMMR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CD70,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,OTP gene|OTP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Janus kinase 2|JAK2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MS2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Histologic type,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Protein Expression,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,RUNX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP1B1 gene|CYP1B1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,nuclear receptor coactivator 1|SRC,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Convenience food,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Liposomes,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,KDM8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Cations, Divalent",Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,HMMR gene|HMMR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Disulfiram,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LBX1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,IDO1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Molecular Fingerprint of Tumor,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,healthful behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,"2,5-dichloro-4-bromophenol",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Cullin Proteins,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Carbon,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BRMS1 gene|BRMS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PLXNB1 gene|PLXNB1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,RUNX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"SMO protein, human|SMO",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Lemon extract,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,invariant chain|CD74,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,survivin,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Cell-cell adhesion molecule,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Introns,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FAN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Apocrine adenocarcinoma,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,FOXC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MYB gene|MYB,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
CAUSES,Aluminum,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,RBBP7,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,quinoxaline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Germ-Line Mutation,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,YBX1,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,isoflavonoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Spontaneous abortion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Receptors, Nuclear",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PLG gene|PLG,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,FASTK Gene,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AUGMENTS,CYP2S1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,S100A11 gene|S100A11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Fenretinide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CDC25A gene|CDC25A,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,MDM2 gene|MDM2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,AUSTRALIAN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,UTS2R|SLC14A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RAD51,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,NRDC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,S100A1|S100B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Chemoprevention,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Field crops,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Core needle biopsy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NOV,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,TP53BP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Antigens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ATM gene|ATM,Contralateral breast cancer,Genetic Factors,0.0,0.001998001998001998
AFFECTS,Pharmacologic Substance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ERBB2 gene|ERBB2,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,Mammary Neoplasms,Sporadic Breast Carcinoma,Other,0.0,0.0
DISRUPTS,NCOA7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ALCAM gene|ALCAM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,SPDEF gene|SPDEF,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,ESR1 gene|ESR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,CXCR4 gene|CXCR4,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,"Receptors, Steroid",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,beta catenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,SERPINE1 gene|SERPINE1,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
CAUSES,Cancer Promoting Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Linoleic Acids, Conjugated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Metabolic Marker,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CXCL10 gene|CXCL10,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
CAUSES,CBX7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,caveolin 1,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,MMP9 gene|MMP9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"TIMP2 protein, human|TIMP2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BEX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Growth,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,SOX18,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MAP Kinase Gene,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,CD44 gene|CD44,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,intraoperative radiotherapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Gallic acid,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,ATP2B2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KIT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RAD51B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Lipids,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,FBXW7 gene|FBXW7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ESR2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,diindolylmethane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,S Phase Arrest,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MALAT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ASAP1|MYCBPAP,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,hypercholesterolemia,Breast cancer recurrent,Other,0.0,0.004995004995004995
AUGMENTS,Functional RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,COX7A2L gene|COX7A2L,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Gelsolin|GSN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,F3 gene|F3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Primary Neoplasm,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,aurora kinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCL22 gene|CCL22,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Vascular Endothelial Growth Factor C|VEGFA,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Primary carcinoma of the liver cells,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CRY1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CIP2A,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Berberine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Vimentin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,IL2-inducible T-cell kinase|ITK|SLC22A3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,KIF11,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ATG4B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Chloroquine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TMEM88,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Tumor Suppressor Genes,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
CAUSES,Proto-Oncogene Proteins c-myc|MYC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Cysteine,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,RNA-Binding Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FGF1 gene|FGF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SFRP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PFN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Alport's syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ERCC1 gene|ERCC1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Diphosphonates,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,Overweight,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,Collagen,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,STAT3 gene|STAT3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PARK7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Malignant neoplasm of prostate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,molybdenum disulfide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,OIP5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CHEST PATHOLOGY,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,oleocanthal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neuromedin U|NMU,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CASP9 gene|CASP9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Angiopoietin-2|ANGPT2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DEAE-Dextran,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Disaccharides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LEPR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ESR2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,docetaxel,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Reproductive History,Contralateral breast cancer,Other,0.0,0.001998001998001998
AUGMENTS,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,dieckol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Lovastatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Therapeutic Touch,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Smoking Status,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Phenformin,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,CCL13 gene|CCL13,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Taxanes,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,teleocalcin,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,ligustilide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Biogenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,C-terminal binding protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TNFAIP8L3,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,LGR5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immune response,Breast cancer metastatic,Immunological Factors,0.0,0.027972027972027972
AFFECTS,Malignant neoplasm of urinary bladder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Polyaromatic hydrocarbon,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,matrine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Protein phosphatase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CCR7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Glucuronosyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,interleukin-17E,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Proto-Oncogene Proteins c-akt|AKT1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,MAGEA2,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,"Genes, Regulator",Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Inactivation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Somatostatin Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SLC9A3R1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Docosahexaenoic Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CDX2 gene|CDX2,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,RCCD1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIRN34A gene|MIR34A,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,NBAT1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Neuropilin-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Inflammation,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,H19 gene|H19|HILS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"kallikrein 5, human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Inflammation,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Endothelin-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Breast cancer invasive NOS,Breast cancer metastatic,Other,0.0587,0.027972027972027972
AFFECTS,Ethanol,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,FOXM1 gene|FOXM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Fatty Acids, Omega-3",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NSUN2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Primary carcinoma of the liver cells,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lysine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cadherins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MTA3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Membrane Transport Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Trichloroethylene,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
COMPLICATES,topical application,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"KLK5 protein, human|KLK5",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Non-alcoholic fatty liver,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Age at menarche,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Sleep behavior finding,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,ESR2 gene|ESR2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,NOD2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCL4 gene|CCL4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Oligonucleotides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,receptor,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Antiepileptic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,"Linoleic Acids, Conjugated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GSTM3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SIRT7,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Neoplasm,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,Progesterone level,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Aptamer,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,FABP4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,E2F7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,zinc-binding protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cell Proliferation,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,Hydroxyestrones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KRT5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Isoprostanes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Coffee intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Choline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,WWOX,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,PPM1D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Transcriptional Regulation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,GATA4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,everolimus,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,decorin|DCN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Epidermal Growth Factor Receptor|EGFR,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Dessert,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PHF5A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ITGA2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,thymoquinone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cucurbitacin B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Thyroid Hormone Receptor Alpha-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,dronedarone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,FOXC1 gene|FOXC1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Menarche,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,kaempferol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Encounter due to prophylactic surgery, unspecified",Familial cancer of breast,Other,0.0,0.003996003996003996
CAUSES,zileuton,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,APC,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,Stanolone,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Loops,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,polycylic aromatic hydrocarbons-DNA adduct,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,XRCC1 gene|XRCC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Fibronectins,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,"Neoplastic Syndromes, Hereditary",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,APOE gene|APOE,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Ceramides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ATP phosphohydrolase|DNAH8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Metabolic syndrome,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Angiogenesis,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,CDKN1B gene|CDKN1B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Spectroscopy, Nuclear Magnetic Resonance",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Radiofrequency ablation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ANAPC15,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDC2 gene|CDK1|POLD1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,EZH2 gene|EZH2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,lapatinib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Apolipoprotein A-I|APOA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,UGT1A6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Integrins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CHES1 gene|FOXN3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,NES gene|NES,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,S100A8 gene|S100A8,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,Emodin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Raloxifene,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,Neoplasm progression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fasting,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TOB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fatty fish,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,caveolin 1,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,RAD51C gene|RAD51C,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
AFFECTS,Anti-Anxiety Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,"Receptors, Progesterone|EREG|ESR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Polyunsaturated Fatty Acids,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,P-Glycoprotein,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Hormone replacement therapy,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Recreation,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,CDKN1A gene|CDKN1A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Endopeptidases,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,BRCA1 gene|BRCA1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Osteoporosis,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Estrogen Replacement Therapy,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,LACRT gene|LACRT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Phenelzine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Oral Contraceptives, Low-Dose",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nortriptyline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Overweight,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Diet,Breast Carcinoma,Behavioral Factors,0.0,0.027972027972027972
PREDISPOSES,Overoptimism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nonpuerperal mastitis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Health promotion behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Binding Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"IGFBP2 protein, human|IGFBP2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Excision,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,somatotropin-binding protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Behavioral change,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Smoking,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,Alkaline Phosphatase,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,RFC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Health-related behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
CAUSES,Androgen Receptor|AR,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,phenylalanyl-glycyl-valyl-statyl-alanyl-phenylalanine methyl ester,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Aromatase,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Gonadotropins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mutation,bilateral breast cancer,Genetic Factors,0.0,0.0
PREDISPOSES,CCND1 gene|CCND1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,bexarotene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Serum Albumin,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Diastasis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Antineoplastic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Diabetes type,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ataxia Telangiectasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TMEM131L,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MMP14 gene|MMP14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,16q12,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Macrophage Colony-Stimulating Factor,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Cell Cycle Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Goserelin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Air Pollution,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Biotinidase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,UBE2S,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Carcinoma, Ductal, Breast",Noninfiltrating Intraductal Carcinoma,Other,0.0396,0.01098901098901099
AFFECTS,Primary Lesion,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Mastectomy,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Vincristine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Punctate calcium deposition,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Hodgkin Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dietary Supplements,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Endotoxins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,IRS1 gene|IRS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Valine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,STN gene|EEF1A2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Excessive weight gain,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Drinking pattern,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Prunes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Thyroid Hormones,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Cosmetic procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Drug Exposure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CCL5 gene|CCL5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Autoimmune hypothyroidism,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
AFFECTS,Nuclear Receptor Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Alcoholic Beverages,Female Breast Carcinoma,Demographic Factors,0.0,0.004995004995004995
PREDISPOSES,VASOMOTOR SYMPTOM,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,epigallocatechin gallate,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,agonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tipifarnib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Activins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MUC4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Personal Satisfaction,Familial cancer of breast,Other,0.0,0.003996003996003996
CAUSES,PALB2,Familial cancer of breast,Other,0.0,0.003996003996003996
AFFECTS,lapatinib,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Interleukin-8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Steroidal Estrogen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,trichostatin A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KLK5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Family history of breast cancer,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Rare Diseases,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,deceased,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Telomere Maintenance Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,cyclin-dependent kinase 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,conjugation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,overdiagnosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Sirolimus (substance),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NR5A2|P2RX5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Diabetes Mellitus,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,KRT20|C17orf97,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NR3C1 gene|NR3C1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Receptors, Progesterone",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,zeaxanthin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,BRCA3 gene|BRCA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,heparanase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CD40 Ligand|CD40LG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,interleukin-19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Calgranulin A|S100A8,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Physical therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Red Meat Consumption,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Muscular Dystrophy, Facioscapulohumeral",bilateral breast cancer,Other,0.0,0.0
PREDISPOSES,Instability,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diabetes Mellitus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CSH2 gene|CSH2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Actin bundling protein,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,IL8 gene|CXCL8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,KIF2A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Apoptosis,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,MTHFR gene|MTHFR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,HMGA2 gene|HMGA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,AKR1C4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ABCC10,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCDC91,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ribonucleotide reductase M2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MT1A|MT1B|MT1E|MT1F|MT1G|MT1H|MT1JP|MT1M|MT1L|MT1X|MTNR1A|ALG1|MT1IP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cadmium Compounds,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mutation,Female Breast Carcinoma,Genetic Factors,0.0,0.004995004995004995
AFFECTS,psychological distress,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PALB2,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AUGMENTS,HIF1A gene|HIF1A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Insulin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,Alcohol products,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mammography abnormal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Copper,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,germin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Smoking,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Pharmaceutical Preparations,Breast cancer recurrent,Other,0.0,0.004995004995004995
AUGMENTS,Hyaluronan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,diindolylmethane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Disorder of pregnancy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sleeplessness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RRM2 gene|RRM2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,Sirolimus (substance),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Soluble ErbB-1|EGFR,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Silence,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gene Family,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PELP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fertility care,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MMP11 gene|MMP11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Mammographic microcalcification,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,MIRN93 gene|MIR93|MIR9-3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Urokinase,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Protein p53|TP53,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Tumor Suppressor Genes,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Rye flour,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Clusterin|CLU,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gonadal Steroid Hormones,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Diffusion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Co-morbid conditions,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,regular physical activity,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,C-KIT Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,MICE gene,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,Mitotic/Spindle Checkpoint,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Angiogenesis,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Alcohol consumption,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,claudin 6,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,NEK2,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Somatotropin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CHD5 gene|CHD5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Glutamate-Cysteine Ligase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PERP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,EGF gene|EGF,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Mammaplasty,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Mammographic breast density,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Autoimmunity,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
AFFECTS,Sunlight,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PARD6A|PWAR6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cardanol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,None|SLC16A3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carcinoma in situ of breast,Breast cancer invasive NOS,Other,0.0304,0.00999000999000999
AFFECTS,Corn Oil,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Zinc,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AUGMENTS,UCA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"CHEK1 protein, human|CHEK1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Non-Viral Vector,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,aglepristone,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,White bread,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen effect,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BRCA1 gene|BRCA1,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,Disability NOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ERCC2 gene|ERCC2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Disease,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
DISRUPTS,"Calcium, Dietary",Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Radiation,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,Fluorodeoxyglucose F18,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Interleukin-18,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,chemokine receptor,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,CCND1 Gene Amplification,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Integrin alphaV,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PROX1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Dioxins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cisplatin/cyclophosphamide/etoposide protocol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PINX1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,BST2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Ethanol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,aldehyde dehydrogenase 1|ALDH1A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Membrane Transport Proteins,Contralateral breast cancer,Other,0.0,0.001998001998001998
DISRUPTS,Tryptophan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Vitamin D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Baresthesia,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Taurine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breast arterial calcification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FBXW7 gene|FBXW7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,palmitoleic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,LPO,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Amphiregulin|AREG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PROTEIN KINASE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,C14orf166 gene|RTRAF,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,EGFR Protein Overexpression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RPS6KA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FBXO31 gene|FBXO31,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FABP4 gene|FABP4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Peroxisome Proliferator-Activated Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GATA3 gene|GATA3,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Reexcision,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Encounter due to breast augmentation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vimentin|VIM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GAS5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MAPK12 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,tacrolimus binding protein 4|FKBP4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,COPS5,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
CAUSES,ZNF350,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Air Pollutants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Hyperostosis, Diffuse Idiopathic Skeletal",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,celecoxib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CD151,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Fenretinide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Signal Transduction Pathways,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Breast Cancer Model,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ellagic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FGFR1 gene|FGFR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Immunomodulators,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ADA,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,HADHA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,N-acetyltransferase 1|EREG|ESR1,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,Antiplatelet therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,BRCA2 gene|BRCA2,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
AFFECTS,TIMELESS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Annexin A2|ANXA2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Work stress,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cancer Promoting Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,RHBDD1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Heparan Sulfate Proteoglycan|HSPG2|SDC2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,LAMTOR5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MALAT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PGD,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,"Diabetes Mellitus, Non-Insulin-Dependent",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"MAPK14 protein, human|MAPK14",Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Estrogen Receptor Status,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,Liver Cirrhosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Brain Neoplasms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Genes,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,Oranges,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Fatty Acids, Saturated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Edema,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,SESTAMIBI,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Aspirin,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Onions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Lamins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Androstenedione,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Body mass index,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,LINC00518,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,DDT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Overweight,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,ID2 gene|ID2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,thrombospondin 4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Histone Deacetylase Inhibitor,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,AQP3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ranolazine,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,mannuronic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KIF4A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,exemestane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Repeat Surgery,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,PIP5K1C,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,KRT19 gene|KRT19,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Luteolin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ectopic Expression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SOCS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,AQP5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MFAP5 gene|MFAP5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CCL20 gene|CCL20,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ENPP2|SMG1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FTO,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Vitamin D3 Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PDLIM2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SDC1 gene|SDC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,gamma-Linolenic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Supportive care,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,CD44 gene|CD44,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,RBMS3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,VIPR1,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,triptolide,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,targeting,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
CAUSES,Skin Lymphangiosarcoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Coronary heart disease,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Metformin,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Phosphorus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Rosacea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PUF60,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,YAP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MAFG gene|MAFG,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,"1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,oncostatin M|OSM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Dexamethasone,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Phthalimides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,HDAC9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,VIM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CISH,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,ADAMTS1 gene|ADAMTS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Honey bee venom,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Antigens,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,C-Phycocyanin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NEAT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant Neoplasms,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,ATP-Binding Cassette Transporters|ATP8A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Antisense RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SNHG1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Metals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,mRNA Expression,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Anaplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ABCA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SDC1 gene|SDC1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
CAUSES,Cytochrome P-450 CYP1A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GLI3 gene|GLI3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Tissue-Specific Gene Expression,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Egg Food Product,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Hyperglycemia,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Valproic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MDM4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Proto-Oncogene Proteins c-jun|JUN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,MDM2 gene|MDM2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,E-Cadherin|CDH1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pollutant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Medication use,Breast cancer invasive NOS,Pharmacological Factors,0.0,0.00999000999000999
AFFECTS,Chinese herbal medicine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TIMM13,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"PER2 protein, mammalian",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Cyclin-Dependent Kinase Inhibitor 2A|CDK4,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,silybin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PCB 138,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP2C8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIRN192 gene|MIR192,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Extracellular Matrix Proteins,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Phenols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TRIM44,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Quinoxalines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PXDNL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Vitamins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TUFT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,transcription factor PML,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Silence,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Premenopause,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,PTP4A3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDK12,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carcinosarcoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tumor stage,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Monocyte Chemoattractant Protein-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,JPH1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Transcription Repressor/Corepressor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,UBE2V1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,RUNX2 gene|RUNX2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,APRIN gene|PDS5B,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Chalcone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,BMX gene|BMX,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Mitogen-Activated Protein Kinase 3|MAPK3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,everolimus,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Alternative Splicing,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,ethylene oxide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FAM53A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Microbicides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GABRA3 gene|GABRA3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,paclitaxel,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,HULC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Trans Fatty Acids,estrogen receptor-negative breast cancer,Other,0.0,0.0
AFFECTS,TGFB1 gene|TGFB1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,silence,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Promoter,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"nuclear receptor subfamily 1, group H, member 2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIR30A wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nance-Horan syndrome,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,intrauterine disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,mercury,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CLDN11 gene|CLDN11,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
COMPLICATES,Secondary malignant neoplasm of bone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MicroRNAs,"Breast Cancer, Familial",Other,0.0,0.0
PREDISPOSES,RHPN1-AS1 gene|RHPN1-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ABCB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BRCA2 gene|BRCA2,contralateral breast cancer,Genetic Factors,0.0,0.002997002997002997
DISRUPTS,ibrutinib,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,Ubiquitin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,Copy Number Polymorphism,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,"Antibodies, Blocking",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TT genotype,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,opium alkaloids and derivative combination cough suppressants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tamoxifen,Early-Stage Breast Carcinoma,Other,0.0,0.0
AFFECTS,letrozole,Early-Stage Breast Carcinoma,Other,0.0,0.0
AFFECTS,Mutation,contralateral breast cancer,Genetic Factors,0.0,0.002997002997002997
AUGMENTS,SIRT4 gene|SIRT4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TP53,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,MIR221 gene|MIR221,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Invasive carcinoma of breast,Malignant neoplasm of breast,Other,0.0328,0.3386613386613387
PREDISPOSES,LINC00963 gene|LINC00963,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,29+,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Polyunsaturated fat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Patient Derived Xenograft,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,"TGFB1 protein, human|TGFB1",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,MIR221 gene|MIR221,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,BHLHE40-AS1 gene|BHLHE40-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SLX4IP gene|SLX4IP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,olaparib,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Contrast enhanced spectral mammography,malignant neoplasm of breast staging,Other,0.0,0.0
CAUSES,SFN,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,MTOR gene|MTOR,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
AFFECTS,SOX21-AS1 gene|SOX21-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Detection,malignant neoplasm of breast staging,Other,0.0,0.0
PREDISPOSES,STAT1 gene|STAT1,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
AUGMENTS,Transcriptome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Macrolides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Gonadal Steroid Hormones,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Rheumatoid Arthritis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,fiber,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immunohistochemistry,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"CISH protein, human|CISH",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NOP2 gene|NOP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,SNHG3 gene|SNHG3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,MDC1 gene|MDC1,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,FOXP1 gene|FOXP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,UBE2M gene|UBE2M,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CD44,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Iodides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MLKL gene|MLKL,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,prolactin,Triple-Negative Breast Carcinoma,Other,0.0,0.0
AFFECTS,subharmonic imaging,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,OSW 1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,STAT3 gene|STAT3,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
CAUSES,HER2-positive carcinoma of breast,Malignant neoplasm of breast,Other,0.0162,0.3386613386613387
AFFECTS,Second line treatment,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Hemangiosarcoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,HEXIM1 gene|HEXIM1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Hormone Receptor Positive,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Genes, Modifier",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Proliferation (morphologic abnormality),Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Suppressor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"WWTR1 protein, human|WWTR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LINC00160 gene|LINC00160,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
AUGMENTS,methanol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FOSB,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,KLHL22 gene|KLHL22,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Postmenopausal state,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cytotoxic Chemotherapy,HER2-negative breast cancer,Other,0.0,0.0
DISRUPTS,HSP90 Heat-Shock Proteins|HSP90AA1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,risk factors,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Cadherins,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Pathogenic,contralateral breast cancer,Other,0.0,0.002997002997002997
PREDISPOSES,information seeking,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,RB1CC1 gene|RB1CC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,RUNX3 gene|RUNX3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Magnetic resonance imaging of breast,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CXCR2 gene|CXCR2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,SIRT6 gene|SIRT6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Ion Channel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Eukaryotic Initiation Factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Flavanol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Epigallocatechin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SIRT1 gene|SIRT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,apigenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AGR2,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,Reactive Oxygen Species,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Vitamin D3 24-Hydroxylase|CYP24A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BHLHE40 gene|BHLHE40,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Epicatechin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"KRT10 protein, human|KRT10",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,UBE2D2 gene|UBE2D2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CST3 gene|CST3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,P-Cadherin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PRS gene|PRS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Easy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,C8A gene|C8A,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
AFFECTS,Radionuclide Imaging,malignant neoplasm of breast staging,Other,0.0,0.0
CAUSES,CTBP1-AS2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,silence,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cancer-Predisposing Gene,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
PREDISPOSES,NEAT1 gene|NEAT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Caffeinated coffee,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,steroid glycoside,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,5-methyltetrahydrofolate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hypertrophy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SNAI3 gene|SNAI3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,lapatinib,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
CAUSES,rucaparib,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Vascular Endothelial Growth Factor A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FZD7 gene|FZD7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,cisplatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Kynurenine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,ZFPM2-AS1 gene|ZFPM2-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Visual Accommodation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,mTOR Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Biological Markers,Female Breast Carcinoma,Other,0.0,0.004995004995004995
COMPLICATES,CTHRC1 gene|CTHRC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Crown-Like Structures of the Breast,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,UBR1 gene|UBR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,NMU,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,xanthomicrol,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Crown-Like Structures of the Breast,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"HLA Class I Histocompatibility Antigen, Alpha Chain G",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Receptors, Adrenergic, beta-1|ADRB1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,angiotensin converting enzyme 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"YAP1 protein, human|YAP1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,polyphenols,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Lipids,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,GPER1 gene|GPER1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,rasagiline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,JMJD6 gene|JMJD6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Regulatory Sequences, Nucleic Acid",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PPP2R2B gene|PPP2R2B,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
DISRUPTS,cisplatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Epidermal Growth Factor Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Neutrons,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,HHEX gene|HHEX,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,ERRFI1 gene|ERRFI1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Dietary Alcohol,Invasive carcinoma of breast,Behavioral Factors,0.0,0.008991008991008992
AUGMENTS,"CD9 protein, human|CD9",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ZFAS1 gene|ZFAS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,"CREB1 protein, human|CREB1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,mannose receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RCC2 gene|RCC2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,HER2-targeting Agent,HER2-positive carcinoma of breast,Demographic Factors,0.0,0.008991008991008992
AFFECTS,Anti-Angiogenesis Effect,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Volatile Organic Compounds,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,gemcitabine,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
COMPLICATES,Obesity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pulmonary Metastasectomy,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,Epidermal Growth Factor Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ATM,Hereditary Breast and Ovarian Cancer Syndrome,Other,0.0,0.0
AFFECTS,Neoplasms by Site,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Systemic Therapy,Locally advanced breast cancer,Other,0.0,0.0
DISRUPTS,MST1 gene|MST1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Alcohol dehydrogenase,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,TRIM6 gene|TRIM6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Tissue Inhibitor of Metalloproteinase-3|TIMP3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,honokiol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,HNF1A-AS1 gene|HNF1A-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Low BMI,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"CD274 protein, human|CD274",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,human MUC1 protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ethanol,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,GZMK gene|GZMK,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,pembrolizumab,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,COL10A1 gene|COL10A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CHAF1A wt Allele|KAT2B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,IFNG gene|IFNG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Nicotinate-nucleotide pyrophosphorylase (carboxylating),Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,lipid mediator,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,High birth weight,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mean score,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,VPS35 gene|VPS35,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,water channel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TNFRSF11A gene|TNFRSF11A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LINC01977 gene|LINC01977,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,vinorelbine,Carcinoma breast stage IV,Other,0.0,0.0
CAUSES,Cytochrome P450|CYP2B6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DEGS1 wt Allele|DEGS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Atypical hyperplasia,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Second line treatment,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,WNT7B gene|WNT7B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Biological Markers,malignant neoplasm of breast staging,Other,0.0,0.0
CAUSES,Reactive Nitrogen Species,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Programmed cell death ligand 1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,CYTOR gene|CYTOR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Vitamin supplementation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIR506 wt Allele,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,MIR31HG gene|MIR31HG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,MIR31HG gene|MIR31HG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,NF-kappa B,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,MTERF3 gene|MTERF3,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,bisphenol A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,lutein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GAS5 gene|GAS5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,estrogen receptor-positive breast cancer,Malignant neoplasm of breast,Other,0.0175,0.3386613386613387
CAUSES,voacamine,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,GLUCOSE-6-PHOSPHATASE,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,atmospheric pollution,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Sphingolipids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,directive therapy,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Pathologic Neovascularization,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,"3,3'-diindolylmethane",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PFKFB4 gene|PFKFB4,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,Interferon-alpha,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Biological Response Modifiers,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,Metastatic malignant neoplasm to brain,Luminal B Breast Carcinoma,Other,0.0,0.0
CAUSES,Angiogenesis Inhibitors,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,FABP4 gene|FABP4,Recurrent Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
PREDISPOSES,Imbalance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Candidate Disease Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Chlorpyrifos,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Treatment Protocols,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,Agent,HER2-positive carcinoma of breast,Demographic Factors,0.0,0.008991008991008992
DISRUPTS,Androgen Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Long Intergenic Non-Protein Coding RNA,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Xenobiotics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TRPV6 gene|TRPV6,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
PREDISPOSES,MMP11 gene|MMP11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Interstitial Collagenase,Breast Carcinoma,Demographic Factors,0.0,0.027972027972027972
PREDISPOSES,AMD1 gene|AMD1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,E2F1 Transcription Factor|E2F1|UBE2L3,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,SOX2 Transcription Factor|SOX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Proton Pump Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,3F8 antibody,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Increased prolactin level,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,PET/CT scan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,UBA5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,DEAD Box Helicase p68|DDX5|KHDRBS1|POLD3|GATAD2B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Food, Organic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,rutecarpine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Epstein-Barr virus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,bruceine D,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Breast Cancer Therapeutic Procedure,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,TBX15 gene|TBX15,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Kynurenine 3-monooxygenase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ovary; insufficiency,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PIM1 gene|PIM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hormone Therapy,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,AIFM2 gene|AIFM2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,ZBTB7A|AKIRIN2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Trace Elements,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,MCM3AP-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RPPH1 gene|RPPH1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"protein tyrosine phosphatase, non-receptor type 1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,estrogen use,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Metronomic Chemotherapy,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,PALB2 gene|PALB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,kinase inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Adriamycin,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,epithelial to mesenchymal transition,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,Adverse Event Emergency Room Visit,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,SNHG3 gene|SNHG3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,TUBA4A gene|TUBA4A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,WDR43 gene|WDR43,estrogen receptor-negative breast cancer,Genetic Factors,0.0,0.0
PREDISPOSES,AMIGO2 gene|AMIGO2,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
DISRUPTS,SNHG1 gene|SNHG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Intronic Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Mammaplasty,Stage 0 Breast Carcinoma,Other,0.0,0.0
CAUSES,"Dolichyl-Diphosphooligosaccharide-Protein Glycosyltransferase Subunit 1, human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,glucose high,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,aspirin,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,Elevation procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,GATA3 gene|GATA3,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,TMEM130 gene|TMEM130,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,oleyloxyethylphosphorylcholine,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Plasma Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RASSF1 gene|RASSF1,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
PREDISPOSES,BNIP3 gene|BNIP3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Overdiagnosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,erbB-2 Receptor|ERBB2,Recurrent Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,fibroblast activation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Elevated Expression,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,COMT gene|COMT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"leptin receptor, human|LEPR",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PTPN2 gene|PTPN2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,FGFR4,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,FERMT2 gene|FERMT2,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
PREDISPOSES,"Receptor Tyrosine-Protein Kinase ErbB-4, human|ERBB4",Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,atezolizumab,Locally advanced breast cancer,Other,0.0,0.0
AFFECTS,Aromatase Inhibitors,Malignant neoplasm of female breast,Treatments,0.0,0.0
AFFECTS,MEG3 gene|MEG3|FAM129B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Parity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,limonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SHMT2 gene|SHMT2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,EIF3B gene|EIF3B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,MIR21 gene|MIR21,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Suspensions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ultrasound Tomography,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Parallel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,mRNA editing,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
CAUSES,Transcription Coactivator,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lymphatic Invasion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Precision Medicine,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
COMPLICATES,Binding Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MicroRNAs,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,IRAK1 gene|IRAK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TSPAN8 gene|TSPAN8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Genetic Loci,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ergocalciferol,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
COMPLICATES,Lymphedema,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nicotinate-nucleotide pyrophosphorylase (carboxylating),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Confirmation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,cytokine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ALDH2 gene|ALDH2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,interleukin-21,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NTN4 gene|NTN4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Tumor necrosis factor receptor 11b,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CCL18 gene|CCL18,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
AUGMENTS,TLN1 gene|TLN1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,Cell-Free DNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Low health literacy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,genistein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TIMM8A,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Free triiodothyronine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,HAUS5 gene|HAUS5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,LINC01315 gene|LINC01315,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Targeted Therapy,Triple Negative Breast Neoplasms,Treatments,0.0,0.01898101898101898
AUGMENTS,DLGAP1-AS2 gene|DLGAP1-AS2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Chromosomal translocation,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,SOX10 gene|SOX10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,lipid mediator,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,terminal differentiation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,UBE2T gene|UBE2T,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Male fertility,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Intraoperative Radiation Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Uptake,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,GHET1 gene|GHET1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,PGM5P3-AS1 gene|PGM5P3-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,exenatide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cancer care,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Hereditary Breast and Ovarian Cancer Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Mortality, Premature",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ZNF582-DT gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,"Receptor, PAR-1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,EBF1 gene|EBF1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Recurrent infections,Malignant neoplasm of breast,Herpetic Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CENPW gene|CENPW,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,GP5 gene|GP5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,CYP2W1 gene|CYP2W1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Matrix Metalloproteinases,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,CDK6 gene|CDK6,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
PREDISPOSES,MFNG gene|MFNG,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,"Amino Acids, Branched-Chain",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fast Foods,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,asparaginylendopeptidase,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,MCM10 gene|MCM10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"SFN protein, human|SFN",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CD44,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,tao hong si wu decoction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KDM4A gene|KDM4A,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,prolactin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Asbestos,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FOXF2 gene|FOXF2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,CENPW gene|CENPW,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,somatostatin receptor 1|SSTR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GJA1 gene|GJA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,"RNA, Long Untranslated",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,MELK gene|MELK,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
DISRUPTS,TIMM8A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CASP9 gene|CASP9,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
PREDISPOSES,Blood group AB,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Cooking Practices,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mean score,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Phytochemicals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PFKFB3 gene|PFKFB3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Chemicals,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
COMPLICATES,Acquired Immunodeficiency Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Acute infectious disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SLC6A14 gene|SLC6A14,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,RPS6KB1 gene|RPS6KB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SULT1A1 gene|SULT1A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Dysbiosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Alkaloids,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,medication use,Malignant neoplasm of breast,Pharmacological Factors,0.0,0.3386613386613387
PREDISPOSES,Chemokine CXCL12,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,Oral intake,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,AMACR wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,calreticulin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,CUEDC2 gene|CUEDC2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,NU 7441,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Prognostic Factors,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,Purinoceptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,sorafenib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,trichloroethylene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,estrogens,Advanced breast cancer diagnosis,Hormonal Factors,0.0,0.0
AFFECTS,"LATS1 protein, human|LATS1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,KIF11 gene|KIF11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,nesiritide|NPPB,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,IRS2 gene|IRS2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Gene Expression,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,CHEK2 gene|CHEK2,contralateral breast cancer,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,Lymph-vascular invasion,Invasive Ductal Breast Carcinoma,Other,0.0,0.0
AFFECTS,NR1H3 gene|NR1H3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,isoleucylvaline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"HMGB3 protein, human|HMGB3",Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,MTNR1B gene|MTNR1B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Morbidity - disease rate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"DNA Breaks, Double-Stranded",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Observation - diagnostic procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Histone Demethylases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Therapeutic procedure,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,maintenance of pluripotency,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Female Breast Carcinoma,Carcinoma of Male Breast,Other,0.0174,0.004995004995004995
AFFECTS,Tumor Microenvironment,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,MIR382 wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hepatocyte Growth Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SAFB2 gene|SAFB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,trichostatin A,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,MicroRNA 367-3p,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,selenium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Flash,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Substance P Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Autophagy,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,sauchinone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Vascular Endothelial Growth Factors|VEGFA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PARP9 gene|PARP9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Sentinel node (disorder),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"interleukin-1, beta",Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Prolactin Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,interleukin-6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cancer/Testis Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DDX3X gene|DDX3X,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
DISRUPTS,parecoxib sodium,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,PTPN13 gene|PTPN13,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Vigorous physical activity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Biomodulin T,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,KAT7 gene|KAT7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Vigorous physical activity,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,Ocular Cicatricial Pemphigoid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"RNA, Circular",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,IMPACT gene,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,IGF2BP1 gene|IGF2BP1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
DISRUPTS,Chalcone,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Degenerative polyarthritis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,PRMT2 gene|PRMT2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,PCAT19 gene|PCAT19,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Genes,Hereditary Breast and Ovarian Cancer Syndrome,Genetic Factors,0.0,0.0
AUGMENTS,SFXN1 gene|SFXN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,glycyrrhetinic acid,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,TWIST1 gene|TWIST1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Psychosocial procedure,Early-Stage Breast Carcinoma,Other,0.0,0.0
AUGMENTS,SFXN2 gene|SFXN2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Proliferation (morphologic abnormality),HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,hydrochloride,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Reproductive tract infection,Malignant neoplasm of breast,Herpetic Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Apolipoprotein A-I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoadjuvant Systemic Therapy,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,IGF1R gene|IGF1R,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,SOX9 gene|SOX9,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Anthropometric Measures:-:Point in time:^Patient:-,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,triclosan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ETV7 gene|ETV7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Luteolin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"FRAP1 protein, human|MTOR",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,New Target Lesion Identification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,sirolimus,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,SMIM10L2A gene|SMIM10L2A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Adrenergic beta-Antagonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Premenstrual Tension,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,Secondary malignant neoplasm of breast,Other,0.3988,0.002997002997002997
AFFECTS,"CDK7 protein, human|CDK7",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,LINC02568 gene|LINC02568,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
AFFECTS,morusin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Invasive carcinoma of breast,Noninfiltrating Intraductal Carcinoma,Other,0.0328,0.01098901098901099
DISRUPTS,quinacrine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,polyphenols,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Challenge:Type:Point in time:^Patient:Nominal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Emodin,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,KCNQ1OT1 gene|KCNQ1OT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Angiotensin II receptor antagonist,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,propofol,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,ERBB2 gene|ERBB2,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
PREDISPOSES,Cardiac dysfunction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SNHG11 gene|SNHG11,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,glucose,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mental disorders,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SLC7A11 gene|SLC7A11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Tn antigen,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,TIPARP gene|TIPARP,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,pirarubicin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,"TNK2 protein, human|TNK2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Trichorhinophalangeal dysplasia type I,Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,Lymph Node Metastasis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,glycosylation,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,Adrenergic beta-Antagonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,beta-Glucans,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,rebastinib,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Indicators,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,MIR182 gene|MIR182,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,receptor for advanced glycation endproducts,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ATP2C1 gene|ATP2C1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,malignant disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,zoledronate,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Hypofractionated radiation therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,berberine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FOXA1 gene|FOXA1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Synapsin I,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,interleukin-8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,postmenopausal syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,thymidine kinase 1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,metformin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SIGLEC15 gene|SIGLEC15,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,formononetin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,MIDEAS gene|ELMSAN1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Amino Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,OTUB1 gene|OTUB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,leptin receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,High Density Lipoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dried fruit intake,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
CAUSES,VEGFA gene|VEGFA,Invasive Ductal Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,LAYN gene|LAYN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PIK3CB gene|PIK3CB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Raw vegetable,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Genes,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
PREDISPOSES,RHOT1 gene|RHOT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Inflammatory Response,Invasive Ductal Breast Carcinoma,Other,0.0,0.0
AFFECTS,STAT3 gene|STAT3,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
CAUSES,polyphyllin II,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,SB 203580,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,hydnocarpin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,UHRF1 gene|UHRF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PAXX gene|PAXX,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Decreasing,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,venetoclax,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,doxorubicin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Consideration,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,ANXA9 gene|ANXA9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SF3B1 gene|SF3B1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Chest asymmetry,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Positive Regulation of Oxidative Stress Process,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
CAUSES,CERS4 gene|CERS4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"MMP11 protein, human|MMP11",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"MAP3K8 protein, human|MAP3K8",Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,Androgens,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
CAUSES,takinib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Squalene monooxygenase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RIN2 gene|RIN2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,G protein-coupled receptor kinase 4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Proteome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ABCB1,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,"Diet, Western",Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AUGMENTS,YTHDF1 gene|YTHDF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,INSM1 gene|INSM1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,"PTGS2 protein, human|PTGS2",Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,AZGP1 gene|AZGP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,directive therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CIB1 gene|CIB1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Carney Complex,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,NCBP1 gene|NCBP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,NEU1 gene|NEU1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,factor XIII,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ELAVL2 gene|ELAVL2,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Breast-Conserving Surgery,Locally advanced breast cancer,Other,0.0,0.0
AFFECTS,momordicoside K,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Soybeans,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,APOBEC3A gene|APOBEC3A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,ROS1 gene|ROS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,SNORD49B gene|SNORD49B,Early-Stage Breast Carcinoma,Genetic Factors,0.0,0.0
AFFECTS,ezrin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Details of education,Malignant neoplasm of breast,Educational Factors,0.0,0.3386613386613387
AFFECTS,MYC gene|MYC,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,SIPA1 gene|SIPA1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,"ORF74 protein, Human herpesvirus 8",Triple Negative Breast Neoplasms,Herpetic Genetic Factors,0.0,0.01898101898101898
AFFECTS,RBM24 gene|RBM24,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,FOXO3 gene|FOXO3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,NT5DC2 gene|NT5DC2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,CERNA2 gene|CERNA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,PTPRG-AS1 gene|PTPRG-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Androgen Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pharmaceutical Preparations,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,Genes,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,SF3A2 gene|SF3A2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,SLC7A11 gene|SLC7A11,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,PDK1 gene|PDK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Reproductive History,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Lipidome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BAIAP2L1 gene|BAIAP2L1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Malignant Neoplasms,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,Cell Cycle Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Endocrine System Diseases,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Viscosity,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Hormone Receptor,malignant neoplasm of breast staging,Other,0.0,0.0
DISRUPTS,NUDT1 gene|NUDT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CONOTRUNCAL ANOMALY FACE SYNDROME,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Corticotropin-Releasing Hormone,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,receptor for advanced glycation endproducts,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Intravascular Metastasis,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,MAPK8 gene|MAPK8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,PDZK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,tibolone,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,CpG Islands,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PARP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CXCL12 gene|CXCL12,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
AFFECTS,ATF3 gene|ATF3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Soy Milk,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TRPM7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neuregulin 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BCL-2 Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TRAF4 gene|TRAF4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Breast cancer metastatic,Malignant neoplasm of breast,Other,0.0306,0.3386613386613387
DISRUPTS,Estrogen Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Chronic inflammation,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,EPHA10 gene|EPHA10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,STAT3 gene|STAT3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,GSTO2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"FRAP1 protein, human|MTOR",Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,"CYP2B6 protein, human|CYP2B6",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LECT2,Breast cancer recurrent,Other,0.0,0.004995004995004995
DISRUPTS,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Transferase Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,DNA repair protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,p-hydroxycinnamaldehyde,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,maspin|SERPINB5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,arginylarginine|ABL2|RERE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Biosensors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NCOA1 gene|NCOA1,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
CAUSES,SRC gene|SRC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FOXD3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Secondary malignant neoplasm of lung,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ARF6,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,GPER1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,arsenite,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,catalpol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TRANCE protein,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,pigment epithelium-derived factor,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,AMOT gene|AMOT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Health behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
DISRUPTS,3' Untranslated Regions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estrogen Receptor beta|EREG|ESR1,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AFFECTS,CYP2C19 gene|CYP2C19,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,NFKB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GIT1 gene|GIT1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
CAUSES,mammaglobin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Angiotensin II Type 1 Receptor Blockers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estrogens,Female Breast Carcinoma,Hormonal Factors,0.0,0.004995004995004995
DISRUPTS,LIN28A,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,25-hydroxyvitamin D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diet good,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AUGMENTS,p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,mdm2 protein|MDM4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BMP4|BMP4,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Signal Pathways,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,YBX1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,deferiprone,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Medroxyprogesterone 17-Acetate,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Detection,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,"Carcinogens, Environmental",Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AUGMENTS,Genistein,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Noninfiltrating Intraductal Carcinoma,Malignant neoplasm of breast,Other,0.0692,0.3386613386613387
PREDISPOSES,3/4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FOXP2,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Smoking,Sporadic Breast Carcinoma,Other,0.0,0.0
AUGMENTS,WWTR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Breast Microcalcification,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,Tungsten,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Botanicals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HNRPM gene|HNRNPM,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,RAB22A,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,PARP1 gene|PARP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,docetaxel,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,BIRC7 gene|BIRC7,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,BCL2L11 gene|BCL2L11,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Squamous cell carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Heme,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,fraxetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Seafood,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Animal fat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,GATA3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Molecular Chaperones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,lard,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mammographic microcalcification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MicroRNAs,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,"Genes, Suppressor",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Neoplasm,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Intercellular adhesion molecule 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Colorectal Cancer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,S100 Proteins|S100A1|S100B,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,BRCA3 gene|BRCA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,S100A8 gene|S100A8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Pteridines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Finding of antibody titer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hemorrhage,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Evolution,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,PCSK6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Reserpine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Interleukin-6,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,MIRN10B gene|MIR10B,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,CTSL gene|CTSL,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,ERBB2 gene|ERBB2,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Malignant Neoplasms,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,ERBB4 gene|ERBB4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Positive Test Result,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Selective Estrogen Receptor Modulators,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Estriol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Serum Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Genome,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Detection,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Selenium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Nitric Oxide,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Aromatase Inhibitors,Breast cancer metastatic,Treatments,0.0,0.027972027972027972
CAUSES,Study models,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Prostate-Specific Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mitogen-Activated Protein Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,FABP7|MAS1L,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ERBB2 gene|ERBB2,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Retinoblastoma Genes,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
CAUSES,leukemia inhibitory factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Phytochemical,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Lactoylglutathione Lyase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,BRCA2 gene|BRCA2,Female Breast Carcinoma,Genetic Factors,0.0,0.004995004995004995
DISRUPTS,Flap Endonuclease-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Gastrointestinal Neoplasms,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,TNFSF11 gene|TNFSF11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,E-Cadherin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,thymalfasin,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Progestogen only oral contraceptive,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Vegetables,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Technetium Tc 99m Sestamibi,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Potato,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Deletion Mutation,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Integrin beta3|EEF1B2P2|BHLHE22,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,NLRP3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gynecomastia,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,DNA,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Fluorouracil,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Mammary Neoplasms,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Chemopreventive Agent,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,Arginine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Blind Vision,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,family background,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Antispasmodics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Chromosome 11 Short Arm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Caffeine,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Hydralazine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Skin problem,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,N-Acetylneuraminic Acid,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,cell motility,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Intraductal Hyperplasia,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Fibroadenoma,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Malignant Neoplasms,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Milk Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ductal Carcinoma,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Buserelin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,ASK Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Carcinoma,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
CAUSES,benzanthracene,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,CHEST PATHOLOGY,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Thiotepa,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Milk, Human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fibronectins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CEACAM5 gene|CEACAM5,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
CAUSES,HPR gene|HPR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Mitoxantrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Polyomavirus Middle T Antigens,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,trastuzumab,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Peanut Agglutinin,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,PREMARIN USE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"VEGF protein, human|VEGFA",Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Androsterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,limonene,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,erbB-2 Receptor|EGFR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Histologic type,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Angiostatins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,sex hormone-binding globulin receptor,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Leucine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Indicators,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Tumor Suppressor Genes,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,PBP gene|DOCK3|PEBP1|PKD1|MED1|PPBP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,rac-PK beta|AKT2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Immunoconjugates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,NME2,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Glycoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,National origin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Candidate Disease Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Antigens,Breast cancer stage II,Other,0.0,0.0
AFFECTS,Fetal Growth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,tumor growth,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,alpha-Linolenic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Protease Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,formestane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Equine laminitis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Protease Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Cell Cycle Proteins,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,CD4 gene|CD4,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,CA-15-3 Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HSPB8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Growth Factor Receptors,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Androgens,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Endometrial Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Telomerase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,perlecan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Amphiregulin|AREG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Cyclin D1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Study models,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Vascular Endothelial Growth Factor Receptor-2|VEGFA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,riboflavin-binding protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Progesterone increased,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Interleukin-18,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Brain Neoplasms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Micronutrients,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cytochrome P-450 CYP1A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Detection,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,c-myc Proto-Oncogenes|MYC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Therapy responder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Angiogenesis Factor,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Epithelial-Stromal Communication,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immunization,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Hydrocarbons,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NF-kappa B,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Oncogene ErbB2|ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Punctate inner choroidopathy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,resveratrol,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,17q23,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Preventive Services - Orthodontics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,sphingosine kinase-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Endopeptidases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Environmental Pollutants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,EPSTI1 gene|EPSTI1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,Brain hemorrhage,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Molecular Pathology,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Thrombus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,response,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,AKT2 gene|AKT2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Transgenes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Protein Kinase C|PRRT2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Serpins,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Cyclooxygenase 2 Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tamoxifen,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Endocrine therapy,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Uterine activity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carotene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Transcript,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,fulvestrant,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"CBFB protein, human|CBFB|NFYA|NFYB",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MSN gene|MSN,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,Human Chorionic Gonadotropin|CGA|HTC2|CGB5,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Colony-Stimulating Factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,VEGF gene|VEGFA,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
CAUSES,BARD1 gene|BARD1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
CAUSES,"prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Renal tubular disorder,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Dinucleotide Repeats,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Isothiocyanates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,GADD45A gene|GADD45A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,TSG101 gene|TSG101,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,Fanconi's Anemia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,progesterone analog,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Mouse mammary tumor virus infection,Breast Carcinoma,Herpetic Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Abnormal digestive tract function,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LRRC15,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Angiotensinogen|AGT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Receptors, Progesterone|PGR",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Poland Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,STK11 gene|STK11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,BIN1 gene|BIN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,4-nonylphenol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,P-Selectin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CLSPN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Doxazosin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LZTS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dopamine Antagonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,IL6ST gene|IL6ST,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cell Adhesion Molecules,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Fibrinogen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,adduct,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tomography,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Clusterin|CLU,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hereditary Malignant Neoplasm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CASP8 gene|CASP8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Acne,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Wine intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Coumestrol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Lymphoid neoplasm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Vitamin D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pulmonary toxicity,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,"Xeroderma pigmentosum, group C",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IGFBP1 gene|IGFBP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Membrane receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Carcinogenicity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,APOE gene|APOE,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Pulmonary Embolism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,5'-AMP-activated protein kinase,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Transforming Growth Factor beta Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,E2F4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Mucinous Neoplasm,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Paroxetine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,syndecan 1 protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Recombinant Transforming Growth Factor-Beta 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PSMA5|AP5Z1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RHOC gene|RHOC,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
CAUSES,Neoplasm,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Body mass index,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,CXCR4 Receptors|CXCR4,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Farnesyl Transferase Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Antihypertensive Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
CAUSES,Ethylene Oxide,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Cysteine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,catenin p120(ctn) protein|CTNND1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Homologous Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PTN gene|PTN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,SCTR gene|SCTR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Complex Extracts,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Biopsy,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Repetitive Region,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,NBS1 gene|NBN|NLRP2,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
AFFECTS,Quercetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IL6R,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Genes,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Stromal Cell-Derived Factor 1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,SULT1A1|SLC45A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ethylene Oxide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,BEX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,steroid hormone receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,semapimod,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Excretory function,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,polyphenols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Hamartoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Serum Folate Level,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,of 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Nucleotide Excision Repair,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Plasmin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Focal Adhesion Protein-Tyrosine Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,bone morphogenetic protein 5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Tobacco smoke,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mammaplasty,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,PES1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Transgenes,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,INPPL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dyslipidemias,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PROTEIN KINASE|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,KL gene|KL,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,nucleic acid inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KLLN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PIWIL1,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,chemokine,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Estrogens,Sporadic Breast Carcinoma,Hormonal Factors,0.0,0.0
PREDISPOSES,CYP3A5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,adjuvant therapy,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
CAUSES,Breast cancer metastatic,Malignant neoplasm of breast,Other,0.0306,0.3386613386613387
PREDISPOSES,"Medical care, unspecified",Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AUGMENTS,Proto-Oncogene Proteins c-akt,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,TWIST2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,estrogen receptor gamma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ADIPOQ,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ZNF703,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Progestins,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,PELP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MAPK8 gene|MAPK8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,FGFR2 gene|FGFR2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Phosphotransferases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,P-Glycoprotein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,sarcoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Annexin A6|ANXA6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Reactive Oxygen Species,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,thymidine kinase 1,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Chromosome 10 Short Arm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Protein phosphatase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CD44 gene|CD44,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,CD24,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,butylbenzyl phthalate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Transcription Factor 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MAPK12 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Plasminogen Activator Inhibitor 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,S100A2 gene|S100A2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,antiangiogenesis therapy,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Monocyte Chemoattractant Protein-1|CCL2,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,SIX1,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Heat Shock Protein 27,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dipyridamole,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Transforming Growth Factor Beta 2|NEUROD1|TUBB4B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PARD6A|PWAR6,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,TUBB4A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,plumbagin,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,SIX1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,6-bromo-2-naphthyl sulfate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"FRAP1 protein, human|MTOR",Female Breast Carcinoma,Other,0.0,0.004995004995004995
DISRUPTS,beta catenin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,KLF9 gene|KLF9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cyclin-Dependent Kinase 4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,FOXO3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TNFRSF10B gene|TNFRSF10B,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,corrigendum,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Beta-glucuronidase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CLDND1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Germ-Line Mutation,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Dietary Supplements,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,plumbagin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SNHG12,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Fibroblast Growth Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Ion Channel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Metabolic syndrome,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Evolution,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Ceruloplasmin|CP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Promoter Regions (Genetics),Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,interleukin-22,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SOX17,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pyruvate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cholesterol levels raised,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,MC1R,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Signaling Molecule,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,Inflammatory Breast Carcinoma,Other,0.3988,0.000999000999000999
AUGMENTS,Protein C Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dichlorodiphenyldichloroethane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Nicotinamide adenine dinucleotide (NAD),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,NR4A1 gene|NR4A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Dexamethasone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,TWIST1 gene|TWIST1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,NUCB2 gene|NUCB2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Risk Reduction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MSI2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Diethylstilbestrol,Noninfiltrating Intraductal Carcinoma,Behavioral Factors,0.0,0.01098901098901099
CAUSES,IL33,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CXCL9 gene|CXCL9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,TRPV4,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Berries,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Margarine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,IGF1R gene|IGF1R,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,GPR116 gene|ADGRF5,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,Docosahexaenoic Acids,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Protein phosphatase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Colorectal Cancer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GIT1 gene|GIT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,DNA Adducts,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,chemoprotection,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Radiation therapy,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,RGS2 gene|RGS2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ABCB6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NUP155,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,atorvastatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Signaling Molecule,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,kinase inhibitor,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Adenomatous Polyposis Coli,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Reactive Oxygen Species,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Glioma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplasm progression,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,UBE3A,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,CLDN2 gene|CLDN2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,NUMB,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,liraglutide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BRMS1 gene|BRMS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Acute myocardial infarction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mammography finding,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,radiosensitization,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP2B6 gene|CYP2B6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,membrane-type 1 matrix metalloproteinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Thiamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PLAT gene|PLAT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptor Status,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,TARDBP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Zinc,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PIWIL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MMP,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Hyperinsulinism,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,KLF17,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SHARPIN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DACT2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,APBA3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Benzoic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CYC1 gene|CYC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Late pregnancy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,jatrophone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"ABCG2 protein, human|ABCG2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Thiazolidinediones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CISH,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,PPM1D,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,tumor growth,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,calmodulin-dependent protein kinase II|CAMK2G,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,calmodulin-dependent protein kinase II|CAMK2G,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Oncogenes,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
COMPLICATES,Fibrosing adenosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BCYRN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FGF2 gene|FGF2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,KRAS gene|KRAS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CXCL1 gene|CXCL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"Amino Acids, Branched-Chain",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ALDH1A3 gene|ALDH1A3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Prostaglandin-Endoperoxide Synthase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,nucleolin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Arachidonic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Vitamin D Analog,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,caveolin 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Anaphylaxis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Parabens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ARRDC3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MST1R gene|MST1R,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,SENP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BCL2 gene|BCL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,grasp,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Endogenous Retroviruses,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCR7,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,PRLR gene|PRLR|PTP4A3,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Esters,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"ESR1 protein, human|ESR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Manganese Superoxide Dismutase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lasso,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PIK3R1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,PTHLH gene|PTHLH,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,uptake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Proto-Oncogene Proteins c-jun|JUN,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Collagen Type IV,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Recombinant Interferon-gamma|IFNG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GGN gene|GGN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ADH1C|ADH5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CLOCK gene|CLOCK,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PARP9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ATF4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Taxol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Receptors, LH",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Liposomes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tobacco use,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,BCAS3 gene|BCAS3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,N NOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Sentinel Lymph Node Biopsy,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,wogonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MCM10 gene|MCM10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Glutamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Embryonic Development,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Tobacco smoke,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,pentabromodiphenyl ether,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aromatase,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,OIP5-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Linoleic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,TRANSCRIPTION FACTOR,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Dietary Oils,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,NF-kappa B,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Rest,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ARNT2 gene|ARNT2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Black tea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,lysophosphatidic acid,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,PTK6 gene|PTK6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,response,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,ESR1 gene|ESR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Nuclease Sensitive Element Binding Protein 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NES gene|NES,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,norethindrone acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,IQGAP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MicroRNAs,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
CAUSES,Oxytocin,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Galactosamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,S100A9 gene|S100A9,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,NAMPT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MIRN205 gene|MIR205,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Homeo Box Sequence,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Viral Tumor Antigens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Early Diagnosis,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,SNW1 Gene|SNW1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"Carcinogens, Environmental",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RBX1 gene|RBX1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Apoptosis,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,CEACAM5 gene|CEACAM5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Estrogen Antagonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Chromosome 15 Short Arm,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Superoxides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PIP,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Immunoglobulin Fc Fragments,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Cytostatic Agents,Breast Carcinoma,Demographic Factors,0.0,0.027972027972027972
DISRUPTS,vigilin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PTPN13,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,FADS2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fish Oils,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Antibodies,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Vascular Endothelial Growth Factor Receptor-3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Atypical hyperplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Heat-Shock Proteins 70|HSPA4,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,stromelysin 3,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Carrier of disorder,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,FMO5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Endostatins,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Loss of Heterozygosity,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Optimistic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Adrenergic Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Ions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Mammary Carcinoma, Human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Serine Proteinase Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Tumor Necrosis Factor Ligand Superfamily Member 6|FAS,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Atypical proliferation,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,SULT1A1|SULT1A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,C-Peptide,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Lecithin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BONE MASS,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,celecoxib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CAMP,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,FOXM1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Freund's Adjuvant,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,PTGS2 gene|PTGS2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Low Birth Weights,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,letrozole,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Rh Factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Total cholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,High Density Lipoprotein Cholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SSM,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"Contraceptives, Oral",bilateral breast cancer,Other,0.0,0.0
AFFECTS,Contraceptive methods,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Multivitamin preparation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,letrozole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NAMPT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIR519D,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Puberty stage,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,ERCC5 gene|ERCC5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Butter,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Non-infiltrating lobular carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Heat-Shock Proteins 70|HSPA4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vegetable Oils,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Speaking,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Weakly positive,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,adjuvant therapy,Breast cancer stage II,Other,0.0,0.0
PREDISPOSES,Growth Factor,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"Breast Fibrocystic Change, Proliferative Type",Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"Transcription, Genetic",Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,poor health,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,nimesulide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Eicosapentaenoic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Flavones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Magnetic Resonance Imaging,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Adrenal Cortex Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,tibolone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Short Tandem Repeat Polymorphism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Long chain fatty acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Antibiotics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ADRB3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Magnetic Resonance Spectroscopy,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Biopsy,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Specific antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GPR30 gene|GPER1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Ill-at-ease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Detection,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
DISRUPTS,pterostilbene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PKP3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Proto-Oncogene Protein pp60 (c-src)|SRC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Ethanol,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Contralateral breast cancer,Malignant neoplasm of breast,Other,0.0189,0.3386613386613387
AUGMENTS,GDI2 gene|GDI2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cadherins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Osteogenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Klinefelter's Syndrome,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AUGMENTS,Acetaldehyde,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ezrin|EZR,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,LIG4 gene|LIG4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Silence,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Hypertension induced by pregnancy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,APOB gene|APOB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Asleep,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Obesity,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,Interleukin-17,Sporadic Breast Carcinoma,Other,0.0,0.0
DISRUPTS,Estrogen Receptor beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Gelatinase B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Food,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LPCAT3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Therapeutic procedure,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Neoplasm progression,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,CALML3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ODAM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MRE11,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RPS6KB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Macrophage Chemotactic Factors,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,cytokine,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Vitamin B12 intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,butein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,heparanase,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,estrone sulfate,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,atovaquone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CYP24A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Chemokine (C-X-C Motif) Ligand 1|CXCL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estradiol,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
DISRUPTS,Proliferating Cell Nuclear Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Computed Tomographic Colonography,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,VASOMOTOR SYMPTOM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Folic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,osteopontin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,cadherin 5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Steroid hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,aldehyde dehydrogenase 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Connexin 43,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fruit intake,Breast cancer recurrent,Other,0.0,0.004995004995004995
DISRUPTS,Interleukin-12,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,biological_process,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,ADAM29,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TYRP1 gene|TYRP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Estradiol + norethindrone acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GAL3ST1|SLC35A1|CASZ1|CST12P,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estrogen Receptor alpha,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,HORMONE REPLACEMENT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Chemotherapy-Oncologic Procedure,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,EMSY,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Atypical hyperplasia,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Dinoprost,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Chemotherapy, Adjuvant",Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Insulin Resistance,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Cytokeratin 18,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Disease,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Transforming Growth Factor beta,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Residual Cancer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Interstitial Collagenase,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Nickel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Breast Feeding,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
CAUSES,BCCIP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CHI3L1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Antigens,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,"Anti-Inflammatory Agents, Non-Steroidal",Breast cancer recurrent,Demographic Factors,0.0,0.004995004995004995
AFFECTS,Somatostatin analog|SST,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Interferon Type II|IFNG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Mixed Function Oxygenases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IL1RN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cyclin D1|CCND1,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"Breast Fibrocystic Change, Proliferative Type",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,S100A4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,sake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Protein Family,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MDM4 gene|MDM4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cadmium,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Xq25,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,XRCC5 gene|XRCC5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,transduction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Infectious Mononucleosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Oils,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,EGFL7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PROM1,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,DCSTAMP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,gefitinib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GLIS3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,trastuzumab,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,AXILLARY LYMPH NODE METASTASIS,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Sleep Apnea Syndromes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Water,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,regional differences,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,perfluorooctane sulfonate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Isoenzymes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Riboflavin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HP gene|HP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Breast cancer invasive NOS,Carcinoma in situ of breast,Other,0.0587,0.001998001998001998
AFFECTS,Second Primary Cancers,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Alcoholic Beverages,Breast cancer invasive NOS,Demographic Factors,0.0,0.00999000999000999
PREDISPOSES,Infant feeding method NOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Weight Gain,Breast cancer recurrent,Other,0.0,0.004995004995004995
CAUSES,Methionine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DMD|BEST1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Localized Malignant Neoplasm,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AFFECTS,Wine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Physical function,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Metaplasia,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Aldehydes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Biopsy,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Estradiol,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,snail transcription factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,phenethyl isothiocyanate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Black tea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Performance,Breast cancer recurrent,Other,0.0,0.004995004995004995
CAUSES,oridonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,claudin 1 protein,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Alleles,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,volatile substances,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Poultry Meat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mammography,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,CDKN2A gene|CDKN2A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Diabetes, Gestational",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cognitive Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,high-dose chemotherapy,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Oxytocin Receptor|OXTR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,S100A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Does hit,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Fine needle aspiration biopsy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Large Neutral Amino Acid-Transporter 1|SLC7A5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Iodine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Monomeric GTP-Binding Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,APEX1 gene|APEX1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Primary disease,Breast cancer recurrent,Other,0.0,0.004995004995004995
AUGMENTS,pigment epithelium-derived factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Phyllodes Tumor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Diphosphonates,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,SOSTDC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"EZH2 protein, human|EZH2",Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,Blood Coagulation Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Catechin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Night sweats,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Seeks information,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,Carcinoma of Male Breast,Other,0.3988,0.004995004995004995
DISRUPTS,Flavones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Adverse event,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,hydroxytyrosol,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,REXO1|ZFP42,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,VEGFA,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,FOLR1 gene|FOLR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Night Nurse,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IL8RB gene|CXCR2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,NEK2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Female,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Inflammation,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Body Weight decreased,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Aminolevulinic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cerebrovascular accident,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Powerlessness, low",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diffusion Magnetic Resonance Imaging,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hypoglycemic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,"Echocardiography, Three-Dimensional",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pregnancy,Familial cancer of breast,Other,0.0,0.003996003996003996
PREDISPOSES,Atypical lobular hyperplasia,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Endothelin Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CHEK2 gene|CHEK2,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,Polymerase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mammographic breast density,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,ESTROGEN+PROGESTERONE RECEPTOR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Lasofoxifene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hormones,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,Mammography,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Estrus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alkylating Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Prevention,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,breast implant procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Analgesics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Adenosine Triphosphate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Anti-Anxiety Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,Mitoxantrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DNA,Breast cancer recurrent,Other,0.0,0.004995004995004995
AUGMENTS,PVT1 gene|PVT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,RNA-Binding Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Solid tumor,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Homologous Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,protopanaxadiol,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,CDCA4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SDCBP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PTPN1 gene|PTPN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,no positive axillary nodes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gout,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sugar candy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tyrosine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Acetaminophen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TRIM33,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SLC50A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FUT2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LINC01638,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PIMREG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Interleukin-17,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,strictinin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,phenyl ether,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Plasma glucose result,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,advanced disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Atypical proliferation,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,SLC50A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ezrin|EZR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,beta catenin|CTNNB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Coal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RNF115,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,S100B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SP1 gene|SP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,activated RNA polymerase II transcription cofactor 4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Progesterone Receptor Status,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,HCP5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,nitric oxide receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RUSC1-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Glucocorticoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Anticholesteremic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,TSC1 gene|TSC1|CCL26,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Materials,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Pharmaceutical Preparations,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"CHEK2 protein, human|CHEK2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Juvenile carcinoma of the breast,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Disease recurrence,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,TFF3,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,HOTAIR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Collagen Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PCB 180,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gold,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DNA Excision Repair Protein ERCC-5|ERCC5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,XBP1 gene|XBP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Tumor Burden,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Energy Balance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor Immunity,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
PREDISPOSES,ERBB2 gene|ERBB2,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,HIF1alpha protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HAX1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,LARP4 gene|LARP4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"RNA, circular",Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,angiotensin II,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,cedrelone,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Flavones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Catechol O-Methyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Phototherapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SMAD4 gene|SMAD4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Malignant Neoplasms,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Neoadjuvant Therapy,Breast cancer stage III,Other,0.0,0.000999000999000999
AFFECTS,Nicotinamide Phosphoribosyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"E2F1 protein, human|E2F1|UBE2L3",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,LOXL1-AS1 gene|LOXL1-AS1,Invasive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
AUGMENTS,"2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,punicalagin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PAK4 gene|PAK4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FAM83H-AS1 gene|FAM83H-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,folic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Late menarche,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,STARD8,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Cream,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Protein Isoforms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,chalcomoracin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"PTGS2 protein, human|PTGS2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Phosphoglycerate dehydrogenase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Genome,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Hexokinase 2|HK2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,insulin detemir,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"PKN1 protein, human|PKN1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ELF5 gene|ELF5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Mutant Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,apolipoprotein D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Prophylactic treatment,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,TRANSCRIPTION FACTOR,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Fibromyalgia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KISS1R gene|KISS1R,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Genes,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,compromise,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Sentinel node (disorder),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Sleep Apnea, Obstructive",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Chlorpyrifos,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CCL5,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,CTCb regimen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Phosphoric Monoester Hydrolases,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,aluminum,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SLCO6A1|GSTK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insoluble fiber (substance),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carbon Ion Radiotherapy,Early-Stage Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,H19 gene|H19|HILS1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,risk factors,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Prolactin Receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,BCL11A gene|BCL11A,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,PPFIA1 gene|PPFIA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Polybrominated Biphenyls,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PPFIA1 gene|PPFIA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,PARP1 gene|PARP1,Hereditary Breast and Ovarian Cancer Syndrome,Genetic Factors,0.0,0.0
DISRUPTS,SOX9 gene|SOX9,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,Primary care provider:Identifier:Point in time:Provider:Nominal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CBR3-AS1 gene|CBR3-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,limited use,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Polycystic Ovary Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RNF111 gene|RNF111,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,steroid receptor coactivator AIB1|NCOA3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,betaine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,risk factors,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,Multiparametric Magnetic Resonance Imaging,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,new information,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pharmacotherapy,Luminal B Breast Carcinoma,Other,0.0,0.0
AFFECTS,Lyophilized powder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,genistein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Blood Glucose,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,S-adenosylmethionine,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,Malignant Neoplasms,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Polypeptides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MNX1-AS1 gene|MNX1-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,removal technique,Stage IV Inflammatory Breast Carcinoma,Other,0.0,0.0
AUGMENTS,N-Myc Downstream Regulated Protein 1|NDRG1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Dicarboxylic Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,glycerin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ENC1 gene|ENC1,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
CAUSES,acetylcysteine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NORAD gene|NORAD,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
CAUSES,Mammary Tumorigenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Biological Markers,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,CXCL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SOX2 Transcription Factor|SOX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Genes,estrogen receptor-negative breast cancer,Genetic Factors,0.0,0.0
PREDISPOSES,MEG3 gene|MEG3|FAM129B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CA10 gene|CA10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,interleukin-6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NME1 gene|NME1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Biological Response Modifiers,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,MIR326 gene|MIR326,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Interferons,Basal-Like Breast Carcinoma,Other,0.0,0.003996003996003996
PREDISPOSES,"Scoliosis, unspecified",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PART1 gene|PART1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,erbB-2 Receptor|ERBB2,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,MIR451A wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,YTHDF3 gene|YTHDF3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Pharmacotherapy,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,leptin,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,S100A14 gene|S100A14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Biopolymers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TMPRSS13 gene|TMPRSS13,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,nervous system disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,folate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TRIO gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,HSD17B4 gene|HSD17B4,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
AFFECTS,Carcinoma of Male Breast,Malignant neoplasm of breast,Other,0.0253,0.3386613386613387
DISRUPTS,Luteolin,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,"CCND2 protein, human|CCND2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Piperlongumine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,thidiazuron,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,methylate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplasms by Site,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Behaviorial Habits,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
DISRUPTS,UBR1 gene|UBR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CCR5 gene|CCR5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Receptor Tyrosine-Protein Kinase ErbB-4, human|ERBB4",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CAVIN3 gene|CAVIN3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,epithelial to mesenchymal transition,Carcinoma breast stage IV,Other,0.0,0.0
CAUSES,mitoxantrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"TFF1 protein, human|TFF1",estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
CAUSES,Neoplasm Metastasis,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,Polysaccharides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,estrogens,Triple Negative Breast Neoplasms,Hormonal Factors,0.0,0.01898101898101898
AUGMENTS,"WWTR1 protein, human|WWTR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Transforming Growth Factor beta,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
COMPLICATES,contralateral breast cancer,Right-Sided Breast Neoplasms,Other,0.0,0.0
AFFECTS,Systemic Therapy,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,PRMT5 gene|PRMT5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,DNA replication checkpoint,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Fermented Foods,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NF2 gene|NF2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,PLEKHA7 gene|PLEKHA7,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,Ultraviolet B radiation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,B3GNT2|B3GNTL1,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,STRN3 gene|STRN3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Transcription factor genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,ZMYND8 gene|ZMYND8,Refractory Breast Carcinoma,Genetic Factors,0.0,0.0
AUGMENTS,ZEB1 gene|ZEB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,SOX6 gene|SOX6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,RSPO2 gene|RSPO2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,PEBP1 gene|PEBP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Thymidylate Synthase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Screening mammography,malignant neoplasm of breast staging,Other,0.0,0.0
PREDISPOSES,RARRES2 gene|RARRES2,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,EIF4A1 gene|EIF4A1,Invasive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
DISRUPTS,CA13 gene|CA13,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
AFFECTS,Mouse Model,Basal-Like Breast Carcinoma,Other,0.0,0.003996003996003996
AFFECTS,Adverse event,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FOXK1 gene|FOXK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,NUP43 gene|NUP43,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,MYCN gene|MYCN,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,tamoxifen,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,sanguinarine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,HNRNPK gene|HNRNPK,Invasive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
AUGMENTS,ERRFI1 gene|ERRFI1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,STUB1 gene|STUB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,S100A7 gene|S100A7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Clinical Significance,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Breast size,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Elevated C-reactive protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Triple Negative Breast Neoplasms,Malignant neoplasm of breast,Other,0.0298,0.3386613386613387
PREDISPOSES,BTNL9 gene|BTNL9,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,CDC25C gene|CDC25C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Profilin 2,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,HMGB1 Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Performance,Recurrent Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,PDCD4 gene|PDCD4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,dendrophenol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MDM2 gene|MDM2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hydrogel,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,"Receptors, Opioid, kappa",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ZNF132 gene|ZNF132,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Pathogenic Variant,"Breast Cancer, Familial",Other,0.0,0.0
PREDISPOSES,Physical stress,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,NRBP2 gene|NRBP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PCAT1 gene|PCAT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Disease,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AFFECTS,metoclopramide,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Borg Category-Ratio 10 Perceived Exertion Score 5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,TPT1-AS1 gene|TPT1-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,KIAA1755 gene|KIAA1755,Female Breast Carcinoma,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,LINC00467 gene|LINC00467,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hormone Therapy,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Homeobox Protein ARX,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tripterine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,NORAD gene|NORAD,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,HAGLR gene|HAGLR,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Proto-Oncogene Proteins c-sis|PDGFB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cell Cycle Checkpoints,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Inhibitor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Reaching,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,nucleoside diphosphate kinase A|NME1,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,Antibodies,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Cytochrome P-450 CYP1A1|CYP19A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LINC00894 gene|LINC00894,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MIR373 gene|MIR373,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Monoclonal Antibodies,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,BABAM2-AS1 gene,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,"Migration, Cell",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,melatonin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,docetaxel,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,CXCL13 gene|CXCL13,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,METTL3 gene|METTL3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cigarette smoke (substance),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Oncogene Proteins,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,nucleolin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,"Benzimidazole derivatives, antinematodal",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,OVOL1 gene|OVOL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Transforming Growth Factor beta,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,Matrix Metalloproteinase 3,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Moderate risk,contralateral breast cancer,Other,0.0,0.002997002997002997
PREDISPOSES,PTPN11 gene|PTPN11,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,DPP9 gene|DPP9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,STAU2 gene|STAU2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,GATA3 gene|GATA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,peroxiredoxin I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,OMA1 gene|OMA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,IL17RB gene|IL17RB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Extraction,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,Protein-Lysine 6-Oxidase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hypermethylation,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,RABIF gene|RABIF,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,calreticulin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,piperine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cultured Milk Products,Malignant neoplasm of breast,Ethical and Cultural Factors,0.0,0.3386613386613387
PREDISPOSES,Biological Response Modifiers,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,NEIL2 gene|NEIL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Hesperidin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,AKR1C1 gene|AKR1C1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LINC01094 gene|LINC01094,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Copy Number Polymorphism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Matrix,Triple-Negative Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,cannabinoid receptor,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
CAUSES,CASQ2 gene|CASQ2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Pharmaceutical Preparations,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,LRP6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Platinum Compounds,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Very rare,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Raw Foods,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CBR3-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,VEGFA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TUBA1C gene|TUBA1C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
COMPLICATES,LINC02381 gene|LINC02381,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LGALS3BP,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Abnormality,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SH3BGRL gene|SH3BGRL,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,RGMA gene|RGMA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,SARS-CoV-2 P.1 variant,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,SEMA6D gene|SEMA6D,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,HSPA5 gene|HSPA5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Mucin-1 Antigen,Early-Stage Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,BARD1 gene|BARD1,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
DISRUPTS,NDRG2 gene|NDRG2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FOXP3 gene|FOXP3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cell secretion,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Inhibitor,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,oleuropein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,HSPA5 gene|HSPA5,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Pharmacotherapy,contralateral breast cancer,Other,0.0,0.002997002997002997
PREDISPOSES,erbB-2 Receptor|ERBB2,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Histological type,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,BACH1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,monooxyethylene trimethylolpropane tristearate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LPAR6 gene|LPAR6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,interferon type II,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PELI1 gene|PELI1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,KPNA2 gene|KPNA2,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,ZMIZ2 gene|ZMIZ2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,UBA6-AS1 gene|UBA6-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,calcitriol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nutritional status,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MALAT1 gene|MALAT1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,tanshinone,Female Breast Carcinoma,Other,0.0,0.004995004995004995
DISRUPTS,anhydroicaritin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,interleukin-10,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 6|IGFBP6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Agonist,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,kinase targeted therapy,Malignant neoplasm of breast,Treatments,0.0,0.3386613386613387
AFFECTS,Cancer-Predisposing Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,ANKDD1A gene|ANKDD1A,Early-Stage Breast Carcinoma,Genetic Factors,0.0,0.0
DISRUPTS,Inhibitor,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,BNIP3 gene|BNIP3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Candidate Disease Gene,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AUGMENTS,HCAR1 gene|HCAR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,MED1 gene|MED1,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,Environmental Estrogen,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
CAUSES,PROX1 gene|PROX1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
DISRUPTS,Histone deacetylase inhibitor,Basal-Like Breast Carcinoma,Other,0.0,0.003996003996003996
AUGMENTS,perilipin 2,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,estradiol high,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Stat3 protein,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,Immune Checkpoint Inhibitors,Triple Negative Breast Neoplasms,Immunological Factors,0.0,0.01898101898101898
AFFECTS,ZFR gene|ZFR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,DNMT1 gene|DNMT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,RUNX2 gene|RUNX2,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Signal Transduction,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,dinaciclib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,cholecalciferol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,HSPBP1 gene|HSPBP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MAP Kinase Kinase 5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mouse Model,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,MSH2 gene|MSH2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,First relationship,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CDK1 gene|CDK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,tumor suppressor activity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Acute Promyelocytic Leukemia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,B3GNT5 gene|B3GNT5,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,Incomplete penetrance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,pioglitazone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,quercetin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,Tumor Suppressor Genes,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,Hydrogel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LINC00662 gene|LINC00662,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,KIF4A gene|KIF4A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Inflammation Mediators,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Hypothalamic inhibiting factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,aucubin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Citrates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Cyclin D1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LINC01234 gene|LINC01234,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ethanol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Copy Number Polymorphism,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Therapeutic immunosuppression,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,polyethylene glycols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Ryanodine Receptor 2,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,RAD51D gene|RAD51D,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,ALYREF gene|ALYREF,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Breast Measurement,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,perfluorononanoic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"POSTN protein, human|POSTN",Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,RAD51B gene|RAD51B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,PNO1 gene|PNO1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,Oncogenes,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,PIK3R1 gene|PIK3R1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MicroRNAs,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,OTUD6A gene|OTUD6A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MEG3 gene|MEG3|FAM129B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,CXCL14 gene|CXCL14,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,CDKN2A gene|CDKN2A,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Immunoregulation,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Complement System Proteins,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,Negative,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Large Neutral Amino Acid-Transporter 1|SLC7A5,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,plumbagin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MYC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Serum autoantibodies,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LINC00520 gene|LINC00520,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,TPD52L2 gene|TPD52L2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Glucosephosphate Dehydrogenase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ATP6AP1 gene|ATP6AP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MIR1294 gene|MIR1294,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
COMPLICATES,Psychosocial Intervention,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SLC31A1 gene|SLC31A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,RNase P,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,TGFB2-AS1 gene|TGFB2-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,inhibitor-of-apoptosis protein,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,MYCL gene|MYCL,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,erbB-2 Receptor|ERBB2,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,MDM2 gene|MDM2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Hypoxia,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,DIO3OS gene|DIO3OS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,centromere protein F,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,N4BP3 gene|N4BP3,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,SOD2 gene|SOD2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ZNF667-AS1 gene|ZNF667-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Free Energy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Inhibitor,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AUGMENTS,Parafibromin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RECQL5 gene|RECQL5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,RBCK1 gene|RBCK1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Dietary Fatty Acid,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
DISRUPTS,MIR506 gene|MIR506,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ZSWIM1 gene|ZSWIM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Vascular Endothelial Growth Factors|VEGFA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MIR21 gene|MIR21,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PALB2 gene|PALB2,contralateral breast cancer,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,Genes,contralateral breast cancer,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,MCF2L-AS1 gene|MCF2L-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Low Dose Radiation Therapy,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,"pregna-4,17-diene-3,16-dione, (17Z)-isomer",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Osteoporosis,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
CAUSES,Histone deacetylase inhibitor|HDAC9,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,NR1H3 gene|NR1H3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Inflammation,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Aryl Hydrocarbon Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ALDH2 gene|ALDH2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,cytotoxic T-lymphocyte antigen 4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Genes,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,PCSK1 gene|PCSK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Drug Repositioning,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,YBX1 gene|YBX1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Plasmids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LINC00536 gene|LINC00536,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,HNF1A gene|HNF1A,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,CALML5 gene|CALML5,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,SOY ISOFLAVONES,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Vimentin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RBCK1 gene|RBCK1,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
AUGMENTS,MYO6 gene|MYO6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Metric (substance),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Clusterin,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Hydroxymethylglutaryl-CoA reductase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TLE5 gene|AES,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Light Exercise,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Drinker,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CREB1,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,bufalin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Alanine Aminotransferase 1, human",Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,cytidylyl-3'-5'-guanosine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Snacks,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HAR1A gene|HAR1A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,TMED3 gene|TMED3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Anaplastic carcinoma,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,NUMB gene|NUMB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,internal risk factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fasting blood sugar result,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CENPL gene|CENPL,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,BRCA2 gene|BRCA2,Hereditary Breast and Ovarian Cancer Syndrome,Genetic Factors,0.0,0.0
AFFECTS,First line treatment,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Long Intergenic Non-Protein Coding RNA,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,glabridin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Toothache,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PCAT19 gene|PCAT19,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Food antioxidant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,oleanolic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Increased risk,contralateral breast cancer,Other,0.0,0.002997002997002997
DISRUPTS,quercetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SLC2A1 gene|SLC2A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,EIF4A3 gene|EIF4A3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Antibody-Drug Conjugates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SOD1 gene|SOD1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"ANGPT1 protein, human|ANGPT1",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Resistance Process,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,caveolin 1,contralateral breast cancer,Other,0.0,0.002997002997002997
CAUSES,CYP1B1 gene|CYP1B1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Global Longitudinal Strain,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoadjuvant Chemotherapy,Luminal B Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Degenerative polyarthritis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Coherent,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ethanol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Matrix Metalloproteinase 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GPR141 gene|GPR141,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,HFM1 gene|HFM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,tamoxifen,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,LGALS3 gene|LGALS3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Neoadjuvant Chemotherapy,HER2-negative breast cancer,Other,0.0,0.0
AFFECTS,Physiologic calcification,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,ZSCAN18 gene|ZSCAN18,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,NNAT gene|NNAT,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
AFFECTS,Radioimmunotherapy,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Patient age,Triple Negative Breast Neoplasms,Demographic Factors,0.0,0.01898101898101898
DISRUPTS,CREBZF gene|CREBZF,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,OTUD1 gene|OTUD1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,HMMR gene|HMMR,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Elements,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Natural Products,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,dihydroartemisinin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RNA Sequence,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Luteolin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Severe (severity modifier),Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,BCKDK gene|BCKDK,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Noninfiltrating Intraductal Carcinoma,Invasive carcinoma of breast,Other,0.0692,0.008991008991008992
PREDISPOSES,"Anesthetics, Inhalation",Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
CAUSES,Tumor Antigens,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,disulfiram,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,Caffeic Acid Phenethyl Ester,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Immune Tolerance,Secondary malignant neoplasm of breast,Immunological Factors,0.0,0.002997002997002997
PREDISPOSES,Menstrual status:Type:Point in time:^Patient:Nominal:Stated,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MicroRNAs,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Neoadjuvant Chemotherapy,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,INSM1 gene|INSM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FUNDC2 gene|FUNDC2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,Parafibromin|CDC73,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ubiquitin-protein ligase,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,euphorbia factor L1,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,Mammary Neoplasms,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,NOX4 gene|NOX4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Stereotactic Body Radiation Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NT5E gene|NT5E,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,FOXQ1 gene|FOXQ1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ERBB2 Gene Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,KLRB1 gene|KLRB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,YTHDF1 gene|YTHDF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Micelles,Carcinoma breast stage IV,Other,0.0,0.0
CAUSES,MAPK1 gene|MAPK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,platinum,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,CD160,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Polygenic Traits,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Transfer RNA,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,e protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,METTL3 gene|METTL3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Basis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,graphdiyne,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Collagen Diseases,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,VIRMA gene|VIRMA,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,DNAJA1 gene|DNAJA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SMAD4 gene|SMAD4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Obesity,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Biological Response Modifiers,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Hippo Signaling Pathway,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,beta sitosterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LRRC37A2 gene|LRRC37A2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,FZD8 gene|FZD8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ZNF148,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Possible,estrogen receptor-negative breast cancer,Other,0.0,0.0
DISRUPTS,quercetin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Tumor Microenvironment,estrogen receptor-negative breast cancer,Other,0.0,0.0
AFFECTS,VASP gene|VASP,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,Responsive Disease,Early-Stage Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Clinical Significance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nail-Patella Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CREB3L1 gene|CREB3L1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,DHP107,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,H19 gene|H19|HILS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PSME3 gene|PSME3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,MDH2 gene|MDH2,Recurrent Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
PREDISPOSES,FZR1 wt Allele|CDH1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PFKP gene|PFKP,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,RNF185 gene|RNF185,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Tumor Microenvironment,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,interleukin-1 alpha,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RNA I,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Cheese intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Genes,Invasive Ductal Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,Oncogene Proteins,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,PARD3 gene|PARD3,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,USP4 gene|USP4,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AUGMENTS,STING1 gene,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Origin of Life,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tyrosine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,mitogen-activated protein kinase p38,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,SLC38A3 gene|SLC38A3,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
DISRUPTS,METTL7A gene|METTL7A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"TNF protein, human|TNF",Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,ASAH2 gene|ASAH2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,DCTD gene|DCTD,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Malate dehydrogenase (decarboxylating),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,AICARDI-GOUTIERES SYNDROME,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,dasatinib,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,DNA Sequence,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immunogenic Cell Death,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,Protein Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carboplatin/Etoposide/Melphalan Regimen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Genes,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,ST14 gene|ST14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,RENBP gene|RENBP,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
PREDISPOSES,Cigarette smoke (substance),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NAT10 gene|NAT10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Pubertal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hypoxia,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,SNORD16 gene|SNORD16,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ARID1A gene|ARID1A,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,NUDCD1 gene|NUDCD1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PKD2 gene|PKD2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,phosphatidylethanolamines,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Body composition measure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplastic Cell Transformation,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,ZMIZ1 gene|ZMIZ1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Emotional hypersensitivity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Withanolides,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,HER2-positive carcinoma of breast,Malignant neoplasm of breast,Other,0.0162,0.3386613386613387
PREDISPOSES,KDM1A gene|KDM1A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Triterpenes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,nervous system disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PRMT6 gene|PRMT6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,YY1 gene|YY1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,MIRN181A gene|MIR181A2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Huntington Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,cyanidin 3-O-glucoside,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Rare Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,equol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,OGG1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hypoxia-Inducible Factor 1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Ultrasonography,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,DYRK2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Proteins,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Mitomycin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Leukotrienes,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,Therapeutic agent (substance),Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,miltefosine,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,FOXA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Heparitin Sulfate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Collagen,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,BRCA1 gene|BRCA1,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
AFFECTS,Ovulation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoplasm Metastasis,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,PSD4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gamma synuclein|SNCG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCAAT-Enhancer-Binding Protein-beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,camalexin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ESR1 gene|ESR1,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,CUL3,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Streams,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TOX3,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,FLT1 gene|FLT1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Annexin A2,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,ORAI3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,fluvastatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,KDM6B,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,"CRK protein, human|CRK",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Progestational Hormones, Synthetic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCR5 gene|CCR5,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
CAUSES,HOXD10 gene|HOXD10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,TRPV6,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,bexarotene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RAC-Alpha Serine/Threonine Kinase|AKT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,dihydroceramide desaturase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CIP2A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Creatinine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Stearates,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Proteins,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,PIK3CA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KLF8 gene|KLF8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Supplementation,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,methylcobalamin-coenzyme M methyltransferase|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Ubiquitin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Protein Family,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"Anti-Inflammatory Agents, Non-Steroidal",Breast cancer recurrent,Demographic Factors,0.0,0.004995004995004995
AFFECTS,Angiotensin II Type 1 Receptor Blockers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"TGFB1 protein, human|TGFB1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,anthracene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MYC Family Genes|MYC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,RBBP8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Beverages,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,HSP90 Heat-Shock Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fat graft,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,mitogen-activated protein kinase p38|CRK|MAPK14|MAPK1|AIMP2|GRAP2|AHSA1|POLDIP2,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Ki antigen|PSME3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hormone Receptor,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Benzimidazoles,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,IRAK4 gene|IRAK4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Heart Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,lysophosphatidylethanolamine,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Does hit,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,cDNA Library,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Flavonoids,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,osteoblast cadherin,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,HOXD@,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,TFF3,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Lovastatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,EPHB2|MAPK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GTF2H1|SQSTM1|KHDRBS1|NUP62|DCTN4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AXILLARY LYMPH NODE METASTASIS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,APOA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,genistin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GRPR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TRIM62,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,tau Proteins|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"NAT1 protein, human|NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tipifarnib,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,low protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,C-KIT Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Autophagy,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,LRIG1,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,erlotinib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Dimethyl sulfone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"TRIP10 protein, human|TRIP10",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SRD5A2 gene|SRD5A2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Acetate,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Tumor Markers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,XRCC2 gene|XRCC2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Thrombospondin 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCNA2 gene|CCNA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Proline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,icaritin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MDC1 gene|MDC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,gene polymorphism,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Biopsy finding,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TWIST1 gene|TWIST1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,"NOS3 protein, human|NOS3",Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,GFRA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prolactin|PRL,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,CDKN1A|TCEAL1|NSG1|H3F3AP6,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,dehydroepiandrosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"Anti-Inflammatory Agents, Non-Steroidal",Breast cancer invasive NOS,Demographic Factors,0.0,0.00999000999000999
AFFECTS,formononetin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,8q22,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Effective communication,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Phospholipids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Ataxia Telangiectasia,Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,Common Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BRCA2 gene|BRCA2,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
CAUSES,DNA,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Stress,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,peptide hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,retinyl methyl ether,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,PROTEIN KINASE,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Negative Finding,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aneuploidy,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,"technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Ethinyl Estradiol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DNA Sequence,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"SOD2 protein, human|SOD2",Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,E-Selectin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Neoplasm Metastasis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Exogenous hormones,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"Fruit, Citrus",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ETV4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LMO7 gene|LMO7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Antigens,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AUGMENTS,Plasminogen Activator Inhibitor 1|SERPINE1|SERPINB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,peptide hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Glutaminase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cheese,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Androgenic precursors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TP53 gene|TP53,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,HOXA1 gene|HOXA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,dihydroxy-vitamin D3,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Virus,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,spasmolytic polypeptide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aminoglutethimide,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Monoclonal Antibodies,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,3-hydroxytamoxifen,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Relate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Histological finding,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Steroid Use,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Low-Density Lipoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ESTROGEN USE,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Prednisone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Prolactin|PRL,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Caffeine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hyperplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Therapeutic Abortion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Fatty Acids, Nonesterified",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Augmentation mammoplasty,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Malignant neoplasm of breast,Contralateral breast cancer,Other,0.3988,0.001998001998001998
AFFECTS,MICE gene,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Smoking History,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sialyltransferases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CATHEPSIN D|CTSD,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Monoclonal Antibodies,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Genes, vpr",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Genome, Human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,mucinous carcinoma-associated antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Polymerase,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Dietary Fiber,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AUGMENTS,Insulin Receptor|INSR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Non-smoker,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mixed Function Oxygenases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Estradiol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PCAF gene|KAT2B,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,CCND1 gene|CCND1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Fluphenazine Hydrochloride,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,SHBG gene|SHBG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Lymphoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NODULAR DENSITY,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carcinoembryonic Antigen,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Ionizing radiation,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
CAUSES,Serine Protease,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,SH Protease,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Breast cancer recurrent,"Carcinoma, Ductal, Breast",Other,0.0174,0.002997002997002997
AFFECTS,3-hydroxytamoxifen,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Study models,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,Glucagon,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Insulin,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Secondary malignant neoplasm of liver,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Autologous bone marrow transplant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,cytokine,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Histocompatibility Antigens,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,PGR gene|PGR,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
CAUSES,Epidermal Growth Factor|EGF,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,beta-Chemokines,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,PIN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vascular Endothelial Growth Factor C,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Signaling Molecule,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Insulin-Like-Growth Factor I Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Microsatellite Instability,Sporadic Breast Carcinoma,Other,0.0,0.0
AUGMENTS,Genes,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,DNA Polymerase I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ZNF217 gene|ZNF217,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Laminin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,riboflavin-binding protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Raw vegetable,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Carcinoma in Situ,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Transferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CDKN2A|CDKN2D|F9|REG1A|IL23A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,EIF3S6 gene|EIF3E,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Inositol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SULT1A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SAFB gene|SAFB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Angiogenesis,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
CAUSES,Primary Carcinoma,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Inositol,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Differential Diagnosis,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Tumor Markers,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"EPIDERMAL GROWTH FACTOR, HUMAN",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PRMT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Folate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aneuploidy,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Mitogens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hyperlipidemia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Bilirubin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,cyclin E2|CCNE2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SPARC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ID-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Germ-Line Mutation,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
DISRUPTS,Globo-H,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MYC gene|MYC,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,Metformin,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,"TACC1 protein, human|TACC1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Hydrocarbons, Halogenated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Genetic syndrome,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Hormones,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,Platinum,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,EGb 761,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,celecoxib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Nulliparity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,B-pyridine,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Pathologic Processes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ELF3 gene|ELF3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Meal pattern NOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Diastasis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PLAUR gene|PLAUR,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Fumarate Hydratase|FH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Vidal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Thyrotropin-Releasing Hormone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,E-Cadherin|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AXIN2 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CCL2 gene|CCL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Fluoxetine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estrogen Receptor beta|ESR2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,bone sialoprotein,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Thiazolidinediones,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,EZH2 gene|EZH2,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
DISRUPTS,antireticular cytotoxic serum,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ERA-923,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,CD151,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,restriction enzyme,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Tretinoin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Multiparity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Tankyrase|TNKS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,SEPT9 gene|SEPT9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Beans,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Steroids,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,betaIG-H3 protein|TGFBI,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,integrin-linked kinase,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Tea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PTHLH gene|PTHLH,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
CAUSES,T gene,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,zeaxanthin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Vitamin A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Gonadal Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Smoking,Familial cancer of breast,Other,0.0,0.003996003996003996
PREDISPOSES,CD109,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,ERBB2|NEU1|NEURL1,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,IRS2 gene|IRS2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
CAUSES,SRC,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Small RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Heterocyclic Amines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PSIP1 gene|PSIP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Aromatic Amines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TBX3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CA9 gene|CA9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Integrin alpha6beta1,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Angiopoietin-2,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,LMO4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Antidepressive Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,IGF2 gene|IGF2,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,SCTR gene|SCTR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Fetus size,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estrogens,Sporadic Breast Carcinoma,Hormonal Factors,0.0,0.0
AFFECTS,"Shc1 protein, mouse|SHC1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ERbetacx,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,multicatalytic endopeptidase complex,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Abnormal result,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Environmental Estrogen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Selective Estrogen Receptor Modulators,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,PP5 protein-serine-threonine phosphatase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lesion,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,IGFBP3 gene|IGFBP3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Vascular Endothelial Growth Factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,N-3 fatty acid intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cell invasion,Breast cancer recurrent,Other,0.0,0.004995004995004995
CAUSES,TRANCE protein|TNFSF11,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Genes, Homeobox|LBX1",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,WISP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,WWP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Water,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NDRG1 gene|NDRG1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,Combination Drug Therapy,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Eating habit,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,alanylalanine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MUC5B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Secondary malignant neoplasm of bone,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,genetic element,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,"DICER1 protein, human|DICER1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cyclophosphamide,Breast cancer stage II,Other,0.0,0.0
PREDISPOSES,"Nuclear Receptor Subfamily 4, Group A, Member 1",Breast cancer recurrent,Other,0.0,0.004995004995004995
CAUSES,Xanthine Dehydrogenase|XDH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,NOTCH1 gene,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,Bloody nipple discharge,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cell Adhesion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CCL18 gene|CCL18,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,trans-resveratrol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,phospholipase C beta2|NEUROD1|TUBB4B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PTK2B gene|PTK2B,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,ABCB1 gene|ABCB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cytochrome P-450 CYP2D6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Signal Transduction Pathways,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Prolactin Receptor|PRLR,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,CCL2 gene|CCL2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Receptor Protein-Tyrosine Kinases,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,RGS Proteins|PITX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TNFSF11 gene|TNFSF11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,PRS gene|PRS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cyclin D1|CCND1,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,ADIPOR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Bone remodeling,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,ADRA1D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hypoxia,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,"Receptors, Progesterone|EREG|ESR1",Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Pharmacotherapy,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,osteopontin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,cell fate determination,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,N-Cadherins,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,LSP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Stromal hyperplasia,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Gene Expression Alteration,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cessation of life,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,UNC45A,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Human Papilloma Virus Vaccine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,JTB gene|JTB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CISH,Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,Process,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Protein Overexpression,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Systemic disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,IGF1R,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Candidate Disease Gene,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,artesunate,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Adrenergic beta-Antagonists,Breast cancer recurrent,Other,0.0,0.004995004995004995
AUGMENTS,Selectins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Paraffin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Extravasation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Alkaline phosphatase isoenzyme,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,heparanase,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Hormone Receptor Test,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Calcium, Dietary",Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Interleukin Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,denbinobin,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Proline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,AXL gene|AXL,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,FAT4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,prophylactics use,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CD100 antigen|SEMA4D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,TIAM1 gene|TIAM1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,HDAC9,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Tumor Suppressor Genes,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,ERBB2 gene|ERBB2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Stiff-Person Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TAZ gene|TAZ,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Ethanol,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,COPS5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KDM1B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cigarette Smoking,Contralateral breast cancer,Other,0.0,0.001998001998001998
AUGMENTS,CBX1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,metabolic abnormality assessment,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Metabolism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,UHRF1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Ethacrynic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,asparaginylendopeptidase,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Transcript,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,UHRF1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sweet's Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,heparanase|HPSE,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Prions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PTPN12 gene|PTPN12,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"Antigens, CD25",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PLK1 gene|PLK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,NUCB2,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Fibroblast Growth Factor 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Keratin,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,PER1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"EPIDERMAL GROWTH FACTOR, HUMAN",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Intercellular adhesion molecule 1,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,5'-AMP-activated protein kinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Metals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Polyethylene Glycols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,flavanone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,WT1 gene|WT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Acetaldehyde,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SLC2A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Physiologic Responses,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,BRCA2 gene|BRCA2,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,SMYD2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIRN96 gene|MIR96,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Dimethylformamide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PVT1 gene|PVT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Systemic poison,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Stereotactic radiotherapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"Receptors, Progesterone|PGR",Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,CD47 gene|CD47,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,mitogen-activated protein kinase 7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TGFBR2 gene|TGFBR2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Reactive Oxygen Species,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,"ESR2 protein, human|ESR2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,lard,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Angiotensins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CPEB4 gene|CPEB4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,triplet codon-amino acid adaptor activity,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AFFECTS,Nicotine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,osthol,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,ginkgetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,HOXD13,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,diallyl trisulfide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,citrate lyase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pharmacotherapy,Breast cancer stage III,Other,0.0,0.000999000999000999
DISRUPTS,PPP2R1A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"TGFB1 protein, human|TGFB1",Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Hydroxamic Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ADIPOR2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor necrosis factor receptor 11b,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Phospholipids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Interleukin-1 alpha,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Infrared radiation therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MMP12,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"STC1 protein, human|STC1",Breast cancer recurrent,Other,0.0,0.004995004995004995
DISRUPTS,DANCR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,baicalein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HMGA2 gene|HMGA2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Benzodiazepines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Breast cancer stage III,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,Glycerol-3-Phosphate Dehydrogenase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Adhesions,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Neprilysin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,WBP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"MFNG protein, human|MFNG",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Placental Growth Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Anthocyanins,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Mesothelioma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Lipopolysaccharides,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,"Dysplasia, fibrous",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HGF gene|HGF,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,RBBP1L1 Protein|ARID4B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TERT gene|TERT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,hypercholesterolemia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,RETN gene|RETN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,SYNJ2BP,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,phenylpyruvate tautomerase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,LIMK1 gene|LIMK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Camellia sinensis extract,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mutant Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Dioxygenases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SRCIN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Receptors, Calcium-Sensing",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,17beta-HSD 7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,RET gene|RET,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Immunotoxins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PNPLA2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,DNA,Familial cancer of breast,Other,0.0,0.003996003996003996
CAUSES,NRF1 gene|NRF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,L-2-amino-4-phosphonobutyrate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"8-oxoguanine-DNA glycosylase, human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PCDH10 gene|PCDH10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"NOS3 protein, human|NOS3",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RUNX2,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Mitosis,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,NOTCH1 gene,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
AFFECTS,CDK4 gene|CDK4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Riluzole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Androgens,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
CAUSES,Prostaglandins E,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CD4 gene|CD4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Tiron,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,TOLLIP gene|TOLLIP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CASP10 gene|CASP10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,sorafenib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Paclitaxel,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Pharmaceutical Preparations,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Cytochrome P-450 CYP2E1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CCNB1 gene|CCNB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Dendritic Cell Vaccine,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,cyclin B2|CCNB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,receptor,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,atamestane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,BARD1 gene|BARD1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,N-(4-aminophenethyl)spiroperidol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GACAT3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Aspartate Transaminase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Therapeutic Intervention,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,UBAP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FOXC1 gene|FOXC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Bombesin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BRIP1,Familial cancer of breast,Other,0.0,0.003996003996003996
CAUSES,Homologous Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,indole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,AKTIP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LMO4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Alternative Therapies,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SIRT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,JAG1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FOXM1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"NAT2 protein, human|NAT2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Acetylcysteine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Diet,Noninfiltrating Intraductal Carcinoma,Behavioral Factors,0.0,0.01098901098901099
PREDISPOSES,LTB4R2 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,fisetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Dopamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,chemokine receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin-Like Growth-Factor-Binding Proteins|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BRCA1 gene|BRCA1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,XPA gene|XPA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,rhodioloside,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,HOXB5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Nitric Oxide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NES gene|NES,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,YBX1,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,CDKN1B gene|CDKN1B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,proteomic profiling,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mastectomy,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,MIRN384 gene|MIR384,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,SNAI1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MFAP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MAL gene|CD8A|MAL|MKL1|TIRAP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hyperinsulinism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MTDH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Diabetic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,TRANCE protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Genistein,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,CD24,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Breast hyperplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,mixed drink,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Mitogen-Activated Protein Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Thrombospondin 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hodgkin Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Diet,Breast Carcinoma,Behavioral Factors,0.0,0.027972027972027972
AFFECTS,CYP2A6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Wound Healing,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Candidate Disease Gene,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
CAUSES,Depo-Provera,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Hydrocortisone,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Estrogen receptor negative,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Malnutrition,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Violence,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Methotrexate,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,BP3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tumor Antigens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Permeability,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Transplantation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CISH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin-Like Growth Factor I,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,SULT1A1|SULT1A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 3,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Tumor Promoters,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,tibolone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Indicators,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Menopausal Status,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,HYAL1 gene|HYAL1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,Cell division,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SFRP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,letrozole,Breast cancer recurrent,Other,0.0,0.004995004995004995
AUGMENTS,Genes,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,SLC13A2|SLC13A5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sexual function,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,bone metabolism,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Androgens,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Carcinoma in Situ,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,MIRN21 gene|MIR21,Ductal Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,Lactate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,telomerase activity,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Seasoning,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carcinoembryonic Antigen,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Atypia,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Test Result,Familial cancer of breast,Other,0.0,0.003996003996003996
PREDISPOSES,Pathologic stage,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Janus kinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PRL gene|PRL,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,B VARIANT NOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Shock,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RARA gene|RARA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Antioxidants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gonadorelin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,progesterone receptor B|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,biological_process,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Gelatinase B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MAP Kinase Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"TGFB1 protein, human|TGFB1",Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,E2F1 gene|E2F1|UBE2L3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,VEGFA,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,soy protein isolate,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,"Polycyclic Hydrocarbons, Aromatic",Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AUGMENTS,MED28,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,Selenium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Immunoglobulin A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MED28,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ARHI gene|DIRAS3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,claudin 6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Superior Vena Cava Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,S100 Proteins|S100A1|S100B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Precancerous lesions,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,PLEKHF1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Associated symptom,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,WNT5A gene|WNT5A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,2q34,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,fucoidan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,5-7-oxo-zeaenol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"ESR1 protein, human|ESR1",Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,EGFR|ENAH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,coactivator-associated arginine methyltransferase 1|CARM1,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,ACKR3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Chloroquine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"Ribosomal Protein S6 Kinases, 70-kDa|UBASH3B",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Does play,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Weight maintenance regimen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RAP1GDS1|KIFAP3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Methionine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LPO,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PIP,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,ING1 gene|ING1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,proneurotensin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dehydroepiandrosterone Sulfate,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,PRKD1 gene|PRKD1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AUGMENTS,EGb 761,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TIAM1 gene|TIAM1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AUGMENTS,mortalin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PTEN gene|PTEN,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
DISRUPTS,CACNA1A,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,osteopontin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,biological_process,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,XIST,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CISH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Interleukin-6|IL6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,COX5B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Adenoid Cystic Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,AHNAK,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MRPS18A gene|MRPS18A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,no positive axillary nodes,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Vitamin B2 intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,chitotriosidase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PROSTATE SPECIFIC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Adjuvant response,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,E-Cadherin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Platinum salt,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Insulin Receptor|INSR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ATM gene|ATM,Female Breast Carcinoma,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,Mineralocorticoid Receptor|DHCR24,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CREB3L1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Melatonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Antilipemic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AUGMENTS,ITK gene|ITK,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,Interleukin-6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CXCL10 gene|CXCL10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Fibroadenoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MicroRNAs,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,FANCM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,6/6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Thyroxine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,antibody therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gastrin|GAST,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Peanuts - dietary,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Pancreatic carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KIF4A gene|KIF4A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,DNA Repair Gene,Female Breast Carcinoma,Genetic Factors,0.0,0.004995004995004995
AFFECTS,Acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breast Microcalcification,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Compete,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IL1B gene|IL1B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,IL4R gene|IL4R,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Crystallins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MSX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,YBX1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,valdecoxib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Mitomycin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Enhancing Lesion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PRRT2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Sulfuric Acid Esters,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,EGFL7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CXCL13 gene|CXCL13,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,Contralateral breast cancer,Other,0.3988,0.001998001998001998
AUGMENTS,beta catenin,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AUGMENTS,ERBB3 gene|ERBB3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,LRRC3B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Nitric Oxide Synthase Type II,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Thromboplastin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
CAUSES,Amyloid beta-Protein Precursor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CD24,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CAPN9 gene|CAPN9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,KIAA1199 gene|CEMIP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,BMP1|PRCP|PGPEP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,baicalein,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,ACE gene|ACE,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,alpha2HS glycoprotein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PFAS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Microdissection,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,VEGF gene|VEGFA,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,Diet,Breast cancer invasive NOS,Behavioral Factors,0.0,0.00999000999000999
AFFECTS,tibolone,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,collagenase 3|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Histopathology,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Chondroitin Sulfates,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Malathion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"VEGF protein, human|VEGFA",Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Cholecalciferol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,phenethyl isothiocyanate,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Encounter due to breast reduction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Detection,Familial cancer of breast,Other,0.0,0.003996003996003996
DISRUPTS,CYLD,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TBX3,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Elongation Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FOXC1 gene|FOXC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,H19 gene|H19|HILS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,patient retention,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,gefitinib,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,USF1 gene|USF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Oxytocin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,WWOX gene|WWOX,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,usnic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Ferritin level,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Folic Acid Antagonists,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Norethindrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,toxicant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DACH1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cacodylic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hyperinsulinism,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Venous Thrombosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,WWOX,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,USH2A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cigarette smoke,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,c-myc Genes|MYC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Antirheumatic Drugs, Disease-Modifying",Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,PTH gene|PTH,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,NET1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SDC1 gene|SDC1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,MXD1|MAD1L1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Flavonols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Pancreatic leak,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,TOP2A gene|TOP2A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Bilateral oophorectomy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Depo-Provera,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GSTM1 gene|GSTM1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Neck Neoplasms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,gamma-Glutamyl Hydrolase,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,CATALASE,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Estrogen Receptor alpha,Sporadic Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Leeks (dietary),Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Thromboembolic event,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Vasospasm,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,G-T mismatch-binding protein|MSH6,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,Therapeutic Intervention,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Biological Response Modifiers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP2D6 gene|CYP2D6,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,Micellar Paclitaxel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Oxalates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"PHEMX protein, human|TSPAN32",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MED19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Performance,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,ECT2,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,LINC00461,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,USP1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,DKK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PIP5K1C,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Abnormal protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Feeding and dietary regimes,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
COMPLICATES,Malignant meningitis,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,ENPP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SMAD7 gene|SMAD7,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,"NRIP1 protein, human|NRIP1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BITTER MELON FRUIT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CD71 antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Factor VIII-Related Antigen,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,PVR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Juice,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Glucocorticoids,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,CYGB gene|CYGB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Food,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,LRP6,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Relapse,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cyclin-dependent kinase inhibitor 1B|CDKN1B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Manual reduction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Natural Products,Breast cancer recurrent,Other,0.0,0.004995004995004995
AUGMENTS,"RNA, Messenger",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Interleukin-6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Paraoxonase 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Interleukin-1 beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PARVA gene|PARVA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ZEB2-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CKS2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Anthracycline Antibiotics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,beta-elemene,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,mammaglobin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,lipocalin 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,caspase-8|CASP8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pancreatic Polypeptide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"MPP3 protein, human|MPP3",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,IL17F,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,claudin 6,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Gangliosides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Apolipoprotein A-I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,AFAP1L2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Doxorubicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,AMD3465,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,CCAT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,shogaol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Osteoporosis, Postmenopausal",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Translocase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Taking medication,Malignant neoplasm of breast,Pharmacological Factors,0.0,0.3386613386613387
PREDISPOSES,N-Acetylneuraminic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Collagen,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,MicroRNAs,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,CYP2C8 gene|CYP2C8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,EZR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Monoacylglycerol Lipases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ABRAXAS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Heat-Shock Proteins 70,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,bone morphogenetic protein 2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,parathyroid hormone-related protein,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,HULC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PARITY,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Proanthocyanidins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cell transformation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Thyroid Hormone Receptor Beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Anthocyanidins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,26S proteasome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Macrophage Activation Syndrome,Invasive carcinoma of breast,Demographic Factors,0.0,0.008991008991008992
DISRUPTS,LINC00665,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Enrich (product),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"interleukin-1, beta",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"CEACAM5 protein, human|CEACAM5",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neurophysiology - biologic function,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,rucaparib,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,zoledronic acid,Early-Stage Breast Carcinoma,Other,0.0,0.0
AFFECTS,Metaplastic carcinoma of breast,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,fucoidan,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,ERBB3 gene|ERBB3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,LINC00520 gene|LINC00520,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,TRIP6 gene|TRIP6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Enzyme Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cholesterol hydroxylase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,anastrozole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Thromboplastin,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,MIR182 gene|MIR182,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ROR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,COL10A1 gene|COL10A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,CpG Islands,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,chloroxoquinoline,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,ZNF10 gene|ZNF10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,KDM5B gene|KDM5B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Genome,"Breast Cancer, Familial",Other,0.0,0.0
PREDISPOSES,bis(4-hydroxyphenyl)sulfone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sex Hormone-Binding Globulin,Noninfiltrating Intraductal Carcinoma,Demographic Factors,0.0,0.01098901098901099
AFFECTS,HMGA2 gene|HMGA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PAQR4 gene|PAQR4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ZFP36L1|BRF1|MST1L,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Hydrogel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,nobiletin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CALCIUM HOMEOSTASIS,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Targeted Therapy,Carcinoma breast stage IV,Treatments,0.0,0.0
AFFECTS,PTTG1 gene|PTTG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hormones,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,Epidermal Growth Factor Receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,"Breast Cancer, Familial",Malignant neoplasm of breast,Other,0.0171,0.3386613386613387
DISRUPTS,Aptamer,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Xenograft type of graft,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ASAP1 gene|ASAP1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,"Genes, Essential",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Risk Behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Graft acceptance,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,TRPM4 gene|TRPM4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SNORA71B gene|SNORA71B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,marizomib,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,MARS gene|MARS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ergocalciferol,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,Estrogen Receptor beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Transcriptome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Positive Transcriptional Elongation Factor B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ENO1 gene|ENO1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,SCUBE2 gene|SCUBE2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Cell Proliferation,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,AGR2,estrogen receptor-negative breast cancer,Other,0.0,0.0
DISRUPTS,DLG3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mevalonate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MKI67 gene|MKI67,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,dinoprost,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Epicatechin-3-Gallate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pathologic Response,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"T-Cell Surface Glycoprotein CD4, human|CD4",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TMEM165 gene|TMEM165,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
CAUSES,Tumor-Associated Process,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PROM1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Contralateral Prophylactic Mastectomy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDC2 Protein Kinase|CDK1,Luminal B Breast Carcinoma,Other,0.0,0.0
AUGMENTS,MMP10 gene|MMP10,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
AFFECTS,Androgen Receptor,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,ENC1 gene|ENC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Xenograft Model,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Cytologic atypia,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,"AGR3 protein, human|AGR3",estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Smoked food,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GA-Binding Protein Transcription Factor|GABPA|NFE2L2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,platinum,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HLCS gene|HLCS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Functional Food,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,UNC5B gene|UNC5B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ITPKC gene|ITPKC,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,cyclophosphamide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Stat3 protein,Basal-Like Breast Carcinoma,Other,0.0,0.003996003996003996
DISRUPTS,DNMT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Unlikely,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CXCL2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PART1 gene|PART1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,SPRY4-IT1 gene|SPRY4-IT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,cyclovirobuxine D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Salts,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Extranodal Extension,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ADAMTS8 gene|ADAMTS8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Obstruction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fluid intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Periodontitis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Chronic Obstructive Airway Disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,mammary gland involution,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIR100HG gene|MIR100HG,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,PALB2 gene|PALB2,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
AFFECTS,MIR497 gene|MIR497,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,YY1 gene|YY1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,"TRIM25 protein, human|TRIM25",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Ganetespib,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Phosphoinositide Phosphatases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,HAND2-AS1 gene|HAND2-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Expression procedure,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Mastectomy,Stage IV Inflammatory Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Iodides,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,SRCIN1 gene|SRCIN1,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,Eicosanoids,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,ciclesonide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Adipose Tissue Deposition,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PLEKHA7 gene|PLEKHA7,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
DISRUPTS,CDC25B gene|CDC25B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Breast normal,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Neoadjuvant Systemic Therapy,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,MKI67 gene|MKI67,Invasive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,estrogens,Invasive carcinoma of breast,Hormonal Factors,0.0,0.008991008991008992
PREDISPOSES,Ferritin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"RNA, Circular",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,"Transcription, Genetic",Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,HLA-F-AS1 gene|HLA-F-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Red Meat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DSCAM-AS1 gene|DSCAM-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,APLN gene|APLN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,heparanase,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,RING1 gene|RING1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,K-ras Oncogene|KRAS,Invasive Ductal Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,Patient age,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,"Metabolic Process, Cellular",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Digital Mammography,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,EIF3A gene|EIF3A,Invasive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,PFKL gene|PFKL,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Genes,Hereditary Breast and Ovarian Cancer Syndrome,Genetic Factors,0.0,0.0
PREDISPOSES,"Sleep Disorders, Circadian Rhythm",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,No effect,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,HMGA2 gene|HMGA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"CD274 protein, human|CD274",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Insulin Receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,leptin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,EPHA2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,rutin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Chemotherapy Regimen or Agent Combination,Triple Negative Breast Neoplasms,Demographic Factors,0.0,0.01898101898101898
DISRUPTS,ZEB1 gene|ZEB1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Long Interspersed Nucleotide Element-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Decreasing,Basal-Like Breast Carcinoma,Other,0.0,0.003996003996003996
AFFECTS,Heat shock proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Transforming Growth Factor beta,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,MLN4924,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDKN2B gene|CDKN2B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cyclin-Dependent Kinase 4,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,Ataxia Telangiectasia,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Mutation,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,ACTL8 gene|ACTL8,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,"CD274 protein, human|CD274",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,BCL6 gene|BCL6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Dietary Modification,Noninfiltrating Intraductal Carcinoma,Behavioral Factors,0.0,0.01098901098901099
AFFECTS,SIRT3 gene|SIRT3,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,FOXO6 gene|FOXO6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Pathologic Complete Response,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,"Neoplasm, Residual",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Glucocorticoid Receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,METTL3 gene|METTL3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"STK11 protein, human|STK11",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Transferrin,estrogen receptor-negative breast cancer,Other,0.0,0.0
AFFECTS,Transforming Growth Factor beta,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,KIF18B gene|KIF18B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PDLIM7 gene|PDLIM7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,RFX5 gene|RFX5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,other medicated shampoos in ATC,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,Nicotinamide Phosphoribosyltransferase,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,PUM1 gene|PUM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,gene interaction,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,prevention effectiveness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FGFR1 wt Allele|FGFR1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,AFAP1-AS1 gene|AFAP1-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,IMPACT gene,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,Medical record number:ID:Pt:^Patient:Nom,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,EEF1E1 gene|EEF1E1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"CD69 protein, human|CD69",Malignant neoplasm of female breast,Other,0.0,0.0
PREDISPOSES,Interleukin-12 Subunit p35,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,HIF1A gene|HIF1A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Transformation, function",estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,Dovitinib,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,CASC16 gene|CASC16,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,"RNA, Messenger",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDC20 gene|CDC20,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,multidrug resistance-associated protein 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"CD9 protein, human|CD9",Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,physiological aspects,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Possible,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,cell cycle regulator,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,MIR937 gene|MIR937,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ERBB2 gene|ERBB2,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,CBR3-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RAD54B gene|RAD54B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Luteolin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"GPER protein, human|GPER1",Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,LRP6 gene|LRP6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MEG3|FAM129B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Recurrent pregnancy loss,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pregnancy-Associated Plasma Protein-A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SCUBE2 gene|SCUBE2,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,Physical function,contralateral breast cancer,Other,0.0,0.002997002997002997
PREDISPOSES,Disaccharides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MORC2 gene|MORC2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,G-Protein-Coupled Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ACTG2 wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GATA3 Transcription Factor|GATA3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Vascular Endothelial Growth Factor A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IL18 gene|IL18,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ABI1 gene|ABI1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AUGMENTS,"BCAR3 protein, human|BCAR3",Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Cell Growth,Early-Stage Breast Carcinoma,Other,0.0,0.0
AFFECTS,SHARPIN gene|SHARPIN,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,COVID-19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fibrillar Collagen,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Antitumor Response,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"DKK3 protein, human|DKK3",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Matrix Metalloproteinase 13,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LIG3 gene|LIG3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,cadmium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Phosphotransferases,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,WLS gene|WLS,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,collagen,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Positron-Emission Tomography,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,PLB1 gene|PLB1,estrogen receptor-negative breast cancer,Genetic Factors,0.0,0.0
PREDISPOSES,USP41 gene|USP41,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,REPLETE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SMYD3,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,SP7 gene|SP7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"CDK7 protein, human|CDK7",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Oligonucleotides,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
DISRUPTS,"CD69 protein, human|CD69",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,Alkaloids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BCL6B gene|BCL6B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TWSG1 gene|TWSG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,SPARC gene|SPARC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,CTNNB1 gene|CTNNB1,Ductal Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,BCL6B gene|BCL6B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Whole Grains,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ergocalciferol,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
DISRUPTS,Limonins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ipatasertib,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,MYD88 gene|MYD88,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,genistein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Poly-L-lactic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,rosuvastatin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Hormone Therapy,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Reproductive Behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,"TNFSF13 protein, human|TNFSF13","Breast Cancer, Familial",Other,0.0,0.0
CAUSES,"RNA, Long Untranslated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Biological Markers,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Estrogen Receptor Modulators,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Effective Communication,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,glucose oxidase,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,estradiol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIR10B gene|MIR10B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,MIR139 gene|MIR139,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,CDC20 gene|CDC20,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,1 time,Luminal B Breast Carcinoma,Other,0.0,0.0
AUGMENTS,"CTGF protein, human|CTGF",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,"CD69 protein, human|CD69",Triple-Negative Breast Carcinoma,Other,0.0,0.0
AFFECTS,paclitaxel liposome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TPI1 gene|TPI1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Acclimatization,Malignant neoplasm of female breast,Other,0.0,0.0
AFFECTS,imipramine,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,AMACR wt Allele,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,MKI67 gene|MKI67,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,TPI1 gene|TPI1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,limited use,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CDK6 gene|CDK6,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,MAP1LC3C gene|MAP1LC3C,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Pathogenic Variant,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,Pseudogenes,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,cyclin B2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TTYH3 gene|TTYH3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,cyclooxygenase 2,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Proliferation (morphologic abnormality),Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,HSPG2 gene|HSPG2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ATM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LINC01234 gene|LINC01234,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Individual Exposure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ELP3 gene|ELP3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Methylation Site,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Experimental Result,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pneumocystis jiroveci pneumonia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DST gene|DST,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,CYP2S1 gene|CYP2S1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,High glycemic index food,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RNA-Binding Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GTF2H1 gene|GTF2H1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Tomography, Emission-Computed",Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,ginsenoside Rg3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ULBP2 gene|ULBP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,MEF2C gene|MEF2C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Antioxidants,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,skill,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Plasma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,alpha Karyopherins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Mammary Carcinoma, Human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Bioavailable testosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SPOP gene|SPOP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Anthropometric Measures:-:Point in time:^Patient:-,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,CUL4B gene|CUL4B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,MMP13 gene|MMP13,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,TaqI POLYMORPHISM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Anthracycline Antibiotics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TIMM8A gene|TIMM8A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"TRIM25 protein, human|TRIM25",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,inhibitors,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Pathologic Response,Locally advanced breast cancer,Other,0.0,0.0
AUGMENTS,RET,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Contrast used,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MicroRNA 205-5p,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CLIC1 gene|CLIC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,HSPA8 gene|HSPA8,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,aflatoxin B1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"ZFP36 protein, human|ZFP36",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Decreased Expression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ERBB2 gene|ERBB2,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AUGMENTS,LINC00473 gene|LINC00473,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,clopidogrel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"3,3'-diindolylmethane",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Alkaloids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,vemurafenib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,WBP2 gene|WBP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Histone deacetylase inhibitor,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,ezrin,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,microphthalmia-associated transcription factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,WNT9B gene|WNT9B,Triple-Negative Breast Carcinoma,Genetic Factors,0.0,0.0
AUGMENTS,beta-2 Adrenergic Receptors,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Menopausal syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CXCR4 gene|CXCR4,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
AFFECTS,testosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LINC00667 gene|LINC00667,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Mutation Abnormality,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,lycorine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Performance,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Operative Surgical Procedures,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Animal feed (substance),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SPON2 gene|SPON2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,Mucosa-Associated Lymphoid Tissue Lymphoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,mannose,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MTOR wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CRABP2 gene|CRABP2,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,BTG4 gene|BTG4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Alanine Aminotransferase 1, human",Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
DISRUPTS,ZSCAN1 gene|ZSCAN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,USP20 gene|USP20,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
PREDISPOSES,AFAP1-AS1 gene|AFAP1-AS1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
DISRUPTS,KMT2A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PFKFB3 gene|PFKFB3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,treatment options,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"CD69 protein, human|CD69",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MCAM gene|MCAM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,hydroxybenzoic acid,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,20-40 years,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Retinoblastoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Lipoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Treatment Protocols,Luminal B Breast Carcinoma,Other,0.0,0.0
CAUSES,Toxin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Diesel Exhaust,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immunoregulation,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Problem,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
DISRUPTS,Singlet Oxygen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,BARRIER,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Bone Morphogenetic Protein Receptors,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
AUGMENTS,ZNF451 gene|ZNF451,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,"Genes, env|ERVW-1|ERVK-20|ERVK-18|ERVK-32",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,taxifolin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,RAD52 gene|RAD52,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,CCR7 gene|CCR7,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,macroautophagy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CXXC5 gene|CXXC5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Androgen Receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Increased risk,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,TYMSOS gene|TYMSOS,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,systemic administration,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,cinobufagin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Cancer Relapse,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Increased size (finding),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IMPACT gene,Invasive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,Axillary node METASTASIS,Breast cancer stage II,Other,0.0,0.0
DISRUPTS,NR1D1 gene|NR1D1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CD103|ITGAE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Genes,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
AFFECTS,anastrozole,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,risk factors,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,brusatol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hepatitis C,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Menopause,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,Suppressor,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,HLA-G gene|HLA-G,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,DLGAP5 gene|DLGAP5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,bruceine A,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,"IL5 protein, human|IL5",HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,pimavanserin tartrate,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Histone deacetylase inhibitor|HDAC9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Transformation, function",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,BCPR Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,hydroxypropylbetadex (0.58-0.68 MS),Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,VIRMA gene|VIRMA,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,Piperlongumine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Immune,Triple Negative Breast Neoplasms,Immunological Factors,0.0,0.01898101898101898
CAUSES,Antigens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,EZH2 gene|EZH2,Invasive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
AFFECTS,BHLHE41 gene|BHLHE41,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,medroxyprogesterone acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SHC4 gene|SHC4,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,USP4 gene|USP4,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Diagnosis,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Anoikis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dichloroethylenes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SRRM4 gene|SRRM4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Not significant,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,paraffin,Invasive Ductal Breast Carcinoma,Other,0.0,0.0
AUGMENTS,multicatalytic endopeptidase complex,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PTK2 gene|PTK2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Screening mammography,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,SKP2 gene|SKP2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,USP30 gene|USP30,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,thyme oil,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AIMP2 gene|AIMP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,maduramicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,FOXO1 gene|FOXO1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,TWIST1 gene|TWIST1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
CAUSES,"PIK3CB protein, human|PIK3CB",Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,cholecalciferol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"TLR2 protein, human|TLR2",HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,NSUN2 gene|NSUN2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FOXA2 gene|FOXA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,FBXO8 gene|FBXO8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,SNORA73B gene|SNORA73B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Present,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,SCARNA4 gene|SCARNA4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,PLK4 gene|PLK4,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,MIR130A gene|MIR130A,malignant neoplasm of breast staging,Genetic Factors,0.0,0.0
PREDISPOSES,fiber,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"membrane protein, SARS-CoV-2",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,Mutant Proteins,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,Bacteroides fragilis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,epiberberine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,progesterone,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Benign foot rot,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Protease Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Bloody nipple discharge,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,decanoylcarnitine,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
COMPLICATES,Fibrous Dysplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,RBMS3 gene|RBMS3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Non-infiltrating lobular carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tegafur,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SF3A2 gene|SF3A2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,Xenobiotics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,COL5A1 gene|COL5A1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Signs and Symptoms,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Score,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Multiple Sclerosis,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,NF-kappa B,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,MTA1 gene|MTA1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Increased risk,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,obeticholic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Hypolipidemic Agents,Triple Negative Breast Neoplasms,Demographic Factors,0.0,0.01898101898101898
AFFECTS,Cessation of life,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,ETNK1 gene|ETNK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Antigens,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"Receptor, Melatonin, MT1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Steroids,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Protein Isoforms|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Behavior,Breast cancer invasive NOS,Behavioral Factors,0.0,0.00999000999000999
DISRUPTS,Folic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,protein-tyrosine kinase c-src|SRC,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Human Papilloma Virus Vaccine,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Testosterone,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Oncogenes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Warfarin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MAD2L1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Bicarbonates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Carcinomatous peritonitis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Deoxycytidine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,phosphatidylinositol 3-kinase gamma,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Fluorouracil,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,PITPNM1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Psoralens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RAI3 gene|GPRC5A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,BRD4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Janus kinase 1|JAK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Metastasis Suppressor Genes,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,exemestane,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,invariant chain|CD74,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,helicase|HFM1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,VIP gene|VIP,Female Breast Carcinoma,Genetic Factors,0.0,0.004995004995004995
DISRUPTS,STK11 gene|STK11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,C-Peptide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carcinogenesis,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,GPR161,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IRF2 gene|IRF2,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
CAUSES,"Embolism, Tumor",Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,DNA Methyltransferase,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Brain-Derived Neurotrophic Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SOD3,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Blood flow,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Pyrones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SMAD2 gene|SMAD2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,Transforming Growth Factor beta,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,BRCA2|BLID,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,neuropeptide Y|NPY,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SIX2,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,SMAD2 gene|SMAD2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,"DNA, Double-Stranded",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SMAD3 gene|SMAD3,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,HIF1A gene|HIF1A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Estrogens,Carcinoma of Male Breast,Hormonal Factors,0.0,0.004995004995004995
AFFECTS,Systemic disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Genes, Immunoglobulin",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TUNAR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,andrographolide,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Progesterone,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,HOXB13,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DDX26 gene|INTS6|DDX56,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,UBE2I,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ADORA2B gene|ADORA2B,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,"Genes, env|ERVW-1|ERVK-20|ERVK-18|ERVK-32",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,chymotrypsin A,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Oral Solution,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Spironolactone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ceramides,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
DISRUPTS,Nitric Oxide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IGF1R gene|IGF1R,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Mutation,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
DISRUPTS,Adriamycin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MIRN205 gene|MIR205,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,ATP6V1C1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Therapeutic procedure,Familial cancer of breast,Other,0.0,0.003996003996003996
AFFECTS,Red meat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fusion Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Hepatitis C virus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Invasive Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Eukaryotic Initiation Factor-4E|EIF4E,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of gastrointestinal tract,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Insulin-Like-Growth Factor I Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIRN200B gene|MIR200B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,TP53BP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pharmaceutical Preparations,Contralateral breast cancer,Other,0.0,0.001998001998001998
AUGMENTS,Iron,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MAGEC2,Breast cancer metastatic,Demographic Factors,0.0,0.027972027972027972
DISRUPTS,"EZH2 protein, human|EZH2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Thiopurine S-Methyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ATP1B2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NANOG,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Pteridines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,combretastatin A-4 disodium phosphate,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,MMP14 gene|MMP14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Chronic heart failure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Receptors, Tumor Necrosis Factor, Type II",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Ro 48-8071,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TAAR5|NR2E3,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,FGF1 gene|FGF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Lymphatic Diseases,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Placebos,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,VEGFC gene|VEGFC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of cervix uteri,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SOX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Oxidoreductase,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,DOCK1 gene|DOCK1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,GAD2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Galactosyltransferases,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,proteomic profiling,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,Gynecologic Surgical Procedures,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,beta-cryptoxanthin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NDP,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,MIRN203 gene|MIR203A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Promoter Regions (Genetics),Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Multiple Myeloma,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Cholesterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Norepinephrine,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"Tuberculosis, Pulmonary",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Retinoid X Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,aldehyde dehydrogenase 1|ALDH1A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Prolactin|PRL,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Integrin beta3|ITGB3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CD29 Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Calcitonin Receptor|CALCR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PTHLH gene|PTHLH,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Prolactin|PRL,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Estrogen Antagonists,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,ABCC1 gene|ABCC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Tamoxifen,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,KIF20A gene|KIF20A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Glucosephosphate Dehydrogenase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Leucovorin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,MLLT11,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BRCA2 gene|BRCA2,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
CAUSES,WBP2 gene|WBP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Aspirin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,particle,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,6p12,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,E-Cadherin,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Endobronchial metastases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Regulatory Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fibrinogen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,mdm2 protein|SLURP1,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Cholangiocarcinoma,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Sex Hormone-Binding Globulin,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Gene Mutation,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
CAUSES,Fruit,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,IGFBP7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diabetes Insipidus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid",Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Relationship problems,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Secondary malignant neoplasm of axilla,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Free Radicals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SLOPE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Calcitonin,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Adrenalectomy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Adriamycin,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,16 alpha-hydroxyestrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Estriol,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Malignant disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Large Cell Lymphoblastic Lymphoma,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Caseins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Orchitis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FCE 21336,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,leukemia,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,TAG 12,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Body measure result,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,S-Phase Fraction,Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,Idarubicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,alpha-Lactalbumin,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Fucose,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,sterculic acid,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"Nuclear Receptor Subfamily 4, Group A, Member 1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Difluoromethylornithine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Aflatoxin B1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,fibrosarcoma,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Shock,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Doxorubicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Enovid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Platinum,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,ERVW-1|ERVK-20|ERVK-18|ERVK-32,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Interferons,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hypophysectomy,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Cellular Retinoic Acid Binding Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cerebellar degeneration,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Response Elements,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,dromostanolone propionate,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Stimulant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Trace Elements,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,Familial cancer of breast,Other,0.3988,0.003996003996003996
PREDISPOSES,Clinical finding,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BAG3,Female Breast Carcinoma,Other,0.0,0.004995004995004995
DISRUPTS,"Linoleic Acids, Conjugated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ductal Breast Carcinoma,Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,Telomerase,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Readiness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FGFR1 gene|FGFR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Manganese Superoxide Dismutase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Operative Surgical Procedures,Familial cancer of breast,Other,0.0,0.003996003996003996
PREDISPOSES,blood lipid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,placental protein 11|ENDOU,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PTHLH gene|PTHLH,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,BRCA2 gene|BRCA2,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,Immune status,Breast Carcinoma,Immunological Factors,0.0,0.027972027972027972
PREDISPOSES,Antihistamines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Pleural effusion disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,butyrate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NCOA3 gene|NCOA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Specific antibody,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Sulfhydryl Compounds,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,stanniocalcin 2|STC2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carcinogens,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"Genital Diseases, Female",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,fluoranthene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,17q21,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Sterically Stabilized Liposome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Nitrosamines,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Early Diagnosis,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
CAUSES,Small T-Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,NME1 gene|NME1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,Serine Protease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Mutagens,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,sarcoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Prostate-Specific Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Cyclin Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Immunotoxins,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,RNA,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Histidine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Androgens,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Silicones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Tumor Suppressor Genes,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
AFFECTS,Somatropin|GH1|GGH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Radiation therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NRG1 gene|NRG1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,"Ether, Ethyl",Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,cyclooxygenase 2,Carcinoma in situ of breast,Other,0.0,0.001998001998001998
AFFECTS,c-myc Genes|MYC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Nucleic Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,small molecule,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,factor C,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Plants, Edible",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Raloxifene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,COMT gene|COMT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Genes, Homeobox",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Risk factor, cardiovascular",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pregnancy History,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AR gene|AR,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
CAUSES,SHBG gene|SHBG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,telomerase activity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mutant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gene Amplification,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Watermelon,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Transcriptional Repression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LTA gene|LTA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Genomic Instability,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Nuclear Matrix-Associated Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HSD17B1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Fibrin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SLC39A6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neuropeptide Y Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,AVP,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Chocolate milk,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"ESR1 protein, human|ESR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,fulvestrant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Coping Behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Testosterone Propionate,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Peptide Hydrolases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,dominant allele,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Matrix Metalloproteinases,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,SLIT3|SLIT2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CTCFL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,5-lipoxygenase-activating protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Thyroid Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Therapeutic procedure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tissue-Inhibitor of Metalloproteinase-1|TIMP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,VEGF gene|VEGFA,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
PREDISPOSES,Metalloproteases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cheese,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Manganese Superoxide Dismutase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,WNT5B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fluctuation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diagnostic radiologic examination,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Alanine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CXC Chemokines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Adhesions,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,SLC3A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,EP300 gene|EP300,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,PTN gene|PTN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Phytoestrogens,Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of prostate,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Ha-ras Oncogenes,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,Gonadotropins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Testicular Diseases,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AUGMENTS,Endopeptidases,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,"Receptors, Progesterone|PGR",Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Tissue factor antibody,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Insulin-Like Growth Factor II|CD74|GCNT2|TCN2|VIPR1|TAF8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"LGALS3BP protein, human|LGALS3BP",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,cysteinylglycine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Aspirin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,myricetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitamin E,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Adriamycin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,prolyl-proline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hormone Receptor,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Heterocyclic Amines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Eating,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Siramesine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CALCIUM PHOSPHATE CRYSTALS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Quantitative Trait Loci,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LGI1 gene|LGI1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,BMI1 gene|BMI1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,5-Trimethoxyamphetamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,5'-NUCLEOTIDASE|TRIM33,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,ADAMTS4|ADAMTS3,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,alpha 1-Antitrypsin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Prolactin Receptor|PRLR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Benzodiazepine Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Antibodies,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SKI gene|SKI,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,LFNG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Functional RNA,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,TNFSF11 gene|TNFSF11,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,gemcitabine,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Encounter due to drug use,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Receptors, Progesterone|EREG|ESR1",Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Dancing,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,valylvaline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Toremifene,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,glypican 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Gelatinase A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,doxifluridine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Doxorubicin,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Transient Receptor Potential Channels,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Phosphorylcholine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Fruit, Citrus",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Stanolone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,4-octylphenol,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Aromatase Inhibitors,Contralateral breast cancer,Treatments,0.0,0.001998001998001998
CAUSES,RA 25,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pressure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,letrozole,Contralateral breast cancer,Other,0.0,0.001998001998001998
AUGMENTS,GATA3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AURKA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Glucocorticoid Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AIP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogens,Breast cancer invasive NOS,Hormonal Factors,0.0,0.00999000999000999
PREDISPOSES,MCAM gene|MCAM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,SKP2 gene|SKP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,IL2 gene|IL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PARP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TP53 gene|TP53,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,Apigenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Histiocytoma, Malignant Fibrous",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cellular process,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ADIPOR2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ALK gene|ALK,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,Drug resistance,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,17q21,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BHLHE41,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,"Cholesterol, Dietary",Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,HIF1A gene|HIF1A,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AUGMENTS,arrestin3|ARR3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LDL Cholesterol Lipoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ERBB4 gene|ERBB4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,versican|VCAN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Insulin, Regular, Human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,vinorelbine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,HRAS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HOXB9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Retinoblastoma Genes,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Tumor Suppressor Genes,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,Phosphatidylinositols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,thyroid microsomal antibodies|TPO,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"DNA, Single-Stranded",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,bakuchiol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Estrogens,Noninfiltrating Intraductal Carcinoma,Hormonal Factors,0.0,0.01098901098901099
AUGMENTS,"9,10-Dimethyl-1,2-benzanthracene",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Herceptin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FABP7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KLF10,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,epidermal growth factor receptor VIII,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Angiogenesis Inhibitors,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,GAPD gene|GAPDH,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,HRG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Oncogene ErbB2|ERBB2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,PANDAR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Lymphoma, Large-Cell, Diffuse",Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Proto-Oncogene Proteins p21(ras),Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,protein kinase C zeta,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,parathyroid hormone-related protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CNS disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,BRCA1 gene|BRCA1,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
AFFECTS,"Antiretroviral Therapy, Highly Active",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Cytotoxic T-Lymphocyte-Associated Protein 4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Vitamin D Deficiency,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,APP gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Fatty-acid synthase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,IL4 gene|IL4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,KLF8 gene|KLF8,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Membrane Proteins,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,KNG1 gene|KNG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Proteome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,germacrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ADAR1|ADAR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Fibroblast Growth Factor Receptor 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Acute inflammation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Proteins,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,COX7A2L gene|COX7A2L,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,chemokine,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,PORPHOBILINOGEN SYNTHASE|ALAD,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Clinical Treatment,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hyaluronan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,DDX3X,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,[M]Skin appendage adenoma,Breast Carcinoma,Demographic Factors,0.0,0.027972027972027972
AFFECTS,mead acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Metabolic syndrome,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Protein antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SLC19A3,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,May-Hegglin anomaly,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,ANXA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MIRN182 gene|MIR182,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Sulfonylurea Compounds,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,bone morphogenetic protein 4,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,multicatalytic endopeptidase complex,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BMI1 gene|BMI1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,beta catenin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,angiogenin|ANG,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,DOK7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NKX2-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Antihypertensive Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
CAUSES,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,apolipoprotein E-2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,pyridoxine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GPR55,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Dyslipidemias,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,"Cystadenocarcinoma, Serous",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cathepsin L|CTSL,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Adenosine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Anthracyclines,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Inflammatory disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CCT2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DEFA1|CBX5|DEFA1B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MFAP5 gene|MFAP5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Stopped work,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,cyclin-dependent kinase 3,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,preference,Familial cancer of breast,Other,0.0,0.003996003996003996
AFFECTS,Gene Expression,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,DMPK|IGHD1-7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NF-kappa B,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,TRIM28,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Consanguinous Mating,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Biotin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PAQR3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PTF1A,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,temozolomide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Disease Progression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SUMO1P3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,SMAD3 gene|SMAD3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Secretory Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cilium biogenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Echinococcosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fatty Acid-Binding Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immune defect,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
AUGMENTS,SLC4A7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Benzene,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,5'-NUCLEOTIDASE|NT5E,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumorigenesis,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,KISS1 gene|KISS1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Sleep Disorders,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,copper-binding protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ID2 gene|ID2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,MIRN21 gene|MIR21,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,PRDX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,phospholipase C delta 1|DLK1|DLL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tamoxifen,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Interleukin-18,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ARHGEF5 gene|ARHGEF5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CCAT2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SENP2 gene|SENP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Acetate,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Fibroblast Growth Factor Receptor 1|FGFR1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,TRPS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,nuclear receptor coactivator 1,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Thioctic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DNA amplification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,inorganic phosphate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,RBM38,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,F2-Isoprostanes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,stromelysin 3,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,IkappaB Kinase beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,BCL2 gene|BCL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Transforming Growth Factor beta,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Pathogenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,MDM2 gene|MDM2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ADAMTS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carcinogenesis,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,ETS1 gene|ETS1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Cantaloupes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Need for isolation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Colorectal cancer metastatic,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Quinones,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Glucocorticoid Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,D4-GDI,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,Benzodiazepine Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,E2F4 gene|E2F4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,DMBT1 gene|DMBT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,retinoic acid receptor beta 2,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
CAUSES,alpha Catenin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Phosphoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cyclic AMP-Responsive DNA-Binding Protein|CAMP,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,BANCR,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,LINC00310,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gonadotropins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SIRT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,attenuation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Quercetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Smoking,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Rice,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PTGER1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Pancreatitis,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
DISRUPTS,PHGDH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,fulvestrant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 3|IGFBP3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GAB2 gene|GAB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Malignant Neoplasms,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AUGMENTS,Lysine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Is informed,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NFKB1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Tumor Promoters,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Signaling Molecule,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fatty fish,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Combined Oral Contraceptives,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Serpins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BRCA1 Protein|BRCA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hydroxyl Radical,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lindane,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Irritable Mood,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Progesterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cytochrome P-450 CYP1A1,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Gelatinase A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Transcription Repressor/Corepressor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Local excision,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
CAUSES,Transcript,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TWSG1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Endometriosis, site unspecified",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,G22P1 gene|XRCC6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Invasive Lesion,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,PTGIS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Disease Progression,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,nuclear receptor coactivator 1|SRC,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,"7,3'-dihydroxy-4'-methoxyisoflavone",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TBXAS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"TERT protein, human|TERT","Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,CBS gene|CBS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,childhood brain tumor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MNX1,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,MMP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,EEF1A2 gene|EEF1A2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Light,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Coconut milk,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gonadal Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SKP2 gene|SKP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Carcinoma,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Malignant neoplasm of breast,bilateral breast cancer,Other,0.3988,0.0
AFFECTS,Epithelial hyperplasia,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Alcohol consumption,Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,"RNA, Messenger",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Testosterone,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,FAU,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GLO1 gene|GLO1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Smoke,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GNRHR gene|GNRHR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"RNA, Messenger","Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
CAUSES,PPAR gamma|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,2-hydroxyestrone,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Non-Aspirin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"TACSTD2 protein, human|TACSTD2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TACSTD2 gene|TACSTD2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Bioluminescence,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CXCR3 gene|CXCR3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Epstein-Barr Virus Infections,Malignant neoplasm of breast,Herpetic Genetic Factors,0.0,0.3386613386613387
AFFECTS,RUNX2,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,MED28,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
DISRUPTS,Proteins,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,IL23R gene|IL23R,Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
AFFECTS,Proteins,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Family problems,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TOX3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,BRCA2 gene|BRCA2,Contralateral breast cancer,Genetic Factors,0.0,0.001998001998001998
AUGMENTS,MIRN27A gene|MIR27A,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AUGMENTS,C19orf12,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AR gene|AR,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,Sexual exposure,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,vitamin supplement,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Physical therapy exercises,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,prohibitin|PHB,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DDX3X,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RHOC gene|RHOC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Neprilysin|MME,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ionizing radiation,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Vaccination,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,WNT2 gene|WNT2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,daidzein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Agent,Breast cancer metastatic,Demographic Factors,0.0,0.027972027972027972
AUGMENTS,XRCC3 gene|XRCC3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,DNA Sequence,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,VEGFA,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Inorganic arsenic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prolactin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,drospirenone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SLC5A7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,STK11 gene|STK11,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,Norethindrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ADM gene|ADM,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Vascular Endothelial Growth Factor C,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gonadal Steroid Hormones,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,chronic stressor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Expressed Sequence Tags,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Metformin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,FOS gene|FOS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,MIRN370 gene|MIR370,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,mRNA Expression,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,ADAM12,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Lamins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Homologous Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"Insulin, Regular, Human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Metric,Familial cancer of breast,Other,0.0,0.003996003996003996
AFFECTS,"Chemotherapy, Adjuvant",Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,ixabepilone,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,pertuzumab,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,BAG1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Bulimia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tissue Model,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"2-methyl-5,6-cyclopentapyrimidine",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Insulin-Like-Growth Factor I Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,crocetin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Study models,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,DIO3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Prevention,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,French fries,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cyclooxygenase 2 Inhibitors,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Opioids,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,FOXP3,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,"Receptors, Progesterone|PGR",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptors,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,Digoxin,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,AGAP2-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aspirin,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,CNTN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prolactin|PRL,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Androgens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Epirubicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IL1A gene|IL1A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,allograft inflammatory factor-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Transforming Growth Factor beta,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Tobacco smoke,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Genes,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,matriptase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Malignant neoplasm of breast,Breast cancer recurrent,Other,0.3988,0.004995004995004995
AFFECTS,Olive oil - dietary,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,VDR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,apolipoprotein E-4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Anti-Inflammatory Agents, Non-Steroidal",Breast Carcinoma,Demographic Factors,0.0,0.027972027972027972
AUGMENTS,FOXQ1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,letrozole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Antimony,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Sirolimus (substance),Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Cessation of life,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,proto-oncogene protein c-crk,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Antipsychotic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
DISRUPTS,Telomerase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Gelatinase B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Sterically Stabilized Liposome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Materials,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TCF4 gene|TCF4|TCF7L2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Functional RNA,Familial cancer of breast,Other,0.0,0.003996003996003996
CAUSES,Insulin-Like Growth Factor I|IGF1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Phosphatidylethanolamine Binding Protein|ZHX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PGLS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,2'-Deoxythymidine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immunoliposome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Fibroblast Growth Factor 7,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,YARS gene|YARS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,inhibin B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Interleukin-4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CHEK2 gene|CHEK2,Female Breast Carcinoma,Genetic Factors,0.0,0.004995004995004995
CAUSES,Cysteine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Harvest of stem cells,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,calcification,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Dioxins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TGM2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,methionine synthase reductase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carcinoma in Situ,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,GC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Positive Lymph Node,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,perchlorate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ASAP1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Calcium Channel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Sexual Dysfunction,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,FTY 720,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MIRN210 gene|MIR210,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,C1QBP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MCAM gene|MCAM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,CCL2 gene|CCL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,PITX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KISS1 gene|KISS1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,Dissociation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mammography,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,"PTTG1 protein, human|PTTG1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CA-15-3 Antigen,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Protein Expression,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"PER2 protein, mammalian",Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,bilateral breast cancer,Malignant neoplasm of breast,Other,0.0179,0.3386613386613387
PREDISPOSES,Estrogen Receptor Status,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,TP53 gene|TP53,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,MAPK12 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,membership,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,astaxanthine,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,tomography,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,CD151,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,HSPA5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Promoter (Genetics),Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,thrombocytosis,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,CHD8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Single Nucleotide Polymorphism,Contralateral breast cancer,Other,0.0,0.001998001998001998
CAUSES,Endometrial Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Aryl Hydrocarbon Receptor|AHR,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,aldehyde dehydrogenases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Environmental Tobacco Smoke,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AOX1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PTGS2 gene|PTGS2,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,hepcidin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PROTEIN KINASE|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RHBDD1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Obesity,Contralateral breast cancer,Other,0.0,0.001998001998001998
AFFECTS,GABARAP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SEMA4C,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Systemic Therapy,Breast cancer recurrent,Other,0.0,0.004995004995004995
AUGMENTS,E2F5 gene|E2F5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Gynecological history NOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Disease,Contralateral breast cancer,Other,0.0,0.001998001998001998
DISRUPTS,Fertility Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Fibrinogen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TOP2A gene|TOP2A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cataract,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Antithrombin III,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYTOR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,METHOTREXATE TREATMENT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Glutamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SP7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCND1 gene|CCND1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,disorder control,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Environmental Tobacco Smoke,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,citron rho-interacting kinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MUTYH,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,Opioids,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,IMPAD1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PTPRC gene|PTPRC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,desires,Contralateral breast cancer,Other,0.0,0.001998001998001998
AFFECTS,CXCL14 gene|CXCL14,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TMEM68,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ovariectomy,Contralateral breast cancer,Other,0.0,0.001998001998001998
AUGMENTS,Bone Morphogenetic Proteins,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ENPP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,syringin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,KPNA2,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Propofol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ELK3 gene|ELK3|KCNH8,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,"Metabolic Detoxication, Drug",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FRZB,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Therapeutic regimen,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,PSMD3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CYP4Z1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,FOXP3,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Infiltration,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Nuclear Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SNHG6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,beta-Chemokines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Redness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CYP4Z2P,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RANTES|CCL5,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,PDCD1 gene|PDCD1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CST1|CLSTN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Azurin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Macrophage Chemotactic Factors,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,Peptide YY,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,LINC00968,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Glucose,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Intraductal Hyperplasia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Moderate Exercise,Breast cancer invasive NOS,Behavioral Factors,0.0,0.00999000999000999
AFFECTS,Malignant neoplasm of breast,"Carcinoma, Ductal, Breast",Other,0.3988,0.002997002997002997
AFFECTS,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PHLDB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitronectin|VTN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,LINC00707,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Glucocorticoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,C1orf106,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sedentary lifestyle,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,CUL2 gene|CUL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,heparanase|HPSE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"PIK3CA protein, human|PIK3CA",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,metabolomics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Lymphocytic infiltration,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Porifera,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carbon Dioxide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,survivin|BIRC5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Phosphotransferases,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,ADCY4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SRC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CLDN1 gene|CLDN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,SIDT1 gene|SIDT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Respiration,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Minerals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Translation, Genetic",Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,Integrin alpha4beta1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,E-Cadherin,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,Ablation,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,tacrolimus binding protein 4|FKBP4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"FBXW7 protein, human|FBXW7",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,protein kinase C nu|DIO3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Toll-Like Receptor 5,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,"Genes, Regulator",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LINC01614,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RASAL2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,EIF4A1|EIF4A2,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,SFN gene|SFN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,B lymphocyte-induced maturation protein 1|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immunity,Triple Negative Breast Neoplasms,Immunological Factors,0.0,0.01898101898101898
AFFECTS,Desire for food,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Short Sleeper Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,other medicated shampoos in ATC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Matrix Metalloproteinase 9,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,Minisatellite Repeats,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LINC-ROR gene|LINC-ROR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,derivatives,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"RNA, Messenger",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,Pharmaceutical Preparations,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,stevioside,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TP53,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Breast Microcalcification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"CD69 protein, human|CD69",Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,hydroxybenzoic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Household composition,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ELAVL1 gene|ELAVL1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,MicroRNA 335-5p,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Stat3 protein,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Healthy Lifestyle,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,copper,Lobular carcinoma in situ of breast,Other,0.0,0.0
PREDISPOSES,"RNA, Long Untranslated",Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,gamma-Tocopherol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"FRAP1 protein, human|MTOR",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TSIX gene|TSIX,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,multiple pathologies,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,Adiponectin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,peer support,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCL18 gene|CCL18,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,rasagiline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"ITK protein, human|ITK",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DOK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RPS6KA6 gene|RPS6KA6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Growth Hormone Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,veliparib,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,elements of cancer genetics risk assessment and counseling,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
PREDISPOSES,Clinical information:Finding:Point in time:^Patient:Narrative,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,artesunate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Pads,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cannabinoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Checkpoint kinase 1,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,PLSCR1 gene|PLSCR1,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
AFFECTS,vinorelbine,HER2-negative breast cancer,Other,0.0,0.0
PREDISPOSES,CXXC5 gene|CXXC5,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
AUGMENTS,MYH10 gene|MYH10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Marital Status,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Single Nucleotide Polymorphism,contralateral breast cancer,Other,0.0,0.002997002997002997
PREDISPOSES,assessment.initial,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ethyl acetate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,N-acetyltransferase 1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,BRCA1 Gene Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PROM1,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Adjuvant Therapy,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
CAUSES,Genes,Ductal Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
DISRUPTS,CLDN15,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,DNASE1L2 gene|DNASE1L2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Syndrome,"Breast Cancer, Familial",Other,0.0,0.0
AUGMENTS,diethylstilbestrol,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,WDR41 gene|WDR41,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,NEUROD1 gene|NEUROD1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,ZNF326 gene|ZNF326,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,Multiple malignancy,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,C5 gene|C5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,"E2F1 protein, human|E2F1|UBE2L3",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,water,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Fatty Acids, Essential",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,catechin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Energy Metabolism,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,methacrylamide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,GAS5 gene|GAS5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,TGFB1 gene|TGFB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hypersensitivity,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,NEDD9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SHC3 wt Allele|GDF1|RNH1|PPP1R13L|SHC3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,timosaponin AIII,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RCC2-AS1 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SPX gene|SPX,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,RNF5 gene|RNF5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,MVP wt Allele|RPSA|LRP1|PTPRA|MVP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mastitis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Insulin Resistance,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,phosphorus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Chronic inflammatory disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tumor Antigens,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Peptide Hydrolases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Anticoagulants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Human cells,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Beta protein,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,paclitaxel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,AGTR1 gene|AGTR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Educational Status,malignant neoplasm of breast staging,Educational Factors,0.0,0.0
AFFECTS,LINC01705 gene|LINC01705,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ATF3 gene|ATF3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,pseudouridine synthase 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CONOTRUNCAL ANOMALY FACE SYNDROME,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AXL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,parathyroid hormone,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,PTTG1 wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PDCD4-AS1 gene|PDCD4-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,MIR30E gene|MIR30E,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"SLC6A2 protein, human|SLC6A2",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,cytokine,estrogen receptor-negative breast cancer,Other,0.0,0.0
PREDISPOSES,SETD5 gene|SETD5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CPEB1 gene|CPEB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MIR497 gene|MIR497,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,SYVN1 gene|SYVN1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,Heating,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SOX4 gene|SOX4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CYP27A1 gene|CYP27A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,SEMA7A gene|SEMA7A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Hemeproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cellular signal transduction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FABP7 gene|FABP7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Advanced Breast Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,metformin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ZC3H13 gene|ZC3H13,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ING4 gene|ING4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Glucocorticoids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,GAS6 gene|GAS6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,NUDT3 gene|NUDT3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,hormone response element,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ADIPOQ wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Risk Scores,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Neoadjuvant Chemotherapy,Locally advanced breast cancer,Other,0.0,0.0
PREDISPOSES,Geographic pattern,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LINC00511 gene|LINC00511,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,IQGAP1 gene|IQGAP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,CARNS1 gene|CARNS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,dihydroartemisinin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TWIST1 gene|TWIST1,estrogen receptor-negative breast cancer,Genetic Factors,0.0,0.0
AUGMENTS,IMPACT gene,malignant neoplasm of breast staging,Genetic Factors,0.0,0.0
AFFECTS,HNF1A-AS1 gene|HNF1A-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,cyclic compound,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GFUS gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TP53,Hereditary Breast and Ovarian Cancer Syndrome,Other,0.0,0.0
AFFECTS,SEMA7A gene|SEMA7A,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
AFFECTS,LINC00665 gene|LINC00665,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Biological Factors,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,LINC00665 gene|LINC00665,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Lupus Coagulation Inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"GAS41 protein, human|YEATS4",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Bariatric Surgery,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,hippo signaling,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,valine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Social Risk Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Sodium metavanadate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Anthracyclines,Carcinoma breast stage IV,Other,0.0,0.0
CAUSES,Epigenome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,prenatal exposure,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Post-mastectomy radiotherapy,Locally advanced breast cancer,Other,0.0,0.0
AUGMENTS,PCAT1 gene|PCAT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ABCC9 gene|ABCC9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Piwi-Interacting RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prognosis bad,estrogen receptor-negative breast cancer,Other,0.0,0.0
AFFECTS,Imaging Techniques,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Paste,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SNHG6 gene|SNHG6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,POU4F1 gene|POU4F1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"PPARGC1B protein, human|PPARGC1B",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,multiple pathologies,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Neurofibromatosis 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LINC00511 gene|LINC00511,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Syndecan-4,estrogen receptor-negative breast cancer,Other,0.0,0.0
CAUSES,MicroRNAs,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Vitiligo,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Matrix Metalloproteinase 9,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,R & C,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Negative,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,MIR137 gene|MIR137,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,FZD2 gene|FZD2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,NME1 gene|NME1,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,triclosan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MALAT1 gene|MALAT1,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,IMPACT gene,Recurrent Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,lapatinib,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,DNAJA1 gene|DNAJA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,hyaluronic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Handling,"Breast Cancer, Familial",Other,0.0,0.0
PREDISPOSES,pamidronate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LRRC3B gene|LRRC3B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Non-Cancer Related Death,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HSP90AA2P gene|HSP90AA2P,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,estrophilin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,STAT5A gene|STAT5A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,"IL5 protein, human|IL5",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,FOXP3 gene|FOXP3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"WWTR1 protein, human|WWTR1",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Very Important,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDKL3 gene|CDKL3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
COMPLICATES,FBXL16 gene|FBXL16,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,fulvestrant,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,"CD69 protein, human|CD69",Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,Primary MicroRNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CDH4 gene|CDH4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,SEPTIN9 gene|SEPT9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,cadmium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,everolimus,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,RUNX2 gene|RUNX2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Stat3 protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Teratogenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FBXL20,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ZNF24 gene|ZNF24,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,6-Phosphofructokinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,DNA Modification Methylases|DNMT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,phytochlorin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SNAI2 gene|SNAI2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CK-34 beta E12,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,H1-5 gene|HIST1H1B,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,STC1 gene|STC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Carcinomatosis,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Interleukin-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TRIM31 gene|TRIM31,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cyclin-Dependent Kinase Inhibitor Proteins,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,DNA Modification Methylases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Integral Membrane Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,>65 years,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,cholesterol,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Functional modification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,YAP1 gene|YAP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Monosaccharides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Aurora Kinase A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Antral Follicle Count,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,mifepristone,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,Aquaporin 1|AQP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,removal technique,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,UNC 0638,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MCM4 gene|MCM4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,EIF4EBP1 gene|EIF4EBP1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Stat3 protein,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
DISRUPTS,echinacoside,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Protein Phosphatase 2A,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,CDK1 gene|CDK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Growth Differentiation Factor 15,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Metabolite,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CI 994,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aryl Hydrocarbon Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Breast Cancer Model,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,VEGFA gene|VEGFA,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,"Promoter Regions, Genetic",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,rasagiline,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,"Dolichyl-Diphosphooligosaccharide-Protein Glycosyltransferase Subunit 1, human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Early Diagnosis,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,SP6 gene|SP6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,TRIM32 gene|TRIM32,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,tissue markers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ATP11B gene|ATP11B,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
DISRUPTS,ATG4A gene|ATG4A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"TFF3 protein, human|TFF3",Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,ATP2B1 gene|ATP2B1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,MRPS30-DT gene|MRPS30-DT,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,MIR342 gene|MIR342,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,"BMI1 protein, human|BMI1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"Antibodies, Anti-Idiotypic",Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,Hepatitis B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hypoxia,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,STING1 gene,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,CLTC gene|CLTC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,GAS5 gene|GAS5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,WTAP gene|WTAP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,PPP1R14C gene|PPP1R14C,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,liraglutide,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,DSTN gene|DSTN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,norethindrone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TRIM28 gene|TRIM28,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,erbB-2 Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PSAT1 gene|PSAT1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,LINC00466 gene|LINC00466,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,NAA25 gene|NAA25,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Oncogenes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,CD29 Antigen|B3GNT2|B3GNTL1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,TLN1 gene|TLN1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Binding Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ergocalciferol,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,vexibinol,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,DANCR gene|DANCR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Mammographic Breast Density,contralateral breast cancer,Other,0.0,0.002997002997002997
DISRUPTS,WASF3 gene|WASF3,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,DNAJB4 gene|DNAJB4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Diet, Healthy",Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Radiation,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
COMPLICATES,Acne,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,"Peroxisome Proliferator-Activated Receptor Gamma, human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ATP6AP2 gene|ATP6AP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,PINK1 gene|PINK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,AKAP3 gene|AKAP3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Diet, High-Fat",Triple Negative Breast Neoplasms,Behavioral Factors,0.0,0.01898101898101898
PREDISPOSES,SETDB1 gene|SETDB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,KLF8 gene|KLF8,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
DISRUPTS,E2F1 gene|E2F1|UBE2L3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Late chronotype,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ginsenoside M1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,VARIANT OF UNKNOWN SIGNIFICANCE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NEK2 gene|NEK2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Interleukin-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Catabolism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,pimozide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Aurora Kinase A,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,andrographolide,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,Apoptosis,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,MAFG-DT gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,FOXD3-AS1 gene|FOXD3-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Protac,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ADGRF1 gene|ADGRF1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Liver Cirrhosis,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Breast present,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MND1 gene|MND1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,1 time,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,survivin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,MAFG-DT gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,calcium,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,CDK11A gene|CDK11A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,oleanolic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MBNL1-AS1 gene|MBNL1-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"SDC1 protein, human|SDC1",Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,LINC02620 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Scorpion Venoms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Toxic Epidermal Necrolysis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Primary Sj??gren's syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TRIM4 gene|TRIM4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Oxysterols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MFNG gene|MFNG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Disease,Malignant neoplasm of female breast,Other,0.0,0.0
PREDISPOSES,Heat-Shock Proteins 70,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,CBL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,erbB-2 Receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,Cytochrome P450,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Angiogenic Process,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,MAZ gene|MAZ,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FANCM gene|FANCM,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
AFFECTS,BIRC5 gene|BIRC5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,NR2E1 gene|NR2E1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,TNFRSF9 gene|TNFRSF9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,multiple pathologies,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NAT10 gene|NAT10,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,caveolin 1,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,IGHE gene|IGHE,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Hematoxylin,malignant neoplasm of breast staging,Other,0.0,0.0
COMPLICATES,NUP210 gene|NUP210,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Elective Surgical Procedures,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,MIR409 gene|MIR409,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,CENPK gene|CENPK,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Operation on breast,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,metformin,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,TRIO gene,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Positron Emission Tomography and Magnetic Resonance Imaging,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,JMJD6 gene|JMJD6,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,MCAM gene|MCAM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ROS1 wt Allele|ROS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,UBE2C gene|UBE2C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,ROBO3 gene|ROBO3,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
DISRUPTS,carbidopa,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,"TRIM25 protein, human|TRIM25",estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,trastuzumab,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,"GTP-Binding Nuclear Protein Ran, Human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,stigmasterol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Small Molecule,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Polypeptides,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Coitus,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CD274,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PTPN7 gene|PTPN7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,COL11A1 gene|COL11A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,ZNF217,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,benzopyrene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ELAVL2 gene|ELAVL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Endometriosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,GNG5 gene|GNG5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Acclimatization,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Biological Response Modifier Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,iron increased,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ICOS gene|ICOS,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Neonicotinoid insecticide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SYNJ2BP-COX16 gene|SYNJ2BP-COX16,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,IL1RN gene|IL1RN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,WFDC21P gene|WFDC21P,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,ST8SIA1,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Dietary Selenium,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,HER2-positive carcinoma of breast,Other,0.3988,0.008991008991008992
AUGMENTS,tamoxifen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TBATA gene|TBATA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,WNT9B gene|WNT9B,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,olaparib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Benign Prostatic Hyperplasia,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,SAV1 gene|SAV1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,pyridine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RNF126 gene|RNF126,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,FAC1 protein|PDC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,lapatinib,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Hormones,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,DNA Binding Agent,Triple Negative Breast Neoplasms,Demographic Factors,0.0,0.01898101898101898
AFFECTS,Neuregulins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PFKP gene|PFKP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Ultrasound-Guided Core Biopsy,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,ADCY5 gene|ADCY5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,progesterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PRDM16 gene|PRDM16,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Adult Liver Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IGF2BP2 gene|IGF2BP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Lignans,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Cancer/Testis Antigen,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,ABCB1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,acrylamide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Adverse reaction to drug,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lymphatic Invasion,Invasive Ductal Breast Carcinoma,Other,0.0,0.0
AFFECTS,Uveitis,Early-Stage Breast Carcinoma,Other,0.0,0.0
AFFECTS,laser irradiation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Amides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Carbohydrates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Endocrine Disruptors,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,"DNA, Catalytic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PHGDH gene|PHGDH,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,High Level,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
CAUSES,Selective Estrogen Receptor Down Regulator,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Adjuvant Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"PON2 protein, human|PON2",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,KLF9 gene|KLF9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,"CD274 protein, human|CD274",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,pimagedine,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
DISRUPTS,RNF43 gene|RNF43,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,myosin VI,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,doxorubicin liposome,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,MIR31HG gene|MIR31HG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Proteome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Place of Birth,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CLDN4 gene|CLDN4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Estrogen Receptor alpha,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,Malignant neoplasm of endometrium,hereditary breast/ovarian cancer - BRCA1,Other,0.0,0.0
PREDISPOSES,CHMP4A gene|CHMP4A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,PCAT19 gene|PCAT19,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of lung,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,vitamin E,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Very low density lipoprotein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"NEK9 protein, human|NEK9",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PZP gene|PZP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Fixatives,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
CAUSES,ethanol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AEBP1 gene|AEBP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,dose-response relationship,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,erbB-2 Receptor|ERBB2,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,GABRD gene|GABRD,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MIR93 gene|MIR93|MIR9-3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,benzopyrene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Antisense RNA,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,3 times,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,RNA,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,Tn antigen,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
DISRUPTS,royal jelly,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,BARRIER,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,Apoptosis Inhibiting Proteins,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Aurora Kinase A,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Cell-Free DNA,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Structural modification,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,KRT1 gene|KRT1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Poly(ADP-ribose) Polymerase Inhibitors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,personal health,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,metformin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SOAT1 gene|SOAT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,interferon type II|IFNG,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,bruceine D,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,bone morphogenesis,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
PREDISPOSES,Proto-Oncogene Proteins p21(ras)|CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Feces,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cervical Cancer Screening,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Ultrasonography,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,SNHG11 gene|SNHG11,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,sevoflurane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Postoperative chemotherapy,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
DISRUPTS,Peptides,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Malignant neoplasm of breast,Triple Negative Breast Neoplasms,Other,0.3988,0.01898101898101898
AFFECTS,calcium,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Dietary Zinc,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,"Platelets, CTCAE",Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,"Analgesics, Opioid",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,hydrocortisone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"RNA, Circular",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Osteopenia,Malignant neoplasm of female breast,Other,0.0,0.0
AFFECTS,cantharidin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CD24 gene|CD24,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,pregnane X receptor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,MIR195 gene|MIR195,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,White meat intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"7,3'-dihydroxy-4'-methoxyisoflavone",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,SPATA13 gene|SPATA13,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
AFFECTS,"RNA, Untranslated",Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,Carcinoembryonic Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RARB,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DNAJB4 gene|DNAJB4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"IL7 protein, human|IL7",HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
CAUSES,fos-related antigen 1|FOS,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,USP10 gene|USP10,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Aurora Kinase A,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,risk factors,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Stat3 protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,echinacoside,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Administration, Oral",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Matrix,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,CKS2 gene|CKS2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,CYP3A4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,abemaciclib,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cell markers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,beta-eudesmol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,TIPARP gene|TIPARP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,CDC2 Protein Kinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,LILRB1 gene|LILRB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,antineoplaston A10,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TENM1 gene|TENM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,vasomotor symptom,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,lindane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Malignant neoplasm of breast,Invasive carcinoma of breast,Other,0.3988,0.008991008991008992
AFFECTS,ULBP2 gene|ULBP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,PDGFRB gene|PDGFRB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Tumor Suppressor Genes,estrogen receptor-negative breast cancer,Genetic Factors,0.0,0.0
AUGMENTS,doxorubicin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CHRNA6 gene|CHRNA6,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,LINC-ROR gene|LINC-ROR,Invasive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
PREDISPOSES,GPNMB gene|GPNMB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Decreased Immunologic Activity [PE],Triple Negative Breast Neoplasms,Immunological Factors,0.0,0.01898101898101898
AUGMENTS,POU4F1 gene|POU4F1,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,BCSC-1 Protein|VWA5A,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Intrapartum fetal hypoxia,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,FNDC5 gene|FNDC5,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AUGMENTS,SNORA73B gene|SNORA73B,Early-Stage Breast Carcinoma,Genetic Factors,0.0,0.0
CAUSES,"9,10-Dimethyl-1,2-benzanthracene",Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,"PIK3CB protein, human|PIK3CB",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,metacresol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,paired basic amino acid cleaving enzyme,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Hypolipidemic Agents,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
PREDISPOSES,HDAC2 gene|HDAC2,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Cancer Prevention,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,elongin B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"BSG protein, human|BSG",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,astaxanthin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"Receptor, PAR-1",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,HINT1 gene|HINT1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,LILRB2 gene|LILRB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Comorbidity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"glutamate carboxypeptidase II, human|FOLH1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,pyruvate dehydrogenase kinase 4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Low-Density Lipoproteins,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Fat-free mass,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"PKN1 protein, human|PKN1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estrogen Receptors,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,cyclooxygenase 2,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,"N-succinyl-1,2-dioleoylphosphatidylethanolamine",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Binding Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,alpha-adrenergic receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Oral form sodium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Phentolamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,TET1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,caffeic acid phenethyl ester,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Secondary malignant neoplasm of skin NOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cyclin-Dependent Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"MCL1 protein, human|MCL1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BUB1 gene|BUB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Protein Isoforms|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,Pharmaceutical Preparations,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,CCAAT-Enhancer-Binding Proteins|EBP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Methylation,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,EB 1089,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,RAD51C gene|RAD51C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,RARRES1|GPRC5A|MED15,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,heparanase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Quantitative Trait Loci,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,alkylglycerophosphoethanolamine phosphodiesterase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Biological Phenomena,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CDK7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fibrosing adenosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FGF10 gene|FGF10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TACC2 gene|TACC2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Anticoagulants,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,targeted prevention,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,pigment epithelium-derived factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MicroRNAs,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,MIRN23A gene|MIR23A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Vitamin D,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,NEDD9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vegetable Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,XBP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RBM5 gene|RBM5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,perfluorooctanoic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Genes,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,Docosahexaenoic Acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,RECK,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Agent,Familial cancer of breast,Demographic Factors,0.0,0.003996003996003996
AFFECTS,MIRN326 gene|MIR326,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,GRN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HOTAIR,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,SP1 gene|SP1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,Mucins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Chemotherapeutic agent,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,Phosphatidylethanolamine N-Methyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Carcinogens,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AUGMENTS,Estrogen Receptor beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SP1 gene|SP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,discoidin domain receptor 2,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Annexin A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Excision,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,ABL2|RERE,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,SPAG5,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,Benign ovarian cyst,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,hormonal changes,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AUGMENTS,PKM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Methylnitrosourea,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,THY1,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,Weaning,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Adaptor Signaling Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PARP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,HOXA9 gene|HOXA9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MIRN195 gene|MIR195,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,XRCC5 gene|XRCC5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PAWR gene|PAWR,Breast cancer recurrent,Genetic Factors,0.0,0.004995004995004995
AFFECTS,N-Acetylneuraminic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,IGKV1-16|FAM49B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FOXA1,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Metalloproteases,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Paclitaxel,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Radioisotopes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PITPNM3,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,HIC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CpG Islands,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Organochlorine pesticide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MCM3AP|FIG4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TNFRSF12A,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,CTSG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Sporadic Breast Carcinoma,Malignant neoplasm of breast,Other,0.0365,0.3386613386613387
PREDISPOSES,MYC Family Genes|MYC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Kinesin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ERBB2 gene|ERBB2,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
CAUSES,"EZH2 protein, human|EZH2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Phosphatidylinositols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,IL33,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Developmental Process,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,OPRM1,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,K-ras Oncogene|KRAS,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Transforming Growth Factors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Growth Factor Gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,High energy food,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Medical follow-up,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ADGRF5,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,sulfamate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Malondialdehyde,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"3,4-Methylenedioxyamphetamine",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malignant transformation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nucleic Acids,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,pioglitazone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Interleukin-8,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,rosiglitazone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Telomerase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Cocci,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,KRT5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CCL28,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,calusterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,"Leukemia, Myelocytic, Acute",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Metals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Soy Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Serine Proteinase Inhibitors,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,DELIVER,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,bone sialoprotein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Physical findings,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,prohibitin|PHB,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Maximal Voluntary Ventilation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NCOA2 gene|NCOA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hepatocyte Growth Factor,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Acylation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Primary biliary cirrhosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ELP3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,DDT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Conception,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Lactalbumin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,paclitaxel liposome,Sporadic Breast Carcinoma,Other,0.0,0.0
AUGMENTS,CTU1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Glucose Transporter,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Drug resistance,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Thrombospondins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cesarean section (finding),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,particle,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Thrombospondin 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GSTO2 gene|GSTO2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Running,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Asthenia,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,midkine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Prolactinoma,bilateral breast cancer,Other,0.0,0.0
AFFECTS,Misonidazole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Abdominal obesity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Complement System Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,cholanthrene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Adriamycin,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Lymph Node Involvement,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Estrogen Receptors|EREG|ESR1,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Caffeine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Carcinoma, Cribriform","Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,"3,4-Methylenedioxyamphetamine",Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Dietary Fats,Breast cancer metastatic,Behavioral Factors,0.0,0.027972027972027972
AFFECTS,Endocrine Surgical Procedures,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,PROTEIN INTAKE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ras Oncogene,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
COMPLICATES,Malignant Neoplasms,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,Cholestyramine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Diethylstilbestrol,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
PREDISPOSES,Immunologic Deficiency Syndromes,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
DISRUPTS,Estrogenic,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,radical mastectomy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Markers, DNA",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Serum,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Rheumatoid Arthritis,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,ptaquiloside,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,monoclonal antibody CC49,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Fibroblast Growth Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Radiation,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AUGMENTS,Prolactin|PRL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Cycasin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Bromocriptine,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,impaired glucose tolerance,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prolonged periods,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,leukemia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Transferase,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,Prolactin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Trimetrexate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Stabilization,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ras Oncogene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Paroxetine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Bone Density,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,PTPRF,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,N-Acetylneuraminic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,SYK gene|SYK,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,heparanase|HPSE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Fenretinide,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,"Estrogens, Catechol",Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AFFECTS,Metalloproteases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Proline,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Free Radicals,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Sedentary lifestyle,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Acetate,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Vitamin E intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Physical activity,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,parathyroid hormone-related protein|PTHLH,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,alpha-Linolenic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BCAS2 gene|BCAS2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Nitrites,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ingestion,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Endopeptidases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,P-Glycoprotein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sarcoidosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,LGD 1069,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Tetranucleotide Repeats,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Endometrial adenocarcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,chemokine receptor,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,"polio, NOS",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SMAD4 gene|SMAD4,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
CAUSES,ETS Variant Gene 6 Protein|ETV6,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,parathyroid hormone-related protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Leukemia P388,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Cardiovascular Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Peptides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Treatment/Psychosocial Effects,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Silicones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,chromosome 11q,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Chemotherapeutic agent,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
DISRUPTS,Lymphocyte antigen CD82|CD82,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,6-nitrochrysene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,GSTP1 gene|GSTP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,17q23,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Tenascin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,PTEN gene|PTEN,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Dissection,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,WWOX,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Cytochrome P-450 CYP1A1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Agent,Carcinoma of Male Breast,Demographic Factors,0.0,0.004995004995004995
CAUSES,beta-hexachlorocyclohexane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,inhibitors,Sporadic Breast Carcinoma,Other,0.0,0.0
AUGMENTS,Growth Factor Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SLC12A3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Epidermal Growth Factor Receptor|EGF,Sporadic Breast Carcinoma,Other,0.0,0.0
AFFECTS,Adrenalectomy,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Thyroidectomy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Malignant Neoplasms,Breast cancer recurrent,Other,0.0,0.004995004995004995
DISRUPTS,BCL2 gene|BCL2,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
AFFECTS,Polyamines,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Restriction fragment length polymorphism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Transforming Growth Factor alpha,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"Fats, Unsaturated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prostaglandins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,WWOX gene|WWOX,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Therapeutic agent (substance),Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
DISRUPTS,Selective Estrogen Receptor Modulators,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Premature Birth,Female Breast Carcinoma,Other,0.0,0.004995004995004995
CAUSES,"Cell Transformation, Neoplastic",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"PRSS8 protein, human|PRSS8",Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Axillary Lymph Node Dissection,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,Radioisotopes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Angiogenic Switch,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,"Liver Failure, Acute",Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
CAUSES,Estradiol,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Gene Amplification,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Gene Mutation,Familial cancer of breast,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,CD55|TCN2,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AFFECTS,Pharmaceutical Adjuvants,Malignant neoplasm of breast,Immunological Factors,0.0,0.3386613386613387
AUGMENTS,Durapatite,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cysteine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Protein Tyrosine Kinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Estrogens, Synthetic",Malignant neoplasm of breast,Hormonal Factors,0.0,0.3386613386613387
AFFECTS,Growth Factor Receptors,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,SELPLG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Gruyere cheese,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Study models,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,chemokine receptor D6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DPYS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HFE,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
DISRUPTS,"Linoleic Acids, Conjugated",Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,NUCLEAR MITOTIC APPARATUS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CLEC14A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Thrombospondins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Angiotensinogen|AGT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Sermorelin|GH1|GGH,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Night shift worker,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ASAP1|MYCBPAP,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,NELFB,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ITGB3BP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ubiquitin-protein ligase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,isopeptidase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Specific antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Breast radiotherapies,Contralateral breast cancer,Other,0.0,0.001998001998001998
AUGMENTS,glutathione S-transferase pi,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfate",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Tumor Suppressor Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ADH1C,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Adenomatous Polyposis Coli,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,methyl group,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,gamma-Tocopherol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Polymorphism, Genetic",Sporadic Breast Carcinoma,Genetic Factors,0.0,0.0
AFFECTS,CXCL12 gene|CXCL12,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
CAUSES,Fibroblast Growth Factor Receptor 2|FGF7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,STK6 gene|AURKA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Tocopherols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Regulatory Sequences, Nucleic Acid",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Environmental Estrogen,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AUGMENTS,Genistein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Disease,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,exemestane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PREDICTED,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,RNF115,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Aromatic Amines,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,NOD2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hyperandrogenism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CDK10 gene|CDK10,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Protein-tyrosine kinase inhibitor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Grapes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PDIA6,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,Thalidomide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,multicatalytic endopeptidase complex,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Fatty-acid synthase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Benzene,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,andrographolide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Atrophy of vagina,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,APC gene|APC,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,docetaxel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"FOLR1 protein, human|FOLR1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RIN1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FOXA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,HBP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HSD17B2 gene|HSD17B2|HSD17B7P2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Dietary Modification,Familial cancer of breast,Behavioral Factors,0.0,0.003996003996003996
PREDISPOSES,Aborted pregnancy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Second Primary Cancers,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,5'-NUCLEOTIDASE|NT5E,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Glial Fibrillary Acidic Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Oncogene Proteins,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Interleukin-8|EREG|ESR1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SNAI1,Breast cancer recurrent,Other,0.0,0.004995004995004995
CAUSES,Tumor proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PPIA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CYP2C19 gene|CYP2C19,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,S-Adenosylmethionine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Alpha tocopheryl succinate,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,NCSTN gene|NCSTN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Stearates,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Aryl Hydrocarbon Receptor|AHR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,estrone sulfate,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,DEK gene|DEK,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Dihydrofolate Reductase|DHFR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Acrylamide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Silicon,Breast cancer recurrent,Other,0.0,0.004995004995004995
DISRUPTS,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Xenograft procedure,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Long chain fatty acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ERBB2 gene|ERBB2,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Prognostic Factor,bilateral breast cancer,Other,0.0,0.0
PREDISPOSES,RAB27B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PARP1|COL11A2,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,D4-GDI,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TIMM17A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Heat shock proteins,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,ADM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,erbB-2 Receptor|ERBB2,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,docetaxel,Breast cancer stage II,Other,0.0,0.0
AUGMENTS,BCAR1 gene|BCAR1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,exemestane,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,SOX4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,TEK gene|TEK,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Alleles,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Sleep Deprivation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MST1R gene|MST1R,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,ITGA5 gene|ITGA5,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Interstitial Collagenase,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,epithelial cell differentiation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Human Papilloma Virus Vaccine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Quinones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ERBB2|NEU1|NEURL1,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
CAUSES,Garlic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,VCP gene|VCP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,GLI1 gene|GLI1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,VEGFA,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,Body mass index procedure,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,"PTH protein, human|PTH",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AVP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Genes,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,SPDYA,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,CD24,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,cytochrome P-450 CYP1B1|CYP1B1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ORALIT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Lithium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,nuclear receptor coactivator 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,phenylalanylphenylalanine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Norepinephrine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,S100A6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Carcinoid Tumor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,High Density Lipoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,IL8 gene|CXCL8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Estrogens,Breast Carcinoma,Hormonal Factors,0.0,0.027972027972027972
DISRUPTS,caveolin 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MAPK15,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Velcade,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DNAJA3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,GATA3,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,collagenase 3,Breast cancer metastatic,Demographic Factors,0.0,0.027972027972027972
AUGMENTS,HSPA1A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"progesterone, micronized",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Carcinoma, Ductal, Breast",Malignant neoplasm of breast,Other,0.0396,0.3386613386613387
AUGMENTS,casein kinase II,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Paget's Disease,Breast Carcinoma,Demographic Factors,0.0,0.027972027972027972
AFFECTS,Tristetraprolin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,SUSD3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"[M]Adenocarcinoma, metastatic, NOS",Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,"CTTN protein, human|CTTN",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,iturin A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SNX9 gene|SNX9,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,PSPHP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PML gene|PML,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Post-Transcriptional Regulation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Genistein,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Naphthalene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Purines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,toll-like receptor 4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Interleukin 6 Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Epstein-Barr virus DNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Growth stimulant,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SLOPE,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,CLOCK,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PTGER2|SPAG11B,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Vitamin D Deficiency,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,BRCA2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MIRN10A gene|MIR10A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SULF2 gene|SULF2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Metaplastic carcinoma,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,CD4 gene|CD4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,AMOTL1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tubeimoside I,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,1/24,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RORA gene|RORA,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,SH3PXD2A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LY6K,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"DICER1 protein, human|DICER1","Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,cofilin|CFL1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Little's Disease,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,MLLT11,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,FOXP3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Uridine Diphosphate Sugars,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FBXO42,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CMTS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ARGININOSUCCINATE LYASE|ASL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Functional RNA,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Mitogen-Activated Protein Kinase 13|MAPK13,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Platinum,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,9-deoxy-delta-9-prostaglandin D2,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,EGFR gene|EGFR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"Ribosomal Protein S6 Kinases, 70-kDa",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Transcript,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,bone morphogenetic protein 6,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,SOD1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vitamin B1 Intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CDKN1C gene|CDKN1C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,TP53 gene|TP53,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,ESR2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,RHOC gene|RHOC,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,costunolide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,LATS2 gene|LATS2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,RELN gene|RELN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,anthracene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MEG3|FAM129B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,chemokine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ZNF143,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fibrosing adenosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,EIF2S1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,cytokine,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Increased effect,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"PER2 protein, mammalian|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NF-Kappa B p65,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Hazards, Environmental",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,mitochondrial DNA replication,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,NF-AT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,peptide T amide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ERBB2,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"HDAC5 protein, human|HDAC5",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,indoleamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FYN gene|FYN,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,FOXO3A gene|FOXO3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,EHMT2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ethylene glycol,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
PREDISPOSES,Pasta intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Beads,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Thioridazine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SCARA5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CDCA7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,DDAVP,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Pyruvate Kinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,hepatitis B virus X protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Prolactin,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,nicotinamide phosphoribosyltransferase|NAMPT,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Morphine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CYTOR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NOTCH1 gene,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
AFFECTS,Doxorubicin,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Estrogens,"Carcinoma, Ductal, Breast",Hormonal Factors,0.0,0.002997002997002997
AFFECTS,LAPTM4B gene|LAPTM4B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Oncogene ErbB2|ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Activated-Leukocyte Cell Adhesion Molecule,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,B-pyridine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Alkanes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Fusion Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Prior Therapy,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,SNHG14,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,parathyroid hormone-related protein|PTHLH,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,Vitamin D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ACKR3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,LACTB,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,IkappaB Kinase beta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PAWR gene|PAWR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Granulocyte Colony-Stimulating Factor,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,BCL6 gene|BCL6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Growth Factor,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,"Diet, Fat-Restricted",Breast cancer recurrent,Behavioral Factors,0.0,0.004995004995004995
PREDISPOSES,ITGB3 gene|ITGB3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,MIRN423 gene|MIR423,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,NNT-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KISS1R,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,IL32,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ferrocene,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PPP2R2A,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,schizandrin B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CHI3L1,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,osteoactivin,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,N-myristoyltransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,caspase-3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Platelet Factor 4|PF4,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Chromosomal Rearrangement,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Tomography, Emission-Computed",Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,P3H1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,lymphocyte product,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DICER1 gene|DICER1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,IkappaB Kinase epsilon,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Peutz-Jeghers Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pancreatic carcinoma,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
CAUSES,SYK gene|SYK,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,ZNF326,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ZIC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Polymerase|ERVK-9|ERVK-19|ERVK-11,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HNRPM gene|HNRNPM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,LBH589,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pharmaceutical Preparations,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,ADRA1D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Saethre-Chotzen Syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"UBD protein, human|UBD",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,8-hydroxy-2'-deoxyguanosine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Thromboplastin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,WWC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mammographic breast density,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
CAUSES,PGC,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ERR1 protein|ESRRA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Estradiol Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Oncogenes,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
COMPLICATES,Sterol Regulatory Element Binding Protein 2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,cryptochrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,MMP2 gene|MMP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,alpha-Fetoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Fusion Protein,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,BLM gene|BLM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,DDR2 gene|DDR2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,SMYD3 gene|SMYD3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"HDAC5 protein, human|HDAC5",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,TAZ gene|TAZ,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,REPS2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ARHI gene|DIRAS3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Somatostatin analog|SST,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CYP2B6 gene|CYP2B6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Atherosclerosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,versican|VCAN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Urokinase,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,ARHI gene|DIRAS3,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,participation,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Tenascin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Organic solvent product,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fat tissue increased,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Androgen Receptor|AR,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Tegafur,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Desipramine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Serpins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Angiogenesis Factor,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,Size of lymph node,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ADH1B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Malignant neoplasm of prostate,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,"Transcription, Genetic",Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,decisiveness,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Vaccines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,caffeinated beverage,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
DISRUPTS,High Density Lipoproteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pharmacotherapy,Contralateral breast cancer,Other,0.0,0.001998001998001998
AFFECTS,Monocyte Chemoattractant Protein-1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Gene Products, Protein",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,RAC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Oncogene, RET|RET",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,cultural differences,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Epiregulin|EREG,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Fertility,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Buformin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RGS17,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,protein kinase D,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
DISRUPTS,Adrenergic beta-Antagonists,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"CHEK1 protein, human|CHEK1",Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,RGS17,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Vitamin E,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cytochrome P-450 CYP2D6,Breast cancer recurrent,Other,0.0,0.004995004995004995
CAUSES,Invasive Carcinoma,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,Nucleolar Organizer Region,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Mayonnaise,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,ING1|LTB|CENPK,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Hormone level abnormal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fibromyalgia,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Signal Pathways,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Body mass index,Contralateral breast cancer,Other,0.0,0.001998001998001998
AFFECTS,Increased Metabolic Rate,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,PROM1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,monocyte activation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,retinoic acid receptor alpha,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Signaling Molecule,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,STARD3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Estratest,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,ERBB2 gene|ERBB2,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
CAUSES,Nucleosides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GLO1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Myristic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Cell Cycle Checkpoint Genes,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Gonadotropin-Releasing Hormone Analog,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Doxorubicin,Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Breast cancer recurrent,Other,0.0,0.004995004995004995
AFFECTS,BMP4|BMP4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NOS3 gene|NOS3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Recreation,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Malignant neoplasm of thyroid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Primigravida,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Alcohol consumption,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,PPARGC1B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CD4 gene|CD4,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,DDIT4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Axillary Lymph Node Involvement,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptor beta|ESR2,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,Leukocyte Elastase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,[D]Mammogram abnormal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NEUROD1|TUBB4B,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Hay fever,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Down-Regulation,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Recombinant Interferon-gamma|IFNG,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,URI1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LAPTM4B gene|LAPTM4B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ABCC5,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,IL17F,Sporadic Breast Carcinoma,Other,0.0,0.0
AUGMENTS,POP4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CSH1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,patient characteristics,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,Smoking Behavior,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,"PSMD10 protein, human|PSMD10",Breast cancer metastatic,Other,0.0,0.027972027972027972
DISRUPTS,CLDN1 gene|CLDN1,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
CAUSES,XRCC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Estrone,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,PRL gene|PRL,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Sex Hormone-Binding Globulin,Breast cancer invasive NOS,Demographic Factors,0.0,0.00999000999000999
AFFECTS,Liver and Intrahepatic Biliary Tract Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Mangifera indica extract,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Cytotoxic agent,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
AFFECTS,NAP1L2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DNAJC27,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Secondary malignant neoplasm of lymph node,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Endocrine therapy,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,TRANSCRIPTION FACTOR,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
CAUSES,RBL2 gene|RBL2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Folate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MASS LESION,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,"Anesthesia, Conduction",Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,TGFBR2 gene|TGFBR2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Stathmin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sequela of disorder,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Cigarette Smoking,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,astragaloside IV,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PRRX2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,crocin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ING5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Radiation therapy,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Annexin A2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Breast Microcalcification,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Endocrine Gland Neoplasms,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TRANSCRIPTION FACTOR,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Proton therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,brucine,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Oncogenic Viruses,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,histone deacetylase 3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Growth Factor Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Encounter due to Screening for malignant neoplasm of breast,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Infiltration,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,FTO,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SDC1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Metals, Heavy",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KLHL7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RETN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PIP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Glutamic Acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,stem cell therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Fibroblast Growth Factor 7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,genetic element,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"SBEM protein, human|MUCL1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,WT1 gene|WT1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cytochrome P-450 CYP2D6,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,PTGS2 gene|PTGS2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,CHES1 gene|FOXN3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ACACA|BMS1,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,decorin|DCN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,inhibitors,Familial cancer of breast,Other,0.0,0.003996003996003996
DISRUPTS,Phospholipids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Financial circumstances,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,beta catenin,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,2q33-q34,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PERP,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,XRCC5 gene|XRCC5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,NEK2,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Interleukin-10,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Osteonectin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Candidate Disease Gene|AR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,Carcinoma in situ of breast,Other,0.3988,0.001998001998001998
PREDISPOSES,"Subarachnoid Hemorrhage, Aneurysmal",Noninfiltrating Intraductal Carcinoma,Demographic Factors,0.0,0.01098901098901099
PREDISPOSES,Placental Hormones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,thiopurine,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,NFKBIA gene|NFKBIA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Body mass index,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
AFFECTS,Mutation,Inflammatory Breast Carcinoma,Genetic Factors,0.0,0.000999000999000999
AFFECTS,Cholesterol Esters,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CYP17A1 gene|CYP17A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Boiled potato,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hypothyroidism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,TNFRSF1B gene|TNFRSF1B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CHEST SYMPTOM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ERBB2|NEU1|NEURL1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Morphogenesis,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,Ritonavir,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Estrogen-progestin preparation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Soluble ErbB-1|EGFR,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,RANTES,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Microsatellite Repeats,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,CCAAT-Enhancer-Binding Protein-delta,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Local Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Thymidylate Synthase,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,CD68,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DES EXPOSURE,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ZNF365 gene|ZNF365,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LHX1 gene|LHX1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ERCC3 gene|ERCC3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,RNASE3L gene|DROSHA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SABER,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,BABAM1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Estrogenic,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,Xenobiotics,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ductal Carcinoma,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,oncoprotein p21|CDKN1A|SLC12A9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hematoxylin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Single Nucleotide Polymorphism,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Dietary Modification,Breast cancer recurrent,Behavioral Factors,0.0,0.004995004995004995
AFFECTS,Mitogens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SCREEN TECHNIQUES,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,erbB-2 Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Adenomatous goiter,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PFKFB4,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Mutagens,Malignant neoplasm of breast,Demographic Factors,0.0,0.3386613386613387
CAUSES,ETV4 gene|ETV4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Ovulation Induction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SRC gene|SRC,Breast cancer invasive NOS,Genetic Factors,0.0,0.00999000999000999
PREDISPOSES,Disintegrins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FCGR3A gene|FCGR3A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,S 1 (combination),Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,CONSTITUTIONAL ORIGIN,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,HSPA5,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Abdominal circumference,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,tibolone,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,LAMTOR3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DSCAM-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Bone Morphogenetic Proteins,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Epstein-Barr Virus Infections,Breast Carcinoma,Herpetic Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Cooking,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Lymphedema,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Diuretics,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,TRANCE protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Trihalomethanes,Female Breast Carcinoma,Other,0.0,0.004995004995004995
PREDISPOSES,Syndrome,Breast Carcinoma,Other,0.0,0.027972027972027972
CAUSES,Angiogenesis Factor,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PMS2 gene|PMS2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,fatty acid amide hydrolase,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
PREDISPOSES,Histologic type,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Endocrine System Diseases,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,"Iron, Dietary",Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,JMJD6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cadaverine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
COMPLICATES,cytokine,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,XRCC1 gene|XRCC1,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AFFECTS,FRA16D,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,S100A7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Thioglucosides,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dietary fat intake,Breast cancer invasive NOS,Behavioral Factors,0.0,0.00999000999000999
AFFECTS,PNU,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MED19,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,CYTOR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Phytoestrogens,Breast Carcinoma,Hormonal Factors,0.0,0.027972027972027972
PREDISPOSES,ID2 gene|ID2,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,Fruit,Breast cancer recurrent,Other,0.0,0.004995004995004995
PREDISPOSES,UBE2N,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,GJB2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"Chemotherapy, Adjuvant",Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,LATS1 gene|LATS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MDM2 gene|MDM2,Breast cancer metastatic,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,ENPP2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KRT8,Breast cancer invasive NOS,Other,0.0,0.00999000999000999
AFFECTS,PTCSC3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ubiquitin-protein ligase,Breast cancer metastatic,Other,0.0,0.027972027972027972
CAUSES,Arsenic,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,AQP4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,salinomycin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,HMGN2 Protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Proliferating Cell Nuclear Antigen,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Mandibular right first molar abutment,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Genome, Human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cathepsins B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,FAM84B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,AQP7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Ca(2+)-Transporting ATPase|CA2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,therapeutic use,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,GJB2 gene|GJB2,"Carcinoma, Ductal, Breast",Genetic Factors,0.0,0.002997002997002997
AFFECTS,verbenone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PTH-Parathyroid hormone level result,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Recurrent Carcinoma,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,moderate drinking,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,RBM12B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CASC9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,EIF4EBP1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MIRN106A gene|MIR106A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,FUT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,1-Phosphatidylinositol 4-Kinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Cullin 1,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Transferrin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PIEZO2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Vinegar,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,v-myb Genes|MYB,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Interferon Type I,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,UCHL3,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Kinesin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,BCL11A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Circadian Rhythm Disorders,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Dipeptidyl-Peptidase IV|DPP4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,lysyllysine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CDK6-associated protein p18,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,ubiquitin-protein ligase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,FAM13A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LINC01133,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,APOBEC3B,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
DISRUPTS,honokiol,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,reverse transcription polymerase chain reaction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,H19 gene|H19|HILS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"TSLP protein, human|TSLP",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Secondary malignant neoplasm of spinal cord,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,bone sialoprotein,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,Ephrin B Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Obesity,Contralateral breast cancer,Other,0.0,0.001998001998001998
PREDISPOSES,ATXN3,Breast cancer metastatic,Other,0.0,0.027972027972027972
AUGMENTS,PCB 118,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CERS6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ingredient,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PIM1 gene|PIM1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,cardamonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,"Oligonucleotides, Antisense",Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,RAB1A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cyclin-Dependent Kinase Inhibitor 2A|CDK4,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Solvents,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DSCAM-AS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pancreatic carcinoma,Ductal Breast Carcinoma,Other,0.0,0.000999000999000999
PREDISPOSES,centromere protein F,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,paracrine,Breast cancer metastatic,Other,0.0,0.027972027972027972
AFFECTS,Adrenergic Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MIRN133B gene|MIR133B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PCB 101,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Docosahexaenoate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Bleomycin|BLM,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,MDM1,Familial cancer of breast,Other,0.0,0.003996003996003996
PREDISPOSES,WISP1 gene|WISP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Paracrine Communication,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Cisplatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cathepsins|CTSS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,LIMS1 gene|LIMS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,SORBS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,erbB-2 Receptor|ECD,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SIX1 gene|SIX1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hydrogel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SULF1 gene|SULF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Dopamine Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,p65|RELA|SYT1|GORASP1|WNK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MAGI2-AS3 gene|MAGI2-AS3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cell-Free DNA,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,Annexin A1|ANXA1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,beta-site APP cleaving enzyme 1,"Carcinoma, Ductal, Breast",Other,0.0,0.002997002997002997
PREDISPOSES,SOX5,Breast cancer metastatic,Other,0.0,0.027972027972027972
PREDISPOSES,OGDHL,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Postmenopause,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,SP 1049C,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,systemic administration,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,Chronic disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Parabens,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,talazoparib,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,insulin isophane,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,KDM6A gene|KDM6A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Interferon Signaling Process,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fibroblast Growth Factor 2|FGF2,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,UGT1A4 gene|UGT1A4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Alcohol intake above recommended sensible limits,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ATOX1 gene|ATOX1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"KISS1R protein, human|KISS1R",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Infertility risk,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,levothyroxine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DNA Repair Gene,Hereditary Breast and Ovarian Cancer Syndrome,Genetic Factors,0.0,0.0
CAUSES,DNA Modification Methylases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ceramide kinase,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,"Promoter Regions, Genetic",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,GAS1 gene|GAS1,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,Primary Neoplasm,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,cisplatin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,F2R gene|F2R,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,"Receptor, Notch4",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,LINC00668 gene|LINC00668,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,chitosan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,tumor protein D52|TPD52,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,IGFBP7|SFPQ,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,SH2B3 gene|SH2B3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,Carcinogens,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,physiological aspects,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,prothrombin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,cisplatin,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,MRTFA gene|MKL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,FDG-Positron Emission Tomography and Computed Tomography Scan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,lead,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,SEPT7 gene|SEPT7,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AUGMENTS,"E2F1 protein, human|E2F1|UBE2L3",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Apolipoprotein E|APOE,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,GATA3 gene|GATA3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,methylene chloride,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,AGO1 gene|AGO1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,tryptophan,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Antineoplastic Agents,Carcinoma breast stage IV,Demographic Factors,0.0,0.0
AUGMENTS,CSK gene|CSK,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
PREDISPOSES,"Receptors, Progesterone",Breast cancer stage III,Other,0.0,0.000999000999000999
AFFECTS,Microinvasive tumor,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,Estrogen Receptors,Breast cancer stage III,Other,0.0,0.000999000999000999
AFFECTS,Estrogen Antagonists,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,OSW 1,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Saponin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ATF4 gene|ATF4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Genes, Essential",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Late Relapse,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AUGMENTS,PBX1 gene|PBX1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,VLDLR gene|VLDLR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,WNT6 gene|WNT6,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,EXT1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SIRT3 gene|SIRT3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,TGFB1 gene|TGFB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,ZBTB1 gene|ZBTB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Cyclin B1|CCNB1,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Growth pattern,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Biological Markers,Recurrent Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,ELK1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Hypoxia,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Ginkgo biloba extract,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,CXCR2 gene|CXCR2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Fenamole,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Rocky,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,IQGAP1 gene|IQGAP1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,PSMG3-AS1 gene|PSMG3-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Lactones,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sapphire,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Antioxidants,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,HER2/Neu Positive,HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,FBXW5 gene|FBXW5,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,MIR451A wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Protein Kinases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,EPDR1 gene|EPDR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,bis(4-hydroxyphenyl)sulfone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SPINT1-AS1 gene|SPINT1-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CXCR1 gene|CXCR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MIR26B gene|MIR26B,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,TUFT1 gene|TUFT1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Alternative Splicing,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,S100P,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,glycogen synthase kinase 3 beta,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Ingredient,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,ZG16B gene|ZG16B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,triptolide,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Photosensitizing Agents,Carcinoma breast stage IV,Demographic Factors,0.0,0.0
AFFECTS,Isolate - microorganism,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Potassium Channel,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,KMT5A gene|KMT5A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,SNHG7 gene|SNHG7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,resistin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Treatment Status,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,SETD2 gene|SETD2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"BMPR1B protein, human|BMPR1B",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PKM gene|PKM,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Lymphangiogenesis,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Nucleic Acid Probes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,shikonin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Suppressor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,berbamine,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Germ-Line Mutation,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,"Discoidin Domain-Containing Receptor 2, Human|DDR2",Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,MEDAG gene|MEDAG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cell Cycle Control,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,MicroRNAs,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,Protein Quaking,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Malaria,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,arginine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,STIP1 gene|STIP1|TFIP11|NECAB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of oropharynx,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,prolactin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Non-infiltrating lobular carcinoma,Recurrent Breast Carcinoma,Other,0.0,0.000999000999000999
DISRUPTS,Stat3 protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Collagen Type IV,Carcinoma breast stage IV,Demographic Factors,0.0,0.0
PREDISPOSES,TPX2 gene|TPX2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,IFNGR1 gene|IFNGR1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,proline,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,VEGFA gene|VEGFA,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Echogenic,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,crocin,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,Open Reading Frames,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIR374B gene|MIR374B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,AQP3 gene|AQP3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Metric (substance),Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,FGD5-AS1 gene|FGD5-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,SNHG15 gene|SNHG15,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,methylate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ginsenoside Rh1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MicroRNA 19B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,cryptotanshinone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,cyclin A2|CCNA2,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,alpha-hydroxyglutarate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ZNF213 gene|ZNF213,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,SRSF1 gene|SRSF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,FAT3 gene|FAT3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Low expression,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MYC,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Tumor Burden,Carcinoma breast stage IV,Other,0.0,0.0
CAUSES,Transgenes,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
DISRUPTS,metformin,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,IL6ST gene|IL6ST,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Cytokinesis,Basal-Like Breast Carcinoma,Other,0.0,0.003996003996003996
AFFECTS,NME1 gene|NME1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Challenge:Type:Point in time:^Patient:Nominal,HER2-negative breast cancer,Other,0.0,0.0
AUGMENTS,CUL4B,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,HOXB7 gene|HOXB7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,"BAG Family Molecular Chaperone Regulator 3, human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dietary carbohydrate intake,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
AFFECTS,Mouse Model,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,cinnamic aldehyde,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,FBXO15 gene|FBXO15,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,RNA Polymerase I|ERVW-4,Basal-Like Breast Carcinoma,Other,0.0,0.003996003996003996
AFFECTS,FGD5-AS1 gene|FGD5-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,TRAPPC10 gene|TRAPPC10,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AUGMENTS,CT83 gene|CT83,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Thyroid microsomal antibodies,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,cytokine,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,PSMC2 gene|PSMC2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,Cell Adhesion Molecules,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,FTO gene|FTO,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,4-aminohippuric acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Increased risk,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,PTPRT gene|PTPRT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Serine-tRNA Ligase|TRNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Coal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,PCYT1A wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,BRD4 gene|BRD4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PDCD11 gene|PDCD11,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,Beta-glucuronidase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ruyiping,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Multiparity,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Glucocorticoids,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Genes,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
AFFECTS,MIR31 wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,AEBP2 gene|AEBP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Breast Density,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,erbB-2 Receptor|ERBB2,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AUGMENTS,GATA3 gene|GATA3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,HOXA1 gene|HOXA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Progranulins,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,DPP8 gene|DPP8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ACE2 gene|ACE2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PCNT gene|PCNT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,TIMM17A gene|TIMM17A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,CXCR5 gene|CXCR5,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,DPP7 gene|DPP7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Phytochemical,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIR34A,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Neoadjuvant Therapy,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,PALB2 gene|PALB2,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
AFFECTS,Lymphocyte antigen CD82|CD82,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SMUG1 gene|SMUG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,GABPA|NFE2L2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SEMA4C gene|SEMA4C,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
DISRUPTS,SEPTIN9 gene|SEPT9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,UBQLN1 gene|UBQLN1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,cyclin-dependent kinase inhibitor 1B|IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,human papillomavirus,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,PITPNM1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ADAR gene|ADAR,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,RBMS3 gene|RBMS3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,SOX10 gene|SOX10,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
AFFECTS,Cell Growth,Breast Carcinoma,Other,0.0,0.027972027972027972
PREDISPOSES,MAL2,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Ribosomal Proteins,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Interventional procedure,Early-Stage Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,T-Cell Receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Immunohistochemistry,Breast Carcinoma,Other,0.0,0.027972027972027972
DISRUPTS,CDK1 gene|CDK1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Indicators,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,ketamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,ADAMTS9-AS1 gene|ADAMTS9-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,NAA50 gene|NAA50,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Analgesics, Opioid",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Inflammatory Bowel Diseases,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,FBXL16 gene|FBXL16,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Triglycerides,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AUGMENTS,"N-methylsulfonyl-12,12-dibromododec-11-enamide",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PVT1 gene|PVT1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
PREDISPOSES,Dietary Polyphenol,Malignant neoplasm of breast,Behavioral Factors,0.0,0.3386613386613387
DISRUPTS,VIRMA gene|VIRMA,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Core needle biopsy,malignant neoplasm of breast staging,Other,0.0,0.0
AUGMENTS,HOTAIR gene|HOTAIR,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
PREDISPOSES,MicroRNAs,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,CSTB wt Allele|CST6,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
CAUSES,Molecular Target,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Thioredoxin 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,LINC00174 gene|LINC00174,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Malignant neoplasm of breast,Carcinoma breast stage IV,Other,0.3988,0.0
AFFECTS,quiescence,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,chromosome loss,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,BCLAF1 gene|BCLAF1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,decitabine,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,NR2F1-AS1 gene|NR2F1-AS1,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,docetaxel,Triple-Negative Breast Carcinoma,Other,0.0,0.0
AFFECTS,GNG13 gene|GNG13,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,False Positive,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
AFFECTS,IGLC2 gene|IGLC2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,Neoplasm Metastasis,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,chemokine receptor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Food Consumption,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"herstatin protein, human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IRAK3 gene|IRAK3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,SLC2A1 gene|SLC2A1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,cytidylyl-3'-5'-guanosine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MicroRNA 1246,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,curcumin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Orosomucoid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,WTAP gene|WTAP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Married (finding),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"NOS1 protein, human|NOS1|NANOS1",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Androgen Receptor,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AFFECTS,ESR1,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,Premature Menopause,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CALCIUM/VITAMIN D,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
PREDISPOSES,CGAS gene|CGAS,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,Postmenopausal status NOS,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"TNF protein, human|TNF",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Cellular Apoptosis Susceptibility Protein,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,carbohydrate analog,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,TRIM72 gene|TRIM72,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Fatty-acid synthase,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Fatty pancreas,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MicroRNA 205-5p,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,cholesterol,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,MIR451A wt Allele,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,secretory protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Calcium Signaling,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,DUSP8 gene|DUSP8,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
COMPLICATES,Adrenal Gland Hyperfunction,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
DISRUPTS,Sodium Butyrate,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ethanol,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Body position,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,PSAT1 gene|PSAT1,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
AUGMENTS,CCNE1 gene|CCNE1,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
AUGMENTS,dehydrodolichyl diphosphate synthase,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,Oxysterols,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,sinomenine hydrochloride,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SIN3A gene|SIN3A,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Malignant neoplasm of breast,Basal-Like Breast Carcinoma,Other,0.3988,0.003996003996003996
PREDISPOSES,MicroRNAs,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,YTHDF3 gene|YTHDF3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,"RNA, Long Untranslated",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,>40 years,Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,PNO1 gene|PNO1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,GSDME gene|GSDME,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,TRANSCRIPTION FACTOR,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,FERMT1 gene|FERMT1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Cell Cycle Checkpoints,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,G-Protein-Coupled Receptors,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,MIR449A gene|MIR449A,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Hypersensitivity,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Warburg Effect,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,CDK18 gene|CDK18,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Revival,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Genes,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
AUGMENTS,ILF3 gene|ILF3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,ROS1 gene|ROS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,fluid flow,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,CCNA2 gene|CCNA2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,NSRP1 gene|NSRP1,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,SOX13 gene|SOX13,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Segmental Mastectomy,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AUGMENTS,Methylnitrosourea,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,MAFG-DT gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,LINC00665 gene|LINC00665,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,JAG1 gene|JAG1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,PIEZO1 gene|PIEZO1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,CHAC1 gene|CHAC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Retinoblastoma Protein|RB1,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,Discoidin Domain Receptor 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,inecalcitol,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SDC1 gene|SDC1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,specific immunity,Triple Negative Breast Neoplasms,Immunological Factors,0.0,0.01898101898101898
PREDISPOSES,H19 gene|H19|HILS1,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
DISRUPTS,CDH2 gene|CDH2,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
AFFECTS,Diagnosis,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
CAUSES,Molecular Target,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Candidate Disease Gene,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
AFFECTS,"Membrane Potential, Mitochondrial",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,asparagine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SERPINB2 gene|SERPINB2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Leisure physical activity,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,DST gene|DST,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ISYNA1 gene|ISYNA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"TLR2 protein, human|TLR2",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,TFE3 gene|TFE3,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,"FRAP1 protein, human|MTOR",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Vitamin D Analog,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,ST8SIA6-AS1 gene|ST8SIA6-AS1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,Primary Sj??gren's syndrome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,margetuximab,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"ERCC5 protein, human|ERCC5",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PROM1,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,gamma-Glutamylcyclotransferase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,SLC16A3 gene|SLC16A3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,ELOVL5 gene|ELOVL5,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,Transforming Growth Factor beta Receptors,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Adipokines,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,PTPN18 gene|PTPN18,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,ezogabine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SPI1 gene|SPI1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,SARS1 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,VDR,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,tumor growth,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,"Radiosurgery, Stereotactic",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,SEMA3B-AS1 gene|SEMA3B-AS1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Antibody-Drug Conjugates,HER2-negative breast cancer,Other,0.0,0.0
PREDISPOSES,Phytochemicals,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Trichorhinophalangeal dysplasia type I,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Chemoimmunotherapy,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,hla gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,testosterone,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Tandem Repeat Sequences,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SAA1 gene|SAA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Wild Type,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Offered,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,PRSS22 gene|PRSS22,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
PREDISPOSES,glutamic acid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Pesticides,Malignant neoplasm of female breast,Other,0.0,0.0
PREDISPOSES,copper,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Thyroid dysfunction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"PTK2 protein, human|PTK2",Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,navitoclax,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Heterogeneous-Nuclear Ribonucleoprotein U,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,MIR217 gene|MIR217,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,dihydrotanshinone I,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
CAUSES,TP53 gene|TP53,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
AFFECTS,inhibitors,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
AUGMENTS,pertuzumab,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Circulating MicroRNA,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Emotional hypersensitivity,Breast Carcinoma,Other,0.0,0.027972027972027972
AUGMENTS,USP46 gene|USP46,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,BCAR4 gene|BCAR4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Genetic Carriers,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,chromium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,TMEM9 gene|TMEM9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,USP10 gene|USP10,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
CAUSES,Neoplastic Cell Transformation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Hormone Receptor Positive,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
AFFECTS,Positive Regulation of Apoptosis,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,IFNK gene|IFNK,Basal-Like Breast Carcinoma,Genetic Factors,0.0,0.003996003996003996
AFFECTS,sulfoenolpyruvate,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Surviving free of recurrence of neoplastic disease,contralateral breast cancer,Other,0.0,0.002997002997002997
PREDISPOSES,IGSF9 gene|IGSF9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Liver carcinoma,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
DISRUPTS,icariin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,TP53 gene|TP53,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,Pyruvate Kinase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Dietary Intake,estrogen receptor-positive breast cancer,Behavioral Factors,0.0,0.008991008991008992
PREDISPOSES,Performance,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,omega-3 fatty acids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Pyrimidine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"Soluble Interleukin-6 Receptor Subunit Alpha, Human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CMTM7 gene|CMTM7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Genes, Duplicate",Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Sphingolipids,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,NAD+ kinase,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,GDF2 gene|GDF2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,ENPP1 gene|ENPP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,ANXA1 gene|ANXA1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Fibronectins,Inflammatory Breast Carcinoma,Other,0.0,0.000999000999000999
CAUSES,fructose,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,GLIS3 gene|GLIS3,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,ABCG1 gene|ABCG1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Mucin-1 Antigen,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,"estrogen receptor alpha, human",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,DACH1 gene|DACH1,Carcinoma of Male Breast,Genetic Factors,0.0,0.004995004995004995
PREDISPOSES,Skin tanning,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,"DKK3 protein, human|DKK3",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DPT gene|DPT,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,MYC,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,Experimental Result,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,Diagnostic assessment,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Puberty,estrogen receptor-positive breast cancer,Other,0.0,0.008991008991008992
PREDISPOSES,Oral health,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CLDN6 gene|CLDN6,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,TNF receptor-associated factor 6|TRAF6,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"RNA, Circular",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,NORAD gene|NORAD,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,AKR1A1 wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,CXCL8,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ethanol,Female Breast Carcinoma,Other,0.0,0.004995004995004995
AUGMENTS,LONG INTERGENIC NONCODING RNA PINKY|PNKY,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,Acetyl-CoA Carboxylase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Secretome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,histone deacetylase 2,Invasive carcinoma of breast,Other,0.0,0.008991008991008992
PREDISPOSES,Cancer Vaccines,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,"interleukin-1, beta|IL1A|IL1B",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,MIR223 gene|MIR223,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,abemaciclib,Carcinoma breast stage IV,Other,0.0,0.0
AFFECTS,SPARCL1 gene|SPARCL1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,SFRP2 gene|SFRP2,Noninfiltrating Intraductal Carcinoma,Genetic Factors,0.0,0.01098901098901099
AFFECTS,"YAP1 protein, human|YAP1",Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AUGMENTS,MAP kinase kinase kinase 7,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,"SFRP1 protein, human|SFRP1",Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AFFECTS,Treatment Protocols,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Immunologic Factors,Secondary malignant neoplasm of breast,Immunological Factors,0.0,0.002997002997002997
PREDISPOSES,cathepsin Z,Early-Stage Breast Carcinoma,Other,0.0,0.0
PREDISPOSES,Basis,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
AFFECTS,TPBG gene|TPBG,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Estrogen Receptor Status - Clinical Trial Eligibility Criteria,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Pathologic Processes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DSCR9 gene|DSCR9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,"DDIT3 protein, human|DDIT3",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,nerve growth factor,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Ultrasonography,malignant neoplasm of breast staging,Other,0.0,0.0
PREDISPOSES,Nicotinamide N-Methyltransferase,Carcinoma breast stage IV,Other,0.0,0.0
AUGMENTS,Biological Response Modifiers,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,garcinone E,Carcinoma breast stage IV,Other,0.0,0.0
DISRUPTS,GW 4869,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,imipramine,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,ARHGAP25 gene|ARHGAP25,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Abnormal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,NLRP12 gene|NLRP12,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
DISRUPTS,FBXW2 gene|FBXW2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"RTN4 protein, human|RTN4",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,interleukin-8,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
CAUSES,TAF8 wt Allele,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,PEDS1 gene,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,IL19 gene|IL19,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Lactates,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,DNAJB6 gene|DNAJB6,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,UBE3B gene|UBE3B,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,ZNF703 gene|ZNF703,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Extraction,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,metformin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,Performance,Papillary carcinoma of the breast,Other,0.0,0.0
AFFECTS,Terpenes,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,OTUB1 gene|OTUB1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,MAF1 gene|MAF1,HER2-positive carcinoma of breast,Genetic Factors,0.0,0.008991008991008992
AFFECTS,magnoflorine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Squalene monooxygenase,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,"plY protein, Streptococcus pneumoniae",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Malignant neoplasm of thyroid,estrogen receptor-negative breast cancer,Other,0.0,0.0
PREDISPOSES,KLF5 gene|KLF5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,directive therapy,Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,interleukin-10,HER2-negative breast cancer,Other,0.0,0.0
DISRUPTS,iridium,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Fresh fruit,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Does ask questions,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,zinc pyrithione,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,Transgenes,Secondary malignant neoplasm of breast,Genetic Factors,0.0,0.002997002997002997
DISRUPTS,SFRP2 gene|SFRP2,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,SOCS3 gene|SOCS3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Post-mastectomy radiotherapy,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,Focal Adhesion Kinase 1,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,KDM2A gene|KDM2A,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,oxaliplatin,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,SIAE gene|SIAE,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,secreted frizzled related protein 1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,LINC02086 gene|LINC02086,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,SERPINA5 gene|SERPINA5,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,Dried fruit intake,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Aptamer,Breast Carcinoma,Other,0.0,0.027972027972027972
AFFECTS,GRAMD1B gene|GRAMD1B,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,DACH1 gene|DACH1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"PIK3CB protein, human|PIK3CB",Carcinoma breast stage IV,Other,0.0,0.0
PREDISPOSES,GBP1 gene|GBP1,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,MBD4 gene|MBD4,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Vitamin supplementation,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,gene therapy,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AFFECTS,MUTYH Gene Mutation,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Tobacco,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Detected (finding),Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Carcinogens,Basal-Like Breast Carcinoma,Other,0.0,0.003996003996003996
CAUSES,Malignant neoplasm of thyroid,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,CHD4 gene|CHD4,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
PREDISPOSES,SLC7A11 gene|SLC7A11,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Liposomes,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,"CREB3L4 protein, human|CREB3L4",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
DISRUPTS,beta catenin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,tomography,Early-Stage Breast Carcinoma,Other,0.0,0.0
DISRUPTS,NOTCH3 gene,Carcinoma breast stage IV,Genetic Factors,0.0,0.0
CAUSES,ROS1 wt Allele|ROS1,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,EPYC gene|EPYC,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,Neoadjuvant Systemic Therapy,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Nuclear magnetic resonance normal,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,EIF4E gene|EIF4E,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AUGMENTS,Stat3 protein,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,"DICER1 protein, human|DICER1",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,reserpine,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AUGMENTS,MGP gene|MGP,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Cytokeratin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
PREDISPOSES,VAMP7 gene|VAMP7,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,"Discharge, body substance",Noninfiltrating Intraductal Carcinoma,Other,0.0,0.01098901098901099
AUGMENTS,QSOX2 gene|QSOX2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
AUGMENTS,NUP155 gene|NUP155,Breast Carcinoma,Genetic Factors,0.0,0.027972027972027972
AFFECTS,scopolamine,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,ZNF410 gene|ZNF410,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,"Culture Media, Conditioned",Malignant neoplasm of breast,Ethical and Cultural Factors,0.0,0.3386613386613387
CAUSES,CD8A wt Allele|CD8A,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Luteinizing Hormone-releasing Hormone Agonist,Carcinoma of Male Breast,Other,0.0,0.004995004995004995
AFFECTS,Saturated fat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
CAUSES,Histone Deacetylase|HDAC9,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Sugars,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Scutellaria barbata extract,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,Erianin,Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
CAUSES,"CDK12 protein, human|CDK12",HER2-positive carcinoma of breast,Other,0.0,0.008991008991008992
AUGMENTS,MIR190B gene|MIR190B,estrogen receptor-positive breast cancer,Genetic Factors,0.0,0.008991008991008992
DISRUPTS,Friend Leukemia Integration 1 Transcription Factor,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SCARNA4 gene|SCARNA4,Early-Stage Breast Carcinoma,Genetic Factors,0.0,0.0
AUGMENTS,"RAI3 protein, human|GPRC5A",Triple Negative Breast Neoplasms,Other,0.0,0.01898101898101898
AFFECTS,"PLK1 protein, human|PLK1",Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,Total body fat,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
PREDISPOSES,JMJD1C gene|JMJD1C,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
PREDISPOSES,PPP1R21 gene|PPP1R21,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
DISRUPTS,BICD1 gene|BICD1,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
CAUSES,Secretome,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AUGMENTS,SLC16A3 gene|SLC16A3,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
AFFECTS,Hypertensive disease,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
DISRUPTS,Triterpenes,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,ANXA9 gene|ANXA9,Malignant neoplasm of breast,Genetic Factors,0.0,0.3386613386613387
CAUSES,Mammary Neoplasms,Secondary malignant neoplasm of breast,Other,0.0,0.002997002997002997
PREDISPOSES,Histopathology finding,Malignant neoplasm of breast,Other,0.0,0.3386613386613387
AFFECTS,Gene Mutation,"Breast Cancer, Familial",Genetic Factors,0.0,0.0
PREDISPOSES,EMP2 gene|EMP2,Triple Negative Breast Neoplasms,Genetic Factors,0.0,0.01898101898101898
